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ABSTRACT
The preparation o f piperazinones, which are important pharmacophores, is reviewed in 
the introduction. This thesis provides an elucidation o f the cyclisation mechanisms 
involving chiral secondary 1,2-diamines both with haloacetates and with 1,2-dicarbonyl 
compounds. The work on selective cyclisations consists o f mainly three parts:
(i) Regioselective preparation o f A.A-disubstituted 5- and 6-piperazinones with
I ^elucidation o f the cyclisation mechanism using D2O and C label;
(ii) Regioselective preparation o f N ,N ''-dibenzyl 3,6- and 3,5-disubstituted piperazinones 
using methyl a-bromophenylacetate, methyl 2-bromopropionate, methylglyoxal, 
phenylglyoxal and benzil;
(iii) Selective preparation o f A-acetates o f 5-substituted piperazinones by 
hydrogenolysis and intramolecular cyclisation in the same reaction pot starting from 
substituted dibenzyl 1,2-diaminoacetates.
Additionally, the total synthesis o f a potential Mi muscarinic agonist for treatment o f 
Alzheimer’s disease was planned and almost completely carried out. The multistep 
sequence presented two challenging steps: regioselective preparation o f a chiral 
piperazinone successfully achieved with the haloacetate cyclisation described above; 
Birch reduction o f a lactam to an aminol, in presence o f an amide, which acts as a 
nucleophile and cyclises to give a 1,1-aminoamide.
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1CHAPTER 1 Introduction
1.1 Biological aspects o f constrained peptidomimetics
1.1.1 Piperazinones: building blocks for peptidomimetics
Proteins have well defined three-dimensional conformations that are necessary 
to exhibit biological activity. Peptides play fundamental roles as ligands to protein 
receptors. However, peptides themselves are poor therapeutic agents due to low oral 
bioavailability as a consequence o f degradation by proteolytic enzymes; and poor 
membrane permeability due to inefficient transport across cell membrane1 and large 
molecular size . Therefore, drug research is focused on the design and preparation o f 
“peptidomimetics”. This term describes a large family o f compounds that show similar 
biological activity to native peptides. Peptidomimetics typically contain unnatural 
amino acids, conformational constraints and groups which mimic peptide bonds, but 
which are not susceptible to hydrolysis3.
The design o f a peptidomimetic is a complex operation that includes a clear 
understanding o f structure-activity relationship and the conformational properties o f the 
target peptide. Determination o f peptide bioactive conformations can be achieved by 
studying multiple conformationally constrained non-peptide analogues4, X-Ray 
crystallography analysis and a combination o f computational and sophisticated 
spectroscopic methods. The introduction o f constraints in peptide structures limits the 
number o f conformational possibilities that they can adopt and consequently reduces the 
entropy cost upon folding into such a conformation. Ideally, small and constrained 
molecules able to “lock” the active conformation o f a peptide should result in higher 
affinity with a receptor, increasing the stability o f the binding and improving biological 
selectivity through elimination o f bioactive conformers that give undesired biological 
responses. Model constrained peptides have been designed to study in detail the 
conformational preferences o f natural and modified amino acid residues.
1.1.1.1 Types o f  modifications
Two basic types o f conformational modifications have been used in analogues: 
non-covalent and covalent modifications. Non-covalent modifications include the 
incorporation o f D-amino acids, N-methyl amino acids and a-methyl amino acids. 
Covalent modifications forming cyclic and polycyclic peptides include cyclic amino 
acids5, disulphide bridges and cyclisation through amide bonds, all o f which are known
2to occur in nature. Covalent modifications can give two main groups of constraints, 
according to the degree of freedom shown by the peptides. One is known as “global” 
constraint that involves the modification of the peptide backbone, usually forcing the 
formation of secondary structures that provides higher conformational stability (Figure
1). The second is the “local” constraint that is confined in a precise region o f the peptide 
backbone and that involves modifications of only one or two residues of the peptide 
sequence (Figure 2).
Figure 1. Global constraint F igure 2. Local constraint
1.1.1.1.1 Global conformational constraint6
Formation of a covalent bond between two distant regions of a peptide creates 
macrocyclic structures that will adopt certain well defined stable conformations. Met- 
enkephalin 1 (Tyr-Gly^Gly-Phe-Met5) is an endogenous ligand for 5-opioid receptors. 
Substitutions of Gly-2 and Met-5 with P,P-dimethyl penicillamine gave [D-Pen2, D- 
Pen5]-enkephalin (DPDPE) 2 (Scheme 1), which was found to be a potent and selective 
5-opioid receptor ligand, with strong analgesic activities7.
HO.
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1 Met-enkephalin
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© n h 3 2 DPDPE
Schem e 1. Cyclisation side chain to side chain to constrain the global conformation
31.1.1.1.2 Local conformational constraint6
Piperazin-2-one (4-aza-S-lactam) rings 3 are good examples o f peptidomimetics 
that create a local constraint using a covalent modification, able to specifically stabilise 
some parts o f a peptide side chain or backbone. Due to the relative rigidity of 
piperazinone rings and to the possibility o f introducing different substituents on the 
ring, piperazinones have been introduced in peptide-like chain compounds as analogues 
o f adjacent amino acids. 2-Piperazinones 3 are building blocks in which the N, and the 
N/ +i atoms o f the peptide backbone are linked by an ethylene bridge and consequently 
in which co„ cp, and v|// torsion angles in compound 5 are restricted compared to the
o
parent peptide 4 .
3 2-Piperazinone 4 Natural 5 2-Piperazinone
peptide peptide analogue
1.1.1.2 Design o f constrained peptidomimetics based on piperazinones
The easiest approach for the design of new constrained analogues involves the 
identification o f particular protons in the desired peptide conformation such as 6 that are 
spatially close together and replacing the protons with an appropriate bridge9, such as an 
ethylene bridge in the case of piperazinone 7 (Scheme 2).
° VA  rv \ a
v n' H h y N'
6 7
Schem e 2. M im icking adjacent amino acids 
The shape of a peptide bond is defined by the three consecutive torsional angles 
(Scheme 3, Table 1). The peptidic bond length is 1.33 A, which indicated its double 
character, due to the second resonance form of the amide.
B ond R otation T orsion a l angle
N H  to C a free V
C a to C = 0 free O
C = 0  to N H  
(peptide bond)
rigid planar CO
O R H h 
S ch em e 3. D efinitions o f  <p, \\i
T ab le  1. Peptidic bond angles and co torsional angles
4Peptide bonds are almost invariably fixed at co = 180° or trans based on the 
relative alignment o f Ca atoms on either side o f the peptide bond. The rigidity o f the 
peptide bond limits the number of arrangements that Pauling’s models10 could fit, 
without distorting bonds or forcing atoms closer than van der Waals radii would allow. 
Without this constraint, the peptide would be free to adopt so many structures that no 
single consistent pattern would emerge. By reducing the degrees o f freedom, a well 
defined set of states emerges. Pauling found two general patterns conformed to atomic 
geometry:
(i) A helical state in which the \j/ and were roughly 60°, twisting repeatedly in the 
same direction, known as an a-helix (Figure 3);
(ii) An extended state for which \|/ = -135° and $  = +135°, where polypeptide chain 
alternates in a zig-zag structure, known as a p-sheet (Figure 4);
F igure 3 . a -helix  (PC M odel 8) F igure 4. p-sheet (PC M odel 8)
The Pauling model-building studies of the early 1950’s were followed by an 
exhaustive calculation of vp and ® space, carried out by Ramachandran. The most 
informative local conformational constraints are those that constraint the backbone cp, \p 
and co torsional angles.
180
Left
h an d ed
alpha-helix.
Right h an d ed  
alpha-helix.
•180
♦ phi-p h i 0 180-180
F igure 5. The Ramachandran Plot
5
Ramachandran and co-workers showed that 
serious steric interferences occurred between 
C =0 groups and amino acid side chain centred 
at vj/ = 120° and serious interferences between 
peptide backbone CO and NH occurred at \j/ = O 
= 0°n . The Ramachandran plot described 
regions where these interactions were favourable 
or not possible (Figure 5).
As amino acid mimics, piperazinones are designed to reduce the conformational 
flexibility and lead to a better binding with the receptor due to reduced entropy.
The substitution on piperazin-2-one rings is also an important aspect for the 
design o f a peptidomimetic as it is possible to “predict” all the possible conformations 
that can exist. High substitution results in hindered structures that are more likely to be 
locked in precise conformations. Unsubstituted rings possess more freedom resulting in 
higher similarity with the endogenous compounds, i.e. acyclic amino acid sequences, 
increasing the possible number o f conformations.
1.1.2 Therapeutic agents based on piperazinones
1.1.2.1 Potent dibasic GPIIb/IIIa Antagonists
A series of 2-piperazinone derivatives, possessing basic moieties at the 3- and 
the 4-positions, were synthesised and evaluated for their abilities to inhibit platelet 
aggregation and for their effect on bleeding times. Among these compounds, TAK-024 
8 showed the most potent inhibitory effect on platelet aggregation, making it a good 
candidate drug for treatment of thrombotic diseases.
NH NH H J  
N \
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NH,
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/  NH 8 TAK-024
h 2n  Dibasic GPIIb/IIIa antagonist
The action o f this drug involves the inhibition o f the platelet membrane 
glycoprotein Ilb/IIIa (GPIIb/IIIa), which cross-links with the plasma protein fibrinogen
6in the final obligatory step in platelet aggregation. This class o f compounds were 
evaluated for their abilities to inhibit ADP-induced platelet aggregation in guinea pig 
platelet rich plasma (in vitro and ex vivo) and for their effect on bleeding time. In the 
course o f study on SARs, 4-amidinophenyl group was found to be indispensable for 
exerting a strong interaction, by reinforced ionic mode o f binding with the negatively 
charged receptor. Its effect was enhanced by introduction o f an extra basic moiety at 
position 3. The reason was it stacking and a lipophilic interaction o f the phenyl ring in 
the additional basic moiety with the receptor, resulting also in higher potency12.
1.1.2.2 Leu-Enkephalin analogues
Leu-enkephalin (Leu-Enk) 9 was the first endogenous opioid penta-peptide 
isolated (Tyr-Gly-Gly-Phe-Leu)13,14. Opioid ligands are produced by the hypophysis 
and hypothalamus in vertebrates and they exert their effect through three major types of 
opioid receptors (p., 5, k) as “natural pain killers”. Leu-Enk is a potent agonist for 8- 
receptors. At the present it is thought that the morphine-like effect is due to the aromatic 
side chains (Tyr, Phe) present in the penta-peptide, that mimic a similar structure in 
morphine. It is also believed that the binding of the neuropeptide to the receptor occurs 
in a conformation containing a 5—>2 p-tum15.
Modifications on the structure o f Leu-Enk, such as the introduction o f a ring that 
bridges two consecutive amino acids created a constrained peptidomimetic 1016 that was 
used as a therapeutic agent.
HO. HO-
NH
10 Constrained analogue of 
Leu-Enkephalin
iTYo
9 Leu-Enkephalin
A wide range o f Leu-Enk analogues based on chiral piperazinone rings have 
been prepared17. Some analogues are based on piperazinones for the first and the second
|  o  I m
residues , and others for the second and third residues . Introduction o f constraints or 
/rara-substituents on Phe4 in enkephalin derivatives, such as azide group or halogens 
have been reported to retain high 8 receptor affinity. However, p-amino group and 
isothiocyanate derived substituents on Phe o f DPDPE 10 resulted in large decrease o f 8 
receptor affinity4.
71.1.2.3 Growth Hormone mimetics
Growth hormone mimetics are used for the treatment o f osteoporosis, wasting 
conditions, recovery and obesity19 and their structure mimic the natural peptide. Among 
this class, growth hormone releasing peptide (GHRP) l 20 11 and NN703 12 were 
prepared in the 1970s and shown to be potent therapeutics for the release o f growth 
hormone (GH). The piperazinone functional group was introduced in this class o f 
molecules, in order to synthesise constrained versions o f a growth hormone mimetic, 
NN7032112. Evaluation with respect to GH-release on rat pituitary cells o f NN703 12 
and its constrained analogues showed that compound 13 was either equipotent or even 
more potent than NN703 itself (EC50 18 nM).
2-Piperazinone rings served as rigid units bridging two consecutive amino acids 
in a peptide and moreover, they lock the substituents in a conformation similar to the 
side chains o f the parent peptide in its bioactive conformation22.
11 G H R P1
12 NN703 13 Constrained analogue of NN703:
NNC26-0737
1.1.2.4 Substance P analogues
Substance P is a member o f the mammalian tachykinin family o f peptides and 
has been implicated in a number of disease states including arthritis, asthma, 
inflammatory bowel disease and depression. Substance P is an 11 amino acid peptide 
(Arg-Pro-Lys-Pro-Gln-Gln-Phe7-Phe8-Gly-Leu-Metn -NH2). Two models o f this peptide 
were proposed as potential conformations responsible for the interaction with the 
receptor NKj. Two different agonists 15 and 17 were designed and prepared in order to
H ftmimic both conformations o f Phe -Phe regions in 14 and 16 (Scheme 4). All the 
analogues were examined for their ability to displace substance P from its NKj receptor. 
Bicyclic compounds such as 15 and 17 inhibited the binding only at high concentration
8with ICsovalues o f ~32 pM. Under the same binding assay conditions Substance P itself 
exhibit an IC50 o f 0.3 nM, indicating that the modification in the analogues reduced 
their affinity by approximately four orders o f magnitudes23.
14 Substance P 
Conformation a
15 Substance P 
Conformation a analogue
16 Substance P 
Conformation b
17 Substance P 
Conformation b analogue
Schem e 4. D ifferent spatial conform ations o f  substance P
1.1.2.5 p-Turn peptidomimetics
1.1.2.5.1 Introduction
p-Tums are important motifs in biologically active peptides and they are 
responsible for their globularity. They are defined as any tetrapeptide sequence with 4- 
10 membered intramolecularly H-bonded ring, in which Ca‘—Cal+3 distance varies from 
4 to 7 A24,25. These four consecutive residues are not present in a-helix and they fold 
back on themselves by nearly 180°26. Hydrogen bonding between the carbonyl o f 
residue i and the amide hydrogen of residue i + 3 is often indicative o f a P-tum, though 
it is not an essential feature . A p-tum reverses the direction of the peptide chain and is 
classified by the G> and ¥  backbone torsional angles of residues i + 1 and i + 2 (Table
2), there are at least 14 types o f p-tum structure.
Type I (Figure 6), II (Figure 7), and IV p-tums are the most prevalent. Type VI29 
are the most rare secondary structures in that they bear a c/s-amide bond between the i + 
1 and i + 2 residues, and thus typically have a proline at the / + 3 residue30.
F igure 6. Type I p-turn (G ly-Ileu-Ileu-G ly) F igure 7. Type II g lycine P-tum (G ly-Pro-G ly-G lu)
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T ab le 2 28. P-turns and their abundances
1.1.2.5.2 fi-Turn mimics
P-Tums have been shown to be important for recognition, binding and for 
receptor affinity in biologically active peptides. Therefore, mimics o f P-tums31 are 
desirable tools for studying the structure-activity relationships responsible for protein
and peptide biology.32
X o ,
HN 1 i+3
i+1 O R 
i+2
19 p-Tum
rRS o VNH
*
r2v
20 p-Turn mimetics
Strategies to design p-tum mimics have often constrained the peptide backbone 
dihedral angles32,33. Bicyclic fused systems such as diketopiperazines 2024, 
azabicyclo[X,Y,0]-alkanone amino acid 2132 have been used as rigid dipeptide 
surrogates that structurally constrain three consecutive dihedral angles, cp, \\i and co, o f a 
p-tum segment within the body of the heterocycle. Conformational analysis o f 21 has 
shown that they mainly mimic type II and IT p-tums. Macrocyclic dipeptide lactams 
such as 22 mimic better the natural diversity of a wide range of turn geometry, due to 
their higher flexibility. Unfortunately, due to the problems for the preparation of 
medium ring size, they have been less investigated. However, new strategies are arising 
to overcome the synthetic difficulties. A recent example, such as the ring closure 
metathesis, partially solved the problem and will lead to more efficient synthetic routes 
and clearer biological evaluation of these complex structures32.
BocHN
21 22
1 0
Substituted bicyclic lactams 24 have particularly been designed as peptide 
mimics o f the type Via P-tum 23. Type VI turn has attracted a lot of attention since it 
appeared to be an important recognition feature for peptide bindings, besides possessing 
the important cis-trans isomerism, implicated in a large number o f biological processes. 
For instance, they seemed to be indispensable for peptide binding to PPIases and for 
peptide hormones.
NH Rt  c>—NHR 
R2
23 Type Via p-turn 24 Bicyclic lactam
3-turn mimetic
The mimic duplicates the conformation of the backbone and disposition o f the 
side-chain atoms of the central two residues of the turn. In particular, bicyclic lactams 
24 represented the two residues of a XaaPro dipeptide unit constrained to the type VI 
turn conformation34.
1.1.2.6 Enzyme inhibition
Similarly, structures based on piperazinone rings are used as scaffolds to prepare 
enzyme inhibitors in particular as proteases inhibitors35 and transition-state enzyme 
inhibitors.
1.1.2.6.1 Proteases inhibition
Proteases are enzymes that catalyse 
amide hydrolysis in proteins. Amides are 
hydrolytically stable under physiological 
conditions and their hydrolysis is slow.
There are two classes of protease 
enzymes. One class catalyses direct amide 
hydrolysis using an enzyme-bound 
activated water molecule as the 
nucleophile.
The second class of enzymes catalyses the amide hydrolysis indirectly by using amino 
acid residues, such as the hydroxyl group o f serine or threonine, and the thiol group of 
cysteine as nucleophiles (Figure 8).
Figure 8 . Protease inhibitor
11
1.1.2.6.2 Mechanism o f  peptidic bond cleavage
For the trypsin and chymotrypsin proteases, the three amino acids: histidine-57, 
aspartate-102 and serine-195 are crucial for the cleavage o f the substrate. The 
mechanism is as follows (Scheme 5). The carboxyl group o f Asp-102 polarises the His- 
57 that then acts as base taking a proton from the nearby serine’s hydroxyl group. 
Serine then acts as nucleophile and attacks the carbonyl group o f the amide substrate to 
give a tetrahedral intermediate (Step A) which is cleaved as the amino group takes a 
hydrogen from His-57 that is now acting as acid (Step B). In the next step, His-57 acts 
as base again abstracting a hydrogen from water and making it nucleophilic (’OH). The 
water nucleophile attacks the carbonyl of the serine ester (Step C). In the final step, the 
bond between serine oxygen and the tetrahedral intermediate is broken (Step D). The 
serine’s oxygen regains its hydrogen from the nearby His-57 (Step E).
/ r'\ ,H — N— Main chain
0 < .  H
H—N—Main chain
H— N—Main chain
H— N—Main chain
S chem e 5. M echanism  o f  peptide cleavage by trypsin and chymotrypsin (adapted from  
http://bm biris.bm b.uga.edu/8010/m orem en/w eblinks/W ebSerineProteases/ProteaseStepl.gif)
1 2
When the tetrahedral intermediates in the step A and step C are generated, the 
negative oxygen has accepted the electrons from the carbonyl double bond and fits 
perfectly into the oxyanion hole. Serine proteases preferentially bind the transition state 
and the overall structure is favored, lowering the activation energy o f the reaction. This 
"preferential binding" is responsible for much of the catalytic efficiency o f the enzyme.
Zinc metalloproteases such as angiotensin-converting enzyme, use zinc metallo 
protease to stabilise the transition state 25 (Step A and C, Scheme 5). Inhibitors have 
been designed which resemble highly activated reaction intermediates37. Therefore, 
transition-state inhibitors such as 26 take full advantage of the ability of the enzyme to 
stabilise its transition state, blocking the enzymatic pathway and should not be 
hydrolysed by the enzyme, so often the amide bond is not present in the inhibitor. They 
bind transition-state better than substrate or products.
25 Transition state
26 Transition state mimic
1.1.2.6.3 Transition-state inhibitors built on piperazinones
Factor Xa 27 is the substrate for the action of trypsin-like serine protease, that 
plays a central role in the blood coagulation cascade and homeostasis38. Piperazinone- 
based peptides 28 were designed and tested as potent transition-state factor Xa 
inhibitors39,40.
-S 0 2Bn
u  r rsi
X  1  J
Thiazole-Arg
27 B nS 02-(D)-Arg-Gly-Arg-Thiazole 28 Transition state Factor Xa 
inhibitor
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The sulphonamide nitrogen of the tripeptide 27  was cyclised on the glycine 
residue to give the unsubstituted piperazinone 28, to introduce constraint into the 
peptide. In order to reduce the peptidic character and the high basicity o f the 
endogenous agonist, a range of lactam ring systems was used as templates to mimic the 
P2-P3-P4 region o f the tripeptide transition state inhibitor 28. The novel inhibitor then 
displayed the desired inhibitory potency for factor Xa and also selectivity against 
thrombin, the final serine protease in the coagulation pathway.
1.1.2.7 Design o f antineoplastic agents
Design of new antineoplastic agents is an area o f a great interest nowadays. 
Important targets are Ras proteins, which are abnormally active in cancer. Ras proteins 
are small GTP-binding proteins (Figure 9) that participate in the regulation o f many 
cellular functions including cell growth, differentiation and intracellular signal 
transduction. Prenylation of the gene Ki-Ras, in particular famesylation of a cysteine 
residue near the protein’s C-terminus, was indispensable for its biological function41 
(Figure 10).
PR O T EIN
Pranyltransfaras*
PRO TEIN
Plasma
membrane
PROTEIN
F igure 942. GTP-bound Ras protein F igure 10. M echanism  o f  prenylation o f  Ras
Prenyltransferases catalyse the transfer o f an isoprenoid (famesyl FP or 
geranylgeranyl GG). Several FPTase inhibitors showed promising activity in preclinical 
and clinical studies, although they were incapable o f inhibiting GGPT. N- 
arylpiperazinone L -178,123 29  acts as a dual prenylprotein transferase inhibitor by 
binding to FPTase in a folded conformation. The potency and selectivity enhancements 
are achieved by enforcing a macrocyclic constraint 30, which yields a highly potent 
FPTase inhibitor but has moderate activity versus GGPTase-I.
ras protein
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a R= H 
b R= Cl 
c  R= CH3 
d R= Allyl
e R = ^ l
f R=
CN CN
29 L-178,123 30 Macrocyclic analogue 
of L-178,123
The imidazole moiety is ligated to zinc, the cyanophenyl group is stacked 
against the isoprenoid chain of FPP, and the benzylpiperazinone portion is in contact 
with key hydrophobic residues. Notably, the cyclohexylethyl group of 30f is angled 
toward a large cavity in the active site. Moreover 30f potently inhibit both enzymes 
(FPTase, GGPTase-I) in cell cultures with relative activities that are almost optimally 
balanced for the inhibition o f Ki-Ras prenylation43.
1.1.2.8 Antifungal therapeutics
Deep mycosis (fungal infection) is difficult to treat without affecting the host 
organisms and nowadays a combination o f azole derivatives is needed to treat them, due 
to resistance gained over the years by the human body. New targets for drugs are the 
SAPs (secreted aspartyl proteases) that are considered as factors o f virulence. SAPs are 
mainly p-sheet structures organised in two domains: Asp-Thr-Gly/Asp-Ser-Gly (Figure
11). In particular, SAP2X of Candida albicans also exhibits a “bilobal” fold44. Its 
mechanism of amide hydrolysis involves nucleophilic attack of a water molecule to the 
amide carbonyl with consequent formation of a tetrahedral intermediate; its breakdown 
generates the products o f the amide hydrolysis. Compounds such as A-70450 31 are 
shown to inhibit SAP2X by forming eight stable hydrogen bonds with the active site o f 
the enzyme.
31 A-70450
F igure l l 45. Secreted aspartyl protease
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1.1.2.9 Natural products containing piperazin-2-one rings
Pseudotheonamides (Ai, A2 , B2 , C, D) 32a and 32b are natural peptides isolated 
from the sponge marine Theonella swinhoei46 (Figure 12). The first three compounds 
(Ai, A2 , B2 ) possess the rare piperazinone and piperidinoiminoimidazolone ring 
systems. These compounds have potent inhibitory activity against serine proteases 
including thrombin, trypsin and plasmin46.
„OH
NH HN
32 Pseudotheonamide
a c/s-A-, 
b trans-A2
F igure 1247. Marine Sponge T heonella  sw inhoei
Substituted 2-piperazinones are present in other sponges, such as the 
Mediterranean sponge Rhaphisia lacazei. Bisindole alkaloid dihydrohamacanthins 33 
and 3448 have been isolated and tested in vitro on NSCLC-N6 carcinoma cell line49. 
They show a myriad of biological responses including cytotoxicity and antitumor 
activities.
33 cis- and frans-3,4-dihydro-hamacanthin A 
a R1=R2=Br 
b R ^H , R2=Br
R1
34 c/s-3,4-dihydro-hamacanthin B 
a R-,=R2=Br 
b R ^H , R2=Br
1.1.2.10 Anti-retroviruses
The synthesis o f nucleoside analogues against the sheep retroviruses was carried 
out. Piperazinone ring was introduced in the nucleoside 35 and it acted as the “base” 
linked to a sugar by aliphatic chains50. It is known that the aliphatic chain not only 
serves as a neutral linkage but also affects the coiling of DNA. Increasing the length of
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the spacer enhances bending of DNA, leading to base pair opening, consequently the 
bases then become susceptible to attack by reactive groups.
Nucleoside 36c showed moderate antiviral activity against a mammalian retrovirus, the 
Visna virus, in sheep choroids plexus cells (SCP cells). It showed cytotoxicity though at 
concentration greater than 170 pM.
HO OH 
35 Uracil-nucleoside
BzO-
BzO OBz
a R1=R2=H 
b Ri=R2=CH3 
c Ri=H, R2=n-Ci0H2i
36 2-Piperazinone RNA- 
nucleoside analogue
1.1.2.11 Alzheimer's Disease (AD)
Among all the CNS diseases, AD has been long considered as one of the most 
obscure and intractable diseases. The syndrome starts with mild cognitive impairment 
with symptoms like occasional, minor lapses in recalling recent event o f daily life that 
gradually deteriorate into a marked dementia, with full disorientation, profound memory 
loss and global cognitive deficits. In the early 70s it was believed that AD was caused 
by a disturbance of the acetylcholine functions in the brain, associated with decreased 
density o f nicotinic acetylcholine receptors in the cerebral cortex. Lately, formation of 
extracellular deposits o f amyloid p-protein (AP) fibrils, dystrophic axons, dendrites and 
diffuse pre-amyloid plaques51 were also considered responsible for the 
neurodegenerative disorders (Figure 13,14).
Sulcus,
Gyrus
Ventricle
Normal Alzheimer's
Figure 1352. H ow  the brain and nerve cells change during F igure 1453. Brain cross-sections  
A lzheim er’s disease (Illustration by Bob Morreale, 
provided courtesy o f  the American Health A ssistance  
Foundation)
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Amyloid deposits are aggregates o f peptides o f 40-43 amino acids. A fs originate 
from the cleavage of glycoproteins called amyloid precursor protein (APP) and they are 
neurotoxic. Although no protease has yet been shown to produce Ap proteins, a number 
of leads exist to help direct an empirical search for such protease. For instance, elastase, 
a serine protease is known to be bound to various amyloids. In addition, plaques and 
tangles have been shown to contain cholinesterases, which have potent serine protease 
activity, p- And y-secretases are believed to be involved in the production o f Ap from 
its precursor APP. Small molecule inhibitors of the latters are under active development 
and some have shown in vivo efficacy in mice51.
Serine protease inhibitors have then showed activity against AD besides being very 
useful for the treatment o f other diseases such as cancer and viral infections (HIV, 
hepatitis and herpes)54. It is well know that muscarinic receptors play an important role 
in memory and the loss of their functions are strictly related with the symptoms of AD.
1.1.2.11.1 Muscarinic receptors
In the late 1980s, molecular cloning techniques identified five different subtypes 
of muscarinic receptors (mi-ms), which are the counterparts o f the pharmacologically 
distinct muscarinic receptors (Mi-Ms). Each receptor shares common features including 
specificity o f binding for the agonist acetylcholine, neurotransmitter o f the para 
sympathetic autonomic nervous system, and the classical antagonist atropine. All 
muscarinic receptors belong to the family o f G-protein-coupled receptors (GPCRs).
Phospholipase C
K+ channel
PKC
A c e ty lc h o l in e  
M u s c a r in i c  M1 
R e c e p t o r
Stimulatory
G-protein
Ca2+ channelCYTOPLASM
| ttndoplaw nlc reticulum  j
F igu re 15. Muscarinic receptor-agonist interaction and effects
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They are located in different areas of the brain and are likely to be involved in 
many different physiological processes. Mi receptors are found in the forebrain, 
especially in the hippocampus and cerebral cortex. M2 are found in the heart and 
brainstem whereas M3 are found in smooth muscle, exocrine glands and cerebral cortex. 
M4 receptors are found in the neostriatum and M5 receptor mRNA is found in the 
substantia nigra55.
The events associated with G protein-coupled receptor activation are as follows 
(Figure 15). The agonists bind to the receptor that is consequently stabilised and can 
promote receptor/G protein coupling. GTP is exchanged to GDP on the G protein a 
subunit. The binding of GTP leads to the dissociation of the G protein from the receptor, 
thereby lowering agonist affinity whereas the agonist dissociates from the activated 
receptor. The G protein consists of three subunit (a, p and y), which also are dissociated. 
The a subunit activates the second messenger, phospholipase C, and the p and y 
subunits can exert independent actions. The a subunit is inactivated by the hydrolysis of  
GTP to form GDP by a GTPase intrinsic to the G protein and can then recombine with 
the p and y subunits. At that stage, the receptor is then in a high affinity state and ready 
for binding another agonist.
The site of action of the Mi receptor agonist appears to be an increase in the 
activity of a protease, a-secretase, through phosphoinositide turnover and stimulation of 
protein kinase C. a-Secretase cleaves the APP in the Ap domain so that Ap cannot be 
produced from APP; muscarinic agonists therefore reduce the levels of Ap produced.
Mi-Selective agonists may be useful to enhance cognitive function in the treatment of 
Alzheimer’s disease56. They are generally relatively small molecule containing 
heterocycles, whereas Mi-selective antagonists are larger molecule containing aromatic
1.1.2.11.2 Alzheimer’s Disease Treatments
Treatments in use nowadays include: acetylcholinesterase inhibitors58, such as 
tacrine 3759, donepezil (Aricept®) 3860 and galantamine (Reminyl®) 3958.
moieties57.
OH
37 Tacrine 38 Donepezil 39 Galantamine
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V-Methyl-D-aspartate (NMDA) antagonists, including memantine 40, ketamine 
41 and glutamate 42; these drugs regulate the activity o f glutamate, a chemical 
messenger involved in information processing and retrieval.
40 Memantine 41 Ketamine 42 Glutamate
Vaccines are a new approach for the prevention o f AD. The principle is to make the 
immune system recognise and destroy the AP plaque formation, stopping the disease.
1.1.2.11.3 Mi Muscarinic agonists design
Mi receptors are found in the central nervous system, especially in the cerebral 
cortex and hippocampus, and in the stomach where they mediate gastric acid secretion. 
Based on their localisation in brain regions associated with learning and memory 
function, drug development efforts focused on the synthesis and biological 
characterisation o f Mi agonists. An ideal drug candidate would present several features 
including high CNS penetrance, high efficacy and selectivity for forebrain receptors and 
a low incidence o f side effects61.
Muscarine is the prototypical muscarinic agonist and it derives from the fly 
agaric mushroom Amanita muscaria (Figure 16). Like acetylcholine, muscarine 43 
contains a quaternary nitrogen, which is very important for the action at the receptor 
anionic site (an aspartate residue in transmembrane domain III).
43 Muscarine
F igure 1662. Amanita muscaria
Classical muscarinic agonists such as arecoline 44, oxotremorine 45 and 
pilocarpine 46 and the use of acetylcholinesterase inhibitors exhibited only modest
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efficacy in the brain and produced a high incidence of side-effects, such as the 
progressive loss of cholinergic neurons and associated decrease in acetylcholine levels. 
Xanomeline 47 displayed higher activity at M\ receptors than at M2 or M3 receptors63.
o c h .
44Arecoline 45 Oxotremorine 46 Pilocarpine 47 Xanomeline
Other compounds with improved selectivity for Mi receptors include talsaclidine 
48, sabcomeline 49 and CDD-0102 50. In particular, the latter improved memory 
function in animal model and displayed a low side effect profile63.
o
49 Sabcomeline48 Talsaclidine 50 CDD-0102
The major problem of all the muscarinic agonists is the low selectivity towards 
the Mi receptors. Medicinal chemists focused on developing larger molecules that could 
interact with accessory binding sites. By binding to sites outside of the primary agonist 
binding pocket, compounds could also interact with residues that are not highly 
conserved between receptor subtypes. Molecule such as CI-1017 51 exhibited improved 
muscarinic receptor selectivity.
OCH,
51 CI-1017
In addition to playing a role in cognitive function, Mi receptors promote a- 
secretases activity, which results in the secretion of non-toxic peptide fragments of 
amyloid precursor protein, and hence decreased Ap deposition.
Nowadays the design and development of muscarinic agonists is central in medicinal 
chemistry because they could become very useful therapeutics for preventing the 
amyloid plaques and neurofibrillary tangle formations, the two main hallmarks of
fi'XAlzheimer’s disease .
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1.2 Chemistry of piperazinones
1.2.1 Strategies for preparation of piperazinones
Ketopiperazines, and their reduced derivatives piperazines, are valuable motifs 
that have found widespread use as conformationally constrained peptidomimetics, as 
well as synthetic intermediates for the construction of biologically active molecules, in 
total synthesis and in the pharmaceutical industry.
Analysis o f the retrosynthesis of these structures leads to a large number o f 
disconnections. Besides the six intramolecular cyclisations that create 12 possible 
electronic fragments, it is in principle possible to consider five [5+1] disconnections that 
lead to twenty possible electronic fragments, four [4+2] disconnections resulting in 
sixteen possible electronic fragments and three [3+3] with twelve possible electronic 
fragments. However, by screening all the possible approaches, and by following the 
natural reactivity o f these compounds and the nature of the functional groups present, 
[4+2] disconnections could be considered the most accessible, also considering the 
easiness o f starting materials preparation.
Three different approaches are shown below and will be illustrated in more 
details: one intramolecular cyclisation, one [4+2] and one [3+3] cyclisations (Scheme
Moreover, since piperazinone rings are frequently included in the backbone of 
non-peptide structures, the presence o f stereogenic centres is often found indispensable 
for the biological activity of these compounds.
6).
R
Schem e 6. Three possible disconnections for piperazinones
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One o f the most facile approaches for the preparation o f 52 is a [4+2] 
disconnection o f N1-C2 and C3-N4, where R ' and R ” are substituents on the 1,2- 
diamine derivatives 53 and R '"  is substituent on the dielectrophile 54 (Scheme 7).
i? ?
NH X .Ry N / o ^ r’n^ nh x
Rm/ S n ^ 3 Rm R" y H X R’
O ^ R "
52 53 54
Schem e 7. Retrosynthetic approach for fully substituted piperazinones
In this case, the reactivity o f the amino groups needs to be controlled to avoid 
formation o f product mixtures, and this can be usually achieved by introducing different 
N-substituents on the 1,2-diamine. In addition, the nature o f the leaving groups on the 
dielectrophile can direct formation of the desired products.
1.2.1.1 Intramolecular cyclisation: Route A
The cyclisation o f compounds such as 58, obtained from jV-benzyl-2-chloro-AL 
(2-oxoethyl)acetamide 57 with primary amines by reductive amination, has been 
achieved starting from iV-benzyl ethanolamine 55 (Scheme 8).
Bn Bn Bn Bn Bn
NH . N . ^ 0  N/INM ... ^f  -J -~(T  T  — C T
OH OH Cl Cl NH Cl 'N
R R
55 56 57 58 59
Sch em e H64. R e a g e n ts  a n d  c o n d itio n s:  (i) ClCH2COCl, EtOAc, sat. N a H C 0 3, 0°C , 20  min, 83%; (ii)  
D M SO , (C O C l)2, Et3N , CH2C12, -78°C-rt, 45 min, 80%; (iii) R -NH 2, N a(A cO )3B H , 0°C
This approach was also successful when chiral centres were present on the rings. 
In 1952, L-2-ketopiperazine-5-carboxylic acid 61 was prepared starting from P- 
chloroacetyl-L-diaminopropionic acid 6065. The latter was obtained by enzymatic 
hydrolysis o f a,p-dichloroacetyl-DL-diaminopropionic acid by hog kidney acylase I 
(Scheme 9).
0
© ,So' K ' ^ Y 3
N ^ O
H
60
HO'
61
+ HCI
Schem e 9.
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This procedure found excellent use for preparation o f novel cholecystokinin 
receptor ligands66, and especially for the synthesis o f the bicyclic piperazine 65, 
building block for the synthesis of analogues of HIV protease inhibitors67 and 
auxiliaries used to study catalytic asymmetric reactions. Synthesis o f the enantiopure 65 
was achieved starting from the readily available V-Cbz L-proline 62 via formation of 
piperazinone intermediate 64, obtained by intramolecular nucleophilic displacement o f 
the cyclic amine to the acyl chloride (Scheme 10). The V-chloroacetyl derivative 63 was 
obtained in four steps via formation of a a-azidoester that was consequently reduced to 
give the desired adduct 63.
Cbz Cl^ (
0 
NH
O ^ H  -  L  /  -C 0 2Me
i  ,C 0 2H H * H A  ' NH
C 0 2Me '----- '  \___ /  C 0 2H
62 63 64 65
Sch em e 10. R e a g e n ts  a n d  c o n d itio n s:  (i) Bu4NI, Et3N , D M A P, C H 2C12, reflux, 70%
1.2.1.1 [4 + 2] disconnection: Route B
Condensation o f 1,2-diamines with 1,2-dielectrophiles is a reliable method to 
prepare piperazin-2-ones. The mechanism involves two steps starting from a Sn2 of the 
amino group to the most reactive electrophilic centre followed by intramolecular BAc2 
(6-exo-trig) to yield the cyclic product.
1.2.1.2.1 Achiral primary 1,2-diamines
Primary 1,2-diamines such as 66 react rapidly with dielectrophiles giving the 
fully substituted adducts. It is possible to obtain the piperazin-2-ones 68 only by 
controlling the moles equivalent o f the reacting haloacetate68,69. The partially substituted 
secondary amine gives the intramolecular cyclisation with one aminoacetate arm of the 
adjacent nitrogen (Scheme 11).
>nh2
EtOOC. 0  C 0 2Et
j L J f r  ra  - a i
NH2 N COOEt N O
k C 0 2Et
66 67 68
Schem e 1 169. R e a g e n ts  a n d  c o n d it io n s : (i) 3 mol. eq. ethyl brom oacetate, K2C 0 3, KI, CH3C N , 60° C
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Primary aromatic 1,2-diamines react slower than the aliphatic ones with 1,2- 
dielectrophiles, due to the electron withdrawing effect o f the phenyl ring. However, Boc 
monoprotection of the o-phenylendiamine 69 is required for the reaction with glyoxylic 
acid, to yield the piperazinone 7170, in order to avoid the formation o f disubstituted 
products (Scheme 12).
Boc H
Ah  ^  ^
„ N R
NH2 H II HO
69 70 71
Schem e 12. R e a g e n ts  a n d  c o n d itio n s :  (i) organoboronic acid, g lyoxylic  acid, H20 ,  M eC N, 80°C, 6 h; (ii)  
conc. HC1, MeOH
1.2.1.2.2 Achiral secondary 1,2-diamines
One of the oldest example of the cyclisation between a N ,N '-disubstituted- 1,2- 
diamine 72 and ethyl chloroacetate 73 was described in 1899 by Bischoff et al7]. They 
explored cyclisations using N,N '--diaryl derivatives with ethyl chloroacetate in presence 
of sodium acetate to prepare A^N'-diarylmonoketopiperazines. A^N'-dialkyl 1,2-diamine 
cyclisation with the same dielectrophile were reported in 1950. The procedure involved 
the slow addition o f the dielectrophile to the boiling diamine72, to prepare N,N'- 
dialkylmonoketopiperazines 76a-e (Table 3).
NH EtO
R T im e (h) T (°C ) 72 recovered (%) 76 (% yield)
a Butyl 17 165 - 44
b Octyl 5 145 - 6
c D odecyl 10.5 165 - 10
d Benzyl 5 135 38 10
e C yclohexyl 9 145 43 15
T ab le  3 . Reaction conditions for cyclisation o f  M N '-dialkylam ines 72 and ethyl chloroacetate
When the A^N'-substituents are the same, both amine groups show the same 
reactivity and the cyclisation reaction will give only one product. However, when the
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substituents are different, the two amines will react differently and in theory, they could 
give mixture o f products.
For instance, preparation of an agonist for h5-HTio receptor 80, potential 
antimigraine agent, was achieved starting from 1,2-diamine and ethyl bromoacetate 
(Scheme 13). Selective protection-deprotection sequences o f the diamine was required 
to direct the exclusive formation of 80. The Boc group was removed first, by treatment 
with TFA, to promote the Sn2 between the terminal amino group and ethyl 
bromoacetate. Subsequently, the benzyl group on N-4 was cleaved to promote the BAc2 
to the ester and to give the cyclised product. Reaction o f 78 with ethyl bromoacetate and 
then removal o f Boc group would have formed the other regioisomer73.
S chem e 13. R e a g e n ts  a n d  c o n d it io n s : (i) M e S 0 2Cl, Et3N , CH2C12; (ii) 2-am inoethylcarbam ic acid te r t-  
butyl ester, K2C 0 3, N al, reflux, IPA; (iii) PhCHO, N aC N B H 3, M eOH , AcO H ; (iv ) TFA, CH2C12; (v) 
ethyl bromoacetate, K2C 0 3, DM F; (vi) H2, Pd on C, HC1 (aq.), EtOH; (v ii) EtOH, reflux
1.2.1.2.3 Secondary 1,2-diamines with one stereogenic centre
The presence o f a stereogenic centre on the ethylene bridge o f A^N'-disubstituted 1,2- 
diamine 81 will also lead to the formation of two possible regioisomers: 5- and 6- 
piperazin-2-ones, 82 and 83 (Scheme 14).
.NHBoc
OEt
80
R R
R’
N l X ) 
R
NHI
R
.0
I
R
82 5-piperazin-2-one 81 83 6-piperazin-2-one
S ch em e 14. Piperazinone regioisom ers starting from a chiral secondary 1,2-diamine
The presence o f a chiral centre could, in principle, modify the reactivity o f the 
amino groups even if the N ,N '-substituents are the same. Hence formation of one 
preferential product should be observed. For instance, regioisomers 85 and 86,
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intermediates for the synthesis o f P-carbolines, have been prepared reacting the same 
chiral 1,2-diamine 84 with two different dielectrophiles74 (Scheme 15).
= NH 
H ■x
EtO"^0
88
Schem e 15. Haloacetates cyclisations o f  a chiral 1,2-diam ine
The mechanistic pathways for both cyclisations showed that there is preferential 
nucleophilic attack by N -l. Our rationalisation o f the result was mainly based on 
modelling the diamine 84. The formation of a relatively “strong” hydrogen bond, 
measured with a molecular mechanics software (1.91 A), between N-4 and the proton of 
N-6, makes the lone pair of N-4 less available for the nucleophilic attack. Hence, N-l 
was the most reactive amine.
By “locking” the structure with the formation of hydrogen bond, 
the higher reactivity of the acyl halide over the chloride, and the 
halo substituent over the ester group, in the dielectrophiles, direct 
the regioselectivity o f these cyclisations.
NH
Preferential attack of one amino group over the other was also observed during 
the synthesis o f macrocyclic compounds75. Piperazinone 91 was the exclusive 
regioisomer formed in the cyclisation step. The cyclic amine attacked the dielectrophile 
first, followed by intramolecular cyclisation of the acyclic amino group on the ester 
group. The presence of the chiral centre adjacent to N-l promoted the higher reactivity 
o f N-4 (Scheme 16).
COOEt
( r ^ r/—N N—v
I f e rEtO >
Ph
89
O-nr
NH HN— v
4 /  7.NH HN— '
OEt
Ph"
-COOEt
COOEt
88 90
. C O O E t  _
/  ^  COOEt
Ph"
rj—N N—v
N \  /  V \  M M f
O '----- ' '— COOEt
91 Macrocyclic chelating agent
Schem e 16. Preferential attack o f  N -4 to the dielectrophile 88
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1.2.1.3 [3 + 3] disconnection: Route C
Compounds such as acetamide 92, when treated with an a-aminoester 93 under 
reductive amination condition, produced JV-acylpiperazinone 96 through the 
intermediacy o f 94, which presumably interconvert via an intramolecular A^N'-acyl 
transfer into the derivative 95. The transamidation-cyclisation step was the rate 
determining step and presence o f acetic acid was the most efficient additive to promote 
the formation o f piperazinone 96 (Scheme 17).
92 93 94 95 96
Sch em e 1776. R e a g e n ts  a n d  c o n d itio n s:  (i) N a(A cO )3BH, acetic acid, 0°C; (ii) A cetic acid, acetonitrile, 
40°C , 24 hr
An attractive feature of this synthetic route is that the incorporation o f C3- 
substitution is facilitated by the wide availability of natural and unnatural amino acids. 
The diastereoselective alkylation of C-3 was also achieved by extracting the a-amide 
proton with /-BuLi, which promoted formation o f amide enolate, followed by Sn2 on 
the alkyl halide10 (Scheme 18).
Boc Boc
97 98
Schem e 18. R e a g e n ts  a n d  co n d itio n s:  (i) f-BuLi, HM PA, RX, 30-90%
1.2.1.3.1 Alternative methods fo r  preparation o f  3-substituted piperazin-2-ones
Michael addition of the nitroethylene 99 with an a-aminoester 100 yielded the 
nitro product 101 , which was subsequently reduced to amine group by hydrogenolysis. 
Intramolecular cyclisation of the amino group to the ester yielded the 2-piperazinones 
103 in an acceptable yield (30-60%). The nitro group can be considered as a protected 
amine which is reduced when the cyclisation step needs to be promoted77.
no2 ?°2Me *«— °2N'i f2Me ?°2Me . . rNr°
[ f  addition k ,  Reduction _ k  ^ Cyclisation _ k  J..
HN R ---------------► N R  ► N R * *  N R
p- ■, 1 IR R’ R’ R'
99 100 101 102 103
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Piperazinone 108, a peptidomimetic of the neurotransmitter Leu-enkephalin, was 
prepared in enantiomerically pure form starting from the protected tyrosine 104 with 
ethyl A-(2,2-dimethoxyethyl)glycinate 105 to give the corresponding dipeptide 106 in 
80% yield. Further treatment o f the acetate with TFA gives the enamine 107, which is 
hydrogenated to the piperazinone 108 in 80% yield (Scheme 19)18.
104 105 106 107 108
Schem e 19. R e a g e n ts  a n d  co n d itio n s:  (i) EEDQ/M eOH; (ii) 70% aq. TFA, 2 h; (iii) Pd(OH )2, H2, HC1, 
EtOH
1.2.2 Regio- and stereoselectivity in the preparation of chiral piperazinones
A regioselective reaction is one in which one direction of bond making or 
breaking occurs preferentially over all the other possible directions. Reactions are 
termed completely (100%) regioselective if the discrimination is complete, or partially, 
if  the product o f reaction at one site predominates over the product of reaction at other 
sites.
Two possible regioisomers can be prepared from the cyclisation of a chiral 1,2- 
diamine and achiral dielectrophile as shown in section 1.2.1.2.3. Regioselective 
preparation of the two isomers is usually achieved by controlling the reactivity o f the 
amino groups and by choosing the appropriate dielectrophile. When a chiral 1,2- 
diamine reacts with a chiral dielectrophile, the control o f the stereoselectivity becomes 
more complex because of the possible formation of four diastereoisomers, as shown in 
the scheme below.
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2 Regioisomers
_____ A_____
;0 R'R'
Achiral 1,2- 
dielectrophile 4 NI
R RNH
Chiral 1,2- 
dielectrophile
R'V / N^ °  R'V / N^ ° XX
R" R'
Y
4 Diastereoisomers:
2 couples of regioisomers
Preparation of one preferential stereoisomer over the others could also require 
tedious transformations o f amines protection-cyclisation-deprotection. In order to 
summarise, for the asymmetric synthesis o f piperazinones, regioselectivity can depend 
on two main factors:
• Reactivity of the amino groups (level of substitution o f the starting material);
• Nature of the leaving groups in the dielectrophiles.
1.2.2.1 Preparation o f 5-substitutedpiperazinones
The use of an amine protection-deprotection sequence is illustrated by the 
preparation of the 5-substituted piperazinone 110. The Boc protecting group reduces the 
reactivity of the primary amine 109 allowing initial reaction o f the secondary amine at 
the acyl bromide terminus of bromoacetyl bromide. Acidic deprotection revealed the 
primary amine which underwent base induced lactamisation to give exclusively 5- 
substituted piperazinone 110; a modest antagonist of the substance P23 receptor (Scheme 
20) 78.
,c f 3
CF •
H
I, li,
CF
H
109 110
S chem e 20. R e a g e n ts  a n d  c o n d it io n s : (i) BrCH2COBr; (ii) M eOH , HCl; (iii) K2C 0 3
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1.2.2.2 Preparation o f 6-substituted piperazinones
Cyclisation o f A-benzyl 2,3-diaminopropionate m 79 with methyl bromoacetate
yielded exclusively the 6-substituted 2-piperazinone 112 in high yield80, due to the 
higher reactivity o f the primary amine over the secondary one (Scheme 21) and the 
higher reactivity o f the acyl over the ester group of the dielectrophile. The monoester is 
a plausible intermediate for this cyclisation.
Schem e 21. R e a g e n ts  a n d  c o n d it io n s : (i) BrCH2C 0 2Me, THF; (ii) H2, Pd-C, MeOH
6-Hydroxymethyl piperazin-2-one 117 was obtained in 5 steps sequence starting 
from Cbz-D-glucosamine 113. Protection of the newly generated secondary amine with 
B0 C2O is essential for the final cyclisation step in order to prevent attack o f the reactive 
secondary amine to the ester. Selective removal of the protecting groups (Cbz and Boc) 
was indispensable for the preparation of only one product. Oxidative cleavage of the 
polyol 115 with sodium periodate and reduction of the aldehyde by sodium borohydride 
yielded the aminoalcohol 116 in high yield (87%). The piperazinone 117 was obtained 
through removal o f Cbz group and spontaneous intramolecular cyclisation. The 
stereochemistry of the chiral centre at position 6, in the final product, is preserved 
during all the transformations (Scheme 22). The piperazinone 117 could be further 
transformed in other target molecules, mimetics o f the RGD (Arg-Gly-Asp) motif22.
OH OH OH
H O -^ r°\ -U . HO'X^VH 1 JL*. Ho4 - OH r XHoA ----t ^ O H  HOA—
NHCbz NHCbz NHCbz
113 114 . 115
M e02C,
M e02C4
111 112
|  iii, iv
functionalise
O- and N-
HO' v
HO
Cbz
NH Boc O
NI
117 Boc 116
OMe
Schem e 22. R e a g e n ts  a n d  c o n d it io n s : (i) G ly-O M e-H Cl, N aC N B H 3, M eOH, reflux; (ii) B oc20 ,  MeOH; 
(iii) N a I0 4, H20 ;  (iv ) N aB H 4, EtOH; (v) H2, Pd/C, MeOH
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The synthesis of piperazinone 117 could also be acheived using an alternative 
retrosynthetic approach, involving the cleavage of N 1-C6 bond and a further cleavage 
of N4-C5 bond. The main backbone was the a-aminoacetamide 120 and (S)-
O I
chloromethyloxirane 121 represented the source of the C6 chiral centre (Scheme 23). 
This method was successfully used for the synthesis o f potent inhibitors o f renin for
O') O 1
treatment of hypertension ’ .
OH OH
i 6
HN’ O 121 (S)-Chloromethyl- 
HO :r>  oxirane
U  , V
Boc 118 °  R 119 R 120
HN4 
Schem e 23. Intramolecular 6 -e x o  cyclisation o f  am ide-epoxide
1.2.2.3 Solid-state synthesis o f piperazinones
Solid phase synthesis has been used for the synthesis o f p-tum analogues. 
Product purities achieved were in the range of 70-88%84,85, starting from cheap starting 
materials. The use o f solid phase synthetic methods has been enormously growing since 
these procedures allow the preparation o f a large range of compounds, from simple 
peptide libraries to small heterocyclic libraries, usually using inexpensive and readily 
available starting materials. For instance, 2-oxopiperazines were obtained by the tandem 
S^/M ichael addition of amines to unsaturated peptoids. The synthesis was based on the 
coupling between an FMOC-amino acid to an unsaturated peptoids anchored to the
or
solid support . The key feature of using solid support is the ease o f solid support 
removal by acidic hydrolysis and the possibility to synthesise different classes of 
compounds at the same time.
Substituted quinoxalinones such as 125 are inhibitors o f aldose reductase and 
partial agonists o f the y-aminobutyric acid (GABA)/benzodiazepine receptor complex. 
Preparation o f 125 was achieved on a solid support in 39% yield from a-aminoesters 
and alkyl halides (Scheme 24). The first step o f this sequence involved the Fmoc 
cleavage from the solid support to free the amine that was coupled with a carboxylic 
acid to yield the aromatic amide 123. The nitro group facilitated the nucleophilic 
aromatic substitution to replace the fluoride with an amino acidic residue and was then 
reduced to a primary amine, which then rapidly participated in intramolecular
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cyclisation on the ester group to yield the piperazinone 125. The secondary amine was
Schem e 24. R e a g e n ts  a n d  c o n d it io n s : (i) DMF:piperidine, 1:1; (ii) (4 -F -3 -N 0 2)P h C 0 2H, H ATU, DIEA; 
(iii) H2N C H (P h)C 02R, DIEA, DMF; (iv) SnCl2- H20 ,  DMF; (v) BnBr, K2C 0 3, acetone, 55° C
It was also possible to obtain diastereochemically pure compounds, such as 128 
and 129, starting from the same substrate. The pseudopeptide 126 can be N- 
functionalised for example by acylation with chloroacetyl chloride. Deprotection, acid 
cleavage and a long reflux resulted in cyclisation to form piperazin-2-ones in reasonable 
yields. Moreover, if the protecting group is Boc, after treatment with trifluoroacetic 
acid, cyclisation to generate 3,4,6-trisubstituted piperazin-2-one 129 was achieved. 
Alternatively, if the protecting group is Fmoc, treatment with mild base formed 5- 
substituted piperazin-2-one 128 on-resin in 35% yield88 (Scheme 25).
Stereoselective reductive amination of P-ketoesters 130 by hydrogenation in presence of 
palladium on carbon as catalyst yielded 5-carbomethylpiperazin-2-ones 134 and 13589. 
Removal of the terminal amine protecting group promoted intramolecular cyclisation to 
the carbonyl group at position 6 (Scheme 26).
o n
then functionalised with a benzyl group .
Fmoc
122 123 124 H
OR
O
Ri O
O
NHPG NHPG
£> N- functionalise
Schem e 25. Alternative cyclisation mechanistic pathways on solid support
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Schem e 26 . D iastereoselective preparation o f  5-carbom ethylpiperazin-2-ones
1.2.3 1,2-Diamines with 1,2-dicarbonyl compounds: Condensation or Cyclisation?
Dielectrophiles such as 1,2-dicarbonyl compounds are used as cyclising agents 
and they show an interesting behaviour with 1,2-diamine90. For instance, aqueous 
glyoxal and its diphenyl derivative benzil have been largely used in condensation 
reaction with aromatic and primary aliphatic 1,2-diamines. The major products of these 
reactions are dehydrated adducts 137 and 14091. The favourable formation o f imines 
intermediates is due to the donation o f the lone pair o f the nitrogen and consequently 
loss of water molecules which is the driving force of the reaction (Scheme 27, 28).
OH OH
c r  ^  c r  ^  .nh2 o ^ P h  Ph
HN' W NH2 ■ I  1  I  JL  + 2  h2oX X  X T  3*” *° N ""  Y ^ nh2 /  y X  138 139 140
o o
136 137
Sch em e 27. R e a g e n ts  a n d  c o n d it io n s : (i) glyoxal, H20 ,  Schem e 2 8 92. R e a g e n ts  a n d  c o n d it io n s : (i) 
reflux, 1 h EtOH, reflux
1.2.3.1 Condensation o f N,N'-disubstituted ethylenediamine with glyoxal
1,2-Dicarbonyl compounds react rapidly with secondary aliphatic and aromatic
1,2-diamines. Dehydration is not possible and different products can be prepared 
according to the reaction conditions. Reaction of A^N'-disubstituted ethylenediamine 72 
with aqueous glyoxal can give three different products: mixture of cis- and trans- 
1,4,5,8-tetraazadecalins 142,143 and bisimidazolidine 144 (Scheme 29).
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72 141 142 143 144
Schem e 29. Possible product o f  condensation o f  glyoxal and 1,2-diam ines
It was found that when R ^ H and when the diamine was in excess, the major 
product was the trans isomer 143, rather than the expected 2,3-dihydropyrazine92. With 
all other substituents, mixtures 142:143 were obtained. Katritzky calculated the energies 
for the isomerisation of 142 and 143 and showed that the trans 143 was the most 
preferred thermodynamic conformation93. When R = Bn, the major product was 
bisimidazolidine 144 at 0° C. If the reaction was run in refluxing ethanol, a mixture 143: 
144 was formed. Subsequently, Wilier and Moore postulated that the initial product of 
the cyclisation was the kinetic bisimidazolidine 14494.
A plausible explanation for the formation of bicyclic products involved the rates 
with which the intermediate 2,3-dihydroxypiperazines 145 either react with another 
mole o f 1,2-diamine leading to the decalin product 142 and 143, or undergo 
rearrangement to the carbaldehyde 146 leading to the bisimidazolidine derivative 144. 
By increasing the reaction time or performing the reaction at higher temperature, the 
kinetic product 144 was slowly converted into the most stable adduct 143.
145 146
During the preparation o f auxiliaries in asymmetric synthesis based on chiral 
diamines, reaction between aqueous glyoxal with A^A'-disubstituted-1,2-diamines 14795 
gave preferentially aldehyde-aminals 148, accompanied by a small amount of the 
piperazinone 149 (Scheme 30).
147 148 149
Schem e 30. R e a g e n ts  a n d  c o n d it io n s : (i) glyoxal, H20 ,  CH2C l2
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In 1941, Hayashi reported the formation of dihydropyrazines 140 as main 
product o f the same reaction starting from 1,2-diphenyl ethylenediamine96 (Scheme 31). 
In 1971, Darko disproved it by showing that lactam formation occurred. He proposed a 
mechanism for this cyclisation, involving the formation of a polar intermediate diaminol 
150 and an imino alcohol 151, which by a protonation-deprotonation sequence form the 
tautomeric lactam 15297.
140 150 151 152
Schem e 31. Preferential elimination o f  one m olecule o f  H20  for the formation o f  piperazinone 152
QO
1.2.3.2 Condensation o f glyoxal with triethylenetetraamine
Theoretically, the condensation of aqueous glyoxal with tetraamine 153 could 
result in any of the 2,6,9-trimethyl-1,3,6,9-tetraaza-cycloundecane 154, 155, and the 
decahydro-diimidazo[l,2-tf,2',r-c]pyrazine 156, and 157. Reaction in absolute ethanol 
at room temperature or in water or in acetonitrile" gave 154 and traces of 155100. In 
water in the presence of calcium hydroxide at 5° C it gave a mixture o f pyrazines 156, 
157 (Scheme 32).
CN h  H lN k  : /  \  s '  \  s '  s / \  s N  IN ..D C K 1 3 S-H-3 (rH-3n h 2h 2n n H K n  n H K n  n n  N
153 154 155 156 157
Schem e 32. R e a g e n ts  a n d  co n d itio n s:  (i) glyoxal, acetonitrile
When aqueous glyoxal was added slowly to a solution o f tetraamine 153 at 0° C, 
formation of the mixture 154:155:156:157 was observed. When the temperature was 
increased, an irreversible isomerisation of species favouring the isomer 157 was 
observed. Back to room temperature the mixture continued to change slowly (Table 4). 
It was found that the molecule o f water was necessary in the mechanism, because it 
opened the cycle to lead to the most stable conformation. The best procedure for 
preparing the c/s-adduct 154 was to run the reaction in presence of traces of water and 
with prolonged heating before the addition of the dielectrophile. Isomers 156, 157 were 
considered to be the kinetic products of the condensation that slowly convert into the 
more stable thermodynamic geminal derivatives 154 and 155.
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R eaction  condition 154 155 156 157
0 °C 60 10 10 20
80° C H20  traces 40 4 ....6.... 50
25° C 20 5 10 65
Tg , ------T able 4. Ratio o f  condensed compounds 154, 155, 156, 157 from C-NM R.
Dimethylglyoxal was used in order to prepare C-functionalised 
tetraazamacrocycles 159 in a similar fashion (Scheme 33)101.
n
NH HN
NH2H2N 
158 159
Schem e 33. R e a g e n ts  a n d  c o n d it io n s : (i) D im ethylglyoxal, CH3CN, 0° C, 2 h
1.2.3.3 Reaction o f N,N '-disubstituted 1,2-diamines and glyoxal'02
In the previous section, it was shown that the reaction of 1,2-diamines and 
glyoxal generally gives traces of piperazinones. However, changes and optimisation of 
the reaction conditions such as solvent, temperature and time, influence the formation of 
different products. A range of symmetric N,N '--disubstituted 1,2-diamines 72 were 
prepared and reacted with aqueous glyoxal in refluxing water for a maximum of 3 hours 
to give 2-piperazinones 76 in good yields except when the 1,2-diamine was aromatic 
76f (Scheme 34, Table 5).
________________R__________ 76 (%) Y ield
f _________ M e______________9 6 .4_______
  £ ___ ' Et  96.7
h  /-Pr  83.8 _~______
i_________ /-Bu_____________ 68.4______
d__________Bn_______________65
 1....................Ph.............................  10 .................
T able 5. N W -substituted piperazinones yields
When different substituents were present on the amino groups, reaction with 
aqueous glyoxal gave mixtures of products. The regioselectivity observed was probably 
directed by the higher nucleophilicity of aliphatic over aromatic amines. Consequently, 
2-piperazinones 161 were major constituents of the 161:162 mixtures, which was 
determined by formation of the most stable iminium ion during cyclisation (Scheme 35, 
Table 6).
i i
R R
72 141 76
Schem e 33 . Cyclisation between A^N'-disubstituted 
l ,2-diam ines and glyoxal
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c
RI
NH
NHI
R'
rV
160 161 162 
Schem e 35. R ea g e n ts  a n d  c o n d it io n s : (i) glyoxal, H20 ,  reflux, 1-24 h
R R % Y ield 161:162 ratio
a Me Ph 90 92:8
b Et Ph 95 96:4
c w-Pr Ph 89 98:2
d n -B u .......Ph.......... 99 98:2
e Me p-M eOPh 60 75:25
f Me Et 93 25:75
T able 6. Y ields and ratios o f  regioisomers 161 and 162 
p-Aminoalcohols react with glyoxal by addition of the amino group to the 
aldehyde function to give an iminium species 164 in a similar way to 1,2-diamines. 
However, oxazolidine 165 formation does not occur (cf. 148) but rather hemiacetal 166 
formation. The latter reacts with strong nucleophile (i.e. thiophenol) but otherwise 
undergo a head-to-tail dimerisation to give the tricyclic product 168103 (Scheme 36).
Ph'
.OH
NH
I
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r°
Ph'
164141
ax- .C M
Ph'' Ny * 
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,Ph
Ph'
165
.O^.OH 
Ph"'’ N©
166
Nu
© .O ^O H  
Ph' N Nu
167
Schem e 36. Formation o f  iminium ion and different mechanistic pathways
1.2.3.4 Glyoxal derivative
1.2.3.4.1 Methylglyoxal cyclisation
Methylglyoxal has been used as a condensation agent with linear tetramines in 
order to prepare selectively functionalised tetraazacycloalkanes. The first step of the 
reaction is the formation of the bis-aminal derivative 159 (Scheme 37).
M i M i M i
C - i . I . i - 1 . . , . .'N ' 'N '
H MeH
NH^N
158 159 160
Schem e 37 . R e a g e n ts  a n d  c o n d it io n s : (i) M ethylglyoxal; (ii) 1,3-Dibromopropane
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The second step is the condensation of the bis-aminal compound with 1,3- 
dibromopropane104. The major inconvenience was methylglyoxal polymerisation. 
Reactions were run at -10° C in ethanol in order to avoid the polymers formation and 
also to reduce of any isomerisation of the products105. There are no examples of 
preparation of 3-methyl-2-piperazinone in literature starting from methylglyoxal.
1.2.3.4.2 Phenylglyoxal cyclisation
Reactions o f phenylglyoxal with primary aliphatic amines give monoimines 
whereas reactions with aromatic amines give mixtures o f imines, amino-hydroxy- 
ketones106.
Phenylglyoxal also reacted with tetramines 170, in order to prepare bis-aminals 
171 at room temperature. In addition, piperazinones 172 can be yielded when the 
obtained bis-aminals are placed in refluxing water107. Bicyclic keto-aminals have also 
been prepared using phenylglyoxal in refluxing benzene (Scheme 38)108.
/— NH HN-1 — v . /— N ^ ^ - N — v .. y— NH/— N -^ ? -0
2 H2N— ' '— N ^ P ' N — '  ' — NH2— N ^ ^n h  n  > h
H Ph H H
170 171 172
Schem e 38. R e a g e n ts  a n d  c o n d it io n s : (i) Phenylglyoxal, rt; (ii) H20 ,  reflux
When phenylglyoxal was reacted with /-ephedrine 173, formation of a mixture 
of diastereoisomers 1,3-oxazolidines 174 and 175 was formed which slowly rearrange 
to the morpholine derivative 176 (35% conversion)109.
PhI 0H— PY w °  pv ° >  /
M e ^ N H  Me ^  ph NfcT N.  Ph
Me Me Me
173 174 175
pY ° y °
M e ^ ^ N  Ph 
Me 
176
Schem e 39. Slow  rearrangement o f  1 ,3-oxazolidines into morpholine
Synthesis o f chiral piperazinones can be done referring to the morpholine 
synthesis starting from P-aminoalcohols and phenylglyoxal 177 as observed in Agami
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work (Scheme 39). The higher nucleophilicity of the amino group over the hydroxyl 
group and the favourable formation of a lactone rather than a lactam lead to the 
formation of only one product (Scheme 40)’l0.
181 180
Schem e 40. M echanistic pathway o f  phenylglyoxal cyclisation
40
CHAPTER 2 Synthesis of secondary chiral 1,2-diamines
2.1 Introduction
In the preceding chapter, it was shown that chiral piperazinones are important 
motifs for the design of peptidomimetics and their preparation could be achieved by 
several approaches. In particular, when chiral 1,2-diamines were utilised as scaffolds for 
building the lactam rings, long reaction sequences were frequently required. If the 
chirality was attributed to one stereogenic centre only, the preparation of one 
regioisomer involved tedious transformations such as protection-deprotection steps of 
the reacting diamine and the use of a particular dielectrophile in order to avoid 
formation of a mixture of products. Increasing the number of chiral centres on the 
piperazinone rings caused a large number of problems for planning of synthetic routes 
due to the possibility of formation of many stereoisomers.
For this reason, our attention was focused on the investigation of a novel and 
simpler way to prepare substituted piperazinones in a regioselective way when only one 
chiral centre was present, and stereoselectively in the presence of two or more. 
Moreover, this investigation was strongly related to the final part of my PhD studies, 
which consisted in the total synthesis of a potential drug for the treatment of 
Alzheimer’s disease.
In particular, a range of (±) chiral N,N '-disubstituted 1,2-diamines 182a-e, with 
only one stereogenic centre at position 2, was prepared. Subsequently, they were reacted 
with achiral 1,2-dielectrophiles. Different N,A'-substituents were placed on the 
diamines in order to observe changes of amino group reactivity towards the 
dielectrophile. The descriptor (±) will be omitted, as it will be assumed that the 1,2- 
diamines prepared were racemic, unless the stereochemistry is specified.
The methoxymethyl group at position 2 was a fixed 
r  component on all the synthesised diamines. Besides
a Benzyl
b Cyciohexyi being the main substituent of our Mi muscarinic
c 2-Methoxyethyl
d Phenyl agonist target, it presented advantages such as easy
e  p-Methoxyphenyl J
detection by NMR and easy measurement of the 
starting material and product ratios.
NH
NH
182
2.1.1 Retrosynthetic approach for preparation of A^TV'-disubstituted 1,2-diamines 
182
One of the most logical retrosynthetic approaches for the preparation o f our 1,2- 
diamines 182a-e involved the cleavage of N1-C2 and C3-N4 to give a dielectrophilic 
compound 183. The addition o f amines to the latter adduct 183 was well know and easy 
to achieve via formation of a three membered ring intermediate. The intermediate 184 
can be prepared starting from the alkene 185 (Scheme 41).
R
c h 30 ' ^ | \ N H ____ ^  ch3o ^ V ' x  s  CH30 ^ j |   V, x ^ |
3 / ' n h  X4 I 
R
182 183 184 185
Schem e 41. Retrosynthesis for preparation o f  diamine 182 (X =  Cl, Br)
According to our retrosynthetic approach, preparation of racemic 1,2-diamines 
was achieved in three steps, starting from the commercially available allyl bromide 186 
(Scheme 41). Initial results within the study on regioselective cyclisations starting from
1,2-diamines run previously in my group (Elsa Garcia Borrell130, Paul Lewis111) showed 
that this route was successful for the preparation of dibenzyl diamines. The extension of 
this procedure for the preparation of different 1,2-diamines, with aliphatic or aromatic 
N ,N '-substituents was then attempted.
B r ^ ^ l i m C H aO "^! » ,  CH30 ^ ''S |^  iii  ^ CH30 '^ X ^
RI
NH
Br NHI
R
186 184 187 182
Schem e 42. R e a g e n ts  a n d  c o n d it io n s : (i) M eONa, MeOH; (ii) Br2, CH2Cl2; (iii) R -N H 2, xylene, /?-TsOH
The first diamine prepared was the dibenzyl derivative 182a and it was 
performed for the first time by EGB. At the beginning of my research project, the 
preparation of the dibenzyl diamine 182a was repeated in order to confirm the 
procedure.
2.1.1,1 Displacement o f  the bromide by methoxide
Following a literature route112, reaction of allyl bromide 186 with sodium 
methoxide in methanol afforded the allyl methyl ether 184 proceeding via SN2 or SN2' 
displacements. The desired ether 184 was very volatile with a boiling point o f 42° C and
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its purification from the reaction mixture, in particular from methanol, was arduous. At 
least three distillations were required, mainly due to the formation of hydrogen bonds 
between the ether 184 and methanol. However, traces o f methanol were usually present 
in the final purified ether 184 (65% calculated yield).
Sn2
c h 3ok  Br^
Sw2' 186
)___^ CH30 ^ |
184
2.1.1.2 Electrophilic addition o f bromine to a double bond
Methyl-3-(l,2-dibromopropyl) ether 189 was prepared in high purity and 
excellent yield (82 %). The mechanism of bromine addition to the alkene bond is well 
known113. It involves two steps starting with the attack o f the alkene bond by the 
electrophile bromine 188, to form a rc-complex, followed by formation of cyclic 
bromonium ion 189 and finally the nucleophilic attack by bromide. The reaction is an 
anti addition and the rate increases as the degree of substitution o f the alkene bond 
increases. The presence of methanol traces in the ether 184, could result in formation of 
by-products such as 190 and 191 but they were not observed.
187189184 188
OCH
OCH-
190 191
2.1.1.3 S;\2 displacement o f the benzylamine to the dibromide 187
The diversity o f the diamines 182a-e is due to the range of amines used in this 
step. The mechanism is exemplified by the benzyl case. The predicted mechanism Sn2 
displacement of the benzylamine 192 to the dibromide 187 involved the attack of 
benzylamine to displace the primary bromide followed by cyclisation to the 
intermediate aziridinium ion 194114. The first displacement would occur on the less 
hindered centre. Both the initial rate of attack and the rate o f formation of the 
aziridinium ion depend on the nucleophilicity o f the nitrogen lone pair.
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Traces o f p-toluenesulphonic acid were added to the reaction mixture in order to 
keep the tertiary amine in the intermediate 194 protonated and ready to be attacked by 
the second benzylamine, therefore avoiding the formation o f a stable aziridine adduct. 
Traces of the acid were enough to catalyse the first intermediates formed, until 
formation of hydrogen bromide that catalysed the rest of the reaction. The stability of 
the intermediate aziridinium ion depends on the nature o f the substituents on the 
nitrogen. The second molecule o f benzylamine again would attack the less hindered 
centre115 to yield the diamine 182a (Scheme 43). Attack o f the most hindered position 
occurs only when a benzylic position is present in the aziridine ring, due to the 
formation of the most stabilised carbocation116,117.
192
Schem e 43. SN2 mechanism o f  the benzylam ine to the dibrom ide
With benzylamine, a potential problem could occur by Sn2 substitution by a 
second molecule of benzylamine at the benzylic carbon of the aziridinium ion 194, to 
form the aziridine 195 and the vV-benzylbenzenamine 196. However, attack on the 
aziridine ring from the benzylamine is more favoured because of ring strain release and 
formation of the final acyclic product 196 (Scheme 44).
Bn
Nh2
CH30 /VWV ® /H J  ___  C H a O ^ V
 ** P  NH Ph N Ph
f  Ph M
B n -N H 2 194 195 196
Schem e 44. Secondary SN2 mechanism
2.2 Aliphatic 1,2-diamines
2.2.1 Synthesis of N ,N -dibenzyl-3-methoxy-propane-l,2-diamine 182a
Preparation of N ,N '-dibenzyl-3-methoxy-propane- 1,2-diamine 182a was carried 
out using the standard procedure; the slow addition o f methyl-3-(l,2-dibromopropyl) 
ether 187 to a refluxing solution of benzylamine (2.2 equivalents) in xylene, in presence 
o f traces of p-toluenesulphonic acid for 24 hours.
44
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Schem e 45. R e a g e n ts  a n d  c o n d itio n s:  (i) B nN H 2, xylene, />T sO H
Purification of the 1,2-diamine 182a from the crude mixture required filtration 
o f benzylamine hydrobromide, extraction from sodium hydroxide solution with ethyl 
acetate and finally purification by flash chromatography (75%). The major problem 
consisted in the separation o f the 1,2-diamine from the unreacted benzylamine. Flash 
chromatography was arduous, due to the high polarity of these compounds and to the 
similar Rf on TLC. All the *11-, 13C-NMR and HRMS data confirmed the postulated 
structure. Surprisingly, no formation of byproducts 195 and 196 was ever observed by 
TLC or NMR, although the aziridine 195 would be volatile.
2.2.1.1 Formation o f imidazolidine derivative
Unexpectedly, basic extraction of the diamine 182a at pH > 11 from 
dichloromethane gave another adduct, the imidazolidine derivative 199 (58% yield), 
formed by nuclophilic substitution o f dichloromethane by the diamine. NMR spectra of 
the crude mixture before the extraction showed the expected signals for the desired 
compound 182a, by direct comparison with the standard diamine previously prepared. 
After extraction, new signals were found in the NMR spectra and TLC displayed a new 
apolar spot (Rf= 0.23 in petroleum ether: diethyl ether, 1:1). When the dibenzyl diamine 
182a was refluxed in dichloromethane alone, complete conversion into imidazolidine 
derivative required 13 days (85% yield). Hence the reaction proceeded very quickly at 
high pH.
The postulated mechanism for formation o f the byproduct 199 involves the Sn2 
from one amino group to the dichloromethane and intramolecular cyclisation, which 
could happen in two possible ways: either via formation of iminium chloride followed 
by a 5-endo-trig cyclisation, or via direct Sn2 of the 7V-chloro derivative in the 5-exo-tet 
mode.
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H3 C O ^ Y N"  ^ Cl H3 C O ' ^ Y NtX  _ ^ H 3CO 5-endo-trig H3CO
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Bn Bn Bn
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Schem e 46. S N2 o f  1,2-diamine to dichloromethane
Evidence of the formation of A-chloromethyl derivative 197 was found in the 
literature, when pyrrolidine was placed in dichloromethane at room temperature. 
However, the higher concentration of the iminium chloride 201 than the A-chloromethyl
1 1 o
derivative 200 in solution was shown by NMR
o
j
V 'N ©  C l°
cr
200 201
The strongly electrophilic iminium intermediate 202 could easily undergo a fast 
reaction in presence o f a suitable nucleophile inter- or intramolecularly. Bicyclic 
systems such as pyrroloimidazolone 203 were isolated in high yield by intramolecular 
Sn2 from the amide amino group to the iminium chloride119. The formation of the 
iminium ion would also justify the 5-endo-Xrig cyclisation, which is not favoured 
according to Baldwin’s rules120.
0 ' ~ c o n h 2 -  Q v °
K  ^  —^ NH
202 203
To the best o f my knowledge, there is only one example closely related to our 
case, which reported the formation of imidazolidine rings by direct Sn2  o f a 1 ,2 -diamine 
to dichloromethane121 by a 1,2-diamine, in presence of potassium carbonate. The 
procedure required three days in refluxing dichloromethane in order to have complete 
conversion into the desired product. However, more common procedures are the 
reactions o f 1,2-diamines with formaldehyde. Reaction o f A-Zso-propylethylenediamine 
204 with formaldehyde 205, in presence of magnesium sulphate and potassium 
carbonate gave the imidazolidine ring 208 in high yield122 (Scheme 47). Also in this 
case, formation of the iminium intermediate allowed the 5-endo-Xng cyclisation.
Scheme 47. Mechanistic pathway of formation of imidazolidine ring
2.2.2 Preparation of Ar,Ar-dicyclohexyl-pentane-l,2-diamine 182b and 3-methoxy- 
AyV'-bis-(2-methoxy-ethyl)-propane-l, 2-diamine 182c
Similarly to the preparation of the benzylamine derivative 182a, 
cyclohexylamine 209 and 2-methoxyethylamine 210 were reacted with methyl-3-(l,2- 
dibromopropyl) ether 187 for the preparation o f MN'-dicyclohexyl- 182b and 3- 
methoxy-MAr'-bis-(2-methoxy-ethyl)-propane- 1,2-diamine 182c, following the standard 
procedure but the yields obtained were quite poor (182b, 25%; 182c 32%). In the case 
o f the cyclohexylamine displacement, solvent concentration was decreased until the 
reaction was run in neat cyclohexylamine, but no improvement was achieved. *H-NMR 
spectra of the crude mixtures showed a mixture o f compounds, which was purified by 
flash chromatography resulting in pure diamine 182b.
In case of the 2-methoxyethylamine, purification was not required because the 
'H-NMR spectra and TLC of the crude mixture after 24 hours in refluxing toluene only 
showed one compound. Extraction of the adduct 182c after basic washes was arduous, 
due to the high water solubility of this diamine. Dichloromethane, chloroform and ethyl 
acetate were all used as extracting solvent but the highest yield obtained was 32%.
2.2.3 Proof of the structures for chiral 1,2-diamines
Each diastereotopic proton, H2 - 3  and H2 - 5  appeared as a double of doublet (dd) 
at different chemical shifts (mostly between 3-4 ppm) in the 'H-NMR. H3 - 6  was a 
singlet (s) at around 3.3 ppm and it was our guide signal for measurement o f protons
182c
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ratios. H-2 appeared as a complex multiplet due to the presence o f four non-equivalent 
vicinal protons. Carbon peaks were assigned using 13C-DEPT and HMBC spectra. NH 
peaks were observed in the 1 H-NMR as a very broad singlet in the downfield region. 
Direct correlation o f geminal protons and corresponding carbon was seen in the HMQC 
( 1* /h ,c )  spectra and unambiguous assignment of each proton and carbon was achieved 
using the long-range coupling observed in the HMBC ( 3* /h ,c )  spectra. IR spectra 
displayed a broad peak at 3400 cm ' 1 which was attributed to NH stretching. The 
accurate mass peak measurements confirmed the expected molecular ions.
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1 H-NMR spectra o f diamine 182b showed H 3 - 6  as a singlet at 8  3.3 ppm and all
the other protons o f the backbone gave the expected splittings. In particular, H-7 gave a
multiplet at 8  2.65 ppm and H - 8  gave a triplet o f triplets (11.2, 3.7 Hz) at 8  2.92 ppm.
The 1 H-NMR spectra o f diamine 182c showed many overlapping signals. Each
diastereotopic proton at C-3 and C-7 appeared as double o f doublet at different shifts ( 8
2.53, 2.65, 2.78, 2.8 ppm respectively for protons a and b). H 3 - 6  gave the expected
singlet at 8  3.28 ppm but surprisingly, H3-9 and H3-12 gave only one singlet, integrating
1 2to six protons, at 8  3.29 ppm. C-NMR showed the presence o f all the expected signals 
and unambiguous assignment was done by HMBC.
2.3 Aromatic 1,2-diamines
2.3.1 Synthesis of aniline- and p-methoxyaniline derivatives
Methyl 3-(l,2-dibromopropyl) ether 187 was reacted with aniline 211 and p- 
anisidine 2 1 2  under similar conditions used for the benzylamine reaction.
The reaction required 50 hrs in refluxing xylene, compared to the 20 hrs for the 
benzylamine displacement, due to the expected lesser nucleophilicity o f aromatic 
amines. Longer reaction times and slower addition of the electrophile gave excellent 
yield of the desired adducts. The reaction progress was easily monitored by TLC, run in 
ethyl acetate:ethanol, 90:10. The diamines were purified by flash chromatography using 
a final gradient o f ethyl acetate, ethanol for elution (85% yield for both diamines 182d-
e).
2.3.1.1 Methyl N,N -diphenyl-2,3-diaminopropyl ether 182d
The singlet for the methoxy group (8 3.4 ppm) was 
correlated by 3J  to C-5 and LL-5 were correlated to C-3. 
Long-range couplings (HMBC) in conjunction with COSY 
spectra allowed unambiguous assignments for all protons 
and carbons. Moreover, it allowed avoiding the deep 
F igure 17. J correlations analysis of the complicated multiplet o f H-2 (Figure 17).
Many overlapped signals were displayed in the aromatic region and consequently it was 
not possible to assign them. It was also possible to observe 2J h ,c  correlations between 
H2-5 and H2 - 3  with C-2.
2.3.1.2 Conformational analysis o f methyl N,N '-diphenyl-2,3-diaminopropyl ether 
182d
The molecular mechanics calculations for our compounds were done using PC 
Model 8. The software found the stable conformations according to the lowest energy 
possible for the structure. The forcefield is called MMX and derived directly from 
MM3. The most likely conformation for methyl N ,N '-diphenyl-2,3-diaminopropyl ether 
182d possesses an hydrogen bond between the amino group far from the chiral centre 
and the oxygen o f the methoxy group (PC Model 8) to form a six-membered ring. The 
hydrogen length was 1.535 A and the MMX energy found was 18.882 kcal. In principle,
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another hydrogen bond could be draw between N-l and the oxygen, giving a five 
membered ring. PC Model 8 did not give any stable conformation for the compound 
182d-II (Figure 18).
182d-l
1 8 2 d-l l
F igure 18. PC M odel 8 
representation o f  diamine 182d
2.3.1.3 Methyl N,N -di-(p-methoxy)phenyl-2,3-diaminopropyl ether 182e
182e
!H- and 13C-NMR data for diamine 182e were almost the same as 
those for 182d, except for the appearance o f extra signals for the 
two methoxy groups on the phenyl rings (8 3.49, 3.52 ppm, H3 - 7
and H3 - 8  respectively). The molecular mechanics software (PC
Model 8) showed that this compound possessed very low energy 
state (17.151 kcal) when a hydrogen bond (1.914 A) was present 
between the amino group at position 4 and oxygen o f methoxy at 
5, as seen for the dianilino derivative 182d-I.
The presence of /?-methoxyphenyl groups created the same steric effects as the
unsubstituted phenyl groups in 173e but the nitrogens could result in slightly higher
nucleophilicity, due to the presence o f a rc-donor.
NH
OCH3
2.4 Synthesis o f  achiral secondary l f2-diamine: N ,N f-dibenzylbenzene-
1,2-diamine 214
One achiral aromatic 1,2-diamine was also prepared in order to have a substrate 
that would not give chiral products when cyclisations were attempted. N,N'-
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dibenzylbenzene-1 ,2 -diamine was chosen for this purpose and two preparative methods 
were investigated.
2.4.1 Reductive amination
Our first attempt was the reductive amination of o-phenylenediamine 212 with 
benzaldehyde 213 in presence of sodium borohydride and iodine (Scheme 50)123 in 
methanol. It was reported that the diamine 214 was obtained in high yield (78%) under 
those reaction conditions.
i
214212 213
S chem e 50. R e a g e n ts  a n d  c o n d itio n s :  (i) N aBH 4,1 2, M eOH
The intended mechanism of the reductive amination involved initial formation of the 
aminol 215 which should dehydrate to form an imine. Under the reaction conditions, 
(which are usually weakly acidic to neutral) imines are protonated to form iminium ions 
which can be reduced with sodium borohydride or sodium triacetoxyborohydride124 to 
yield the alkylated amine product 214 (Scheme 49).
Ph
215
Ph
216 213213212
Reduction
214 218 217
Schem e 49. M echanism o f  reductive amination
In our case, reductive amination reaction did not proceed as expected since only traces 
of the desired diamine 214 were shown by 1 H-NMR spectra. TLC showed many spots 
and purification by flash chromatography gave the byproduct l-benzyl-2 - 
phenylbenzimidazole derivative 223 (30%) as the main reaction adduct. NMR data were 
compared with the literature values and they were consistent with the postulated 
structure, which is derived from a secondary mechanism involving intramolecular
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nucleophilic substitution from the primary amine to the carbon bonded to the iminium 
ion to form a five membered ring intermediate 219. Further reactions led to formation of 
the stable adduct 223 (Scheme 50).
r ±
r U O  H H -
! K / ph (/ ' V ' p = / Ph
H
„  X  r-» — I I >-ph
H2 h
215 216 219 2-Phenylbenzimidazole
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\  r \  Ph. Hw  PhPh. Ph Dk . .©
223 1-Benzyl- 222
2-phenylbenzimidazole
lf ~ Ph —  II JL 2 r Ph —  II I > ^ P h  —  V - P h
N
H H
214
221 220 
Schem e 48. M echanism o f  formation o f  b icyclic products 219  and 223  
2.4.2 Dibenzoylation-Reduction
The successful procedure was a two-step sequence involving the dibenzoylation of o- 
phenylendiamine 212 followed by reduction with lithium aluminium hydride. N,N'- 
dibenzylbenzene-1,2-diamine 213 was obtained in 85% overall yield126 (Scheme 51).
aNH CO -Ph —NH CO -Ph
212 224 225
S chem e 51. R e a g e n ts  a n d  c o n d itio n s :  (i) NaOH, 87%; (ii) L iAlH4, THF, 5 h, 98% .
2.4.2.1 Dibenzoylation o f o-phenylenediamine 212
The diamide, Ar-[2-(benzoylamino)phenyl]benzamide 225 was prepared in high 
yield (87%). It was highly insoluble in a large range o f solvents. The melting point 
found was 310° C, which suggested the formation of hydrogen bonds with a rigid 
structure. When the white solid 225 was crystallised from refluxing DMF, yellow 
needle crystals were obtained after the solution cooled down. 'H-NMR spectra o f the 
crystals in DMSO showed the presence of 14 aromatic protons and the NH groups at 5 
10.5 ppm. ,3C-NMR showed the C =0 at 5 165.9 ppm and many overlapped signals in 
the aromatic regions. NMR did not give us much information about this compound but 
fragmentation found in the mass spectrum (AP+) was quite indicative for this diamide. 
The main peaks observed were at 317 (48%, M +l), 195 (35%, M- PhCO O ) and 122
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(100%, PhCOO). This data matched the values found in literature127. The postulated 
mechanism of fragmentation is shown below. The loss o f the benzoate is favoured and 
is the driving force of the fragmentation cascade. We were intrigued by the 
extraordinary insolubility of the dibenzamide and obtained an X-ray crystal structure to 
shed more light on its origin.
• O PhCOO*
Ph
225
N
H
226
HN:>
Gp—  Ph
N
H
Ph
227 228
J —  Ph
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N 
H
229
Schem e 52. Fragmentation mechanism o f  diam ide 225
2.4.2.1.1 X-Ray o f  crystals ofN-[2-(benzoylamino)phenyl]benzamide diamide 225
In the X-ray crystal structure the two monosubstituted aromatic rings and the 
amide groups lie almost perpendicular to the disubstituted aromatic rings. The 
dibenzamides are arranged in columns with alternate layers in the same orientation and 
there is a 180° turn between each layer. Each amide group is involved in hydrogen 
bonding between the carbonyl group as acceptor in one direction peprpendicular to the 
plane and the NH group as donor in the opposite direction (distance 2.063 A). The 
disubstituted aromatic rings in one column intermesh with the two monosubstituted 
rings o f the adjacent column. The crystal overall consists of alternate layers with the 
same arrangement of bonding but orientated at 180° to each other (Figure 19, 20).
Figure 19. O ff angle dibenzoate trimer 225 F igure 20. Eclipsed dibenzoate trimer 225
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2.4.2.2 Reduction o f the diamide 225 to give N,N'-dibenzylbenzene-ly2-diamine 214
214
Figure 21. PC M odel 8 representation (M M X  energy 28.315  
kcal m ol'1)
The diamide 225 was successfully reduced using lithium aluminium hydride (4
1 -)0
equivalents) according to a known procedure . The diamine 214 was obtained as an 
amber clear oil in high yield (98 %). ’H-NMR spectra of the diamine 214 showed only 
two distinct signals, a doublet (5.8 Hz at 8  4.24 ppm) for the methylene groups and a 
triplet (5.4 Hz at 8  3.58 ppm) for the amino groups. 13C-NMR showed only one CH2 at 
8  48.84 ppm and many overlapped signals in the aromatic region (111.98- 139.45 ppm). 
The structure was confirmed by high resolution mass spectrum and by comparison to 
literature values129.
2.5 Conclusions
In conclusion, four new chiral 1,2-diamines have been successfully prepared in 
three steps starting from allyl bromide. Yields for the diamines with aliphatic N ,N -  
substituents were low (25-32%) whereas aromatic N ,N '-substituents diamines were 
prepared in high yield (85%).
The preparation of imidazolidine adducts by fast addition o f dichloromethane to the 
dibenzyl 1 ,2 -diamine in basic solution was performed which was unknown in the 
literature.
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Chapter 3 Cyclisation of 1,2-diamines and haloacetates
3.1 Introduction
With stocks of the diamines in hand, we turned to methods for the preparation of 
piperazinones. Secondary 1,2-diamines 72 react quickly with dielectrophiles such as 
alkyl bromoacetates 230 (section 1.2.1.2). As expected, the bromide is displaced first 
the alkoxy group. This yields the monoester intermediate 231, which cyclises by 6 -exo­
trig attack of the ester by the amino group to yield the piperazinone 76. If cyclisation 
occurs slowly the diesters 233 are the main products.
R o  
233
Schem e 53. M echanism o f  cyclisation o f  secondary 1,2-diamine and ethyl bromoacetate
The structure of the alkoxy leaving groups on the ester is crucial for controlling 
selectivity. With methoxy leaving groups cyclisation to the piperazinone 76 virtually 
always occurs. Whereas with ethoxy leaving groups, the outcome depends on the 
temperature and the ratio of diamine to haloacetate. At high temperatures and a 1:1 ratio 
of diamine to bromoacetate, cyclisation gives the piperazinone 76, but at 0°C and a high 
ratio of bromoacetate to diamine (e.g. 5:1) the diesters 233c are formed. With f-butoxy 
leaving groups, cyclisation seldom if ever occurs and the main products are the diesters 
233c. No significant difference was observed in the reactions o f bromo- and chloro- 
acetates with diamines130.
3.1.1 Basis of w ork
When a stereogenic centre is present on the ethylene bridge o f the 1,2-diamine 
76, the behaviour o f the two amino groups towards the electrophile is different.
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Schem e 54. Possible attacks o f  the diamines to the ethyl bromoacetate
It was believed that the presence of the chiral centre at position 2 could create a 
greater steric hindrance effect for N-l than for N-4 but the nucleophilic character of 
both amino groups should not be affected. It was therefore anticipated that there should 
be a preference for the formation of piperazinone 238, with one equivalent of ethyl 
bromoacetate. Moreover, few examples in literature are known of preferential or faster 
attack o f the amino group far from hindered centres as the first part o f the reaction 
(route b, Scheme 54). The decreased reactivity of amino groups adjacent to the chiral 
centre was shown during the formation of piperazinone in reasonable yield (17- 57%) 
by reacting primary diamines, with stereogenic centre in position 2, with 3 equivalents 
of bromoacetic acid (Scheme 55). Most plausibly the lactam ring would form from 
incomplete carboxymethylation of the nitrogen closest to the phenyl substituent with 
subsequent ring closure, due to the lower reactivity of N - l131.
c h 2c o o h
NH-
NH2
c h 2c o o h c h 2c o o h
239 240 241
Schem e 55. Carboxymethylation o f  primary diamines. R e a g e n ts  a n d  c o n d itio n s ', (i) 6 eq. brom oacetic
acid, H20 ,  N a H C 0 3, 45°C ; (ii) HCl pH= 1
3.1.2 Previous w ork on cyclisation of 7V,./V-dibenzyl-3-methoxy-propane-l,2- 
diamine 182a
The cyclisation between A^TV-dibenzyl-S-methoxy-propane- 1,2-diamine 182a 
and ethyl bromoacetate 8 8  was deeply explored in the past few years in my group by 
EGB. Surprisingly, regioselective formation of one piperazinone over the other was 
always observed in all the attempts. Ratios found were -9 0 :1 0  for 243:244 (Table 7).
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The standard procedure of the reaction consisted in the slow addition of the 
dielectrophile in slight excess, to a mixture of 1 ,2 -diamines and 1 .1  mole equivalents of 
Hunig’s base in refluxing xylene for 24 hours. Reactions were easily monitored by 
TLC, yields were excellent and the products were successfully purified by flash 
chromatography.
Bn ''vi Bn Bn
I J. 1 1
R ^ N H  EtO ' Y '  RV / N^ °  - N
r1" T  > = 0  J  R ' " T  j  R-
NH \  165°C *  N "N
1 Br I I
Bn Bn Bn
182a 88 243 244
R R' 243 244
a H CH2OCH3 90 10
b H c h 3 89 11
c H Ph 95 5
d c h 3 .... CH3.... 80 20
T able 7. Cyclisation results o f  Elsa G. Borrell MA^-dibenzyl-1,2 diamines with ethyl bromoacetate 130
Since the two piperazinones 243 and 244 were regioisomers, they showed very 
similar Rf on TLC, hence the best method to guarantee their separation was to elute the 
column with a solvent gradient, usually starting from neat petroleum ether and slowly 
adding diethyl ether. This experiment was the starting point of my project and it was 
repeated under different conditions until the ratio 96:4 of products 243a:244a was 
obtained when the reaction was performed at room temperature.
Different dielectrophiles such as methyl bromoacetate and ethyl chloroacetate 
were utilised for the cyclisation and the regioselectivity was always observed, although 
yields obtained varied. In particular, methyl bromoacetate was mainly used when the 
cyclisation was slow, because displacement of the methoxy substituent was faster than 
ethoxy.
3,2 Aliphatic and aromatic l f2-diamines
In all the previous examples, benzylamines gave piperazinones regioselectively 
and in high yield. My investigation was focused on the extension of this procedure to 
new diamines with aliphatic and aromatic A^N'-substituents. Our expectation was to 
observe preferential formation of one regioisomer over the other, also when the 
reactivity of the amino groups was modified by the presence o f different substituents. It
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appeared possible that steric hindrance would have a larger effect with more weakly 
nucleophilic aromatic amines and hence enhance the regioselectivity.
3.2.1 Cyclisation of aliphatic diamines with ethyl bromoacetate
When 7V,AT-dicyclohexyl-pentane- 1,2-diamine 182b and 3-methoxy-Af,A'-bis-(2- 
methoxy-ethyl)-propane-1 ,2 -diamine 182c were reacted with five equivalents o f ethyl 
bromoacetate, the diesters 245b-c were the sole isolated products. But with 1.5 
equivalents of ethyl bromoacetate, the diesters 245b-c were formed as main products,
accompanied by unreacted starting materials.
r  o  
i J f
H3CO'/ S Y ' N"N / X)Et b R  = C6H11 65%  yield
/ v ^ O E t  c R  = CH2CH2OCH3 76% yield
? T
R O 
245
However, when an equimolar amount of methyl bromoacetate was added very 
slowly to the diamines 182 at reflux, formation of piperazinones 246, 247 was observed 
by TLC monitoring. As expected, the piperazinones appeared as close running spots 
which ran faster than the highly polar starting materials. When the amount o f methyl 
bromoacetate was adjusted and the reaction conditions optimised, a 90:10 ratio of 
piperazinones 246, 247 was observed by ‘H-NMR spectra of the crude mixtures.
Measurement o f ratio was done on the integrations found for the methoxy 
groups. Upon basic work up and flash chromatography, analytical pure samples were 
obtained (Table 8). The aliphatic derivatives 182b and 182c showed lower propensity to 
cyclise than the benzyl analogue 182a although their reactivity was expected to be 
similar. This is probably a consequence o f their greater flexibility (compared to the 
benzyl analogues) and hence a lower propensity to adopt conformations suitable for 
cyclisation.
R R RI I I
h 3c o ^  y  V . Q _____ H3c o ^ y  ^  H3CO ^
l
R
182b-e
Br 1
R
246
l
R
247
R Ratio 246:247 Yield 246, % Reaction tim e, hours
b CfiHn 90:10 75 20
c CH3OCH2CH2 90:10 50 138
d Ph 90:10 35 140
e /?-CH3OPh 95:5 30 (both) 140
T ab le 8. Ratio and yields for cyclisations o f  aliphatic and aromatic diam ines 182b-e
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3.2.2 Cyclisation of A^V-diphenyl-3-methoxy-propane-l,2-diamine 182b
The aim o f these cyclisations was to determine if  the regioselectivity achieved 
with benzyl and aliphatic diamines was maintained with aromatic diamines which are 
less nucleophilic. A, A-Diphenyl-3-methoxy-propane-1,2-diamine 182d was reacted 
with ethyl bromoacetate 8 8  according to our standard procedure. The ratio o f 
regioisomers 246d:247d found in the 1 H-NMR spectra o f the crude mixture was 90:10.
The reaction was not complete after the standard 24 hours o f reflux and the 
degree o f conversion into products was ~30%. At that stage, the ratio o f 246d: 247d 
became 92:8. After basic washes and extraction with ethyl acetate, the crude material 
was purified by flash chromatography but the yields o f the two regioisomers were low 
(30%). Probably, this was due to the reduced nucleophilic character o f the aniline 
derivative. This cyclisation needed more arduous conditions in order to go to 
completion. The best result in terms o f ratio and yields was obtained running the 
reaction for 140 hours at reflux. The ratio for piperazinones 246d:247d was 90:10. 
Upon work up and flash chromatography, analytically pure samples were obtained 
(Table 8 ).
When the /?-methoxyphenyldiamine 182e was reacted with ethyl bromoacetate, 
the ratio o f 246e:247e found after 24 hours was 95:5. Once again, the crude was 
purified by flash chromatography but a mixture o f regioisomers 246e:247e was isolated 
(Table 8 ). This represented the most selective cyclisation with ethyl bromoacetate 
performed at reflux temperature.
3.3 Proof o f structure for 2-piperazinones
3.3.1 NMR of N ,N -l,4-diaryl-6-methoxymethyl-piperazin-2-one 246d-e
The formation o f the lactam ring for the 2-piperazinones was evidenced by IR 
peaks between 1660 and 1645 cm '1, consistent with C =0 stretching in a 6 -membered 
lactam ring. The mass spectra (APCI) showed the expected protonated molecular ions. 
For piperazinone 246d, 1 H-NMR spectra showed three pairs o f  signals for the 
methylene groups: H2 - 3  gave two doublets with large coupling constants (17 Hz) at 6  
3.8 and 4.1 ppm; H2 - 5  gave two double o f doublet at 6  3.35 and 4.05 ppm; H2 - 7  gave 
one apparent triplet and one double o f doublet at 6  3.3 and 3.55 ppm. H - 6  gave a
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doublet of quartets and was useful to assign the axial and equatorial positions of each 
proton in the ring.
The methoxy group gave a sharp singlet at 5 3.21 ppm, which was used for 
calculation o f the aromatic:aliphatic ratio of protons. The ,3C-NMR spectra in 
conjunction with the DEPT data showed three methylene carbons, one CH, one methyl 
group and one carbonyl group. The highest frequency signal was for C-2 at 5 168.3 
ppm. The assignment was based on observation o f long-range coupling HMBC, which 
also resulted to be the only technique useful to distinguish 246d  from its regioisomer. 
An interesting effect was observed for Heq-5 and Heq-3 which were engaged in a “W” 
coupling (1.3 Hz).
Hax Hax
246d-e
F igure 22. “W ” coupling constant
Similarly, the 1 H-NMR spectra of piperazinone 2 46e  showed three pairs o f 
signals for the methylene groups at position 3, 5 and 7 and three singlets for methoxy 
groups at position 9, and those at para positions ( 8  3.0, 3.39 and 3.43 ppm respectively). 
Heq-3 showed A “W” coupling with Heq-5 of 1.4 Hz as reported above (cf. 2 4 6 d ).
3.3.L I  Conformational analysis o f N,N'-1,4-diphenyl-6-methoxymethyl-piperazin-2- 
one 246d
Piperazinones generally exist as a twisted half chair or sofa conformer. Atoms 
C-6 , N -l and C2 and the carbonyl oxygen define a plane, which is the “seat o f the 
chair”. C3- and C-5 lie just above and below this plane and N-4 is above the plane and 
constitutes the “back”. In principle the substituent at C - 6  can be in the axial or the 
equatorial position, but coupling constant data between H - 6  and H2 - 5  suggest it is in the 
axial position. The coupling constants between the signals for H - 6  and H-5a or H-5b are
3.3, 2.6 Hz. These low values indicate that H - 6  must be in the equatorial position, 
because in the axial position it would have a large coupling constant with Hax-5. This
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was confirmed by molecular modelling and estimation of the coupling constants using 
PC-Model (Table 9).
Coupling constants
Observed Calculated
“H -6 eq” H -6 eq H -6 ax
Hax-5 3.3 3.48 11.29
Heq-5 2 .6 2.09 3.29
T ab le 9. Coupling constants o f  vicinal protons observed and estimated by PC-M odel 8
Although it might be expected that the conformer with the 6 -substituent in the 
equatorial position would be the most stable, PC-Model showed most stable conformer 
had the methoxymethyl group in the axial position (energy calculated using PC Model 8  
indicated a ratio for axial:equatorial conformers of 92:8 at 25°C, Figure 23). A similar 
case was found in literature describing the preferred conformations o f A-Cbz-2-alkyl-4- 
hydroxy-piperidines132,133.
F igure 23 . M ethoxym ethyl group present in the axial position for piperazinone 246d  (M M X  Energy 
27 .559  kcal m ol'1)
The 6 -substituted piperazinone should show a V  correlation between the 
carbonyl group C-2 and H-6 . If H - 6  was axial, the bond angle between dihedral angle 
H-6 , C-6 , N -l, C-2 should have been -150° (from molecular modelling) which enables 
a quite strong signal for that correlation. No correlation signal was observed, however 
this is not definitive because the signal for the H - 6  is a broad signal hence it could have 
not appeared in the 3 J h , c  because o f its low intensity and hence difficult to observe.
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OCH
Ph
246d 6-piperazinone
By modelling the piperazinone 246d with PC Model 8 , we found that the energy 
calculated for methoxymethyl group in the axial:equatorial conformers gave a ratio of 
94:6, axial equatorial at 25°C. This is essentially the same result as in the aniline 
derivative 246d.
3.3.1.2 X-Ray Crystallographic data for N,N -1,4-diphenyl-6-methoxymethyl- 
piperazin-2-one 246d
Single needle crystals o f piperazinone 246d were obtained by slow evaporation 
of a mixture of petroleum ether and diethyl ether. X-Ray diffraction crystal 
determination yielded the structure shown below (Figure 24). The heterocyclic ring 
appeared almost planar and the methoxymethyl group was in axial position, as predicted 
by the coupling constants calculation. N-l [= N(2), crystallographic numbering], C-2 [= 
C(8 )] and C- 6  [= C(10)] lay in the same plane, perpendicular to the adjacent phenyl 
ring. Therefore, the conformation of the piperazinone ring seems a “sofa” where only C- 
3 [= C(7)] and C-5 [= C(9)] are out of the plane. The two phenyl rings lay in two planes 
which are nearly perpendicular to each other.
Figure 24. X-Ray Crystal structure o f  A^ ,Ar-l,4-diphenyl-6-m ethoxym ethyl-piperazin-2-one 246d
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3.3.2 NMR of TVjTV-M-diphenyl-S-methoxymethyl-piperazin-l-one 247d
"y Similar to H2 - 3  for 6-piperazinone, each proton appeared as a
'Y  doublet with a large coupling constant (17 Hz) at 5 3.9 and 4.1 ppm.
"in 2 o Unfortunately, H-5 gave a multiplet and it was overlapped with the
^  H-NMR spectra showed a sharp singlet for H3 - 9  at 8 3.28 ppm.
doublet o f one proton at position 3.
By measuring the coupling constants for H2 - 6  and H2-7 , it was postulated that H- 
5 was equatorial and subsequently the methoxymethyl group was again in the axial 
position. The coupling constants found for H2 - 6  and H2 - 7  were small (3.6, 2.4 Hz for 
H2 - 6  to H-5 and (9.5 Hz and 4.5 Hz for H2-7 to H-5). The large and small coupling 
constant to H2 - 7  indicate that the side chain was fully staggered relative to H-5. The 
13C-NMR spectra in conjunction with the DEPT data showed three methylene carbons, 
one aliphatic CH, one methyl group and one carbonyl group, beside the aromatic CH.
3.3.2.1 Modelling ofN,N'-l,4-diphenyl-5-methoxymethyl-piperazin-2-one 247d
According to the angles calculated with PC Model 8 , we would have expected 
one strong signal (172°) and one weak signal (73°) for H2 - 6  and C=0. What it was 
actually seen in the HMBC spectra were two strong signals, probably due to an 
overlapping of signals of 2 J correlation between H2 - 3  and C-2.
Moreover, the MMX energy favoured the methoxymethyl in the axial position, giving 
the lowest energy value ( - 2 2  kcal mol*1).
247d 5-piperazinone
Important information was provided by the 3J  
correlation between H2 - 5  and C-3. A very weak 
signal was observed, in accord with the 
calculated angle (-110°). Moreover, there were 
strong signals for the 2J  correlation between H2- 
3 and the C-2 and H2 - 6  and H2 - 7  with the C-5. 
All the data confirmed the postulated structure.S
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c 5 -a x 5 -e q 5 6-fl.v 6 -e q 7a 7b
2 109.8(2) 109.8(2) - 74.8(3) 167.1(3) - -
3 - - 147.4(3) - - - -
5 106.5(3) 133.9(3) 111.3(2) 111.7(2) 112.6(2) 112.6(2)
6 - - 110.7(2) - - 64 .0(3) 177.5(3)
7 - - 108.1(2) 178.9(3) 61.6(3) - -
9 - - - - 52 .7(3) 61 .5(3)
(Figure 25)
N .Af'-M -diphenyl-S-m ethoxym ethyl-piperazin^-one 247d
Figure 25. Methoxymethyl group in axial position Figure 26. M ethoxym ethyl group in equatorial 
(M M X energy 29.468 kcal m o l ') position (M M X Energy 29.541 kcal m ol'1)
The same angles were also measured for the conformer with methoxymethyl 
group in equatorial positions in order to have the other possible set o f data to compare 
against the NMR signals.
C 5 -a x 5 -e q 5 6 -a x 6 -e q 7a 7b
2 108.9(2) 107.3(2) - 73.3(3) 172.6(3) - -
3 - - 110.7(3) - - - -
5 83.3(3) 157.1(3) - 111.3(2) 111.3(2) 112.5(2) 110.0(2)
6 - - 111.4(2) - - 177.8(3) 63 .8 (3 )
7 - - 109.6(2) 52.6(3) 64.2(3) - -
9 - -
T~,— 7 — r -
- 57 .6(3) 56 .5 (3 )
247d (Figure 26)
3.3.3 Conclusions
Methyl N ,N '-diphenyl-2,3-diaminopropyl ether 182d reacted poorly with ethyl 
bromoacetate, and the yields of purified compound were low (-30%).
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However the ratio of regioisomers observed was 
90:10 for 246d:247d hence the reaction was 
H3c o ^ Y Nvf^ °  h3C0 ^ Y "N%1 highly regioselective. In order to optimise the
standard procedure for aniline derivatives, 1 ,2 - 
dianilinoethane 721 was chosen to attempt the 
cyclisation reactions.
246d 247d
k X
3.4 Control reactions
The advantage of using an achiral starting material comes from the easiness for 
data interpretation, besides being a “cheaper” reagent. Formation of one product only in 
the region of piperazinone could be easily monitored by TLC and the NMR spectra 
would present simpler signals to interpret.
3.4.1 Cyclisation of 1,2-dianilinoethane 721 with methyl bromoacetate 230a
The first attempt for this cyclisation was done placing the diamine 721 with ethyl 
bromoacetate for 24 hours in refluxing xylene, according to the standard procedure. 
After the standard reaction time, TLC and NMR of the crude mixture showed a mixture 
of products. Upon purification by flash chromatography, 1,4-diphenylpiperazin-2-one 
761 (10%), the diester 248 (33%) and the monoester 249 (31%) derivatives were 
isolated (Scheme 56).
r NNH
a R = CH3 
b R = Et
761 248 249721
S c h e m e  56. R e a g e n ts  a n d  c o n d itio n s:  (i) Methyl or ethyl bromoacetate, D IEA, xylene, 24  h
In order to increase the yield and reduce the formation of the diester 248, the 
cyclisation was repeated using methyl instead of ethyl bromoacetate which was added 
dropwise over 24 hours into the reaction mixture. After 24 hours at reflux, TLC did not 
show the presence o f starting material and formation of the mixture was once again
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shown in the 'H-NMR spectra of the crude reaction mixture. The ratio o f products was 
the same as the first attempt. After purification, the yield of piperazinone 761 was 
increased to 25%, which is the best result obtained for this cyclisation.
F igure 27. PC M odel 8 representation o f  diphenyl piperazinone 761
IR showed a peak at 1690 cm'1, which was slightly higher than the expected 
value for C=0 stretching for a lactam ring. 1 H -N M R spectra only showed three kinds of 
alicyclic signals: H 2-3  appeared as a singlet at 6  4.0 ppm; H2 -5  gave a double of doublet 
(c/5.3, 5.3) at 5 3.8 ppm and H2 -6  gave another double of doublet (J  5.5, 5.0) at 6  3.52 
ppm.
3.4.2 Cyclisation of 7V,./V-dibenzylbenzene-1,2-diamine with methyl brom oacetate
H
N
N
NH. 0
251250
H3 COr
Br
214 230a
Schem e 57. R e a g e n ts  a n d  c o n d itio n s :  (i) DIEA, xylene, 24  h.
This cyclisation was run according to the standard procedure, this time using 
methyl instead of ethyl bromoacetate. After 24 hours at reflux, TLC of the crude 
reaction mixture showed two overlapping spots in the piperazinone region and the lH- 
NMR also confirmed a mixture of two components in the ratio 67:33. After flash 
chromatography, the fastest spot was collected and assigned the structure of the 
monoester derivative 251 (10% yield) and the slowest spot was the expected 
piperazinone 250 (70% yield). Absorptions in the infra-red spectrum at 1690 and 1743
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cm ' 1 for 251 and 250 were indicative o f lactam and ester carbonyl groups respectively. 
The secondary amine 251, also gave a broad peak at 3349 cm ' 1 due to NH stretching.
3.5 Conclusions on ethyl bromoacetate cyclisation
Exploration o f the potential scope o f extending the regioselectivity observed in 
the cyclisation between N ,N '-dibenzyl 1,2-diamines with ethyl bromoacetate, to new 
“non-benzyl” diamines had revealed some interesting results. High regioselectivity was 
found in all our attempts; therefore its dependency on the presence o f the chiral centre 
was clearly demonstrated. However, the poor conversion o f aromatic diamines into 
products represented a limit for the use o f this procedure. In addition, a deep 
investigation on the stereochemistry and the conformational analysis o f these important 
heterocycles has been completed using a large range o f techniques, amongst which the 
HMBC NMR was the most useful one. Our decision was then to consider again the 
dibenzyl amines with the prospect o f adding a second chiral centre in the piperazinone 
ring and to observe diastereoselectivity during the formation o f products.
3 .6 1,2-Diamines and chiral 1,2-dielectrophiles
As described in the introduction a chiral centre at position 3 is very often found in 
peptidomimetics. The high regioselectivity observed in the cyclisation reactions 
between chiral A,A'-dibenzyl 1 ,2 -diamines and ethyl bromoacetate, was followed by 
our attempts to react the same diamines with chiral 1 ,2 -dielectrophiles such as methyl 2 - 
bromopropionate 252 and methyl a-bromophenylacetate 253.
CH3 Ph
252 253
We had reason to think that the addition o f an enantiomerically pure dielectrophile to 
the diamines could afford one diastereoisomer. The experimental method used was the 
same as the ethyl bromoacetate cyclisation reactions and we postulated the same 
mechanistic pathway, involving initial Sn2  from the most reactive amine to the most 
reactive electrophilic centre and intramolecular cyclisation from the second amine to 
displace the ethoxy group.
67
If the dielectrophile were enantiomerically pure and displacement of bromide 
followed a “pure” Sn2 mechanism a single stereoisomer would result e.g 255 or 257. 
The dielectrophiles used in our work were racemic mixtures, consequently at best a 
mixture o f epimers must be formed. However the newly formed chiral centre is adjacent 
to a carbonyl and hence could be equilibrated to a single thermodynamic product if the 
energies were favourable.
3.6.1 Methyl 2-bromopropionate cyclisation
182a 252 259 260
Schem e 58. R ea g e n ts  a n d  co n d itio n s:  (i) DIEA, xylene, reflux, N 2 atm.
1 H -N M R spectra of the crude showed a mixture of compounds with a ratio 
50:50, calculated using integration of methoxy groups. Upon basic work up, the ratio of 
the two adducts became 58:42 and purification by flash chromatography yielded pure 
sample of the two 6 -piperazinone epimers 259, 260 (30% , 25%  respectively). 6 - 
Piperazinone 259 had Rf = 0.51 and 6 -piperazinone 260 had Rf = 0.39 in a mixture of 
petroleum ether:ethyl acetate, 3:1.
3.6.1.1 1 H-NM R data analysis o f  epimers 259 and 260
The structures of the cis- and trans-adducts 259, 260 were assigned on the basis 
of NMR data which was similar to that reported previously (Table 12). In each case the 
splittings for the H-5 protons showed a large geminal coupling and a small vicinal
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coupling to H - 6  (Table 12). Consequently H - 6  must be equatorial and the methoxy­
methyl substituent is axial in both stereoisomers. If the stereochemistry of the 
piperazinone ring is assumed to approximate to a chair, the C-3 methyl groups of the 
cis- and trans-isomers 259, 260 must be equatorial and axial respectively, conversely H- 
3 must be axial and equatorial respectively. Axial protons usually have lower chemical 
shifts than equatorial protons (cyclohexane, -100°C, H ^ S 1.1, Heq 8  1.6) and consistent 
with the assignments, H-3a* for the c/5 -3 ^ ,6 ax-isomer 259 ( 8  3.05) has a lower chemical 
shift than H-3^ of the trans-diaxial isomer ( 8  3.56).
Bn'
/ r f y
• v s
,Bn
Bn'
r
V
.Bn
259 c/s-3^, 6ax- 
piperazinone
260 trans-diaxial 
piperazinone
Signal 6 -c is -  Piperazinone 6-rnm s-Piperazinone
259 ___________ 260___________
H-3 3.055 (d, 6 .6) 3 .56 (obscured)
H-5a 2.7 (dd, 11.9, 2 .3) 2.65 (dd, 1 2 .0 ,2 .1 )
H-5b 2.15 (dd, 1 1 .9 ,3 .3 ) 2.55 (dd, 1 2 .2 ,2 .5 )
H-6 3.15 (m ) 3.15 (m)
H-7a 3.5 (dd, 8.9, 7.6) 3.5 (dd, 8.9, 1.0)
H-7b 3.43 (dd, 9 .0 , 4 .8 ) 3.4 (dd, 9.0, 3.8)
H3-9 3.09 (s) 3.06 (s)
H-lOa 5.12 (d, 14.9) 5.2 (d, 15.0)
H-lOb 4.01 (d, 14.9) 4 .0  (d, 14.8)
H - l la 3.9 (d, 13.6) 3 .54 (d, 13.2)
H - l lb 3.05 (d, 13.5) 3.55 (d, 13.2)
H3-12 1.5 (d, 6 .7) 1.35 (d, 6.9)
comparison for 6-piperazinones 259 and 260
X Ph
259 cis-Seafia,, adduct
260 trans-diaxial adduct
Ph
3.6.1.2 Equilibration o f l,4-dibenzyl-6-methoxymethyl-3-methyl-piperazin-2-ones 259 
and 260
Ph Ph
f-BuOK
MeOH, rt h 3CO'
Ph 259 Ph 260
It was anticipated that the thermodynamically more stable 3-epimer could be 
formed by equilibration with potassium /-butoxide in methanol. After 7 days at room 
temperature the initial 50:50 mixture of piperazinones 259 and 260 was transformed to
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69:31 (’H-NMR spectrum). The cis-3eq,6ax- adduct 259 predominated over the trans- 
diaxial adduct 260, as was found in the phenyl series (section 3.6.2.1).
3.6.2 Methyl a-brom ophenylacetate cyclisation
Cyclisation using methyl a-bromophenylacetate was run according to our 
standard procedure. After 3 hours of reflux, TLC showed the disappearance o f the 
starting diamine and appearance of two running spots with very similar Rf (0.35 for 261 
and 0.24 for 262 in petroleum etheriethyl acetate, 2:1). 'H-NMR spectra o f the crude 
were very complex but showed only two singlets at -3 .0  ppm, in the ratio 50:50 
assigned to the methoxy groups of the adducts 261, 262.
Only 6-piperazinone diastereoisomers 261, 262 were isolated by flash 
chromatography using a slow gradient o f petroleum ether to ethyl acetate (25%, 35% 
respectively). No 5-piperazinone diastereoisomer was observed or isolated in this 
reaction.
182a 253 261 262
Schem e 59. R e a g e n ts  a n d  c o n d itio n s :  (i) D IEA, xylene, reflux, N 2 atm.
3.6.2.1 1 H-NM R analysis fo r  epimers 261, 262
Similar to the methyl diastereoisomers 259, 260 described above, the assignment 
of the stereochemistry for the phenyl derivatives 261, 262 was complex. Following the 
same considerations made for the previous piperazinones, analysis o f coupling constants 
and chemical shift values was fundamental for determining the stereochemistry. The 
assignment of H-6 as axial or equatorial proton was mainly based on the values found 
for H2-5 vicinal coupling constants to H-6. The small values found for piperazinone 261 
(3.1, 3.5 Hz) suggested that H-6 was equatorial and consequently the methoxymethyl 
substituent was in the axial position. For piperazinone 262, H-5b had a large vicinal 
coupling constant (7.2 Hz) which indicates that H-6 could be axial in this epimer. In this 
case the complex signal for H-6 was interpretable and confirmed the values assigned for 
the vicinal coupling constants for H2 -5 . In previous assignments, the orientation of H-3 
was based on chemical shift, assuming that axial protons are upfield relative to 
equatorial protons. If this method is used with these stereoisomers, the configurations
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are 3^ ,6^  261 and 3ax,6eq 262 which are both cis, which is clearly impossible! If we 
accept the arguments for the orientation of the 6-methoxymethyl group, the phenyl 
groups at C-3 must both be axial or both be equatorial.
.Bn
Bn'
piperazinone piperazinone
Signal 6-c/s-piperazinone 261 6-/ra«s-piperazinone 262
H-3 4 .0  (s) 4.23 (s)
H-5 a 3.0  (dd, 1 1 .8 ,3 .5 ) 2.85 (dd, 1 2 .2 ,4 .1 )
H-5b 2.03 (dd, 1 2 .1 ,3 .1 ) 2 .44 (dd, 12.2, 7.2)
H-6 3.3 (m ) 3.5 (dddd, 7.2 , 5.6, 4 .1 , 3.6)
H-7a 3.61 (dd, 8.8, 4 .5) 3.4 (dd, 9 .6 , 5 .6)
H-7b 3.71 (t, 8.0) 3.25 (dd, 9 .7 , 3 .6)
H3-9 3.18 (s) 3 .09 (s)
H-lOa 3.95 (d, 14.8) 4.05 (d, 14.9)
H-lOb 5.01 (d, 14.8) 5.25 (d, 14.9)
H - l l a 3.71 (d, 13.4) 3.4 (d, 13.6)
H - l l b 3.0 (d, 13.4) 3.18 (d, 13.5)
T able 13. 'H N M R  chem ical shifts and coupling constants
,PhX
H3c o ^ r N> f0i2 261 cis-
Piperazinone
4 N 3 Ph
11^ Ph
10/P h
7 I1
H3C0 « r  Y  262 frans-
5 i ' N ^ P h  PiPerazinone
X
11 Ph
comparison for 6- piperazinones 261 and 262
3.
10.97Hz
4.2 0  Hz
N ,N  -dibenzyl-6-m ethoxym ethyl-3-phenyl-piperazin-2-one 261 , 262
F igure 28. V icinal coupling constant prediction for 
H-6 in equatorial position (PC M odel 8)
Figure 29. V icinal coupling constant prediction for H- 
6 in axial position (PC M odel 8)
Prediction of coupling constants values for H-6 with H2 - 5  and H2 - 7  was done 
using PC Model 8 (Figure 28, 29). We performed equilibration reaction o f the pair of 
epimers in order to establish which conformation was the most stable, trying to find 
similarities with the previous methyl series (section 3.6.1.2)
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N , 0  r-BuOK 
MeOH, rt
261 262
Similar to the equilibration conditions of the methyl derivatives 259, 260, a 
50:50 mixture of epimers 261:262 was dissolved in methanol in presence o f potassium 
/-butoxide. After 48 hours at room temperature, the ratio became 16:84 for 261:262. In 
previous example, the cis-5eq,6a3risomer was the most stable, which indicated that in the 
phenyl series, the epimer 261 should be the preferred of the pair.
Unfortunately this was in contrast with the experimental evidence which 
indicated the piperazinone 262, which has a 6 e9-methoxymethyl group, as the most 
stable o f the pair. In conclusion, for the methyl series, the c/s-epimer having the 
methoxymethyl group in axial position was the most stable, whereas for the phenyl 
series, the most stable epimer had the methoxymethyl substituent in equatorial position.
If we assume that H - 6  is equatorial, due to the higher chemical shifts found for 
both phenyl epimers 261 and 262, then trans-diaxal epimer would be the most stable o f 
the pair. However, the assignment for H - 6  remains unresolved, considering that the 
phenyl group in position 3 did affect the chemical shift of the adjacent proton.
3.6.3 Aromatic diamines
3.6.3.1 Cyclisation o f  methyl a-bromophenylacetate 253 with methyl N ,N  -diphenyl- 
2, 3-diaminopropyl ether 182d
182d 253 263 264
Sch em e 60. R e a g e n ts  a n d  c o n d itio n s :  (i) D IEA, xylene, reflux, N 2 atm.
Cyclisation o f methyl N ,N '-diphenyl-2,3-diaminopropyl ether 182d with methyl 
a-bromophenylacetate 253 was attempted. From the previous cyclisations performed 
with the aniline derivative 182d, it was clearly established that longer reaction times 
were required to promote the cyclisation step, due to the lesser nucleophilicity o f the 
aromatic amines. After 48 hours of reflux, a 50:50 mixture o f two components was 
observed in the 1 H-NMR spectrum. Purification by column chromatography using a
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slow gradient o f petroleum ether, ethyl acetate, ethanol gave pure piperazinones 263 and 
264 (34%, 29% respectively).
3.6.3.1.1 NMR data analysis fo r  epimers 263 and 264
Coupling constants for H - 6  and chemical shifts analysis for H-3, based on the 
same considerations made for the previous diastereoisomers, was made and the outcome 
was disappointing.
The isomer 263 should possess H-3 in axial position ( 6  5.25) and H - 6  also in 
axial position, according to the large coupling constant found for H-5b to H - 6  (5.9 Hz). 
On the same basis, the isomer 264 should have H-3 in equatorial position ( 8  5.6) and H- 
6  in equatorial, too. Once again, the two conformers 263, 264 appeared to be trans- 
diequatorial and trans-diaxial respectively, which clearly cannot be possible.
However, the two epimers were recrystallised from a mixture o f petroleum ether, 
diethyl ether and the X-ray crystallographic data were crucial for elucidating this matter.
Ph Ph
.0
H3CO'
Ph
Ph
6Z -N '
P h  s  Ph 
.Ph / t ^ - N
N-^ 3
Ph Ph
263 trans-diequatorial- 264 trans-diaxial-
piperazinone piperazinone
Signal T r a n s -3 .6-piperazinone 263 T ra n s  3 .6-piperazinone 264
....H-3............ 5 .25  (s) 5 .6  (s)
H-5a 3.65 (dd. 13 2, 4 .1) 3.9 (dd. 1 3 .7 .3 .1 )
H -5b 3.93 (dd. 1 3 .2 .5 .9 ) 4 .32  (dd. 13.7. 1.2)
H-6 4 .09  (dq. 9.5. 4 .0 ) 4 .0 5  (m )
H-7a 3.26 (dd. 9.2. 3 .5) 3.4 (dd. 8.8. 3 .7)
H-7b 3.54 (dd. 9.2. 8 .2) 3 .48  (t. 9 .3 )
H3-9 3.22 (s) 3 .28  (s)
T able 14. N M R  data com parison o f  piperazinones 263 and 264
3.6.3.1.2 X-Ray Crystallographic data o f piperazinones 263 and 264
Yellow needle crystals o f epimers 263 and 264 were obtained by slow 
evaporation o f a mixture o f petroleum ether and diethyl ether. X-Ray crystallographic 
data of piperazinones 263 and 264 showed that H-3 was axial in both diastereoisomers.
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F igu re 30. tra n s -D i e q u a to r ia l  p iperazinone F igu re 31. c is -3 eq,6 m  Piperazinone 264
263
This was in disagreement with our assignment, made on the basis o f H-3 
chemical shifts. H - 6  appeared to be in equatorial position for the epimer 263, giving the 
final conformation as trans-diequatorial. H - 6  for epimer 264 was in equatorial position 
giving the final conformation as cis-3eq,6ax■ As anticipated above, this was controversial 
with our data analysis for H-3. Further study o f the two crystal structures indicated that 
the heterocyclic ring is almost flat. All the atoms of the ring seemed to lay in the same 
plane except for C-5 [= C(l)] which is above the plane. Subsequently, the terms “axial” 
and “equatorial” are not appropriate, since the ring does not possess the conformation of 
a cyclohexyl chair. For instance, the chemical shift o f “pseudo-axial” H-3 could be 
affected by the close presence o f the carbonyl group, resulting in a shift o f ^ -N M R  
signal downfield.
3.6.3.2 Equilibration reaction for piperazinones 263 and 264
Ph
f-BuOK
MeOH, rt H3CO'
;0
PhI
Ph
I
Ph
263 264
Similar to the equilibration reactions o f the previous piperazinone epimers 
(sections 3.6.1.2, 3.6.2.1), pure crystals o f toms-piperazinone 263 were dissolved in 
methanol in presence of potassium /-butoxide. After 48 hours at room temperature a 
40:60 mixture o f  epimers 263:264 was observed in ^ -N M R  spectrum. Parallel to this 
experiment, also crystals o f c/s-piperazinone 264 was equilibrated under the same
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reaction conditions, to give a 20:80 mixture o f epimers 263:264. Thermal equilibration 
o f /raws-piperazinone 263 in deuterated toluene at reflux for 5 days did not show any 
change in NMR spectrum. This indicated that the base was indispensable for extraction 
o f the amide a-proton, even at high temperature.
The ratio found for the first experiment indicated that the cis-3eq,6ax- 
piperazinone 264 was the thermodynamically favoured conformation. This was also 
confirmed by a further equilibration of 84:16 mixture o f 263:264 in deuterated methanol 
that became a 20:80 mixture after 7 days. 1 H-NMR spectra o f the crude showed 
disappearance of H-3 singlets and also confirmed that the lactam enolisation was 
complete by using 2 equivalents o f base. The conversion o f cis- into trans- isomers 
(80:20 ratio) described above was misleading since the rest o f experiments suggested 
that cis-3eq,6ax-piperazinone 264 had the most stable conformation.
3.7 Conclusions
In conclusion , 6-substituted piperazinones w ere successfu lly  prepared reg ioselectively  w ith  
sim ple addition o f  ethyl brom oacetate to the refluxing diam ine. Y ie ld s were low  w ith  arom atic am ines, 
due to their expected reduced nucleophilicity.
R R R
I 1 ,2 - 1 1
H3C O ^ V 'NH dielectrophikL H3CO/ ^ V ^ N'vf^°  h3co^ -  " N
NH N R1 N X )I I I
R
182
R
265
R
266
1,2 -D ielectrop h ile R R 265 266
b ethyl bromoacetate 2-M etlioxvethvl H 90 (50% ) 10
c ethyl bromoacetate C y d o h ex y l H 90 (75% ) 10
d ethvl bromoacetate Ph H 90  (35%)T 10
e ethyl bromoacetate /?-M ethoxyphenyl H 95 (30% ) 5
f M ethyl a-brom ophenylacetate Ph Ph 60:40  (34% . 29% )T -
T ab le  15. C yclisation results o f  aromatic diam ines w ith  haloacetate. R atios calculated in the cm de  
‘H -N M R  (y ie ld s ) .1 X-Ray Crystallographic data available
This procedure was reliable with a large number o f substrates. Earlier experience 
showed that changing the substituent at position 2  did not significantly affect the 
regioselectivity.
Bn Bn Bn
V - NH dielecfrophile
NH ^ N ^ R "  X l ' X DI I I
Bn Bn Bn
242 267 268
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1,2 -D ie lectro p h ile R R ' R " 267 268
a M ethyl brom oacetate H CH2O C H 3 H 90 10
b M ethyl brom oacetate H c h 3 H 89 11
c M ethyl brom oacetate c h 3 CH3 H 80 20
d M ethyl brom oacetate H Ph H 95 5
g M ethyl a-brom ophenylacetate H c h :o c h 3 Ph 4 0 :60  (25% . 35% ) -
h M ethyl brom opropionate H c h 2o c h 3 c h 3 50:50  (30% . 25% ) -
T a b le  16. C yclisation  results o f  benzylam ine deriv ativ e  w ith  haloacetates. A ll the reactions run for 
24  hours at reflux. R atios calculated in  the cru d e1 H -N M R  (yields).
When a chiral dielectrophile was used, even better than expectation, only the 
two epimers of 6-piperazinones were formed. No trace of the other regioisomer was 
seen. This suggests that in the future, it would be worthwhile to attempt cyclisations 
with the pure enantiomeric form of the dielectrophile in order to control better the 
diastereoselectivity.
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CHAPTER 4 A new regioselective way to prepare chiral 
piperazinones
4.1 Introduction
As introduced in chapter 3, chiral 1,2-diamines were reacted with ethyl 
bromoacetate for the preparation of chiral piperazinones 243a and 244a and the 
preferential formation of one regioisomer 243a over the other 244a was observed in all 
the cyclisations performed.
Bn Bn BnI I I
182a 243a 244a
The mechanism of this reaction can be explained as a two steps sequence. The 
first step is a Sn2 of secondary amine to the dielectrophile 230 to displace the halo 
substituent first and to form the monoester derivative 236. The second step could be 
competitive between the intramolecular cyclisation from the second amino group to 
displace the ethoxy group and give the piperazinone 246 (route a) and a second 
intermolecular Sn2  with another molecule of ethyl bromoacetate to displace the bromide 
to give the diester derivative 245 (route b).
?  R'O <V ? 0°)
CH3O ^ Y N^ - ^  ) = 0 _ ^  CH30 " ^ Y < R y  b CH3 0 ^ V N^ o r .
W j T  V
182 R 230 236 R 269 R
a R' = Et = 88
b R' = CH3
I
Mrv _ W1,3 R °  R
c R ' = 'Bu CH3O ^ Y " l' - ^ O R ’
V Y "
R O R
245 244
Schem e 61. Competitive mechanism s for diester and piperazinone formation
When the R groups were aliphatic, such as cyclohexyl and 2-methoxyethane, 
diesters were easily isolated even at very high temperatures. When the R groups were 
aromatic, their formation was rarely observed. Our experience showed that directing the
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formation o f one o f the products 245 and 244a was possible by changing the reaction 
conditions. In particular, low temperature, high concentration o f the reagents and large 
excess o f ethyl bromoacetate gave quantitatively the diester derivative 245, whereas 
high temperature and equimolar concentrations o f reagents gave preferentially the 
cyclised product 246.
These diesters represented important intermediates for the preparation o f a new 
range o f chiral N ,N '-diacetate 1,2-diamines. Benzyl groups acted as protecting groups 
and were easily cleaved by hydrogenolysis, catalysed by palladium catalysts. Our 
expectation was to promote the intramolecular cyclisation o f this new class o f 1 ,2 - 
diamines in acidic conditions, after cleavage of the benzyl groups. Theoretically, two 
possible piperazinone regioisomers, 271 and 272, could form in the cyclisation step 
(Scheme 62).
It was established by previous experiments that the two amino groups possess 
different reactivity. Considering that N-4 is more reactive than N -l, confirmed by all 
our previous cyclisations, attack of the amino group remote from the chiral centre could 
lead to the preferential formation of 5-piperazinone 271.
4.1.2 Conform ational analysis of the two possible piperazinones 271 and 272
Moreover, by modelling the two possible piperazinone regioisomers, other 
considerations could be made. 6 -Substituted piperazinone 272 presented high steric 
hindrance due to two adjacent substituents at position 1 and the acetate group at position 
6 , next to the carbonyl at position 2. Particularly, if the methoxymethyl group at 
position 6  was equatorial, there would be a strong interaction between the adjacent 
groups, which would increase the energy of these compounds.
5-Substituted piperazinone 271 only presented one group next to the carbonyl at 
position 2. Our hypothesis was that only the 5-substituted piperazinone 271 could easily 
be formed in the cyclisation step.
272 6 -piperazinone271 5-piperazinone
H O
O 270
S ch em e 62. Possible cvclisations o f  the 1.2-diam ine 270
H
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272 6 -Methoxymethyl- 
piperazin-2-one
271 5-Methoxymethyl- 
piperazin-2-one
H3CO
OCH
H3CO
EtOEtO EtO
II Methoxymethyl 
in "equatorial"
EtO
Methoxymethyl 
in "axial"
II Methoxymethyl 
in "equatorial"
I Methoxymethyl 
in "axial"
Sch em e 63. Steric hindrance for the formation o f  5- and 6-piperazinones 271, 272
Conformational analysis showed an energy value o f -3.123 kcal m of1 for 5- 
methoxymethyl-(2-oxo-piperazin-l-yl)-acetic acid ethyl ester 271, showing the 
methoxymethyl group could be equatorial position, against 6.575 kcal mol' 1 for the 6 - 
substituted piperazinone 272.
F igu re 32. PC M odel representation o f  5-piperazinone 272
In addition to the mechanistic proposal just made, it was also possible to 
postulate that the hydrogenolysis could have occurred regioselectively by cleaving the 
N-4 benzyl group first and promoting the cyclisation by N-4 alone.
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"OEt H2 R
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Bn O 
245a
a R = H, R' = CH2OCH3 
b R = H, R‘ = CH3 
c R = H, R' = Ph 
d R = R' = CH3
BnIR*
OEt
OEt
■ \ rvN £OEt OEt
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x H x
V
o
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BnIRv .N.
o
OEt
N ^O 
OEt
271 275
4.1.3 Planned synthesis
The overall planned synthesis involved three steps starting from A^A^-dibenzyl- 
2-substituted 1,2-diamine 182a, previously prepared by EGB. One 1,2-diamine (R= H, 
R '=  Ph) was enantiomerically pure (R) and was previously prepared in three steps 
starting from D-phenylalanine130.
BnI
NH
NHI
Bn
182a
Bn O
fr f l
V Y
Bn O 
245a
OEt
OEt
R'x'‘T
S j^ r 0Eto
270a
OEt ijj
V
a R = H, R' = CH2OCH3 
b R = H, R’ = CH3 
c  R = H, R’ = Ph 
d R = R’ = CH3
Sch em e 64. R e a g e n ts  a n d  c o n d it io n s : (i) BrCH2COOEt, DIEA, 24 h reflux; (ii) H2, Pd/C, 24  h, rt; (iii) IT
4.2 Preparation of chiral diesters
Preparation of diesters 245a-d was carried out by placing our 1,2-diamines 
182a-d with a large excess o f ethyl bromoacetate (6 - 1 0  equivalents) in dichloromethane 
and keeping the reaction at 0 ° C, in order to avoid the competitive intramolecular 
cyclisation pathway.
BnI
R NH
’" '" I NHI
Bn
182
Bn O
O k
Bn O 
245
OEt
OEt
R R ' R x tim e % 245
a CH2O C H 3 H 2 hrs 85
b c h 3 C H , 48  hrs 43
c CH? H 24 hrs 65
d Ph H 48  hrs 35
T ab le  17. Y ields for diesters 245 form ation
All the displacements were carried out at high concentration (60% v/v diamine/solvent). 
Yields were satisfactory (43-85%), except for the phenyl derivative 182d that only gave
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35% conversion into the diester 245d. In order to optimise the yield o f 245d, the 
displacement was carried out in neat ethyl bromoacetate but unfortunately no 
improvement was shown. The reasons are still unclear. In principle, the presence o f a 
third phenyl group in the molecule could create more steric hindrance and this is 
supported by the dialkylation o f the dimethyl derivative 245b which also had poor yield 
(43%).
4.2.1 Proof of structures of the chiral diesters 245
^ -N M R  spectra o f 245a-c displayed two distinguishable triplets in the upfield 
region and two quartets for the methylene o f the ester groups. Each benzylic H 2 - 5  and 
H2 - 6  proton gave a doublet at 8  between 3-4 ppm. Large coupling constants (17 Hz) 
were found for the closest (H2-5 ) to the chiral centre, whereas smaller coupling 
constants (13 Hz) were found for H 2-6 . Methylene groups H 2 - 7  and H 2- 1 1 gave mainly 
singlets or doublets with small coupling constants in the downfield region. 13C-NMR 
displayed two distinguishable signals for C =0 in each compound. The assignment o f 
each proton was achieved unambiguously by HMBC correlation. IR spectra indicated 
the presence o f C =0 stretching at 1730 c m 1 for the ester groups.
4.3 Hydrogenolysis for N-benzyl groups cleavage
Cleavage o f the benzyl groups was achieved by hydrogenolysis in presence o f 
palladium (10%) on carbon in methanol or THF using an atmospheric pressure 
hydrogenator. Usually reaction times were 24 hours, although we experienced catalyst 
poisonings, when the conversion into products was -50% . New catalyst was placed and 
the reactions was left for further 24 hours and left to go to completion. TLC and 1H- 
NMR spectra o f the crude mixtures mainly showed formation o f  one product in all the 
cases. The first hydrogenolysis was performed with the diester 245a.
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H3C O ^ 'N ^ N^ ^ O E t  ^  H3C O '^ V 'N>^ V-OEt _____ ^H 3C O ^ ^  'N
/>rx   i^lira nplOEt L /V .  .OEt silica 9el N ^ 0
column 1
I I  Y YBn O o OEt
245a 270a 271a q
Only for this reaction, the crude mixture required flash chromatography due to 
the presence o f two spots on TLC, one o f which was on the baseline. NMR of the crude 
mixture displayed two triplets in the upfield region, attributed to the two ester functions 
270a and no aromatic peak in the downfield region.
This confirmed the cleavage o f the benzyl groups and we decided to purify the 
diester 270a by flash chromatography but to our surprise, piperazinone 271a eluted 
from the column. Probably, the acidic groups o f the silica gel catalysed the cyclisation 
o f the reactive diester. No signals o f the major compound found in the crude mixture 
were observed and the structure was unambiguously assigned. In all other 
hydrogenolysis carried out, 5-piperazin-2-ones 271 were directly formed by 
spontaneous cyclisation.
H
. N ,
r'"X ,X ,o
OEt
271
R R 240*
a c h 2o c h , H 72%
b CH3 c h 3 85%
c CH? H 60%
d Ph H -
0  T ab le  18. Y ields o f  piperazinone after hvdrogenation-
cyclisation o f  diesters. * Y ield  o f  purified products
The crude mixtures, after hydrogenolysis, were mainly composed directly o f 
piperazinones formed by spontaneous intramolecular cyclisation o f the diesters and this 
theory could not be proved. However, when methoxymethyl diamine 242a was reacted, 
we did observe formation o f the diester intermediate 270a, which indicates that the 
regioselective benzyl cleavage did not occur.
4.3.1 Cleavage of N ,N  -dibenzyl-1,2 -diaminoethylenebenzene 245d
When -dibenzyl-1,2-diaminoethylenebenzene 182d was hydrogenolysed 
under the standard conditions, the benzyl groups were not cleaved by hydrogenolysis to 
give the expected “unprotected” diamine 245d. No traces o f the expected piperazinone 
were observed either, but TLC and NMR showed formation o f mixture of products.
82
Probably, a hydrogenolysis o f the three benzyl bonds gave a mixture o f amino-acetic 
acid ethyl ester 276 and phenethylamino-acetic acid ethyl ester 277.
o.Phr'  o
276
OEt
OEt 277
k  oPh
245d
Sch em e 65. Possible products o f  hydrogenolysis for phenyl derivative 245d
^-N M R  after 4 hours o f hydrogenolysis showed signals o f unreacted 245d and 
a large number o f complex, non-interpretable signals.
A new procedure was followed for the benzyl group cleavage for 245d. N- 
Iodosuccinimide was used according to a new method reported by Grayson et al. 134 as 
successful reagent for TV-benzyl cleavage. Unfortunately, a mixture o f products were 
shown by TLC and ^-N M R . IR did not show any signal at -1645 cm '1; a common 
frequency for lactam carbonyl groups, but rather a sharp peak at 1744 which is 
indicative o f esters and a broad peak at 3455 cm' 1 due to the NH stretching.
4.3.2 Proof of structures of 5-substituted piperazinones 271
The first piperazinone isolated was the 5-methoxymethyl-(2-oxo-piperazin-l- 
yl)-acetic acid ethyl ester 271a. The most indicative signals were the methoxy singlet at 
5 3.3 ppm, H2 - 3  that gave two doublets o f 17.5 Hz at 3.5 and 3.6 ppm and the ethoxy 
signals consisting o f one triplet for H3-14 and one quartet for H2-13. HMBC spectra 
confirmed the postulated structure and exclude the possibility o f the other regioisomer 
formation. J  correlations seen were H2 - 6  and C-2, and H2-3 and C-5 and vice versa.
S ign a l 5  (cou p lin g  con stan t)
.....H -3a..... 3 .5  (d. 17.5)
H -3b 3.59  (d. 17.5)
H-5 3 .25  (dddd. 9 .8 . 5 .2 , 4 .4 . 3.3)
H-6 a 3 .19  (dd. 1 0 .7 .3 .3 )
H-6 b 3.29  (111)
H 2-7 3 .37  (t. 4 .9 )
H.,-9 3.3 (s)
H 2-10 4 .05  (d. 10.6)
H 2-13 4 .2  (q. 7.1)
H 3- U 1.22 (t. 7 .1 )
'h .c
EtO
271a
T ab le  19. 1H -NM R signals for 271a
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The methoxy signals in the lH- and 13C-NMR spectra were unequivocally 
assigned and were utilised as the starting point for the assignment o f the other protons. 
The carbonyl groups were observed at different shifts in the 13C-NMR and usually the 
ester C =0 was more downfielded (168 ppm) than the lactam one (167 ppm). IR spectra 
also displayed two C =0 stretching peaks, at 1730 and 1640 cm '1, respectively for the 
ester and lactam functions. Moreover, large broad peaks at 3400 cm ' 1 indicated 
secondary amine N-H stretching. All the isolated piperazinones o f this sequence gave 
comparable spectra.
Regarding the conformational analysis o f these structures, it was predicted that 
substituents at position 2  prefer to be in equatorial position, despite the axial position 
was preferred in the previous series o f piperazinones. The lone pair would prefer to be 
in equatorial position as observed in previous works135 although our model prediction 
displayed them in axial position. In conclusion, no assignment was possible since we 
had insufficient data.
5-M etlioxym ethyl-(2-oxo-piperazin-l-yl)-acetic acid ethyl ester 271a
F igu re 33. M M X  Energy -0 .414  kcal m ol'1: F igu re 34. M M X  Energy 0 .2 6 8  kcal m ol'1:
m ethoxym ethyl group equatorial m ethoxym ethyl group in  axial position
4.4 Amino acids as nucleophiles
Subsequent to the discovery o f regioselectivity for these novel cyclisations, there 
was the need to optimise the preparation o f the “unprotected” diesters. Amino acids 
possess the potential to react as nucleophiles with a dielectrophile when they are placed 
in basic solution and could afford the desired diesters by direct reaction with the
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dibromide 187. In an overview, the nucleophilic displacement was efficient and reliable 
with compounds such as benzylamine, aniline, /?-methoxyaniline, cyclohexylamine and 
methoxyethylamine.
According to the literature, attempts to prepare diglycylethylenediamine using 
glycine chloride or glycine were unsuccessful and the yields reported were usually very 
poor136,141,137. However, reaction of 1,2-dibromoethane with primary amine gave N,N'- 
disubstituted ethylenediamines and homologous polyamines at room temperature in 
good yield138. The most successful result was given by Allevi139, which reported that a 
derivative o f proline reacted with 1 ,2 -dibromoethane to give the expected diamine in 
60% yield.
278 (m ol. eq.) R eaction time Solvent % G lycine recovered
2 50 h  reflux Aq. NaOH 63
4.5 50 h  reflux Aq. NaOH 55
10 7 davs reflux Aq. NaOH 100
6 24  h reflux Ethylene glycol 85
T ab le  20. R eaction results o f  g lycin e and methyl JV,jV'-dibenzyl-2.3- 
diam inopropyl ether. * h i all the reactions. K 2CO3 ( 10% m ol eq.) w as added
Our first attempt was the simple addition of the 1,2-dibromide to 2.5 equivalents 
of glycine in aqueous sodium hydroxide 4.5 M, according to a known procedure139. The 
reaction mixture was refluxed for 24 hours. We expected that the adduct 279 could be 
extracted from the crude mixture at slightly acidic pH due to the presence o f two 
carboxylate moieties. ‘H-NMR showed some glycine residue (up to 65%) as the major 
part o f the mixture and the rest of the signals were very complex. Unfortunately, TLC 
monitoring was not efficient to follow the progress o f the reaction due to the extremely 
high polarity o f these compounds. Higher temperature was reached in refluxing ethylene 
glycol (up to 210°C) for 24 hours but 85% of glycine was recovered.
The unreacted glycine was removed by several precipitations in ethanol. 
Different work up methods were attempted in order to extract the product: dissolution in 
alkali filtration and precipitation at pH l 140; neutralisation to pH 5 141 and pH 6.5-7.0 
followed by extraction with organic solvents. Also recrystallisation in boiling water142, 
butanol143 and isopropanol: water mixtures139 were unsuccessful to extract the product.
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!H-NMR spectra was very complex and the appearance o f many overlapped 
signals indicated the presence o f mixtures at least o f four products. According to the 
presence o f the glycine recovered it was postulated that other possible mechanisms 
could lead to the formation o f other byproducts as 280 and 281. Another plausible 
reason for the presence o f many compounds could be the presence o f different 
protonated forms o f the same product as 282 and 283.
o o
'OH
-  ©klLI
HaCO'^'Y' HsC° '
'NH '""NH
Y
O O
H3COx'*HY B|’
H3CO  ^ 0 V O u. r n ^ V N H2
I 'o e
V 0 0
,0H
O o
280 281 282 283
Our last attempt was done using the simple 1,2-dibromoethane with glycine 
to avoid problems related to the formation o f diastereoisomers and the presence o f 
diastereotopic proton signals present in the ^ -N M R . This method was unsuccessful 
and 90% o f glycine was recovered at the end o f the reaction.
4.5 Conclusions
Ethyl bromoacetate addition to chiral 1,2-diamines gives preferentially diesters 
as main products, when the reactions are performed at 0°C and with an excess o f 
dielectrophile.
High regioselectivity was achieved for the cyclisation o f A,TV-diacetate 1,2- 
diamines to give exclusively 5-substituted piperazinones (60-85%). The cyclisations 
occurred spontaneously in presence o f traces o f acid. 6 -Substituted piperazinone did not 
form due to high steric hindrance problem (three groups next one another).
Attempts o f preparation o f N ,N -diacetate 1,2-diamines starting from amino 
acids resulted in formation o f mixture o f products, impossible to separate by column 
chromatography.
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CHAPTER 5 Chiral 1,2-diamines with glyoxal
5 .7  Introduction
From the preceding chapters, it was established that the presence o f a chiral 
centre on the ethylene bridge of a 1 ,2 -diamine differentiated the reactivity o f the two 
amino groups. Hence preparation o f 6 -piperazinones could be simply achieved with 
high regioselectivity and in good yield starting from aliphatic 1 ,2 -diamines when ethyl 
bromoacetate was used as cyclising agent. Moreover, variation o f the N ,N '-substituents 
did not affect the regioselectivity, but did affect the yield.
Parallel to the ethyl bromoacetate cyclisations with N,N  '-dibenzyl 2-substituted 
1,2-diamines 242a-d, carried out previously by EGB in my group, new attempts on 
cyclisations of the 1 ,2 -diamines were performed with glyoxal.
The addition o f glyoxal to the secondary diamines 242a-d resulted in the selective 
formation of a 10:90 mixture of piperazinones 267:268.
R  R 7 267 268
a H CH2d C H 3 _ 18 82
b H C H , 14 86 "
c  H ________ P h 23 77
d C H .T  ~CH3 14 86
T ab le  21. A ll the reactions run for 24  
hours at reflux temperature
That result was completely unexpected and the cyclisation showed to be reliable with 
the whole range of dibenzyl diamines with different R substituents at position 2130.
Described in this chapter is the investigation into glyoxal cyclisation mechanism. 
Similar to the ethyl bromoacetate cyclisations, our intention was to extend the procedure 
to 1 ,2 -chiral diamines with different N ,N ‘'-substituents, and to clarify the reasons for the 
regioselectivity.
5.1.2 Glyoxal reactivity
Glyoxal is the simplest 1,2-dicarbonyl compound. It is an attractive synthon with 
great synthetic potential. Glyoxal is commercially available in different form, such as 
40% wt/wt aqueous solution, dehydrated trimer or hydrated sodium bisulphite adduct. 
The two aldehyde functionalities are in equilibrium with the hydrate forms in water and 
they can be differentiated144. Glyoxal is very unstable and it reacts with alcohols to give
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a range of products145. For instance, reaction with alcohols yields tetralkoxyethanes 284, 
tetralkoxydioxanes 285 and tetralkoxynaphtodioxanes 286
hY°  r - o h  r o \  / o r  r ° y ° y ° r  r o y ° y ° y o r
H ^ O  H® R o ' b R  roY'^'OR R o Y Y ^ O R
141 284 285 286
Reaction with methanol gives bisdioxolane derivatives 287 and 288145
141
5.1.2.1 Glyoxal and amines
It is well known that aqueous glyoxal reacts with N ,N -di substituted 1,2- 
diamines to afford a range o f products with the C2-symmetric diamines. The products 
148 and 149 were found in a ratio 90: 10146 (section 1.2.3.1). Aldehyde 148a was easily 
transformed into the piperazinone 149a, but the /-propyl analogue 148b was stable to 
column chromatography.
148 289 149
All the known procedures described the formation of piperazinones as secondary 
products, coming from dehydration o f a postulated intermediate diaminol derivative. 
When an equimolar concentration o f glyoxal was used, condensation products were 
mainly observed147.
,o c h 3
o  o  o c h 3 
288
5.1.3 Postulated mechanism of glyoxal cyclisation with secondary 1,2-diamines
The postulated mechanism for the glyoxal cyclisation is shown below (Scheme 
6 6 ). The initial hypothesis for the origin o f the regioselectivity was based on the 
following scheme: there are four possible stereoisomers o f the intermediate diaminols in 
which the R substituent is equatorial, but only those in which at least one o f the 
hydroxyl groups is axial 290I-IV benefit from assisted departure o f the hydroxyl groups 
by the lone pairs on the nitrogens. Moreover the anomeric effect is stabilising for the 
ground state, and in the few cases in which diaminols have been isolated, the trans-
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diaxial stereoisomers have been assigned as the major products. For the axial, 
equatorial-stereoisomers 290II, 290III a/?//-elimination o f water is followed by a 1,2- 
hydride shift in competition with amide enol formation. Elimination from the trans- 
diaxial stereoisomer 2901 required a ring flip to align the C-H bond o f the departing 
proton with the 71-orbitals o f the iminium ions 290II, 290III. When the 3 -axial hydroxyl 
group, undergoes elimination 290II, the ring flip places the substituent in the less 
favourable axial position 291II, whereas elimination o f the 2-axial hydroxyl group 
2901, only resulted in the flip o f a methylene group 2911. Previous investigations on 
glyoxal cyclisations with symmetric 1,2-diamines, confirmed that the 1,2-hydride shift 
occurs preferentially compared to enol formation in the last step o f the cyclisation102.
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Sch em e 66. C yclisation m echanism  o f  1,2-diam ine and g lyoxa l148 (R = O M e)
5.2 Results and discussion
The original procedure used for the glyoxal cyclisations by EGB consisted in the 
slow addition o f the dielectrophile to a refluxing mixture o f diamine in ethanol: water/ 
1:1. The standard reaction time was 24 hours and the reaction progress was easily 
monitored by TLC by workup of aliquots. The glyoxal used was a 40% aqueous 
solution which is commercially available.
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5.2.1 Cyclisation of aliphatic N ,N  -disubstituted 1,2-diamines and glyoxal
Reaction o f cyclohexyl diamines 182b with the aqueous glyoxal was carried out 
in mixture o f water and ethanol (1:1) at reflux for 24 hours. TLC showed two new spots 
identified as regioisomers 246 and 247, by direct comparison to our standard 
compounds, previously prepared in the ethyl bromoacetate cyclisations. ^ -N M R  
spectra o f the crude confirmed the presence o f the expected products with a ratio of 
90:10 for 247: 246.
c h 3o
R R R
ch3o ^ ^ v ^  ch3o ^  ^
NH NI I
R R R
182 246 247
R 2 4 7 :2 4 6  Ratio (yield)
b - Q H „ 90 10
c - CITC1TOCH, 90 (39% ) 1 0 ( 11% )
T ab le  22. Ratios and yields for aliphatic diam ines 182b-c and g lyoxal 141
Ratios were measured comparing the signals to our standard compounds spectra 
and according to the integration found for the methoxy groups. However, purification 
was not performed because the ratio o f products compared to byproducts was only 
around 20%. Attempts to optimise the degree o f conversion into products such as longer 
reaction time were performed but they were unsuccessful.
Similarly, reaction o f the methoxyethyl diamine 182c with glyoxal resulted in 
formation o f the two regioisomers 247c:246c with the expected ratio o f 90: 10. *H- 
NMR spectra o f the crude mixture displayed a good ratio o f 70% for desired products 
compared to unknown byproducts. Upon work up and purification by flash 
chromatography, analytically pure samples were obtained (Table 22).
5.2.2 Cyclisation of arom atic N ,N  -disubstituted 1,2-diamines and glyoxal
Glyoxal cyclisations were also attempted using A-diphenyl-3-methoxy- 
propane-1,2-diamine 182d. From previous cyclisations o f these diamines with ethyl 
bromoacetate, it was shown that the aromatic diamines needed stronger reaction 
conditions to react with the dielectrophiles, due to the lower nucleophilicity o f the 
amino groups.
90
R R RI I I
.NH .N . ^N,
H3CO H3CO ^  H3CO
NH N N'I I I
R R R
182 247 246
R 247:246  Ratio (yield)
(I - C6H 5 90 (17% ) 10(15% )
e  p-C H jO -C eJL- 60 40
T ab le  23. Ratios (yields) in crude H-NM R  for aromatic diam ines 182d-e and glyoxal 141
NMR spectra o f the crude mixture after 15 hours o f reflux showed the presence 
of the piperazinones 247d:246d , in the ratio 90:10. Similar to the aliphatic 
piperazinones, identification of the structures at this stage was easily achieved by TLC 
and NMR spectra, using the standard compounds previously prepared. However, 
measurement o f the ratio between aromatic and aliphatic protons in the ^ -N M R  spectra 
indicated that only 30% of the crude mixture was composed o f the expected 
piperazinones. The rest o f the mixture was composed o f unknown byproducts. 1 H-NMR 
spectra displayed three extra CH3O- singlets and 13C-NMR spectra displayed three new 
carbonyl groups. TLC showed three overlapped apolar spots, impossible to separate by 
flash chromatography. Extraction o f the desired products from the crude mixtures and 
the purification steps were difficult due to the consistency o f the crude mixtures as 
gummy black oils.
More severe reaction conditions were attempted in order to optimise the 
conversion into products. When the diphenyl derivative 182d was refluxed for up to 200 
hours in place o f 24 hours, no increase o f conversion degree was observed.
It was postulated that elimination o f water from the diaminol intermediate, might 
be rate limiting due to the lower availability o f the lone pairs o f the aromatic amine 
relative to those o f the benzyl derivatives studied earlier. Addition o f a catalytic amount 
o f acid might protonate the aminol hydroxyl groups and facilitate loss o f a water 
molecule. Indeed addition o f 0.15 equivalents of /?-toluenesulphonic acid, resulted in 
70% conversion and the same regioselectivity observed previously (90:10, 247d :246d ) 
but the yields were still not satisfactory (10% yield for 5-piperazinone 247d  and 5% for
6 -piperazinone 246d).
The following attempt at this cyclisation with aromatic amines was performed 
using the /?-methoxyaniline derivative 182e. Our hypothesis was based on the presence 
o f the electron-donating group on the phenyl ring that would increase the availability o f 
the amine lone pair for the reaction with glyoxal. Unfortunately, cyclisation o f p-
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methoxyaniline derivative 182e and glyoxal resulted in a 60:40 ratio of piperazinone 
247e:246e. Purification o f the crude mixture was arduous and resulted in a mixture 
90:10 of regioisomers in 35% yield. The degree of conversion into products did not 
improve and the reduced regioselectivity observed was unclear due to the similarity o f 
reactivity between 182d and 182e.
5.3 Achiral aromatic diamines: procedure optimisation
Two achiral aromatic 1,2-diamines were utilised for investigating glyoxal 
cyclisations, without the complication of regioisomer formation. 1,2-Dianilinoethane 
721 was commercially available whereas jV.N-dibenzylbenzene- 1,2-diamine 214 was 
chosen for its rigidity, which has the potential to facilitate cyclisation.
Ph
N -P h Ph
721 214
5.3.1 Cyclisation of 1,2-dianilinoethane with glyoxal
When the reaction was run in ethanol alone instead o f the standard water: 
ethanol mixture, formation o f a complex mixture was confirmed by ^-N M R , which 
displayed many overlapped signals.
Ph H Ph Ph Ph
c H  *  C l  S  ^  C k
1 h ' JL iPh n Ph Ph Ph
284 721 141 285 76I
No piperazinone was detected by TLC or by ^ -N M R  spectra. The only product 
that could be isolated from this mixture was the fastest spot on TLC (Rf = 0.49 in 
petroleum ethendiethyl ether, 1:1) which was l,3-diphenylimidazolidine-2- 
carbaldehyde 284 (5% yield). Reaction of the diamine 721 with dilute aqueous glyoxal 
gave bis-imidazoline 285 (23%) and piperazinone 761 (8 %) plus unreacted starting 
material 721 (31%). By comparing the results o f the reaction in ethanol and water, it was 
clear that water was needed for the cyclisation step, probably for the formation of the 
diaminol.
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5.5.1.1 Addition o f  catalyst
In order to enhance the selectivity towards the piperazinone ring formation and 
to optimise its yield, several catalysts were added to the water. Acetic acid, silica gel, 
sodium chloride and sodium iodide were added to the reaction mixture in catalytic 
amounts (0.1 equivalents). For all the reactions, it was possible to observe the formation 
of the aldehyde derivative 284, the bis-imidazoline 285 and the piperazinone 761, in 
different ratios (Table 24).
Catalyst addition to glyoxal cyclisation reaction
45
Acetic acid Nal NaCI Silica gel
Catalyst (0.1% mol. eq.)
■  284 B285 B76I
A cetic  acid N a l NaCI S ilica  gel
284 0.5 traces traces 1
285 - traces 41 25
761 36 21 15 43
T ab le  24. Addition o f  catalyst to 1,2-dianilinoethane 721 and glyoxal 141. Ratios measured relative to 
aromatics
The addition o f acetic acid resulted in higher selectivity for piperazinone 
formation. The acid catalysed reaction was repeated and the ratio of products was 
monitor at different reaction times to observe the formation o f piperazinone rings. The 
best ratio of products was obtained when the reaction mixture was refluxed for 24 hours 
(Table 25).
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Acid catalysed formation of glyoxal adducts
1 0 0
60
T im e
284 285 76!
284 285 761
3h 25%  33% .....41% ..
T oil >F% "23% ” 77%_
2 4 h ' N o ' 25%  75%  '
T ab le  25. Ratios o f  products for acid catalysed addition o f  glyoxal 141 to 1.2-dianilinoethane 721
5.3.1.2 Postulated cyclisation mechanism
The regular formation o f the aldehyde derivative 284 at the first stage of the 
reaction suggested a new mechanism for the addition of glyoxal to the diamine. The 
first nucleophilic attack occurred from one amino group to one aldehydic function o f 
glyoxal to form the aminol 286. In order to have formation o f the aldehyde derivative 
284, this first step had to be followed by the elimination of a water molecule and 
consequent formation of the iminium ion 287 rather than diaminol formation. The 
second amino group preferentially attacked intramolecularly the most electrophilic 
centre, next to the iminium ion rather than the second aldehydic function to form a 
second aminol.
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The cyclisation was a 5-endo-trig and it was allowed for the presence o f the 
iminium ion, as previously seen in chapter 2. At this point, the mechanism could take 
two possible pathways. The first involves the attack of a second molecule o f diamine to 
the aldehyde derivative 284, to form a second aminol, which loses a water molecule 
forming an iminium ion that cyclises just as previously seen. The final product o f this 
pathway was the bisimidazolidine derivative 285.
The second involves a further transformation o f the aldehyde 284 that could give 
an intramolecular rearrangement to yield the piperazinone. The only evidence found for 
this pathway was the linear correlation between disappearance of the aldehyde and 
appearance of piperazinone in the crude mixture ^ -N M R  spectra.
The diaminol formation, as postulated in section 5.1.3, was not observed during 
the reaction, although it was not easy to monitor due to its high polarity and reactivity. 
The piperazinone formation should then proceed only via rearrangement o f the aldehyde 
derivative 284. A reasonable hypothesis for the mechanism was the attack from the 
amino lone pair to the aldehyde intramolecularly and subsequent formation of 
ammonium ion 290. The following step could involve the formation o f ketone and 
breakage o f the C-N bond to yield the piperazinone 761 (Scheme 67).
ph Ph ?h
r \ J  ► r Nst^oH r"®^h —► f N\
Ph Ph Ph Ph
284 290 761
S chem e 67. Lone pair attack to the carbonyl group
Previous considerations o f this rearrangement, made by EGB, postulated a bond 
migration to form the carbocation 291, stabilised by amino lone pair (Scheme 6 8 ).
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Schem e 68. C -N  bond attack to the carbonyl group
5.3.2 Cyclisation of TV^/V-dibenzylbenzene-l,2-diamine 214 with glyoxal
When the cyclisation o f A^N-dibenzylbenzene- 1,2-diamine 214 with glyoxal 
was performed in ethanol, only the bis-imidazoline derivative 294 (42%) was obtained. 
The rest o f the mixture was composed o f unreacted starting material 214 (20%). For our 
surprise, no signals indicating the formation of the aldehyde derivative 295 were 
observed in the NMR spectra and on TLC.
295 294 214 141 250
When water was used as solvent, adduct 294 (65%) and l,4-dibenzyl-3,4- 
dihydroquinoxalin-2-(l//)-one 250 (3%) were obtained besides unreacted starting 
material (10%). Similarly to the 1,2-dianilinoethane reaction, no piperazinone was 
yielded from the reaction in ethanol. This evidence confirmed that the ethanol really 
interacted somehow stopping the cyclisation step, perhaps reacting with glyoxal itself or 
being too apolar for the formation o f the intermediates. Moreover, for this kind of 
reactions with glyoxal, it was known that the major products are tetra-azadecalins 296 
and not bis-imidazoline 294 as shown in our case.
296 294 297
The distinction between structure 294 and 296 was complex due to the same 
numbers o f atoms and indistinguishable NMR signals. Our data were compared to 
similar compounds149 but the presence o f different substituents created shifts for the 
NMR signals therefore they could not be compared.
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The only test that resulted in unambiguous distinction o f 294 from 296 was 
LRMS. The spectra showed an intense signal at m/z 599 (M +l) and another signal at 
m/z 299, consistent with M/2. The latter value (M/2) indicated that the molecule could 
break in two equal parts and the most obvious conclusion was, that this was possible for 
bis-imidazolidine 294 and not for the fused compound 296.
F igure 35. PC M odel 8 representation o f  b is-im idazolidine 294
5.3.1.3 Overview on aromatic diamines cyclisations
From the preceding paragraphs, it was shown that glyoxal reacted with chiral 
diamines in several ways affording different products. With aromatic diamines, the 
preferred products under standard conditions were aldehyde and bis-imidazolidine 
derivatives and in order to afford the piperazinone rings the reaction needed more 
energetic conditions, such as acid catalysis and longer reaction times.
In an overview for the diphenyl diamine, the imidazolidine derivative was 
considered the first kinetic adduct and its formation could be monitored due to the lower 
reactivity o f the aromatic amines towards the electrophiles. The aldehyde then could 
either interconvert into piperazinone via intramolecular rearrangement or it could be in 
equilibrium with the starting materials that could react to give the diaminol, the other 
postulated precursor of the piperazinones.
The cyclisation proceeded better in water, probably due to the formation o f very 
polar intermediates. The best ratio o f piperazinone over the other possible products was 
achieved with addition of catalytic amount of p-toluenesulphonic acid. Either the 
diaminol or the imidazolidine derivatives could be protonated and converted into the 
thermodynamic piperazinones according to our postulated mechanism.
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5.4 Understanding the glyoxal cyclisation mechanism: enol 
formation or hydride shift?
Parallel to the glyoxal cyclisation with aromatic diamines, further reactions 
between dibenzyl diamine 182a and glyoxal were performed in deuterated water. The 
aim of these experiments was to investigate the cyclisation mechanistic pathway, on the 
basis o f the presence or absence of deuterium at position 3 in the final piperazinones. As 
anticipated in section 5.1.3, it is believed that the last step o f the lactam formation 
occurs via 1,2-hydride shift102. A competitive and plausible mechanism is represented 
by amide enolisation.
In case the 1,2-hydride shift was the only step taking place (Scheme 69, route a), 
deuterium should not be found in the piperazinone. If the piperazinone was formed via 
amide enol (Scheme 69, route b), deuterium should be incorporated in the final adducts.
Bn
N. _OH
Bn
NH
OHNH OH
Bn
299298182a 141
Bn
D -O D
247a
C ° H
Bn301 300 Bn Bn
Sch em e 69. A m ide enol form ation and 1,2-hydride shifts pathways
5.4.1 Deuteration experiments
The aqueous solution o f glyoxal was concentrated with a high vacuum pump and 
diluted with deuterated water three times. Methyl N ,N -dibenzyl-2,3-diaminopropyl 
ether 182a was placed with an 1 : 1  mixture o f deuterated methanol and deuterated water. 
The reaction was refluxed for 24 hours and upon basic work up a 90:10 mixture of 
piperazinone 301:302 and 246a:247a was formed. Analytically pure samples were 
obtained by flash chromatography (74%, mixture of 247a and 301; 26%, 246a and 302).
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NH D20: MeOD,1:1
^  N2 atm.,A  
NH O I
Bn
823  141 1 2  1301 * R1 = H; R2 = D 302 * R1 = H; R2 = D
a R1 = R2 = D a R1 = R2 = D
247a R1 = R2 = H 246a R1 = R2 = H
5.4.1.1 1 H-NM R analysis
JH-NMR of the crude mixture contained all the signals for both regioisomers. 
Integrations for H2 - 3  were smaller than expected due to the incorporation o f deuterium. 
The deuterium content o f 5-piperazinone 247a was not detectable by integration in the 
1 H-NMR spectrum but the ratio proteo:monodeutero:dideutero was 64:28:8 for 6 - 
piperazinone 246a. These ratios were calculated comparing the H2-3 integrations with 
the rest of signals. H^-3 (5 3.55) resulted to be smaller than 14% whereas H^-3 (5 2.98) 
was smaller than 20%. Moreover small broad singlets were observed to be next to each 
H-3 signals, which are due to the monodeuterated methylenes (Figure 36).
5.4.1.2 2H-NM R analysis
A H-NMR was run to confirm the deuterium incorporation in the 6 - 
piperazinone 301 (Figure 37). The test was run in deuterated chloroform, the same 
solvent as previous experiment, for direct comparison to *H-NMR spectra. Two broad 
singlets were observed at 2.98 ppm and 3.55 ppm. According to the proton assignment 
in the 1 H-NMR for the 6 -piperazinone 302, the downfield singlet (at 3.55 ppm) 
represented the deuterium in the equatorial position and the upfield represented the axial 
one. The deuterated chloroform peak was used as internal standard to adjust and assign 
the precise chemical shift to the singlets. The Hz difference measured between the two 
shifts was the same as the one measured for the corresponding signals in the ^ -N M R  
spectra. Moreover, it was possible, using the integrations in 2H-NMR spectrum, to 
calculate the ratio of the two peaks which was D a x : D e q ,  61:39. It was plausible to 
suppose that also dideutero-isomer was present but the absence o f coupled signals did 
not give us any way to confirm it.
* For the two 
1 epimers consult 
the text.
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F igure 37. H-NM R o f  6-piperazinone 
302
F igure 36. H-NM R  o f  6-piperazinone 
302
5.4.1.3 Low Resolution Mass Spectrometry analysis
The molecular weights of the piperazinones 246a, 247a are 324. Upon 
protonation in the mass spectrometer (Cl) a pseudomolecular ion m/z 325 is formed 
(abundance 100%). The unseparated mixture o f products 246a, 247a also showed the 
presence of a peak at m/z 326 (36% abundance, Table 26, column 2), whereas, the 
abundance of this peak due predominantly to the presence o f 13C was predicted to be 
23.5% (Table 26, column 5). Mass spectrometry o f the separated products showed a 
large difference in the degree of incorporation o f deuterium (Table 26, columns 3,4).
Found abundances Theoretical abundances
M ass Peak 90:10 mixture o f 5-piperazinone 301 6-piperazinone 302 246a . 247a
301 and 302
326 (M +D ) 36 31 58 23.5
327 (M +D :) 8 5 21 3.1
328 1 <1 1 -
T ab le 26. LRMS for the mixture 90:10 o f  301 and 302 and isolated piperazinones 
♦The abundance for the m ass peak at m /z  325 is  100%.
The abundances of the peaks at m/z 325-327 were modelled by permutating the 
proportions of the three components in 0.5 % increments 
Ratio calculated for 5-piperazinone 301 was 93.5: 6.5, H: D.
Ratio calculated for 6 -piperazinone 302 was 63: 26: 11, H: D: D2.
It was then established by 1 H-NMR and MS tests that more deuterium was incorporated 
in the 6 -piperazinone 302 than in the isomer 301.
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5.4.2 Control experiments
The evidence of deuterium incorporation in 6 -piperazinone 246a was a strong 
indication that the enolisation was involved in the mechanism although it was not the 
major pathway. The following experiments were done as “control reactions” in order to 
exclude any possible secondary reactions, such as enolisation after cyclisation and 
therefore to prove that deuterium was incorporated during the cyclisation step.
A 90:10 mixture o f 246a:247a was heated in presence o f different deuterated 
compounds, such as “deuterated” glyoxal, deuterated methanol and water mixture. The 
attempt to convert the proto-mixture into the deuterated mixture was unsuccessful. After 
24 hours at reflux, starting materials were completely recovered. No change into 
deuterated piperazinones was observed monitoring by 1 H-NMR and LRMS 
measurements (Table 27).
^Ph ^Ph ^Ph ^Ph
/■‘-u ^ N N .^O
iorii H3C O ^ Y  Y " D H3C O ^ Y  
~ ¥ r *  V S "
247a 246a 301 302
S ch em e 70. R e a g e n ts  a n d  c o n d itio n s :  (i) D 20:M eO D , 1:1, 24 h reflux; (ii) g lyoxal, D 20 ,  24 h reflux
Ph Ph
Mass Peak Found Theoretical
Piperazinone 301 Piperazinone 302
326 (M+l) 24 18 23.6
327 (M+2) 4 2 3.1
T ab le  27. Abundances o f  M +2 in  LRM S
It was clearly established that no deuterium was incorporated in any o f the 
isomers and that enolisation did not take place with the standard reaction conditions. 
These results for both control experiments confirmed that piperazinones are stable and 
they cannot exchange protons in a  to the carbonyl group unless a strong base (/-BuOK, 
MeOH) was present in the reaction mixture, i.e. equilibration o f stereoisomers (cf. 
3.6.1.2).
5.4.3 Postulated mechanism of glyoxal cyclisation in D20
Our initial hypothesis to explain the regioselectivity observed in the cyclisation 
between chiral 1 ,2 -diamines and glyoxal was mainly based on the formation of only one
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diaminol stereoisomer capable to lose a water molecule from position 5, in which the 
lone pair o f the amino group were aligned with the antibonding orbital o f the leaving 
group (section 5.1.3). Moreover, it was considerable that despite the higher 
nucleophilicity o f N-4, observed in all previous work, the water molecule departed from 
the position adjacent to N-l by donation of N -l lone pair.
The deuteration experiment opened new considerations regarding the 
mechanism of formation of the two regioisomers. In particular, the mechanistic pathway 
that led to the 5-substituted piperazinone must have involved a 1,2- hydride shift as 
main pathway, confirmed by the low amount o f deuterium present at position 3 
(Scheme 71).
Bn Bn
u H3c o ^  ^ h@ 1,2-hydride
H3CO y  y  P20   ^ V o h  ^ B n  shift > H3c o  | p~H
‘nh ' o  Bn^  * q t § H V °
Bn H Bn
182a 141 290 247a
S chem e 71. M echanism  for 5-piperazinone involving 1,2-hydride shift
For the 6 -substituted piperazinone 302, in which higher content o f deuterium 
was found, the enolisation was postulated as competitive pathway (Scheme 72).
h3c o
h3c o
O H /©  Rn
H3CO
182a 141 291 (enol
^formation
H3CO
BnI
M' X (H- °)N H 
Bn 
302
Schem e 72. M echanism  for 6 -piperazinone involving am ide enolisation
N
HO
300
5.5 Conclusions
In conclusion, high regioselectivity for the preferential formation o f 5- 
substituted piperazinones was shown in all glyoxal cyclisations.
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T ab le  28. C yclisation results o f  chiral diam ines w ith  glyoxal. Ratios calculated in the crude ‘H -NM R  
spectrum (yield).
The addition of glyoxal to 1,2-diamines resulted in the initial formation of two 
important intermediates, the imidazolidine ring and diaminol; the first, kinetic product, 
was formed at low temperature by formation of iminium ion followed by attack o f N -l 
to the “new” electrophilic centre. The latter was generated by simultaneous and direct 
addition o f both amino groups to the dialdehyde. It was believed that both intermediates 
rearranged into piperazinone rings. The piperazinone formation is under thermodynamic 
control and was usually obtained at high temperature in polar solvent whereas 
imidazolidine ring was formed under kinetic control and formed at the first stage o f the 
reaction usually at low temperatures.
The use o f achiral substrates led to optimisation o f the procedure in order to 
increase the yield of piperazinones in the case o f aromatic diamines and the deuteration 
experiments showed the mechanistic pathways. In particular, two possible mechanisms 
could take place: a 1,2-hydride shift during the formation of 5-substituted piperazinone 
and enolisation for 6 -substituted piperazinone, as shown by the deuterium amount found 
in the regioisomers.
103
CHAPTER 6 Methyl- and phenylglyoxal cyclisations
6.1 Introduction
Parallel to the study on the diastereoselective preparation o f 3,6-disubstituted 
piperazinones, starting from 2 -substituted A,A'-dibenzyl 1 ,2 -diamines and chiral 
haloacetates, further investigations on the cyclisations o f the same chiral diamines with 
asymmetric 1 ,2 -dicarbonyl compounds were performed.
From the preceding chapter, it was established that the addition o f glyoxal to the
1,2-diamines occurred regioselectively with the preferential formation o f 5-substituted 
piperazinones. On the basis of that evidence, attempts for the extension of this 
procedure to preparation o f 3,5-disubstituted rings were carried out.
Described in this chapter are the cyclisations o f methyl- 
306 and phenylglyoxal 177 with the dibenzyl diamine as 
a potential stereoselective way to prepare 3,5- 
disubstituted piperazinones.
6.2 Methylglyoxal
6.2.1 Cyclisation of methyl N ,N '-dibenzyl-2,3-diaminopropyl ether and 
methylglyoxal
Bn Bn BnI I I
Bn Bn Bn
182a 307 259
When an excess o f methylglyoxal 306 (5 mol/equivalents) was added to the 
refluxing mixture o f dibenzyl diamine 182a in water: ethanol, 1 :1 , the colour o f the 
crude mixture went from clear yellow to dark red in a few seconds. The reaction 
progress was monitored by TLC and after 4 hours, the diamine was still present. This 
suggested that there was no reaction taking place. A possible explanation for this 
unsuccessful attempt was that the polymerisation o f methylglyoxal occurred, also 
confirmed by colour changes o f the crude mixture, and that consequently the diamine 
could not react with the dielectrophile. At the end o f the experiment, after 24 hours, the 
diamine starting material was completely recovered.
177306
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The second attempt at the cyclisation was performed using a smaller amount o f 
methylglyoxal ( 1 . 1  mole equivalents) and performing its addition dropwise over 6  
hours. After 110 hours o f reflux, TLC and NMR spectra showed the formation o f two 
products. Their ratio based on the methoxy groups integrations was 90:10 in the 1H- 
NMR spectra. The two adducts were purified by flash chromatography and identified as
3,5-disubstituted piperazinone 307 (15%) and 3,6-disubstituted piperazinone 259 (3%). 
The latter was previously prepared by addition of the dibenzyl diamine 182a and methyl 
2-bromopropionate 252. The structure was confirmed by direct comparison of NMR 
data to the standard piperazinone 259.
The other regioisomer 307 was a new compound and its structure was confirmed 
by full NMR data analysis. The formation o f only one diastereoisomer for each pair of 
regioisomers showed that the cyclisation was somewhat stereoselective. The major 
problem of the cyclisation was the polymerisation o f the methylglyoxal therefore yield 
of products were unsatisfactory. In order to optimise the yield o f piperazinone 307, and 
to decrease the polymerisation of methylglyoxal, the reaction was run in high dilution 
condition and the starting diamine and methylglyoxal were both added dropwise over 8  
hours. The reaction time was prolonged until 210 hours. Several conditions did not give 
any improvement and the yield o f 5-piperazinone obtained was always disappointing.
6.2.2 ^ -N M R  data analysis for l,4-dibenzyl-5-methoxymethyI-3-methyl- 
piperazin-2-one 307
H-5 gave a multiplet therefore the assignment of the stereochemistry was based 
on the vicinal coupling constants found for H2 - 6  (4.2, 6 . 8  Hz) to H-5, which could 
indicate that H-5 was in axial position. From NMR analysis o f  previous 3-substituted 
piperazinone (cf. 261, 262), it was shown that chemical shifts for the proton at position 
3 were not useful in order to assign the stereochemistry at that centre. In this case, H-3 
displays a doublet at 5 3.35 ppm, which is an intermediate value between the expected 
axial (5 3.05, cf. 259) and equatorial ( 8  3.56, cf. 260) protons. The two possibility for 
the conformation of the regioisomer 307 were trans-3ox,5eq and cis-3eq,5eq.
307
dS-3eqi 5gg- trdtlS-3ax, 5^-
piperazinone piperazinone
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Unfortunately, the precise conformation of the adduct 307 could not be assigned 
for the reasons explained above. However, according to the energies calculated with PC 
Model 8, the most stable conformation possesses the methoxymethyl substituent and the 
methyl at position 3 both in axial position.
Ph
V
H3Co^ f  T
,o^ph 
5 -P ip era z in o n e  307
5 -P ip era z in o n e  307
H-3 3.35  (d, 6 .9 )
H -5 2 .95  (m )
H -6a 3.3 (d<t 12.6, 4 .2 )
H -6b 3.2 (dd. 12.6. 6 .8 )
H -7a 3.25  (dd. 9.3. 4 .2 )
H -7b 3.05  (m )
H ,-9 3.03 (s)
H -lO a 3.78  (dd. 17.4, 14.6)
H-lOb 3.78  (dd, 17.4. 14.6)
H - l la 4 .5 5  (d, 14.5)
H - l lb 4 .5 8  (d. 14.5)
H3-12 1.37 (d. 9 .6)
T a b le  2 9 .1 H -N M R  chem ical sh ifts and coupling constant for piperazinone 307
6.3 Phenylglyoxal
6.3.1 Introduction
The cyclisation of methyl a-bromophenylacetate with dibenzyl diamine, 
described in chapter 3, showed to be 100% regioselective, due to the only formation of 
the pair of epimers of 3,6-disubstituted piperazinones. However, the ratio of these 
diastereoisomers found was 50:50 therefore the cyclisation did not show any 
diastereoselectivity. Our prediction for the phenylglyoxal cyclisation was mainly based, 
as for the methylglyoxal case, on the higher reactivity of the aldehyde function over the 
ketone ones present that could lead to formation o f only one pair of epimers, 3,5- 
disubstituted piperazinones.
Moreover, the methylglyoxal cyclisation outcome was very encouraging for the 
ratio of products found and it would probably be a reliable procedure in absence of 
polymerisation reaction of the methylglyoxal.
6.3.2 Phenylglyoxal cyclisation: predicted mechanism
As seen in the glyoxal work, the key intermediates for the formation of the 5- 
piperazinone regioisomers were the imidazolidine adduct, considered as the kinetic 
intermediate, observed and isolated, and the diaminol that was not isolable. Our 
prediction regarding the cyclisation of chiral diamines with phenylglyoxal was as 
follow. Phenylglyoxal is a ketoaldehyde and consequently the most electrophilic centre
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to be attacked by N-4 was the aldehyde part to form the keto-aminol 308. At that stage, 
as already observed in previous cyclisations, two pathways (a and b) could take place.
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S ch em e 73. M echanistic pathways for phenylglyoxal addition to secondary diam ines
The postulated path a involved attack of N -l to the ketone and formation o f the 
diaminol 30915°. The path b involved attack from N -l to the electrophilic carbon of the 
iminium ion. We chose the pathway a as the most feasible leading to the formation o f 
diaminol and consequent elimination o f a water molecule at C-2 to generate a 
carbocation, highly stabilised by resonance from the lone pair o f the nitrogen and from 
the phenyl group. The formation o f a stable carbocation would have lead to the 
formation of the 3,5-disubstituted piperazinone 313.
6.3.3 Cyclisation of methyl N ,N '-dibenzyl-2,3-diaminopropyl ether 182a and 
phenylglyoxal 177
BnI
H3C O ^ V NHPhY C
u NH H ^ ^ O  I
Bn
182a 177
Bn Bn
Ph
H3CO‘H3CO'
Ph Ph
261 262 312
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The cyclisation o f diamine 182a with phenylglyoxal 177 was performed in a 
mixture of ethanol and water, 9:1. As expected, after 30 minutes, formation o f an apolar 
compound was observed on TLC, identified as the kinetic intermediate imidazolidine 
ring. After two hours, TLC displayed the appearance of three overlapped spots in the 
region o f cyclised compounds, by direct comparison to our standard compounds, 
previously prepared in the a-bromophenylacetate cyclisations. The reaction mixture 
was kept refluxing for 20 hours until disappearance of the apolar compound. Upon work 
up and column chromatography, analytically pure sample were obtained: 3,6- 
piperazinone epimers 261 (17%) and 262 (29%) and one diastereoisomer o f 3,5- 
piperazinone 312 (25%).
The cyclisation was not regioselective but showed some diastereoselectivity 
because o f the formation of one epimer of 3,5-disubstituted piperazinones. The structure 
assignment for the adduct 312 will be discussed in the next chapter. Several procedures 
were attempted in order to reduce the amount of 3,6-piperazinones and enhance the 
regioselectivity. The highest selectivity for piperazinone 312 was found when the 
cyclisation was run in ethanol for 84 hours at room temperature (Table 30).
Solvent R eaction  tim e 261 262 312
EtOH:H20 / 9 : l 20 h  reflux 17 29 25
E t0 H :H 20 / 9 : l 84 h rt 11 21 68
EtOH/p-TsOH 24 h r t 14 28 56
EtOH 120 h r t 17 29 53
EtO H /silica gel 24 h rt 28 43 28
EtO H /silica gel 24 h reflux 38 31 30
H 20 / N a l 24 h rt 18 42 40
H20 /  N al 24 h  reflux 21 38 41
DM F 5h rt 42 17 40
T ab le  30. The ratios have been calculated in the crude H -N M R  over the aromatics
6.3.3.1 Isolation o f  five membered ring intermediate
At the beginning o f the reaction of dibenzyl diamine 182a and phenylglyoxal 
177, TLC showed the presence o f two spots in the apolar region. A mixture o f cis- and 
trans- 4-methoxymethyl-l,3-dibenzyl-imidazolidin-2-yl)-phenyl-methanone 315a was 
formed after 30 minutes at room temperature.
182a 177 315a
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After one hour at room temperature, the adducts 315a was isolated and purified 
(20% yield). After 48 hours their amount in the crude mixture decreased to 8%. They 
were the kinetic intermediates that could rearrange into the piperazinones151.
Full NMR analysis showed that the mixture was composed o f cis (65%) and trans 
(35%) isomers. Previous work also showed that the most favourable isomer was the cis- 
imidazolidine.
6 3 3 .2  Isolation o f diaminol intermediate
Bn ?n In the first part o f the reaction, it was also
N PH ^  N , / h
H3co'XSaY^  'vp 0H h3co | | ' ,oh possible to observe the formation o f another
L  J tr -  OH
n Y, | important intermediate, the diaminol 309.
Bn Bn
309 316
After stirring for 2 hours at room temperature, the reaction mixture was 
composed o f imidazolidine 315a (20%), a mixture o f piperazinones (32%) and 
diaminol 309 (30%).
The diaminol 309 was the slowest spot on TLC and its purification was 
impossible due to the continuous and spontaneous conversion into the piperazinones. 
The ‘H-NMR spectra showed the presence o f two sharp singlets at 3 .65 and 4.5 ppm 
that were assigned to the proton o f the secondary and tertiary alcohol groups o f both 
conformers, and the presence o f piperazinones 261 and 262, which initial ratio was 
50:50. IR spectra displayed a weak broad band around 3000 cm '1 and signals due to the 
C-O stretching o f the secondary alcohol.
By monitoring the isolated diaminol for one week, a change in its composition 
was observed by TLC and 1 H-NMR spectra. After 7 days in a vial, the ratio o f 261:262 
had changed to 27:73 and the diaminols signals had disappeared completely. It was 
expected that the diaminols would be converted into 3,5-piperazinone 312 but this was 
not seen.
6.3.33 Postulated 3,6-disubstituted piperazinone mechanistic pathway
The only plausible mechanism for the formation o f 3,6-disubstituted 
piperazinone had to involve the formation o f the iminium ion followed by formation o f 
an aminol by attack o f N-4 to the ketone function. After formation o f the aminol 316, 
the 1,2-phenyl group shift should be postulated as the main pathway. The preference o f
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N-4 to attack the ketone rather than the electrophilic carbon o f the iminium ion could be 
unexpected, as previously seen in the glyoxal work where the same position was 
preferred in presence of another aldehydic function. The alternative and perhaps more 
reasonable mechanism would lead to the formation of the imidazolidine derivative, as 
seen in glyoxal cyclisations.
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However, previous work by Agami showed that 1,2-phenyl shifts to iminium 
ions occurred during the synthesis o f morpholine derivatives although after formation of 
the diol 179. The higher nucleophilicity o f the amino group over the hydroxyl group and 
the favourable formation of a lactone rather than a lactam lead to the formation o f only 
one product152.
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The partial loss o f diastereoselectivity, observed in the phenylglyoxal 
cyclisations, was perhaps due to the higher rate of the iminium ion formation followed 
by the favourable 1,2-phenyl group shift. It was probable that the temperature was 
involved in the competition o f these mechanisms, since it was observed that high 
temperatures promoted loss o f diastereoselectivity, with consequent major formation of 
6-piperazinone.
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6.3.4 Oxidation in situ to prepare phenylglyoxal
0  0  OH
317 177 318
Another attempt at this cyclisation was done following a known procedure in 
which the phenylglyoxal was prepared in situ by oxidation of a-hydroxyacetophenone 
317 with manganese dioxide153. When the a-hydroxyacetophenone was added to the 
mixture o f methyl A, A-dibenzyl-2,3-diaminopropyl ether 182a in EtOH with 
manganese dioxide, only 6% conversion into products was observed, in the ratio o f 
261:262:312, 25:22:53. The crude mixtures were usually dark oils and they were 
composed of mixture of several unknown compounds impossible to purify. It was 
plausible to imagine a sort o f a-hydroxyacetophenone polymerisation occurred.
Another attempt was done using 1-phenyl-1,2-ethan diol 318, oxidised in situ by 
manganese dioxide, to keep the concentration of phenylglyoxal low during the 
cyclisation step, to promote an higher regioselectivity and to avoid the starting material 
polymerisation. Unfortunately, the crude ^ -N M R  spectra showed, also in this case, 
mixtures o f products. However, signals o f the desired piperazinone were very weak 
(<3% conversion). Colour change of the crude mixture occurred hence polymerisation 
could not be avoided even when high dilution condition was kept.
After basic work up of the crude mixtures with dichloromethane,
n
y  l,3-dibenzyl-4-methoxymethyl-imidazolidine 199 was isolated
N\ (80%, section 2.2.4.1). This constituted a further proof that the
Ph
1 9 9  diamines did not react in the reaction pot.
6.3.5 Cyclisation of methyl N jN -diphenyl^^-d iam inopropyl ether 182d and 
phenylglyoxal 177
Phenylglyoxal was also reacted with the less reactive diphenyl diamine 182d. 
After 24 hours at reflux in ethanokwater mixture, the products isolated were the cis and 
trans isomers o f the imidazolidine derivatives 319 and 320. The mixture seemed to be 
the final products of the reaction, also confirmed by running the reaction for longer 
times (72 hours, 40% yield).
^ -N M R  spectra o f the crude after only 5 hours already showed the complete 
conversion of the diamine into two adducts in the ratio o f cis. trans, 70:30. Purification
I l l
by column chromatography gave only one fraction containing both compounds. As 
mentioned earlier, it was expected that these imidazolidine derivatives preferred the cis 
conformation despite the fact the trans should be the thermodynamic isomer and the 
most stable.
319 320
H 319 320
H-2 4.42 (pd. 4.6. 1.7) 4.13 (ddd. 12.3. 8.7. 4 .3 )
H-3a 3.6  (m ) 3.6  (111)
H-3b 3.7 (dd. 9.6. 1.5) 3.76 (dd. 9.0. 7 .8)
H-5 5.9  (s) 5 .72 (s)
H-7a 2.92 (t. 7 .1) 3 .08  (t. 7 .1)
H-7a 3.6 (m ) 3.41 (dd. 9.3. 4 .6 )
H3-9 3.23 (s) 3.2 (s)
T ab le 31. N M R  data comparison o f  c is -  319  and /raws-isom ers 320
Due to the similarity o f these imidazolidine derivatives with piperazinones, most 
signals in the ‘H-NMR spectra were almost the same but the V  spectra showed 
correlations that were not present in the piperazinones spectra.
In particular, the crucial correlation was found between for 
H-2 and H-3 to C-5 and vice versa for both compounds. 
This correlation clearly links all the atoms in a five- 
319 , 320  membered ring.
IR absorption at 1597 cm'1 could suggest the presence o f a conjugated ketone, 
although the value was quite low compared to the literature values for similar 
imidazolidine rings154, which were 1690 and 1675 cm'1 for that conjugated ketone. 
Finally, the LRMS showed one peak at 373 (M +l) and one peak at 265 due to the loss 
o f the stable acylium ion. These data were confirmed by HRMS for both peaks.
6.4 Further investigations on 3,6-disubstituted piperazinone formation
Phenylglyoxal reacted with the dibenzyl diamine giving a mixture o f three 
piperazinones. Even in our best attempt to enhance the selectivity towards our desired 
product, the ratios were disappointing. The high incidence o f unexpected 3,6- 
piperazinone epimers formation suggested that there was a competitive mechanism
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taking place that afforded these two piperazinone, besides the main pathways for 3,5- 
piperazinones.
By evaluating this alternative mechanism, which had to involve a 1,2-phenyl 
group shift we decided to follow further investigations. 13C-labelled phenylglyoxal was 
prepared and reacted with the dibenzyl diamine and benzil was used as “new” cyclising 
agent. The scope of those experiments was to follow the cyclisation mechanistic 
pathway with the label, and to observe the 1,2-phenyl group shift. The label position in 
the piperazinones would be easily detected by NMR, giving important information 
regarding the cyclisation mechanism.
The experiment involving the 13C labelled phenylglyoxal is described in 
following section whereas the benzil cyclisations are described in the next chapter.
6.4.1 13C-labelled phenylglyoxal
6.4.1.1 Postulated mechanism
The insertion o f I3C-label at the aldehydic function o f phenylglyoxal represented 
a useful tool to understand the mechanism of its addition to the diamine. The position of 
the label in the final products could be easily monitored by NMR and could give 
important information regarding the preferential pathways that lead to 3,5- and 3,6- 
disubstituted piperazinones. In particular, our hypothesis concerning the formation of
3,6-disubstituted piperazinones was about a 1,2-phenyl group shift. According to our 
postulated mechanism, our expectation was to find the label at position 3 in the 
piperazinone that would agree with our hypothesis.
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Sch em e 74. Postulated m echanism  for 13C -labelled phenylglyoxal
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6.4.1.2 Preparation o f I3C-phenylglyoxal
13C-labelled phenylglyoxal was prepared by oxidation o f a ,3C-acetophenone 
and selenium dioxide155 in a mixture of dioxane:water, 1:1. The label was present on the 
methyl group of the acetophenone that was converted in aldehyde function. The reaction 
of non-labelled phenylglyoxal was done simultaneously and it was successful.
The oxidation occurred in 24 hours and the work up consisted in easy decantation o f 
solvent followed by evaporation on the high vacuum rotary evaporator to yield the 
labelled-phenylglyoxal as white solid in high yield (79 %).
o
327 321
Schem e 75. R e a g e n ts  a n d  co n d itio n s ', (i) S e 0 2, H20 ,  dioxane
The reaction progress was monitored by NMR. ^ -N M R  spectra of the
acetophenone showed only two 13C satellites for a singlet (5 2.47 ppm, doublet, 127.5
1
Hz), besides the aromatics. C-NMR showed only one signal, corresponding to the 
methyl group at 26.86 ppm.
!H-NMR spectra of the oxidised product 321 showed disappearance o f the two 
satellites and appearance o f other two 13C satellites for a singlet (5 9.5 ppm, doublet,
186.2 Hz), attributed to the aldehyde peak. Similarly, 13C-NMR showed complete 
disappearance o f the methyl peak and appearance o f a carbonyl peak at 191.36 ppm.
6.4.1.3 Cyclisation o f  methyl N ,N  -dibenzyl-2,3-diaminopropyl ether 182a a n d 13 C  
labelled phenylglyoxal 321
The first attempt at the cyclisation was performed in a mixture o f methanol and 
water. Phenylglyoxal was added in slight excess (1.4 equivalents) and the reaction 
progress was monitored by TLC. After 12 hours at reflux, TLC showed a complex 
mixture of compounds amongst which there were the expected spots of the cyclised 
products, besides some unreacted diamine. ^ -N M R  at that stage was really complex. 
More than 7 methoxy groups were displayed in the spectra and the peaks analysis was 
impossible. The reaction mixture was left refluxing longer but no changes were 
observed either on TLC or in the NMR.
Unfortunately, the outcome of the second attempt was the same as the first one. 
13C-NMR spectra o f the crude mixture displayed a mixture of compounds and the label 
was present at carbonyl peaks.
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The reactions were run in 100 mg scale due to the high cost o f the labelled 
acetophenone therefore it was not possible to perform other attempts at the cyclisation. 
Further steps would have involved flash chromatography o f the complex mixture and 
spectroscopic analysis o f each single component. Due to the low amount o f the crude 
mixtures and to the unsuccessful result for 13C label in the NMR, chromatography was 
not carried out as we considered it time consuming without expecting any positive 
outcome.
13C-NMR spectra o f the crude mixture showed the label at carbonyl positions 
and this was a sufficient evidence to exclude the 1,2-phenyl shift during the cyclisation.
6.5 Conclusions
The cyclisation o f the dibenzyl diamine 182a with methylglyoxal was high 
regio- and diastereoselective (90:10 mixture o f regioisomers, 100% formation o f one 
diastereoisomer. The limit o f this procedure was the methylglyoxal polymerisation that 
resulted in poor yield o f products (15%).
The cyclisation o f the same diamine 182a with phenylglyoxal was not high 
regioselective (32:68 mixture o f regioisomers). Unfortunately, 13C labelled 
phenylglyoxal cyclisation reaction did not elucidate the reason o f the unexpected loss o f 
regioselectivity. Further investigations for the cyclisation mechanisms will be described 
in the next chapter.
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CHAPTER 7 Benzil cyclisations
7.1 Introduction
The cyclisation between 13C-phenylglyoxal and dibenzyl diamine, described in 
the final part o f the preceding chapter, indicated that there was no 1,2-phenyl group shift 
occurring for the formation of 3,6-disubstituted piperazinones.
Parallel to that investigation, new cyclisations o f our scaffold diamines with 
benzil were carried out. The idea behind these experiments was to “force” the 1,2- 
phenyl shift, which represented an essential step in the cyclisation mechanism. 
According to our postulated mechanism, preferential formation of piperazinone 332 
should occur. The first step involved the attack from the more reactive N-4 to one keto 
group. At that point, there were two possible choices: the first (path a) was attack o f N- 
1 to the second ketone to form the diaminol; the second (path b) was the departure of 
water molecule to form a tertiary carbocation 328, highly stabilised by resonance from 
the adjacent amino lone pair and the phenyl group.
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The latter path was considered to be the most favourable due to the presence o f 
the reactive N-4 lone pair that would afford the iminium ion 329.
After formation o f the intermediate 329, two possible pathways could take place. 
The path c (blue arrows) involved attack from N -l to electrophilic iminium ion and led 
to the imidazolidine ring 331. The path d (red arrows) involved formation of the new 
aminol 330 by attack of N -l to the second keto function o f benzil. In this pathway, a
1,2-phenyl group shift had to occur in order to complete the lactam formation and to 
restore the tertiary amine.
Our hypothesis also excluded the formation o f the other regioisomer 335 as a 
direct consequence o f the favourite loss of a water molecule in the aminol 327 and 
consequent iminium ion 329 formation (path b).
7.1.2 Benzil reactivity
Benzil is the simplest aromatic a-dicarbonyl compound. The structure o f benzil 
is considered to be flexible with respect to the dihedral angle 0 between the planes of 
the two carbonyl groups. In solution, the most stable conformation is trans form.
To the best o f my knowledge, there are no examples in literature o f benzil cyclisation 
with 1,2-diamines to afford piperazinones. Only few examples o f benzil with amines are 
known. 2-Aminopyridine 336 and benzil in refluxing xylene for 7.5 hours gave 2,2- 
diphenylimidazo-[l,2-a]-pyridin-3-one 338 as main product. The formation o f the imine 
338 had been postulated due to the higher availability o f the 2-amino group over the 
pyridine nitrogen156.
F igu re  38. PC M odel 8 representation o f  benzil
However, Sokov157 postulated the formation o f the diaminol 339, which 
rearranged to the pyridinone 340 through pinacol rearrangement. The outcome o f this 
experiment could be that the formation o f the diaminol at high temperature was faster 
than imine formation.
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7.1.2.1 Biltz synthesis
A close example to our case was the condensation o f benzil 139 or substituted
benzil158 with urea, known as Biltz synthesis, which gave phenytoin 344 in good yield
(74%)159. The proposed mechanism for condensation o f benzil with an alkylurea
requires a 1,2-phenyl group shift. It was also proposed that the condensation reaction,
run in basic solution, proceeded via benzilic rearrangement yielding the same adduct 
3 4 4 1 6 0 , 1 6 1 ^
139
NH
342
7.1.2.2 Benzilic rearrangement
The benzilic rearrangement is the base-induced transformation o f an a-diketone 
into the salt o f an a-hydroxyacid and, in case o f substituted ones, is favoured when Rs 
are modest electron withdrawing groups. It is observed in aromatic, semiaromatic, 
acyclic and in aliphatic as well as heterocyclic a-diketones.
The first step is the reversible addition o f a hydroxide ion to a C =0 group o f the 
a-diketone, giving the negatively charged intermediate. The first intermediate undergoes 
a rate determining intramolecular rearrangement, yielding a second intermediate, which 
is rapidly converted into the salt of he corresponding a-hydroxyacid by proton transfers.
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The migration o f the phenyl group is accompanied by the migration o f the oxygen-
162bound hydrogen atom
o
139 ^  J> 345 346
Schem e 76. B en zilic  rearrangement m echanism
PH o
7,2 Results and discussion
7.2.1 Cyclisation of methyl NtN '-dibenzyl-2,3-diaminopropyl ether 182a in 
ethanolrwater mixture
NH O
NH O
BnI
!_ ». h3co^ ^ N^ °
182a 139
, Ph 
Bn
347
S ch em e 77. R e a g e n ts  a n d  c o n d itio n s :  (i) EtOH:H20, 1:1, reflux, N 2 atm.
The first attempt for the benzil cyclisation was performed using the same 
procedure as the other cyclisations with 1,2-dicarbonyl compounds. The reaction 
mixture was refluxed in ethanofwater (1:1) for 24 hours. By monitoring the reaction 
progress by TLC, only one spot was shown in the apolar region after 3 hours. TLC and 
NMR spectra did not show formation o f piperazinones although one new compound 
was formed. Upon work up and flash chromatography, analytically pure sample was 
isolated (76%).
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The NMR data was consistent with the 1,3- dibenzyl-4- 
^ Ph methoxymethyl-2-phenyl imidazolidine 348 structure. Previous 
work by EGB showed the formation o f the imidazolidine 348 by 
the condensation of the diamine 182a with benzaldehyde 213130. 
This result was unexpected and suggested that the scission o f carbonyl carbon- 
carbonyl carbon bond of benzil might have occurred, affording benzaldehyde and 
benzoate.
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S ch em e 78. Carbonyl carbon-carbonyl carbon cleavage in base
7.2.2 Cyclisation of methyl N ,N '-dibenzyl-2,3-diaminopropyl ether 182a and benzil 
in DMSO
The following attempt at the cyclisation was performed at much higher 
temperature, in DMSO. After 20 hours at 165° C, two new products in the region o f 
cyclised compounds were shown on TLC (Rf= 0.34, 312; Rf= 0.25, 350; petroleum 
ether: diethyl ether, 3:1) and a ratio o f 43:57 was calculated in the crude ^ -N M R  
spectra. Upon basic work up and flash chromatography analytically pure samples were 
isolated.
NMR signals of the minor isomer (11% yield) were familiar to us and 
unexpectedly, they belonged to the 3,5-disubstituted piperazinone isomer 312, isolated 
in the phenylglyoxal cyclisation. The major isomer (30% yield) was unknown and NMR 
data analysis confirmed the structure as the epimer o f piperazinone 350.
Bn BnI I
I I
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312 350
Reaction in DMSO at lower temperature such as 120° C gave mixture of 
imidazolidine adduct and piperazinones in a ratio o f 62:31:6, 350:312:348. Therefore 
the highest selectivity for the piperazinones was achieved at 165° C.
The isolation o f these two piperazinone epimers 312 and 350 was totally unexpected 
and could be rationalised only by the loss o f one phenyl group. This result was 
unpredicted and very exciting. We rationalised that the benzil had to undergo a 
rearrangement involving a scission of R carbon-carbonyl carbon bond to form an a- 
ketoacid or the reduced form, showing the same oxidation state o f phenylglyoxal. 
Dephenylations o f benzil had never been observed during the cyclisation reactions 
earlier in literature. However, it is known that this type o f cleavage was achieved using
2,6-dihalobenzaldehydes with halogen substituents in ortho position.
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7.2.2.1 NMR analysis for 3,5-disubstituted piperazinones 312 and 350
The energies for all the possible conformations o f the 3,5-disubstituted 
piperazinones 312 and 350 were calculated by PC Model 8. It was found that the lowest 
energy belonged to the stereosiomer having both the methoxymethyl substituent and the 
phenyl substituent in equatorial positions (Figure 39).
Unfortunately 'H-NMR data were not complete due to the presence of 
overlapped signals hence the stereochemistry o f these epimers could not be fully 
assigned. H-3 singlets for both epimers were at the same high chemical shift ( 8  4.3), 
which suggested they could be in equatorial position. Small vicinal coupling constants 
(4.9, 2.7 Hz) were found for H2 - 6  to H-5 for the isomer 350, which suggested the H-5 in 
equatorial position. Unfortunately, for the other isomer 312, only one small vicinal 
coupling constant was observed for H-6 b (2.7 Hz) therefore stereochemistry at that 
centre could not be assigned.
According to our previous findings, methoxymethyl substituent should prefer to 
be in axial position. The only conformation we assigned was for piperazinone 350 and it 
was trans-diaxial conformer. If our prediction about H-3 is correct, the piperazinone 
312 should then be cis-3ax,6eq conformer.
As seen in chapter 3, HMBC spectra were necessary to confirm the structures 
unambiguously and to exclude the other regioisomer formation. Both compounds 
showed strong correlations for H2-IO and H2 - 6  with C-2. Moreover correlation of H-3 to 
C-5 and vice versa was also observed.
Ph
312
Ph
Ph 350
F igure 39. Lowest energy found (c/s-diequatorial) by PC M odel 
8 for piperazinone 350
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H 5-P ip eraz in on e 312 5-P ip eraz in on e 350
H-3 4.34 (s) 4 .35 (s)
H-5 3.0 (m) 3.1 (m)
H-6a 3.0 (m) 3.22 (dd, 7 .9 , 4 .9 )
H-6b 3.21 (dd, 1 1 .7 ,2 .7 ) 3.41 (dd, 7 .9 , 2 .7 )
H-7a 3 .16 (dd, 5 .8 , 3.2) 3.23 (m )
H-7b 3.26 (dd, 8.4, 3.2) 3 .52 (m)
H3-9 3.05 (s) 3.05 (s)
H-lOa 4.51 (d, 14.6) 4.41 (d, 14.3)
H-lOb 4.58 (d, 14.6) 4 .6  (d, 14.3)
H - l l a 3.82 (d, 14.0) 3 .6 (d, 13.6)
H - l l b 3.67 (d, 14.0) 3 .54 (d, 13.6)
T ab le 32. ‘H -N M R  chem ical shifts and coupling constants for 3,5-disubstituted piperazinones 312 and 350
7.2.3 Cyclisation of N ,N '-dibenzyl ethylenediamine with benzil
Benzil was also reacted with N ,N '-dibenzyl ethylenediamine 72d in DMSO. The 
scope of the experiment was to confirm the loss of phenyl group in the cyclisation and 
to avoid formation of mixture of stereoisomers.
Bn
Bn Bn
72d 351
After 24 hours at 165° C, only one product was observed on TLC. After work up 
and flash chromatography, pure sample of l,4-dibenzyl-3-phenyl-piperazin-2-one 351 
was isolated (77%). The structure was confirmed by NMR analysis and the same adduct 
was also isolated by addition of phenylglyoxal and a-methyl bromophenylacetate to the 
unsubstituted 1,2-diamine 72d163.
7.3 Conclusions and future work
In an overview, a new regioselective cyclisation for preparation of 3,5- 
disubstituted piperazinones was discovered. The cyclisation was not diastereoselective 
since a 43:57 mixture of epimers was found, according to the NMR methoxy groups’ 
integrations. The dephenylation o f benzil in the cyclisation was completely unexpected 
and was confirmed by a further cyclisation with an unsubstituted 1,2-diamine. The 
reasons of this rearrangement are still unclear but future investigations will be focused 
on benzil behaviour with aliphatic 1,2-diamines, in order to monitor better aromatic 
protons changes in the NMR spectra. Possibly GC-MS experiments could elucidate
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when the phenyl group is lost in the cyclisation mechanism and its nature as negative or 
positive fragment.
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CHAPTER 8 Cyclisation of chiral 1,3-diamine
8.1 Introduction
Monocyclic medium ring nitrogen heterocycles are an important class o f 
compounds that occur in a wide range of natural and unnatural compounds. The term 
medium ring is usually referred to alicyclic compounds having a ring size o f 8 to 11. 
However, 7-membered and 12-membered rings are often included in this category164. 
Azepines and diazapeninones constitute important motifs in medicinal chemistry. Their 
synthesis using conventional ring closure methods is difficult. Amongst all strategies, 
the Staudinger ligation has been reported that provides access to 7- and 9-membered 
lactams165.
On the basis o f the successful investigations on regioselective cyclisations to 
afford piperazinones described in the preceding chapters, attempts to extend this 
procedure to the preparation of diazapenones were performed. The strategy used was 
the same as the previous cyclisations starting from 1,3-diamines and 1,2-dielectrophiles. 
Similarly to our previous work, a chiral centre was placed on the 1,3-diamine starting 
material in order to observe whether regioselectivity was present also for these 
cyclisations.
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8.2 Preparation o f N,N-dibenzylpentane- 1,3-diamine 352
Two different procedures were used for the preparation o f N,N-  
dibenzylpentane-1,3-diamine 352.
NaBH
355 213 352
The one-step way was the reductive amination starting from the commercially 
available Dytec© 1,3-diamine 355 with benzaldehyde 213 in presence of sodium
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borohydride. TLC and NMR of the crude were difficult to interpret due to the presence 
of mixture o f products. The first attempt for this reductive amination was done on 1 g 
scale and the NMR of the crude after only 30 minutes showed the desired product 352 
(68%) and benzyl alcohol (28%).
The second attempt was done on a larger scale (20 g) in more concentrated 
solution. TLC of the crude showed formation of mixture o f at least 6 different 
compounds and NMR showed a lot o f overlapped signals. Only 32% of the whole crude 
was assigned to be the expected diamine 352. Extraction of the product 352 required 
first acidification with hydrochloric acid (pH 1.5) and extraction with dichloromethane 
to remove the benzyl alcohol byproduct. Subsequently, with basic washes (pH 14) and 
extraction with dichloromethane it was possible to isolate the basic products. 
Purification by flash chromatography with the use o f longer column and slow gradient 
from apolar to polar solvents was required. There was an evident loss of crude mixture 
(20%) in the silica gel due to the high polarity of these molecules. The yield o f the 
desired product was disappointing (30%). Byproducts such as mono-, tri- and 
tetrasubstituted adducts were probably formed during the reaction.
The second method used was the two-step sequence o f dibenzoylation o f the 
Dytec© 1,3-diamine 355 with benzoyl chloride in sodium hydroxide, followed by 
reduction o f the diamide 356 with lithium aluminium hydride.
NH CO -Ph
NH CO -Ph
355 224 356 352
Sch em e 79. R e a g e n ts  a n d  co n d itio n s:  (i) NaOH, 89%; (ii) L iA lH 4, THF, 5 h, 55%
The first step was easily achieved in 2 hours. The product was a white 
precipitate in the reaction mixture and its extraction and purification was achieved by 
filtration and water washes, in order to remove the benzoate byproduct. The yield 
obtained was good (60%).
The reduction o f the diamide 356 was performed with lithium aluminium 
hydride in refluxing THF. After six hours, TLC did not show any starting material left 
and one spot on the baseline appeared. NMR o f the crude confirmed the formation of 
the desired diamine in high purify. Extraction of the diamine was done by quenching the 
unreacted hydride and then with basic washes with dichloromethane. The yield was
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60%. Although this was a two-step sequence compared with the single reductive 
amination previously described, this method showed to be more reliable in terms of 
yield and ease o f product purification.
8.2.1 Proof of the ./V-[3-(benzoylamino)-l-ethylpropyl]benzamide 356
Dibenzoylation o f Dytec© 1,3-diamine 355 gave A-[3-(benzoylamino)-l- 
ethylpropyljbenzamide 356 in good yield (91%). It appeared as a white precipitate with 
melting point at 141° C, which was a low value compared with 310° C o f 
phenylendiamine diamide derivative. Recrystallisation was attempted using a wide 
range o f solvents but it resulted to be unsuccessful. NMR of 356 showed a triplet at 0.8 
ppm indicating the terminal methyl group. H2-4 were quite distinguishable showing two 
splitting at 1.93 and 2.92 ppm. The aromatic and aliphatic protons ratio was measured 
using the triplet o f H3-7 as standard. H-2 gave very complex signal due lo high level of 
splitting and at 6.0 ppm it was possible to see a sharp doublet for H-5. 13C-NMR spectra 
showed all the expected signals and the two carbonyl groups at 167.1 (C-9) and 168.8 
(C-8) ppm.
MS spectra showed a M+l peak at 311 (100%) 
and M-PhCOO- 357 at 190 (30%), probably by 
the mechanism involved for the phenylendiamine 
derivative with loss of benzoate (cf. 228).
1 8
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8.2.1.1 Conformation analysis fo r  N-[3-(benzoylamino)-l-ethylpropyl]benzamide 356
The diamide 356 energy calculation 
showed that the most stable conformation 
possessed a hydrogen bond (2.085 A) 
between the amino group N-4 and the 
carbonyl group C-6 o f the opposite side 
chain. This structure resulted to be much 
more flexible than the phenylendiamine 
diamide due to the presence o f the propyl 
chain as bridge between the two amide 
groups in 1,3-relation.
Figure 40. PC M odel 8 representation o f  the 
diamide 356 (M M X  Energy 17.876 kcal mol"1)
Probably the high flexibility did not lock these structures to pack efficiently and hence 
yield crystals.
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8.2.2 Proof of structure of A,yV-dibenzylpentane-l,3-diamine 352
‘H-NMR spectra o f 352 showed the triplet for Hi-7 at 0.8 ppm, some overlapped 
signals at ~1.5 ppm that were assigned to be H2-3 and H2-6. H-3 and H2-5 signals were 
adjacent and distinguishable at ~2.5 ppm. All benzylic protons gave a multiplet at 3.6 
ppm. NMR spectra were similar to the Dytec diamine starting material 355 except for 
the presence o f the benzylic protons. The NH groups gave a broad singlet at 1.8 ppm.
F igu re 41. 1,3-D iam ine 352 PC M odel 8 
representation (M M X  Energy 27 .100  kcal m ol'1)
8.3 Cyclisation of N,N-dibenzylpentane-l, 3-diamine 352 with methyl
bromoacetate 230a
Ph
Ph
352 353 354
S ch em e 80. R e a g e n ts  a n d  c o n d itio n s :  (i) methyl bromoacetate, D IEA, xylene, 24  h
Diazapenones 353:354 ratio was established to be 90:10 after 20 hours of reflux 
in xylene, according to our standard procedure. Ratios were measured according to the 
methyl groups’ integrations. Upon basic work up and flash chromatography, yields of 
isolated 7-substituted diazapenone 353 and for 5-substituted diazapenone 354 were low 
(40%, 2% respectively). The yields were slightly lower than expected when compared 
to the corresponding adducts from the cyclisation o f 1,2-diamine and ethyl
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bromoacetate130. Cyclisation of 1,3-diamines and methyl bromoacetate was expected to 
be more arduous due to the formation o f 7-membered ring.
8.3.1 Proof of structure for 7-substituted diazapenones 353
1 H-NMR spectra analysis was very complex. H3 - 9  appeared as a triplet at 0.8 
ppm and it was used as our signal guide for measuring aliphatic-aromatic ratio and to 
use it as starting point for the HMBC spectra.
F igure 42. PC M odel 8 representation o f  7-substitnted diazapenone 353 (M M X  Energy 24 .824  kcal
m ol'1)
Initially it was believed that the splittings found at 3.9 and 5.2 ppm (d, 14.7 Hz) 
belonged to H2-3 , on the basis o f the similar pattern signals found for methylene group 
next to carbonyl group in the piperazinone rings.
When HMBC spectra were examined, it was found that there 
were strong correlations between those signals and aromatics. 
Therefore those signals had to belong to benzylic protons. H2-3 
protons appeared as doublets with large coupling constants (15.7 
Hz) at 3.4 and 3.5 ppm. All the correlations found confirmed our 
postulated structure.
353
8.3.2 Proof of structure for 5-substituted diazapenone 354
The structure o f diazapenones 354 was unambiguously confirmed by HMBC 
spectra. The most important signals were: correlation between C-2 and H2-7 and C-5 
and H2-3 and vice versa. Benzylic protons were assigned by correlation between H2-10 
and C=0 correlation. H2-3, H2-10 and H2- l l  appeared as doublets with large coupling
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constants (14.4, 15.7 and 13.7 Hz, respectively). No appearance o f correlation between 
the methylene and the carbonyl group was seen. This was crucial for the distinction of 
the two regioisomers.
F igure 43. PC M odel 8 representation o f  diazapenone  
354 (M M X Energy 25 .345  kcal mol"1)
8.4 Cyclisation of N,N'-dibenzylpentane-l, 3-diamine 352 with glyoxal
The first attempt for the glyoxal cyclisation was done using water as solvent, 
instead of the mixture ethanol and water used in the standard procedure. When the 
reaction was left stirring at room temperature, a fast spot could be observed on TLC (Rf 
0.85 in diethyl ether).
lH-NMR at that stage showed a strong singlet around 9.5 ppm, which 
indicated the presence of the aldehyde derivative 358. It was 
calculated to represent the 75% of the whole crude mixture. As also 
observed in the other glyoxal cyclisations, exclusive formation of 
kinetic products was observed at the beginning of the reaction.
According to a known procedure166, the formation of six-membered ring is the 
first step o f the reaction and it is very fast at very low temperature. When the 
temperature was increased until the solvent was refluxing, the crude mixture became 
gummy black oil that was very difficult to work up. The disappearance of the aldehyde 
derivative signal in the NMR and on TLC and the formation of the piperazinones were 
observed by ^ -N M R  spectra. The ratio measured for the isolated piperazinones was 
354:353, 25:2 relative to the aromatics. Purification by column chromatography was 
very difficult because the crude mixture was almost exclusively composed of polar
354
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compounds, impossible to separate by chromatography. It was likely that polymeric 
species formed when the temperature was increased.
The cyclisation reactions were repeated several times in an attempt to monitor the 
change of the crude physical properties but little changes in temperature would suddenly 
change the clear yellow mixture into black oil. A range of different conditions were 
explored to reduce the problem of polymer formation and to optimise the yields o f the 
diazapenones (Table 33). As shown in the table, regioselectivity existed also for the 
formation o f seven membered lactam rings. Final purification by column 
chromatography resulted in poor recovery of the products.
Solvent Reaction time 353 354
H:0 22 hrt traces 5
EtOH rt to 24 h  reflux 3 32
H:0 /E tO H  1:1 rt to 48  h reflux 3 30
T ab le 33. Ratios calculated in  the ‘H-NM R spectra o f  the crude mixture. * Integration o f  aromatic/10  
represents one com posite proton for the material present.
As mentioned previously, one o f the most serious problems of the cyclisation 
reaction was the conversion of the crude mixture into black viscous oil when the 
temperature was increased. It was also observed that high temperatures were necessary 
for the formation of the diazapenones because at room temperature only formation of 
aldehyde 358 was observed. To avoid the problem of polymerisation the dilution was 
increased and each reagent was added dropwise with a syringe over 20 hours. Even in 
this case only 10% of piperazinone 354 formed.
Acetic acid was also used as catalyst to optimise the yields. In this case, the cyclisation 
was run in ethanol but the formation the diazapenone 3 was 6.6%.
8.5 “Crossed” experiment o f  N,N'-dibenzylpentane- 1,3-diamine 352 and 
methyl N,N'-dibenzyl-2,3-diaminopropyl ether 182a
Bn BnBnI
NH
Bn Bn
i
NHNH -Bn
Bn
182a
Bn
353
Bn
354
Bn
244a 243a
Schem e 81. R e a g e n ts  a n d  c o n d itio n s :  (i) glyoxal, EtOH/H20 ,  24 h reflux.
The reaction for the formation o f seven-membered lactam rings showed to be 
poor in terms of yields obtained even when regioselectivity was present. A “double”
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reaction was carried out in the same vessel to confirm this result. N,N-  
Dibenzylpentane-1,3-diamine 352 and methyl A, A-dibenzyl-2,3-diaminopropyl ether 
182a cyclised with glyoxal to give the four expected adducts. After purification pure 
samples of diazapenone 353 (6.9%), diazapenone 354 (12.7%), 5-piperazinone 244a 
(69.8%) and 6-piperazinone 243a (13.2%) were obtained. The major component of the 
crude was the six-membered ring 5-piperazinone 244a as expected. In this case, 
regioselectivity was not observed for the seven-membered rings, this was probably due 
to the presence of the 1,2-diamine also reacting with glyoxal. The 1 H-NMR ratios 
observed were 93:7 for the piperazinones 244a:243a and 63:36 for diazapenones 
354:353
8.6 Conclusions
Methyl bromoacetate cyclisation showed to be regioselective giving a 90:10 
mixture of regioisomers. The major component was the one similar to the piperazinone 
hence the same mechanistic pathways took place. Glyoxal cyclisation was not as 
regioselective as expected giving only 91:9 mixture of regioisomers. Also in this case, 
the major component was the expected adduct. Yields for both cyclisations were quite 
disappointing, probably due to polymerisation of the diamine starting material and for 
the difficulty o f medium size ring formation.
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CHAPTER 9 Towards the total synthesis of 
dibenzyl-3-methoxy-propane-l, 2-diamine
9.1 Introduct
In the introduction part o f this thesis, it was described the biological relevance of 
peptidomimetics as therapeutic agents. Their application in the treatments of CNS’s 
diseases is growing fast. A potential drug for treatment of Alzheimer’s disease was 
designed by Dr. Robin Davies (Pharmacy Department, Cardiff University) and it was 
considered to be an efficient Mi muscarinic agonist. The potential drug 359 is a pure 
enantiomer possessing two chiral centres and is a folded bicyclic system. The hydrogens 
on the two chiral centres are in anti position to each other, according to our PC Model 8  
calculations (Figure 41).
As stated in chapter 1, Mi agonists are usually small molecules (MW 150) 
probably due the small active site of the receptor. Our proposed synthetic pathway for 
0V)-8-benzyl-4-methoxymethyl-2-methyl-hexahydro-pyrrolo[ 1,2-#]pyrazin-7-one 359 
involved 1 0  steps and it was completed previously in my group using racemic starting 
materials.
Regarding its possible interactions with the Mi receptor, the phenyl ring will 
probably create 7r-interactions with other 7t-systems and the oxygens could take part in 
hydrogen bonding with any hydrogen donor present in amino acidic residues o f the 
receptor active site.
359 (S)-8-Benzyl-4-methoxymethyl-2-methyl- 
hexahydro-pyrrolo-1,2-a]pyrazin-7-one
F igure 44. PC M odel 8 representation o f  359
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9.2 Retrosynthetic approach for (S)-8-benzyl-4-methoxymethyl-2-methyl-
hexahydro-pyrrolo /7 ,2-a/pyrazin- 7-one 35 9
The most practical disconnections are shown below. The three intermediates 
360, 361, and 362 represented the key compounds of the main sequence.
N -B n
359
I 361360
h3c o
BnI
NH
NHI
Bn
362
S ch em e 82. Retrosynthesis o f  b icyclic  system  359
Previously in my group, Paul Lewis carried out the total synthesis of the racemic 
bicyclic compound 359. raoA,A-Dibenzyl-3-methoxy-propane- 1,2-diamine 362 was 
prepared starting from allyl bromide in three steps in appreciable yield, as previously 
described (section 2.1.1). In the pure enantiomer sequence, the preparation of the same 
diamine 362 required 4 steps starting from D-serine. All the other steps were the same 
for both racemic and enantiomeric routes. The racemic synthesis was carried out to have 
some indications regarding every step of the route and to optimise procedures and 
yields.
As anticipated earlier, the synthetic route for the enantiomerically pure 
compound was composed o f 10 steps. During the racemic synthesis, it was possible to 
observe some difficulties. The first was represented by the regioselective preparation of 
piperazinone 361, which was successfully resolved by performing the ethyl 
bromoacetate cyclisation, as shown in chapter 3. The second was surely the most 
complicated and still unclear reduction reaction o f the lactam 360 followed by 
spontaneous cyclisation to yield the bicyclic system 359. A model compound was then 
prepared in order to have cheap starting material and to investigate the reduction 
mechanism.
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9.3 Synthesis o f  enantiomerically pure (S)-8-benzyl-4-methoxymethyl-2- 
methyl-hexahydro-pyrrolo [1,2-z/pyrazin-7-one 359
Preparation o f the diamine 362 was achieved starting from D-serine in 4 steps. 
The overall yield was 49%. The second part of the total synthesis, starting from the 
enantiomerically pure diamine 362 was planned to be o f further six steps.
Due to time reasons and to the unsolved problem regarding the amide reduction 
in the last step, it was not possible for me to complete the total synthesis. However, 
isolation of intermediate 369 was successfully achieved and many attempts at the Birch 
reduction-cyclisation step were performed on a model compound.
|_|
® H H N Ph
H (Q -|^NH3 1 .  H O ^ ^ N' Y Ph " » HO^S^NY Fh Hi > ^  V
co f C02H0 o^ N H °  O ^N H °
363 364
Bn Bn
368369
I Bn
Bn 365 366
j ,v
Bn Bn
h 3c o  -Ny * °  v h3c o ^  ' NH
N NHI
Bn Bn
367 362
VIII
O
h 3c o  - J U .  H3c o ^ ^ N ^ ~ Bn
.0
361 360 359
S ch em e 83. R e a g e n ts  a n d  c o n d it io n s :  (i) B zCO Cl, NaOH; (ii) B zN H 2, E D C , CH2C12, Et3N; (iii) M el, 
A g20 ,  CH3CN; (iv) L iA lH 4, THF; (v) Ethyl bromoacetate, DIE A , xylene, 24 h reflux; (vi) H2, Pt, MeOH; 
(v ii) HCOOH, HCOH; (v iii) N a, N H 3, THF, EtOH; (ix) A -benzyl-2-chloro-acetam ide, NaH, THF; (x) Na, 
NH 3, THF, EtOH.
9.3.1 1st Step. Benzoylation of D-Serine
Benzoylation167 o f D-serine was a simple reaction and the amide 364 was 
prepared in high yield (89%, Scheme 84). The mechanism of the reaction involved the 
attack of the carbonyl by the amine, as previously seen. Benzoic acid was the major by­
product therefore purification o f 364 required several water washes or recrystallisations 
of benzoic acid from hot ethanol and water mixtures.
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S ch em e 84. R e a g e n ts  a n d  c o n d itio n s :  (i) BzCO Cl, NaOH, 89%
9.3.2 2nd Step. EDC coupling reaction of (/?)-2-benzoylamino-3-hydroxy-propionic 
acid 364
(^)-A^-(l-Benzylcarbamoyl-2-hydroxy-ethyl)-benzamide 365 was prepared by 
two methods: DCC coupling168 and EDC coupling169 reactions. The former reaction 
gave crude yield o f 90% but required extensive purification to remove DCU by-product, 
lowering the yield to 50%. The latter reaction gave 76% crude yield and it did not 
require further purification because EDU is a water soluble diamide consequently the 
work up only involved washes with water. The presence o f a primary alcohol in the 
diamide 365 made this compound more water-soluble lowing slightly its yield.
9.3.3 3rd Step. Methylation of (/?)-A-(l-benzylcarbamoyl-2-hydroxy-ethyI)- 
benzamide 365
It is very well known that Sn2 o f primary alcohols with alkyl halides occurs 
very slowly. Methylation o f the intermediate 365 was attempted in several ways. One 
successful procedure was addition o f a large excess methyl iodide ( 1 0  equivalents) and 
silver(I) oxide in acetonitrile for 5 days. According to a known procedure170’171, an 
excess o f silver (5 mole equivalents) was required to complete the conversion into the 
product. Unfortunately, this made this reaction too expensive when performed on a 
large scale. Alternative methods were carried out to avoid using large excess of silver 
oxide and to optimise the yield.
H H
364
Bn
365
S ch em e 85. R e a g e n ts  a n d  c o n d itio n s :  (i) B zN H 2, E D C , CH2C12, Et3N , 76%
Other reagents were used like using dimethyl sulphate and sodium hydride in 
DMSO but mixtures of methoxy product 366 (3% after purification) and W-methyl 
(mono- and dimethylated, 30% yield) derivatives were formed.
This reaction never showed to be robust and reliable since every single attempt 
gave different starting material/product ratio. In particular, it presented two main 
problems: 1 ) rate o f Sn2  displacement very slow; 2 ) in some attempts no reaction 
occurred. In order to increase the rate of the reaction, different solvents were used
1 70
(toluene at 0° C, dichloromethane, Kuhn methylation with DMF ) but no improvement 
was seen. Sonication173 was used to break the coating o f silver oxide reagent by silver 
iodide, formed during the course o f the reaction that might have interfered with the 
nucleophilic displacement. Methyl iodide is a low boiling point reagent so the 
temperature could not be increased to improve the rate of the displacement. On 1 g 
scale, the desired product was obtained in 99% yield and it was completed in 3 days 
(Table 34, reaction a). When the reaction was scaled up (-10 g, Table 34, reaction c) the 
complete methylated product (R)-N-[\-(benzyl-methyl-carbamoyl)-2-methoxy-ethyl]-W 
methyl-benzamide 371 was obtained in 99% yield. This unexpected result was perhaps 
due to the higher concentration o f the reagents compared to the solvent, which might 
have activated the amidic groups to act as nucleophiles.
.OCH;
f I
n r N
371365
365 c h 3i A fcO Solvent T im e 366
(grams) (m ol. eq.) (m ol. eq.) (m l) (days) (yield)
a171 1 10 5 CH3CN (20) 3 99%
b 3 25 15 CH?C N (1 0 0 ) 7 75%
c i"oT 25 6 CH3C N  (500) 4 99%
d 1.5 2.1 1.1 toluene+C H 2C l2( 15) 5 60%
e 2.5 2 1 tohiene+C H 2C l2( 30) 4 80%
f 1.5 1.6 1 CH?C N  (15) 5 70%
s 3.5 2 1.5 CH3CN (30) 3 25%
h 1 1.2 1 CH?CN+p> ridine 2 80%
T ab le  34. R eaction conditions for m ethylation o f  intermediate 365. 
*A11 product w as trimethyl derivative 371.
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As shown in the table 32, the reaction was repeated several times and frequently 
gave appreciable yields but it was not reliable in terms of repeatability. A few 
parameters must have changed for every single reaction. The best procedure found only 
required an equimolar concentration o f silver oxide in presence o f a catalytic amount of 
pyridine, to complete the reaction in two days (80% yield, Table 32, reaction h).
9.3.4 4th Step. Preparation of (*S)-A,A^-dibenzyl-3-methoxy-propane-l,2-diamine 
362
The diamide 366 was reduced using an excess o f lithium aluminium hydride (5 
mole equivalents) in refluxing THF for 40 hours. The reaction was efficient and the 
product 362 was obtained in 67% yield.
9.3.5 5th Step. Preparation of N ,N -l,4-dibenzyl-6-methoxymethyl-piperazin-2-one 
367
The cyclisation step to prepare the intermediate 367 captured our attention and a 
lot o f attempts were tried in the past in my group, in order to develop a reliable and 
highly regioselective cyclisation reaction. The best method for the preparation of 367 
was reacting the diamine 362 with ethyl bromoacetate at reflux for 24 hours, which 
gave a 90:10 ratio o f regioisomers 367:372 (cf. Chapter 3). Column chromatography 
was performed and analytically pure sample of the desired piperazinone 367 was 
obtained.
Bn
366
Bn
362
S ch em e 87. R e a g e n ts  a n d  c o n d itio n s :  (i) L iAlH 4, THF, 67%
Bn Bn
Bn
367
Bn
372
HPLC was run at this stage to check the purity o f the enantiomer 367. Analysis 
by HPLC was firstly performed on the racemic intermediate. Two resolved peaks were 
distinguished using a 97:3 mixture o f hexane:isopropanol. Retention time for (S)-
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enantiomer was 9.3 minutes, whereas it was 11.7 minutes for (i?)-enantiomer (peak 
areas R.S, 63:37). When piperazinone 367 alone was injected, only one peak after 9.3 
minutes was observed corresponding to (*S)-enantiomer. No trace of (7?)-enantiomer was 
observed. The R.S  ratio found for the racemic adduct was surprising. Further tests 
would have been required to confirm the data.
9.3.5.1 Alternative route to preparation o f  piperazinone 36 7
Cyclisation was also attempted on the non-methylated adduct 365 in order to 
avoid the tedious and unclear methylation o f diamide 365 previously described (section 
9.3.3). Our hope was to prepare the hydroxy piperazinone 373 and then perform the 
methylation according to easier procedures, to give the adduct 367.
Unfortunately, reaction of diamine 365 with ethyl bromoacetate (1.2 mole equivalents) 
gave mainly, even at room temperature, the diester 374 and unreacted starting material 
365. Our prediction was that the two more nucleophilic amines would react first, rather 
than the hydroxyl group, affording the piperazinone adduct 373. The reason o f the fast 
alkylation o f the diamine 365 at both positions is still unclear, considering that the 
reaction condition and procedure were the same as our “standard” cyclisations. Reaction 
conditions were modified but no improvement was shown. The more reactive methyl 
bromoacetate was slowly added to the diamine but no changes for the products 
formation were shown.
The product 374 was then placed in refluxing xylene and the lactone 375 was 
prepared. The aim of the cyclisation was to observe the selectivity between formation of 
6 - or 7-membered rings.
Bn BnI I
Ph 
I °
. N .  / - s .  NH .N .  J l
H O  H O ^ V ^   ^
N ' '  NHI I I jl
Bn Bn J  °
Ph
373 365 374 375
Formation o f lactone 375 could be explained by the preferential mechanistic 
pathway (Scheme 8 8 , red arrows) where the cyclisation was a 6 -ejco-trig. The other 
possible lactone was the 7-membered ring 376 and its formation was explained by the 
mechanism below (Scheme 8 8 , green arrows). The cyclisation was a 1-exo-Xng process 
but did not occur therefore no traces o f the adduct 376 were observed.
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Bn
OEtEtO- OEt
Bn Bn
374 375Bn I
Bn
S chem e 88. M echanism  o f  cyclisation  o f  the diester 374
9.3.6 6th Step. TV-Benzyl cleavage by hydrogenolysis
I H
Bn
367 368
S chem e 89. R e a g e n ts  a n d  c o n d it io n s :  (i) H 2, 10%  Pd/C
Paul Lewis performed this reaction for the racemic intermediate111. Several 
methods were attempted and the best catalyst for this hydrogenolysis was PtC>2 . The 
same reaction for the enantiomer 367 was carried out in methanol and to our surprise, in 
one case, TV-methylated product 369 was prepared in one step. In this case, the catalyst 
used was palladium on activated carbon ( 1 0 %) and it was plausible to postulate a 
mechanism of reduction o f the starting material 367 to free amine and toluene and at the 
same time oxidation of methanol to formaldehyde, both mediated by the palladium. An 
Eschweiler-Clarke reaction occurred in situ that gave the product 369. This is an 
unusual behaviour: palladium is used as a reducing agent but it performed as an oxidant 
at the same time, in the same reaction pot. Yield o f pure product 369 was excellent.
Bn BnI I
367 369
Sch em e 90. R e a g e n ts  a n d  c o n d it io n s :  (i) H 2, 10% Pd/C, M eOH, 71%
9.4 Investigation on amide reduction reaction
139
As anticipated earlier (section 9.2), the last step of the total synthesis performed 
on the racemic 1,1-aminoamide 360 gave disappointing outcome. The postulated 
mechanism for the reaction was the reduction o f the lactam 360 to aminol 377, followed 
by loss o f a water molecule and formation o f the iminium ion 378. Finally, the 
nucleophilic displacement from the free amide to the electrophilic carbon adjacent the 
iminium ion would afford the desired bicyclic adduct 359 (Scheme 91, pathway a). 
Unfortunately, also the adduct 379 was isolated and it constituted the major product 
from the reduction reaction (Scheme 91, pathway b).
ri
O O Bn H3CO
NH J -  NH
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N—Bn 
359
t H3CO'"VY '< ^  1 o
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S ch em e 91. A m ide reduction-cyclisation sequence o f  1,1-am inoam ide 360
Apparently although the reaction was performed using the minimum o f two 
equivalents o f metal in liquid ammonia, the intermediate 378 was even more susceptible 
to reduction than the starting lactam, resulting in “doubly-reduced” compound 379. In 
order to investigate the reduction, a model compound was prepared and used as scaffold 
molecule.
9.4.1 Preparation of the model compound: l-benzyl-hexahydro-im idazo[l,2- 
fl]pyridin-2-one 370
.0
N. / N"Bn
370
F igu re 45 . PC M odel 8 representation o f  b icyclic  
com pound 370  (M M X  Energy 17.259 kcal m o l1)
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l-Benzyl-hexahydro-imidazo[l,2-a]pyridin-2-one 370 was previously prepared 
by Paul Lewis in my group. The procedure consisted of a three step sequence (Scheme 
92). It started with a nucleophilic attack of acyl chloride 87 by benzylamine (step i) 
followed by Sn2 o f the 7V-benzyl-2-chloro-acetamide 372 by the 8 -valerolactam (step 
ii). Finally a Birch reduction of the adduct 370 to give a 1,1-aminoamide (step iii).
o
o ^BnN K
C, ' N ' Bn J U  O - I V  j > y N' Bn
87 371 372 370
S ch em e 92. R e a g e n ts  a n d  c o n d it io n s : (i) BnNH 2, 0° C, CH2C12; (ii) 5-valerolactam , NaH, THF; (iii) Na, 
N H 3, THF, EtOH
9.4.2 Amide reduction-cyclisation of model compound 372
The reduction was performed several times under different reaction conditions 
(Table 35). Metal such lithium and potassium did not give any reduction reaction 
resulting in fully recover o f the starting material 372. Sodium was the best metal and it 
was used for all successful attempts. The order of reagents addition was changed (NH3, 
EtOH, Na) but no improvement was shown hence it did not affect the reduction 
pathway.
o 0  o
A -  AH K N
^BnN
H I k ~-NL Bn
372 380 381 382
S ch em e 93. R e a g e n ts  a n d  c o n d itio n s :  (i) M etal, N H 3, EtOH, dry THF
In most cases, starting material 372 was recovered and the best ratio of adducts 
380:381 was 21:63 (Table 35, reaction a). When the equivalents o f metal were 
increased, due to the presence o f unreacted starting material 372, reduction of the 
phenyl ring was observed (99%, Table 35, reaction e). The reaction was constantly 
monitored by TLC in order to establish a relation between metal equivalents and 
reduction of the aminol intermediate.
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Metal (m ol. eq.) EtOH (m ol. eq .) 372 380 381 382
a N a (10) 112 16 21 63 -
b L i(5) - 100 - - -
c K  (7) - 99 1 - -
d N a (50) 40 33 - 16 50
e N a 60) 1000 - - 1 99
f N a (20) 100 - - - -
g N a (2) 100 68 - 20 -
h N a (2) 100 50 - 30 -
i N a (0 .5) 100 80 - 8 -
Unfortunately, that could not be establish since same reaction conditions gave 
different outcomes. Other experiments will be performed in the future to investigate and 
optimise reaction conditions and yields.
9.5 Conclusions
Isolation o f intermediate 360 o f the total synthesis was successfully achieved in 
one-pot sequence o f hydrogenolysis o f vV-benzyl and oxidation to TV-methyl group. 
Attempts o f Birch reduction for the model compound were carried out resulting in 
preparation o f product mixtures. Therefore more experiments are needed to optimise the 
reaction conditions for the reduction.
This thesis showed novel approaches and methods for the synthesis of highly 
substituted piperazinones. The studies on the regioselective cyclisations lead to the 
conclusion that secondary benzyl amines can be successfully transformed in a large 
number o f piperazinone derivatives in high yields. Aliphatic and aromatic diamines 
require more energetic conditions to be quantitatively converted into cyclised adducts.
Glyoxal and its derivatives showed to react regioselectively with 1,2-diamines 
and the yields were optimal with the dibenzyl diamine whereas they were poor with 
aliphatic and aromatic diamines.
As shown in Chapter 4, A-benzyl groups can be successfully cleaved using an 
extremely easy procedure and the reactivity o f the free secondary amine could be used 
to introduce these rings into peptidomimetic peptidic sequences.
142
Chapter 10 Experimental data
Compounds were characterised by TLC mobility and LH-NMR spectra. Structures were 
assigned by a standard repertoire o f NMR experiments, IR, MS and HRMS spectra. 
^ -N M R  gave the main information about the number o f protons, shifts and coupling 
constants (complicated splitting were analysed using the Multiplet software). 1H, IH- 
COSY was mainly used to confirm adjacent protons through coupling constants 
connectivity. 13C-NMR showed the number o f carbons and 13C-DEPT 135 showed 
different peaks for each carbon according to number o f attached protons. HMQC (Vh.c) 
spectra allowed us to assign geminal protons through direct connectivity between 
protons and carbons, and to confirm the protons chemical shifts. HMBC ( V h ,c )  spectra 
represented the key experiments for final assignment o f the structure, rooted on 
unambiguous chemical shifts, through the long-range proton-carbon coupling. Solution 
!H and 13C NM R spectra were recorded on a bruker Spectrospin-Avance DPX 400 and 
DPX 500 MHz spectrometers. All measurements occurred at room temperature and are 
referenced to TMS (5 = 0 ppm). The chemical shifts are given in parts per million and 
the coupling constants in Hertz. Solvents used for NMR experiments were mainly 
CDCI3 or C6D 6 .
IR spectra were recorded on a Perkin Elmer- FTIR 1600 Series spectrometer. The 
wavenumber aregiven in cm ' 1 and the following abbreviations are used: br-broad, s- 
strong, w-weak. Solid compounds were run in nujol or dissolved in volatile solvents. IR 
spectra o f oils were run neat.
Compound masses were measured with AP+. Accurate mass peak measurements o f 
molecular ion were set in Swansea at the EPSRC National Mass Spectrometry Service 
Centre, on the basis o f molecular ion found in low resolution mass spectra.
High performance column chromatography was performed on Hewlett-Packard-Agilent 
1100 Series instruments.
Flash column chromatography was carried out using Fischer Scientific silica gel 60A 
(37-70 pm). Analytical thin layer chromatography was carried out using Merck silica 60 
F254 using a UV lamp and phosphomolibdic acid to visualise the components.
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10.1 Preparation of iV,./V-dicyclohexyI-3-inethoxy-propane-l,2-diamine 182d
'NHBr
Xylene, A H3CO”
182d
NHBr
187 209
16
17
Cyclohexylamine 209 (31.74 g, 0.32 mol) in toluene ( 1 0  ml) with p- 
toluenesulphonic acid (0.76 g, 0.004 mol) was refluxed for 30 minutes, followed by 
slow addition of the dibromide 187 (10 g, 0.04 mol). The mixture was allowed to reflux 
for 24 hours before being dried to give a crude mixture as a brown oily substance (4.94 
g). Purification by column chromatography using a slow gradient o f petroleum ether to 
ethanol gave the diamine 182b as brown viscous oil (2.74 g, 25%). Spectroscopic data 
of -dicyclohexyl-3-methoxy-propane-l,2-diamine 182b: 5H (500 MHz, CDC13) 
1.17 (10H, m, cyclohexyl-H); 1.59 (5H, m, cyclohexyl-H); 1.64 (2H, m, cyclohexyl-H); 
1.79 (3H, m, cyclohexyl-H); 2.02 (3H, m, cyclohexyl-H); 2.65 (1H, m, 8 -H); 2.82 (1H, 
m, 3-Ha); 2  9 2  ( 1H> tt J  11.2, 3.7, 14-H); 3.15 (1H, d d J  12.1, 4.0, 3-Hb); 3.3 (3H, s, 7-
H3); 3.39 (1H, m, 2-H); 3.45 (1H, d d J1 .7 , 2.9, 5-Ha); 3  5 5  ( 1H> dd J  " ,  3-9> 5 "Hb);
5C (DEPT, 8 h  jH-13C 1/-COSY) 24.37-33.7 (CH2, 1.17, 1.59, 1.64, 1.79, 10-cyclohexyl- 
C); 45 (CH2, 2.82, 3.15, 3-C); 51 (CH, 3.39, 2-C); 55 (CH, 2.65, 8 -C); 57.5 (CH, 2.92, 
14-C); 59 (CH3, 3.3, 7-C); 71 (CH2, 3.45, 3.55, 5-C); m/z (APCI) 269 (M+l); HRMS 
ES+ calcd for [C16H32N 20]: 269.2587, found: 269.2587, error 0.00 ppm; Rf = 0.59 
(ethyl acetate: ethanol, 4:1).
10.2 Preparation of 3-methoxy-Y,Ar-bis-(2-methoxy-ethyI)-propane-l,2-diamine 
182c
.or
H3CO^ h CO . / v .  Xylene, A H3c O
7 6 2 ^ N H
\ / s IIM A i , a  182c
NH2 ---------------------► 3 l
p-TsOH, N2 atm. ^ NH
Br I 14
187 210 12\ / 0 i i H3
13 15
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A mixture o f 2-methoxyethylamine 210 (12.92 g, 0.172 mol), toluene (30 ml), p- 
toluenesulfonic acid (0.76 g, 0.0043 mol) was placed in a round bottom flask. The 
dibromide 187 (10 g, 0.043 mol) was added slowly and the mixture was refluxed for 20 
minutes. The reaction was allowed to cool to room temperature and the salt formed was 
filtered and washed with toluene. Purification by column chromatography using a slow 
gradient o f petroleum ether, diethyl ether yielded the 1,2-diamine 182c (3.0 g, 32%). 
Spectroscopic data of 3-methoxy-7V,7V-bis-(2-methoxy-ethyl)-propane-l,2-diamine 
182c: 5h  (500 MHz, CDC13) 2.53 (1H, dd J  11.8, 6.7, 3-Ha); 2  6 5  ( 1H> dd J 11.7, 5.2, 3-
Hb); 2.7 (3H, m, 1 2 -^ , 2-H); 2.78 (1H, t J  5.5, 8 -H*); 2.8 (1H, dd J  5.8, 5.4, 8 -Hb); 
3.28 (3H, s, 7-H3); 3.29 (6 H, s, 11-H3, 15-H3); 3.34 (2H, m, 5-H2); 3.41 (4-H, m, 9-H2, 
13-H2); 5c  (DEPT, 8 H, 'H-^C V-COSY) 47 (CH2, 2.78, 2.8, 8 -C); 49.5 (CH2, 2.7, 12- 
C); 51 (CH2, 2.53, 2.65, 3-C); 57.3 (CH, 2.7, 2-C); 58.8 (CH3, 3.29, 11-C, 15-C); 59 
(CH3, 3.28, 7-C); 72 (CH2, 3.41, 9-C); 72.3 (CH2, 3.41, 13-C); 74 (CH2, 3.34, 5-C); m/z 
(APCI) 220 (M +l); Rf= 0.2 (ethanol).
10.3 Preparation of methyl A,./V-diphenyl-2,3-diaminopropyl ether 182d
H3C o " ~ ' Y Br | j - ^ S ^ NH2 Xylene, A B H3£ S - ' ' * V % h
k Br p-TsOH, N2 atm. 3 ]JN^ Ph
H
187 211 182d
A mixture of aniline 211 (7.7 g, 0.08 mol) and /?-toluenesulfonic acid (0.115 g, 
0.06 mmol) in xylene (12 ml) was heated (145°C) in a round bottom flask, fitted with a 
condensor, under a nitrogen atmosphere. Methyl 3-(l,2-dibromopropyl) ether 187 (2.2 
g, 9.5 mmol) was added dropwise from a pressure equalised dropping funnel over one 
hour. The mixture was refluxed under a nitrogen atmosphere for 20 hours. The reaction 
was allowed to cool to room temperature and the salt formed was filtered and washed 
with xylene (7 ml). The filtrate was concentrated under high vacuum to remove xylene 
and any excess aniline. Purification by column chromatography using a slow gradient of 
petroleum ether, diethyl ether yielded the 1,2-diamine 182d (1.31 g, 85.3%). 
Spectroscopic data for methyl N ,N '-diphenyl-2,3-diaminopropyl ether 182d: vmax 
(neat)/cm -1 3400 (str. NH), 3000; 2750; 1625; 1500; 6 H (400 MHz, CDC13) 3.3 (1H, dd 
J  12.6, 6.3, 5-Ha); 3.4 (3H, s, 7-H3); 3.4 ( 1 H, dd J  12.6, 5.5, 5-Hb); 3.5 ( 1H, dd J 9 .4 ,
5.1, 3-Ha); 3.6 (1H, d d ./ 9,4, 3.2, 3-Hb); 3.8 (1H, m, 5-H); 4.0 (2H, bs, N-H); 7.2-6 7
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(10H, m, ar-H); 6 C (DEPT, SH ‘H -13C V-COSY) 45.89 (CH2, 3.5, 3.6, 3-C); 52.80 
(CH2, 3.8, 5-C); 59.65 (CH3, 3.4, 7-C); 73.12 (CH, 3.3, 3.4, 5-C); 113 42-118.38 (CH, 
7.2- 6.7, ar-C); 147.6-148.74 (C, ar-C); m/z(APCI) 257 (M +l); HRMS ES+ calcd for 
[C16H 20N 2O]: 257.1648, found: 257.1651, error +1.1 ppm; Rf = 0.55 (petroleum ether: 
diethyl ether, 1 :1 ).
10.4 Preparation of A,Ar-di-(/J-methoxy)phenyl-2,3-diaminopropyl ether 182e
Xylene, A 
p-TsOH, N2 atm.
/7-Anisidine 212 (26.5 g, 0.21 mol) and /?-toluenesulphonic acid (0.5 g, 2.6 
mmol) were dissolved in xylene (100 ml) and the mixture was heated in an oil bath until 
reflux. Methyl 3-(l,2-dibromopropyl) ether 187 (10 g; 0.043 mol) was added slowly 
with an equalised pressure funnel over 2 hours. The reaction was refluxed for 24 hours 
under nitrogen atmosphere. The crude mixture was allowed to cool to room 
temperature, the precipitate was filtered off and the xylene was removed to give the 
crude product (7.92 g). The mixture was purified by column chromatography using a 
slow gradient o f petroleum ether, diethyl ether, ethyl acetate to give the diamine 182e 
(5.51 g, 85%). Spectroscopic data for 7V,7V-di-(p-niethoxy)-phenyI-2,3- 
diaminopropyl ether 182e: vmax (neat)/cm-13372 (str., NH); 2931 (str., CH); 1617 (str., 
NH); 1240 (str., CN); 1037; 820; 760 (bend., NH); 965; 5H(400 MHz, C6D6) 3.12 (3H, 
s, 7-H3); 3.18 (1H, dd J  12.4, 6.8, 3-Ha); 3.25 (1H, dd 79 .3 , 5.3, 5-Ha); 3.32 (1H, dd J  
9.3, 3.3, 5-Hb); 3.4 (1H, dd J  12.3, 5.3, 3-Hb); 3.49 (3H, s, 9-H3); 3.52 (3H, s, 8-H3); 
3.62 (1H, dq J  5.2, 3.3, 2-H); 6.5- 6.9 (8H, m, ar-H); 6C (DEPT, 5H 'H -^ C  lJ-COSY) 
46.6 (CH2, 3.18, 3.4, 3-C); 53.82 (CH, 3.62, 2-C); 55.05 (CH3, 3.52, 8-C); 55.07 (CH3, 
3.49, 9-C); 58.55 (CH3, 3.12, 7-C); 72.58 (CH2, 3.25, 3.32, 5-C); 113.05-153.16 (CH, 
6.5-6.9, ar-C); m/z (APCI) 317 (M +l); HRMS ES+ calcd for [Ci8H24N20 3]: 317.1860, 
found: 317.1858, error +0.6 ppm; R{= 0.3 (petroleum ether: ethyl acetate, 1:1).
n h 2
187 212 182e
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10.5 Preparation of [(l-{|ethoxycarbonylmethyl-(2-methoxy-ethyI)-aminol- 
methyl}-2-methoxy-ethyl)-(2-methoxy-ethyI)-amino|-acetic acid ethyl ester 245c
o c h 3
21
H3CO— 0920 \vs O
NH 9 Xvlene. DIEA H i o ^ V NN5/ ^ ' 0 / N
h 3c o  " Y  1 Xylene‘ DIEA-  h3C 0 ®l
NH ’  0 C H 3 i N , j  Y  15
'1 2
16
o c h 3 25 J 22 o
HsCO-i
182c 88 245c
Diamine 182c (0.5 g, 0.0024 mol) was placed in a round bottom flask with 
xylene (15 ml) and diisopropylethylamine (0.42 ml, 0.0024 mol). The mixture was 
refluxed for 30 minutes followed by slow addition of ethyl bromoacetate 8 8  (2.84 g, 1.4 
ml, 0.017 mol). The reaction mixture was then allowed to reflux for 24 hours. 
Extraction o f crude mixture with dichloromethane resulted in a brown oil o f the diester 
245c (0.47 g, 54%). Spectroscopic data of [(l-{[ethoxycarbonylmethyI-(2-methoxy- 
ethyI)-amino]-methyI}-2-methoxy-ethyl)-(2-methoxy-ethyl)-amino]-acetic acid 
ethyl ester 245c: vmax (neatycm ' 1 1752.01, 1747.19, 1742.37, 1736.58, 1731.76, 
1726.94 (str., br., C =0 ester); 6 H (CDC13, 500 MHz) 1.2 (6 H, m, 12-H3, 17-H3); 2.9
(2H,m); 3.25-3.26 (9H, s, 7-H3, 21-H3, 25-H3); 3.45 (2H, m); 3.55 (2H, s); 3.61 (2H, 
m); 3.67 (2H, m); 4.1-4.16 (4H, m, 11-H2, 16-H2); 4.57 (2H, m); 4.7 (1H, m); 8 C
(DEPT, 5h , >H-I3C V-COSY); 14 (CH, 1.2, 3-C); 53.5 (CH2, 2.9); 57 (CH2, 3.55); 56.8 
(CH2, 3.61); 56.9 (CH2, 3.67); 59 (CH3. 3.25-3.26, 7-C, 21-C, 25-C); 62-63 (CH2, 4,1- 
4.16, 11-H2, 16-H2); 62.5 (CH2, 4.57); 62.8 (CH2, 4.57); 72 (CH2, 3.45); 172.3-172.9 
(C=0, 10-C, 15-C); Rf= 0.39 (diethyl ether: ethyl acetate, 1:1).
10.6 Preparation of A?,A^-l,4-diphenyl-6-methoxymethyl-piperazin-2-one 246d
Ph
Br/ V V ° Et XVlen e' A ,  H3C O ^ ^ N' - j f °
O DIEA, N2 atm.
4I 
Ph
88 246d
Into a 25 ml two necked round bottom flask methyl #,Af-diphenyl-2,3- 
diaminopropyl ether 182d (0.5 g, 2.4 mmol), diisopropylethylamine (0.47 g, 3.7 mmol)
182d
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and xylene (2.5 ml) were placed. The flask was fitted with a condensor and kept under a 
nitrogen atmosphere. The mixture was warmed and ethyl bromoacetate 8 8  (0.38 g, 2.4 
mmol) was added dropwise with a syringe. Reflux was maintained for 138 hours. The 
reaction mixture was cooled to room temperature and the solvent removed to give a 
viscous dark oil (0.825 g). The crude mixture was purified by column chromatography, 
eluting with a slow gradient of petroleum ether, diethyl ether, ethanol to give white 
needle shaped crystals o f  adduct 246d (0.165 g, 25%). Spectroscopic data for N tN r-
l,4-diphenyI-6-methoxymethyl-piperazin-2-one 246d: Vmax (neat/cm 1) 3010; 2940; 
1645 (str. br., C =0 lactam); 1494; 1450 (str. sh., C-N-C); 5H(400 MHz, CDCI3) 3.21 
(3H, s, 9 -H3); 3.3 ( 1 H, dd J8 .9 , 3.7, 7-H,); 3.35 (1H, dd J  13.0, 3.3, 5-Ha); 3.55 (1H, t
9.2, 7-Ha); 3.8 (1H, d J  17.2, 3-H,); 3.9 (1H, dq 9.5, 3.2, 6 -H); 4.05 (1H, dd 12.9,
2.6, 1.3, 5-Hb); 4.15 (1H, d J  17.1, 1.3, 3-Hb); 7.35-7.25 (10H, m, ar-H); 6 C (DEPT, 
5h *H-13C ’./-COSY) 47.6 (CH2, 3.55, 4.05, 5-C); 52.8 (CH2, 3.8, 4.15, 3-C); 58.6 (CH, 
3.9, 6 -C); 59.2 (CH3, 3.21, 9-C); 70.9 (CH2, 3.35, 3.3, 7-C); 112.6- 141.04 (CH, 7.35- 
7.25, ar-C); 141.7- 147.05 (C, ar-C); 168.3 (C=0, 2-C); (APCI) 297 (M+l); HRMS 
ES+ calcd for [C18H20N2O2]: 297.1603, found: 297.1598, error +1.7 ppm; Rf= 0.25 
(petroleum ether: diethyl ether, 1 :1 ). X-ray crystallography, Crystal data for 
piperazinone 246d: C 17H20N 2O2, FW= 284.35, monoclinic, space group P21/n, a = 
5.8967(5) A, b =16.7331(11) A, c=15.2858(16) A, /?=  91.948(3)°, 1507.4(2) A3 ,
T =  150(2) K, X =0.71073 A, Z = 4, D ( c a l )  = 1.253 Mg/m3, F (0 0 0 ) = 608, / /=  0.083 
mm'1. Crystal character: white needle. Crystal dimension 0.28 x 0.15 x 0 . 1 0  mm3.
10.7 Preparation of 7V,7V-l,4-diphenyI-5-methoxymethyl-piperazin-2-one 247d
9 8
H2Q, EtOH H3CO'
1 8 2 d
To a stirred solution o f methyl A^N-diphenyl^^-diaminopropyl ether 182d 
(100 mg, 2.4 mmol), dissolved in ethanol (25 ml) and kept under a nitrogen atmosphere, 
an aqueous glyoxal solution 141 (40% wt/wt, 0.4 g, 6 8  mmol) was added dropwise. The 
reaction was stirred for 200 hours at reflux. The ethanol was removed and the crude 
product was purified by column chromatography using a slow gradient of petroleum 
ether, diethyl ether, ethanol to give white needle crystals o f adduct 247d (50 mg, 10 %) 
and 246d (23 mg, 5%). Spectroscopic data for AyV-M-diphenyl-S-methoxymethyl- 
piperazin-2-one 247d: Vmaxfaeat/cm'1) 3056; 2985; 1669 (str. br., C =0 lactam), 1498;
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1418 (str. sh., C-N); Sh (400 MHz, CDCU) 3.3 (3H, s, 9-H3); 3.49 (1H, d d . / 9 .4 , 4.5, 7- 
Ha); 3.53 (1H, t J9.5, 7-Hb); 3.8 (1H, dd J  12.7, 2.4, 6 -Ha); 3.93 (1H, d 16.9, 3-Ha); 
4.0 (1H, dd J  12.7, 3.6, 6 -Ht); 4.08 (1H, d 17.0, 3-Hb); 4.13 (1H, m, 5-H); 7.25-7.35 
(10H, m, ar-H); 8 C (DEPT, §h ‘H - ,3C './-COSY) 49.9 (CH2, 3.8, 4.0, 6 -C); 50.3 (CH2> 
3.93, 4.08, 3-C); 52.2 (CH, 4.13, 5-C); 59.5 (CH3, 3.3, 9-C); 68.0 (CH2, 3.49, 3.53, 7- 
C); 112.6- 129.7 (CH, 7.25- 7.35, ar-C); 140.33- 149.01 (C, ar-C); 165.1 (C=0, 2-C); 
m/z (APCI) 297 (M +l); HRMS ES+ calcd for [Ci8H20N 2O2]: 297.1598, found: 
297.1598, error +0.00 ppm; Rf= 0.23 (petroleum ether: diethyl ether, 1:1).
10.8 Preparation of regioisomers l,4-bis-(methoxy-ethyl)-6-methoxymethyl- 
piperazin-2-one 246c and l,4-bis-(methoxy-ethyl)-5-methoxymethyl-piperazin-2- 
one 247c
/ V  .NH  H3CO^
o c h 3
o
NH O
OCHc
182c 141
OCH
o c h 3
246c
o c h 3
16
247c
Diamine 182c (0.5 g, 0.024 mol) was placed in a round bottom flask with a 
mixture o f ethanol: water in 1:1 ratio (20 ml), followed by addition of glyoxal 141 (0.28 
ml, 0.006mol). The reaction mixture was then refluxed for 24 hours resulting in orange 
oil that was then dried. Extraction o f the crude resulted in an orange mixture o f the two 
regioisomers (540 mg, ratio 246c:247c, 10:90). Purification by column chromatography 
using a fast gradient o f diethyl ether to ethyl acetate followed by a fast gradient of ethyl 
acetate to ethanol gave good separation o f regioisomers 247c (70 mg, 11%) and 246c 
(240 mg, 39%). Spectroscopic data of l,4-bis-(methoxy-ethyl)-6-methoxymethyl- 
piperazin-2-one 247c: vmax (C H C ^/cnT 1 1637.4 (m., C =0 lactam); 1119.3 (m.); SH
(CDC13, 500 MHz) 2.44 (1H, dd J  11.8, 3.5, 5-Ha); 2.52 (2H, m, 13-H2); 2.92 (1H, d J
16.6, 3-Ha); 2.95 (1H, m, 5-Hb); 3.18 (1H, ddd J  13.9, 7.7, 4.8, lO-H^; 3.25 (3H, s, 9-
H3); 3.28 (3H, s, 12-H3); 3.29 (3H, s, 15-H3); 3.35 (1H, dd J  16.7, 1.4, 3-Hb); 3.44 (4H,
m, 14-H2, 6 -H, 7-H ^; 3  4 8  (2H> m> H -H 2); 3.58 (1H, d d J  16.6, 8.0, 7-Hb); 3.85 (1H, dt
J  14.0, 4.7, 10-Hb); 5C (DEPT, 5H, 'H -'3C ‘./-COSY) 45.3 (CH2, 3.18, 3.85, 10-C);
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51.63 (CH2, 2.44, 2.95, 5-C); 56.34 (CH2, 2.52, 13-C); 56.69 (CH, 3.44, 6 -C); 57.72 
(CH2, 2.92, 3.35, 3-C); 58.81 (CH3, 3.25, 9-C); 58.98 (CH3, 3.28, 3.29, 12-C, 15-C); 
70.21 (CH2, 3.44, 14-C); 70.71 (CH2, 3.48, 11-C); 72.19 (CH2, 3.44, 3.58, 7-C); 167.97 
(C=0, 2-C); m/z (APCI) 260 (M +l); HRMS ES+ calcd for [Ci2H25N20 4]: 261.1809, 
found: 261.1811, error +0 . 8  ppm; Rf = 0.63 (Ethanol). Spectroscopic data of 1,4-bis- 
(methoxy-ethyl)-5-methoxymethyl-piperazin-2-one 246c: vmax (n ea t)cm 1 1683.55- 
1632.45 (str., br., C =0 lactam); 1120.44 (str ); 5H (C6 Df„ 500 MHz) 2.65 ( 1 H, m, 10-
Hg); 2.82 (1H, m, 10-Hb); 2.95 (1H, m, 5H), 3.23 (1H, d J  16.99, 3-Ha); 3.26 (3H, s, 9- 
H3); 3.28 (6 H, s, 13-H3, 17-H3); 3.35-3.5 (11H, m, 7-H2, 6 -H2, 14-H2, 15-H2, 11-H2, 3- 
Hb); 5C (DEPT, 5H, >H-13C lJ-COSY) 46.48 (CH2); 49.7 (CH2); 52.6 (CH2, 2.65, 2.82,
10-C); 54.6 (CH2, 3.23, 3.35-3.5, 3-C); 56.45 (CH, 2.95, 5-C); 58.6 (CH3, 3.26, 9-C);
58.7 (CH3, 3.28, 13-C); 59.1 (CH3, 3.28, 17-C); 70.3 (CH2); 70.4 (CH2); 70.9 (CH2); 
167.37 (C=0, 2-C); m/z (APCI) 260 (M +l); HRMS ES+ calcd for [Ci2H25N 20 4]: 
261.1809, found: 261.1811, error +0.8 ppm; Rf= 0.56 (Ethanol).
10.9 Preparation of regioisomers l,4-dicycIohexyI-5-methoxymethyI-piperazin-2- 
one 46 and l,4-dicyclohexyl-6-methoxymethyl-piperazin-2-one 247b
|12 14i
’11
10
.O
I
h6
I7
20' 18
246b 247b
NH O
NH
182b
Diamine 182b (0.8 g, 0.003 mol) was placed in a round bottom flask with a 
mixture o f ethanol: water in 1:1 ratio (20 ml), followed by addition of glyoxal 141 (0.34 
ml, 0.0075 mol). The reaction mixture was refluxed for 24 hours resulting in orange oil 
that was extracted with sodium hydroxide 2M and dichloromethane. The organic layer 
was then dried over anhydrous sodium sulphate and concentrated to give an orange 
mixture o f the two regioisomers (600 mg, 65%). Spectroscopic data of crude mixture 
of regioisomers l,4-dicycIohexyl-5-methoxymethyl-piperazin-2-one 246b and 1,4- 
dicyclohexyl-6-methoxymethyl-piperazin-2-one 247b174: 5H (CDC13, 400 MHz) 1.16
(22H, m, cyclohexyl-H); 1.62 (22H, m, cyclohexyl-H); 2.4 (1H, m); 3.06(m); 3.2 (m);
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3.27 (m); 3.75 (1H, t); 3.8 (1H, m); 4.32 (1H, m); m/z (APCI); Rf = 0.37 and 0.57 
(petroleum ether: ethyl acetate, 3:1).
10.10 Preparation of AL[2-(benzoylamino)phenyI]benzamide 225
y nhcohQ  
^ nhco^ O
225
Benzoyl chloride 224 (25 g, 0.18 mol) was added dropwise to a solution of o- 
phenylendiamine 212 (10 g; 0.09 mol) in sodium hydroxide 10% w/w (200 ml). The 
dark precipitate was filtered off (4.1 g) and dissolved in refluxing dimethylformamide 
for recrystallisation. Needle white crystals o f dibenzanilide 225 were obtained (3.60 g; 
87%). Spectroscopic data for adduct 225: vmax (neat)/cm_1 3053 (str. NH); 2359 (str., 
CH); 1650 (str., C=0); 1421 (bend., NH); 1257 (str., CN); 758-749; 5H(400 MHz, 
DMSO) 7.3- 7.7- 8.0 (14H, m, ar-H); 10.2 (2H, s, NH); 5C (DEPT, 6H ^ - “ C V-COSY)
126.04- 134.631 (CH, 7.3- 7.7- 8.0, ar-C); 165.9 (C, C=0); HRMS ES+ calcd for 
[C20H 16N2O2]: 317.1285, found: 317.1284, error +3.15 ppm; m. p. 310°C.
10.11 Preparation of N,./V-dibenzylbenzene-1,2-diamine 214
NHCO-
NHCO
225 214
Lithium aluminium hydride (558 mg; 15.5 mmol) was added slowly to a solution 
of THF (20 ml) cooled in an ice bath. The crystals 225 (3 .1 g; 3.1 mmol) were added 
slowly into the solution. The solution was refluxed for 5 hours under a nitrogen 
atmosphere. The reaction mixture was allowed to cool to room temperature and the 
lithium aluminium hydride was quenched adding ethanol (10 ml). The solvent was 
evaporated and sodium hydroxide (1 M) was added until the solution pH 12. The 
mixture was extracted with dichloromethane and dried over anhydrous sodium sulphate. 
The diamine 214 was a red oil (0.85 g; 98%). Spectroscopic data for N ,N -
o
Cl NaOH
212 224
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dibenzylbenzene-1,2-diamine 214125: vmax (neatycm ' 1 3053 (str., NH); 2986; 1596 
(bend., NH); 1265 (str. sh., CN), 737; 704; 6 H (400 MHz, CDCI3 ) 3.58 (1H, t J  5.4, 
NH); 4.25 (4H, d J  5.8, 1-H2, 2-H2); 6 .6 - 6  8  (10H, m, ar-H); 7.2-7 4 (4H, m, ar-H); 6 C 
(DEPT, S ^ H -^ C V -C O S Y ) 30.5 (CH2, 4.25, 1-C); 49.0 (CH2, 4.25, 2-C); 111.9-
139.4 (CH, 7.2- 7.4, ar-C); m/z (APCI) 289 (M +l); Rf= 0.52 (petroleum ether: diethyl 
ether, 3:1).
10.12 Cyclisation of -dibenzylbenzene-1,2-diamine 214 with methyl
bromoacetate 88
Br^ Y
OCH3 DIEA, N2 atm.
Xylene, A
214 88 250
Into a 25 ml two necked round bottom flask A/, A-dibenzylbenzene-1,2-diamine 214 ( 1  
g; 3.47 mmol), diisopropylethylamine ( 6 8 6  mg; 5.31 mmol) and xylene (5 ml) were 
placed. The flask was fitted with a condensor and kept under a nitrogen atmosphere. 
Methyl bromoacetate 8 8  (531 mg; 3.47 mmol) was added with a syringe and the 
reaction was refluxed for 2 hours. The reaction mixture was cooled to room 
temperature, washed with aqueous sodium hydroxide (1 M, 3 ml) and with brine (3 ml). 
The organic phase was dried over anhydrous sodium sulphate and the solvent was 
removed to give the crude mixture (0.21 g). Purification by column chromatography 
using a slow gradient o f petroleum ether, diethyl ether and ethanol gave piperazinone 
250 (120 mg, 70 %) as clear oil. Spectroscopic data for 1,4-dibenzyl-3,4-dihydro-IH- 
quinoxalin-2-one 250: 5H (400 MHz, CDC13) 3.82 (2H, s, 3-H2); 4.33 (2H, s, 8 -H2);
5.12 (2H, s, 7-H2); 6.9-7 3 (14H, m, ar-H); 6 C (DEPT, 5H ‘H - 13C V-COSY) 45.6 (CH2, 
5.12, 7-C); 49.0 (CH2, 4.33, 8 -C); 54.6 (CH2, 3.82, 3-C); 1 12.3- 137.4 (CH, 6.9- 7.3, ar- 
C); 164.9 (C=0, 2-C); m/z (APCI) 329 (M +l); Rf= 0.37 (petroleum ether: diethyl ether, 
3:1).
10.13 Cyclisation of N ,N -dibenzylbenzene-1,2-diamine 214 with glyoxal in EtOH
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os EtOH, A N2 atm.O
141 294
H
N
H
To a stirred solution of N ,N -dibenzylbenzene-1,2-diamine 214 (lg ; 3.47 mmol), 
dissolved in ethanol (15 ml) and kept under nitrogen atmosphere, aqueous glyoxal (40% 
wt/wt, 503 mg; 8.67 mmol) was added. The reaction refluxed for 24 hours. The reaction 
mixture was allowed to cool to room temperature and the solvent was removed to give 
the crude mixture (0.895 g). Purification by column chromatography using a slow 
gradient o f petroleum ether, diethyl ether and ethanol gave the adduct 294 as an orange 
oil (0.441 g, 42%) and the starting material 214 (0.254 g, 20%). Spectroscopic data for
l,3,r,3'-tetrabenzyl-2,3,2',3',tetrahydro-l//,r#-[2,2']bibenzoimidazolyl 294: vmax
(neatycm ' 1 2363; 1593; 1506; 1353- 1297; SH (400 MHz, C6D6) 4.21 ( 4  H, d ./ 16.3, 7- 
H2); 4.58 (4H, d J  16.3, 6 -H2,); 4.65 (2H, s, 2-H); 6 .6 - 7.1 (28H, m, ar-H); 6 C (DEPT, 
5h 'H - i3C V-COSY) 55.53 (CH2, 4.21, 4.58, 6 -C, 7-C); 68.12 (CH, 4.65, 2-H); 
112.023- 139.45 (CH, 6 .6 - 7.1, ar-C); HRMS ES+ calcd for [C42H3 8N4]: 599.3169, 
found: 599.3153, error +2.6 ppm; HRMS ES+ calcd for [C2 iHi9N2]: 299.1543, found: 
299.1546, error -  10.0 ppm; Rf = 0.54 (petroleum ether: diethyl ether, 1:1).
10.13.1 2° Attempt: Cyclisation of /V,/V-dibenzyIbenzene-l,2-diamine 214 with 
glyoxal in H2O
To a stirred solution o f A, A-dibenzylbenzene-1,2-diamine 214 (800 mg; 2.77 
mmol), dissolved in H20  (12 ml) and kept under nitrogen atmosphere, aqueous glyoxal 
(40 % wt/wt, 401 mg; 6.9 mmol) was added. The reaction refluxed for 24 hours. The 
reaction mixture was allowed to cool to room temperature and sodium hydroxide pellets 
(0.5 g) were added. The mixture was extracted with dichloromethane (5x 10 ml), dried 
over anhydrous sodium sulphate, the solvent removed to give a yellow crude mixture 
(0.709 g). Purification by column chromatography using a slow gradient of petroleum 
ether, diethyl ether, ethanol gave the orange adduct 294 (0.467 g, 65 %) and the starting 
material diamine (50 mg, 10 %).
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10.14 Cyclisation of 1,2-dianilinoethane 721 with ethyl bromoacetate 88
Xylene, A
DIEA, N2 atm.
761
O
'V \1 4
'" “ ( D  Br/ Y ° N /  Xylene. A >
721 88  248
Into a 25 ml two necked round bottom flask were placed 1,2-dianilinoethane 721 
(1 g, 4.7 mmol), diisopropylethylamine (929 mg, 7.18 mmol) and xylene (5 ml). The 
flask was fitted with a condensor and placed under a nitrogen atmosphere. Ethyl 
bromoacetate 8 8  (785 mg, 4.7 mmol) was added dropwise with a syringe and the 
reaction mixture was refluxed for 24 hours. The reaction mixture was washed with 
aqueous sodium hydroxide (1 M, 3 ml) and with brine (3 ml). The organic phase was 
dried over anhydrous sodium sulphate and the solvent removed to give crude product 
(0.486 g). Purification by column chromatography of the mixture using a slow gradient 
petroleum ether, diethyl ether and ethanol gave two main products: adduct 761 (47 mg, 
10 %) and adduct 248 (163 mg, 33 %). Spectroscopic data for N ,N -  
diphenylpiperazin-2-one 761102: vmax (neatycm ' 1 3054 (str., NH); 2987 (str., arCH); 
1690 (str., C=0); 1494 (bend., NH); 1265 (bend., arCH); 895 (bend., NH); 734-704; 
S h  (400 MHz, CDC13) 3.52 (2 H, dd J5 .5 , 5.0, 6 -H2); 3.8 (2 H, dd J  53 , 5.3, 5-H2); 4.0 
(2H, s, 3-H2); 6.85-7.2 (10H, m, ar-H); 5C (DEPT, SH *H-13C V-COSY) 46.5 (CH2, 
3.52, 6 -C); 50 (CH2, 3.8, 5-C); 53.4 (CH2, 3-C); 125.75- 129.51 (CH, 6.85- 7.2, ar-C);
167.5 (C=0, 2-C); m/z (APCI) 254 (M+ 1), ES+ calcd for [Ci6Hi6N 20]: 253.1335, 
found. 253.1336, error -3.95 ppm; Rf= 0.16 (petroleum ether: diethyl ether, 1 :1 ); 
Spectroscopic data for {[2-(ethoxycarbonylmethyl-phenyl-amino)-ethyl]-phenyl- 
amino)-acetic acid ethyl ester 248: vmax (neat)/cm_1 3046-2975; 1744 (str. sh., C=0); 
1599-1505; SH (400 MHz, CDC13) 1.2 (6 H, t J7 .1 , 14-H3); 3.62 (4H, s, 6 -H2); 3.97 (4H, 
s, 2-H2); 4.1 (4H, dd J  19.8, 7.1, 12-H2); 6 .6 - 7.15 (10H, m, ar-H); 5C (DEPT, 
6 h ‘H - i3C V-COSY) 14.2 (CH3, 1.2, 14-C); 50.3 (CH2, 3.62, 6 -C); 53.5 (CH2, 3.97, 2 - 
C); 61.1 (CH2, 4.1, 12-C); 126.4-128.3 (CH, 6 .6 - 7.15, ar-C); 171.2 (C=0, 3-C); 
(APCI) 386 (M+ 1); HRMS ES+ calcd for [C2 2H28N20 4]: 385.2122, found: 385.2127, 
error + 1 . 2  ppm; Rf= 0.25 (petroleum ether: diethyl ether, 1 :1 ).
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10.15 Cyclisation of 1,2-dianilinoethane 721 with glyoxal in EtOH
r ”~ 0  t  boh' a 
1  N2atm
284
To a stirred solution o f 1,2-dianilinoethane 721 (500 mg, 2.35 mmol), dissolved 
in ethanol (15 ml) and kept under a nitrogen atmosphere, was added an aqueous 40% 
(wt/wt) glyoxal solution (145 mg, 2.35 mmol) dropwise over 5 minutes. The reaction 
was stirred for 48 hours at reflux. The reaction mixture was allowed to cool to room 
temperature and the ethanol was removed to give the crude product (0.665 g). No 
piperazinone was shown by TLC and in the ^ -N M R  spectrum. Purification by column 
chromatography using a slow gradient of petroleum ether, diethyl ether and ethanol 
gave a mixture o f products containing the adduct 284 (0.35 g, 52% calculated yield). 
Spectroscopic data for l,3-diphenyl-imidazolidine-2-carbaldehyde 28494: 5h (400 
MHz, CDC13) 3.68 (2 H, dd J 8 .5 , 5.6, 4-Ha, 5-Ha), 3.82 (2 H, dd J8 .5 , 5.6, 4-Hb, 5-Hb), 
4.99 (1H, d J  6 .8 , 2-H), 7.5 (10H, m, ar-H), 9.81 (1H, dd J  7.0, 6 -H); Rf = 0.49 
(petroleum ether: diethyl ether, 1 :1 ).
10.16 Cyclisation o f 1,2-dianilinoethane 721 with glyoxal in H2O
HoO
285 761
A solution o f 1,2-dianilinoethane 721 (500 mg; 2.35 mmol) and H20  (10 ml) was 
placed in a two neck round bottom flask. Acetic acid (21.15 mg; 0.35 mmol) was added 
to the mixture and the solution stirred for 30 minutes. Aqueous glyoxal (40% wt/wt,
197.4 mg, 4.525 mmol) was added dropwise over 15 minutes. The reaction mixture was 
refluxed for 24 hours under nitrogen atmosphere. Sodium hydroxide pellets (0.5 g) were
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added and the mixture was extracted with ethyl acetate (3x 15 ml), dried over 
anhydrous sodium sulphate and concentrated to give 0.49 g of crude product (ratio 285: 
761, 69:31). The mixture was purified by column chromatography using a slow gradient 
o f petroleum ether, diethyl ether and ethanol that gave pure samples o f bis-imidazoline 
285 (130 mg, 24%) and piperazinone 9 (51 mg, 5%). Spectroscopic data for bis- 
imidazoline 28594: vmax (neatycm1 3045 (str., arCH); 2985 (str., NH); 1674-1594 
(bend., NH); 1498 (str., arC-C); 1262 (bend., arCH); 896-735; 8H(CDC13) 3.28 (2H, dd 
J  8.3, 5.5, 5-H2); 3.42 (2H, dd J8.1, 5.5, 4-H2); 5.87 (1H, s, 2-H); 6.57-7.15 (20H, m, 
ar-H); 8 C (DEPT, 8 h 'H - 13C ‘./-COSY) 46.45 (CH2, 3.28, 3.42, 4-C, 5-C); 72.41 (CH, 
5.87, 2-C); 112.31-145.65 (CH, 6.57- 7.15, ar-C); (APCI) 447 (M +l); 223 (M/2); 
Rf= 0.48 (petroleum ether: diethyl ether, 1:1).
10.17 Preparation of methoxymethyl-l,4-bis-(4-methoxy-phenyl)-piperazin-2-one 
246e
10
OCH
Xylene. DIEA 
OCH3 N2 atm., A
182e 88
Af,Af-Di-(/?-rnethoxy)-phenyl-2,3-diaminopropyl ether 182e (500 mg, 1 . 5 7  
mmol) was placed in two round flask with diisopropylethylamine (304.4 mg, 3.14 
mmol) and xylene (5 ml). The reaction mixture was heated in an oil bath and methyl 
bromoacetate (480 mg, 3.14 mmol) was added dropwise with a syringe. The mixture 
refluxed under nitrogen atmosphere for 24 hours. The crude was allowed to cool to 
room temperature and was washed with sodium hydroxide (2 M, pH 14) and with brine 
(10 ml). The solvent was removed to give crude mixture (0.809 g). Purification by 
column chromatography using a slow gradient o f petroleum ether, diethyl ether, ethyl 
acetate gave the piperazinone 246e (0 . 1 1 0  g; 2 0  %). Spectroscopic data for 6- 
methoxymethyI-l,4-bis-(4-methoxy-phenyl)-piperazin-2-one 246e129: vmax
(neatycm 1 3052 (str., arC-H); 1656 (str., C=0); 1510 (str., arC-H); 1210 (str., CH-O); 
1307; 895; 831; 737 (bend., arC-H); 6H(500 MHz, CDC13) 3.0 (3H, s, 9-H3); 3.02 (1H,
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dd J  12.5, 3.4, 5-H„); 3.24 ( 1 H, dd J8.8 , 3.4, 7-Ha); 3.39 (3H, s, 10-H3); 3.43 (3H, s, 11-
H3); 3.6 (1H, t , / 9 .0 , 7-Hb); 3.78 (1H, d J  16.7, 3 -Ha); 3.82 (1H, m, 6 -H); 3.85 ( 1 H, ddd 
J  12.5, 3.1, 1.5, 5-Hb); 4.18 (1H, dd J  16.7, 1.5, 3-Hb); 6  8-7.2 (8 H, m, ar-H); 6 C(DEPT, 
8 h ‘H - 13C ‘./-COSY) 49.4 (CH2, 3.02, 3.85, 5-C); 54.46 (CH3, 3.39, 10-C); 54.71 (CH2, 
3.78, 3-C); 54.88 (CH3, 3.43, 11-C); 58.34 (CH, 3.82, 6 -C); 58.69 (CH3, 3.0, 9-C);
70.18 (CH2, 3.24, 3.6, 7-C); 166.06 (C=0, 2-C); (APCI) 357 (M +l); HRMS ES+ 
calcd for [C20H20N2O4]: 357.1809, found: 357.1807, error +4.5 ppm; Rf=0.22 (diethyl 
ether).
10.18 Preparation of 5-methoxymethyl-l,4-bis-(4-methoxy-phenyl)-piperazin-2-one 
247e
h3c o
10
N— OCH3
N - ^ ^ - O C H ,  O 
182e 141
OCH;
N2 atm., A 247e
J/Vr,Ar -Di-(/?-methoxy)-phenyl-2,3-diaminopropyl ether 182e (208 mg, 0.65 
mmol) and water (5 ml) were placed in two neck 25 ml flask. An aqueous solution of 
glyoxal 141 (40 % wt/wt, 1.5 g, 26.2 mmol) was added dropwise with a syringe. The 
reaction mixture was refluxed for 24 hours under a nitrogen atmosphere. The mixture 
was allowed to cool to room temperature, sodium hydroxide pellets (3 mg) were added 
and it was extracted with ethyl acetate. It was dried over anhydrous sodium sulphate and 
the solvent was evaporated to give 0.15 g o f crude mixture. The products were purified 
by column chromatography using a slow gradient o f petroleum ether, diethyl ether, and 
ethanol. The purification gave only one fraction in which both o f regioisomers 247e, 
246e (61 mg, 35%) were present in the ratio 60:40.
10.19 Preparation of 7V,/V'dibenzylpentane-1,3-diamine 352
157
7 6
CHONH- NH
'2
NH
Benzaldehyde 213 (62.3 g, 0.6 mol) and iodine (7.69 g, 0.24 mol) were added to 
a solution o f Dytec© diamine 355 (20 g, 0.19 mol) in methanol (350 ml). The reaction 
mixture stirred at room temperature for 15 minutes. Sodium borohydride (8.98 g, 0.24 
mol) was added slowly and stirring continued for 30 minutes. The reaction mixture was 
diluted with water and HC1 (2 M) was added until pH 1. The mixture was extracted with 
dichloromethane and the aqueous phase was basified until pH 14. It was extracted with 
dichloromethane, dried over anhydrous sodium sulphate and concentrated to give a 
yellow crude mixture (33.89 g). Purification of the mixture by column chromatography 
using a slow gradient o f petroleum ether, ethyl acetate, ethanol gave the diamine 354 
(17.08 g, 33 %) as yellow oil. Spectroscopic data for AyV-dibenzyIpentane-1,3- 
diamine 354: v™* (neatycm ' 1 3297; 2926; 2872; 1947; 1643 (str., NH); 1494; 1453; 
1198 (str., C-N); 734; 5H (400 MHz, CDC13) 0.8 (3H, t J7 .4 , 7-H3); 1.3-1.5 (4H, m, 3- 
H2, 6 -H2); 1.85 (2H, b. s., NH); 2.52 (1H, m, 2-H); 2.6 (1H, ddd 13.4, 6.7, 4.7, 4-Ha);
2.7 (1H, ddd J  13.7, 6.9, 4.6, 4-H,,); 3.69 (4H, m, 8 -H2, 9-H2); 7.18 (10H, m, ar-H); 8 C 
(DEPT, 8 h ‘H - 13C ■j-COSY) 9.86 (CH3, 0 .8 , 7-C); 26.4 (CH2, 1.3, 6 -C); 33.23 (CH2, 
1.5, 3-C); 47.06 (CH2, 2.6, 2.7, 4-C); 51.03 (CH2, 3.69, 9-C); 54.2 (CH2, 3.69, 8 -C);
57.5 (CH, 2.52, 2-C); 126.87- 128.41 (CH, 7.18, ar-C); 140.18- 140.74 (C, ar-C); 
(APCI) 284 (M+ 1); HRMS ES+ calcd for [Ci9H26N2]: 283.2169, found: 283.2166, 
error +1.6 ppm; Rf= 0.1 (diethyl ether).
10.20 Preparation of ./V-[3-(benzoylaniino)-l-ethylpropyl]benzainide 356
NHCO—Ph
NaOH
NHCO—Ph
356
NH-
NH-
355 224
Dytec© diamine 355 (20 g, 0.19 mol) was placed in 2 neck round bottom flask 
in presence of sodium hydroxide (1 M, 300 ml) and benzoyl chloride 224 (80 g, 0.57 
mol) was added dropwise with an equalized pressure funnel. The solution was stirred
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for 2 hours and a white hard precipitate formed (53.6 g). It was filtered off and 
recrystallised from ethanol (52 g, 89 %). Spectroscopic data for 7V-[3- 
(benzoylamino)-l-ethylpropyl]benzamide 356: vmax (neatycm 1 3327; 3053; 1711 
(bend., C=0); 1651 (bend. NH); 1521 (str., NHC=0); 1487; 1264 (str., CN); 895; 734; 
8 h (400 MHz, CDC13) 0.8 (3H, t J  7.4, 7-H3); 1.3-1. 6  (4H, m, 6 -H2, 3-Ha, 5-H); 1.93 
(1H, ddd J  10.8, 9.8, 3.5, 3-Hb); 2.92 (1H, ddt J  13.9, 10.9, 3.7, 4-Ha); 3.97 (1H, tt J 8 .8 ,
4.3, 4-Hb); 4.1 (1H, ddd J  10.9, 5.4, 3.3, 2-H); 6.0 (1H, d ./8 .9 , 1-H); 7.4-78 (10H, m, 
ar-H); 5C(DEPT, S ^ H -^ C  V-COSY) 10.85 (CH3, 0 .8 , 7-C); 28.7 (CH2, 1.3, 6 -C); 35.5 
(CH2, 1.3, 3-C); 36.07 (CH2, 2.92, 3.97, 4-C); 49.16 (CH, 4.1, 2-C); 126.90- 134.21 
(CH, 7.4- 7.8, ar-C); 167.1 (C=0, 9-C); 168.8 (C=0, 8 -C); HRMS ES+ calcd for 
[Ci9H22N 20 2]: 311.1754, found: 311.1753, erro r+3.2 ppm.
10.21 Preparation of N,N-dibenzylpentane- 1,3-diamine 352
NHCO—Ph
LiAIH,
THF
NH—Bn
NH—Bn 
352
-NHCO—Ph 
356
Lithium aluminium hydride (740 mg, 19.5 mmol) was added to THF (30 ml) in 
an ice bath. The precipitate 356 (1.233 g, 3.9 mmol) was added slowly and the reaction 
mixture was refluxing under nitrogen atmosphere for 6  hours. The reaction mixture was 
allowed to cool to room temperature and ethanol ( 2 0  ml) was added to destroy the 
excess of lithium aluminium hydride. The solvent was evaporated and the solution was 
diluted with water and NaOH (1 M) until pH 14. The crude mixture was extracted with 
dichloromethane, dried over anhydrous sodium sulphate and concentrated to give the 
diamine 352 (0.61 g; 55%).
10.22 Cyclisation of AyV-dibenzylpentane-1,3-diamine 352 with methyl 
bromoacetate
NH—Bn
N H -B n
352
Br
Ph10 ,
9
DIEA, xylene
N4
Ph
353
7 N1 0
354
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Diisopropylethylamine ( 9 1 7  mg; 7 .1  mmol) and N,N -dibenzylpentane-1 ,3 -  
diamine 352 (1  g; 3 .5 9  mmol) were dissolved in xylene ( 1 0  ml). The reaction mixture 
was heated to reflux and methyl bromoacetate ( 1 .0 8  g; 7 .1  mmol) was added dropwise 
with an equalised pressure-dropping funnel. The mixture was refluxed for 2 0  hours. 
After cooling to room temperature, sodium hydroxide ( 2  M )  was added until pH 1 4  and 
the reaction mixture was extracted. Brine was added and the mixture extracted again. 
The organic phase was dried over anhydrous sodium sulphate and the solvent was 
removed to give the crude mixture ( 0 . 8 9 6  g). Purification by column chromatography 
using a slow gradient of petroleum ether, ethyl acetate and ethanol gave the diazapenone 
353 ( 2 5  mg; 2 % ) and diazapenone 354 ( 2 7 5  mg; 2 4 % )  as amber oils. Spectroscopic 
data for l,4-dibenzyl-7-ethyI-[l,4]diazepan-2-one 353: Vmax (neatycm1 2 9 6 7 ;  1 6 2 5  
(str. sh., C = 0 ) ) ;  1 4 9 4  (bend., lactam N H ) ;  1 3 5 9  (str., lactam C - N ) ;  5 h  (C D C I 3)  0 .7  (3 H ,  
t J  7 .4 ,  9 -H3); 1 .5 2  ( 1 H ,  d J  1 2 .6 ,  6 -H a); 1 8  ( 3 H ,  m, 8 - H 2, 6 - H b);  2 . 5 2  ( 1H , d J  1 2 .6 , 5 -  
H a); 2 . 7  ( 1 H ,  ddd J  1 2 .6 ,  1 2 .6 ,  3 .6 ,  5 -H b ); 3 .1  ( 1 H ,  m, 7 - H ) ;  3 .5  ( 4 H ,  m, 1 0 - H 2, 1 1 -H 2); 
3 .9 3  ( 1 H , d J  1 4 .7 ,  3 -H a ); 5 .2  ( 1 H , d J  1 4 .7 ,  3 - H b); 7 .2  ( 1 0 H ,  m, ar-H); 6 C (DEPT, 
5 h  ‘H - 13C  ‘. / - C O S Y )  1 1 .6 3  ( C H 3, 0 .7 ,  9 -C ) ;  2 4 .3  ( C H 2, 1 .8 ,  8 -C ) ;  2 8 .1  ( C H 2, 1 .5 2 ,  1 .8 ,  
6 -C ) ;  4 9 . 3 4  ( C H 2,2 .5 2 ,  2 .7 ,  5 -C ) ;  5 1 .6 2  ( C H 2, 3 .9 3 ,  5 .2 ,  3 - C ) ;  5 8 .7 1  (C H , 3 .1 ,  7 -C ) ;
5 9 .7  ( C H 2, 3 .5 ,  1 1 -C ) ;  6 0 .4  (CH2, 3 .5 ,  1 0 -C ) ;  1 2 7 . 0 9 - 1 3 9 .0 5  (C H , 7 .2 ,  ar-C); 1 7 2 .9 9  
( C = 0 ,  2 - C ) ;  m/z ( A P C I )  3 2 3  (M+l); H R M S  E S +  calcd for [C 2iH 26N 20 ] :  3 2 3 .2 1 1 8 ,  
found; 3 2 3 .2 1 1 6 ,  error + 6 .1 8  ppm; R f=  0 .3 7  (ethyl acetate). Spectroscopic data for
l,4-dibenzyl-5-ethyl-[l,4]diazepan-2-one 354: vmas (neatycm'1 2 9 6 7 ;  1 6 2 5  (str., 
C=0); 1 4 9 4  (str., lactam N H ) ;  1 3 5 9  (str., lactam C - N ) ;  8h (C D C 1 3)  0 .8 2  ( 3 H ,  t J  7 .4 ,  9 -  
H 3); 1 .3  ( 4 H ,  m , 6 - H 2, 8 - H 2); 2 . 6 2  ( 1 H ,  m , 5 -H ) ;  3 . 2  ( 1 H ,  m , 7 - H ,) ;  3 .3 5  (1 H , m , 7 -H „ );
3 .4  ( 1 H ,  d / 1 5 .6 ,  1 1 - H ,) ;  3 . 5  ( 1 H ,  d J  1 3 .7 ,  1 0 - H ,) ;  3 . 8  ( 1 H ,  d J  1 5 .7 ,  1 1 -H b ); 3 . 7  ( 1 H ,  
d / 1 3 .7 ,  1 0 - H b);  4 .5 1  ( 1 H ,  d J  1 4 .4 ,  3 - H , ) ;  4 . 6  ( 1 H ,  A J  1 4 .4 ,  3 -H b );  7 .3  ( 1 0 H ,  m, ar-H); 
8 c  ( D E P T ,  S H ' H - n C  ‘. / - C O S Y )  1 1 .3  ( C H 3, 0 .8 2 ,  9 - C ) ;  1 8 .8  (CH, 2 .6 2 ,  5 -C ) ;  2 5 .3  
( C H 2, 1 .3 ,  8 -C ) ;  2 9 .3  (CH2, 1 .3 ,  6 -C ) ;  4 5 .7  ( C H 2, 3 .2 ,  3 .3 5 ,  7 - C ) ;  5 1 .5  ( C H 2, 4 .5 1 ,  4 .6 ,  
3 - C ) ;  5 5 .1  (CH2, 3 .5 ,  3 .7 ,  1 0 -C ) ;  5 7 .8  (CH2, 3 .4 ,  3 .8 , 1 1 -C ) ;  1 2 7 .0 0 - 1 3 9 .0 7  (CH, 7 .3 ,  ar- 
C); 1 7 4  (C=0, 2 - C ) ;  m/z ( A P C I )  3 2 3  (M+l, 1 0 0 % );  1 6 2  ( M / 2 ,  1 2 % ); H R M S  E S +  calcd 
for [C2iH26N20]: 3 2 3 .2 1 1 8 ,  found: 3 2 3 .2 1 1 7 ,  error + 3 .0 9  ppm; R f=  0 .4 6  (ethyl acetate).
10.23 Preparation of l,3-dibenzyl-4-methoxymethyl-imidazo!idine 199
160
H3CO‘
NHI
Bn
182a
BnI
NH
DIEA, N2 atm 
CH2CI2, A *
10 Ph 
199
Methyl N ,N '-dibenzyl-2,3-diaminopropyl ether 182a (300 mg, 1.05 mmol) was 
placed in a round bottom flask with diisopropylethylamine (547.3 mg, 4.23 mmol) and 
dichloromethane (7 ml). The mixture was refluxed for 300 hours. The reaction mixture 
was allowed to cool to room temperature and sodium hydroxide (2 M) was added until 
pH 14. The mixture was extracted with chloroform, dried over anhydrous sodium 
sulphate and the solvent evaporated to give a pure imidazolidine 199 as a yellow oil 
(255 mg, 85%). Spectroscopic data for l,3-dibenzyl-4-methoxymethyl-imidazolidine 
21: v„iax (ncat)/cm~3 2952; 1512; 897; SH (400 MHz, CDC13) 2.5 (1H, dd 5.9, 6 -
HRMS ES+ calcd for [C19H 24N2O]: 297.1961, found: 297.1963, error -4.72 ppm; Rf= 
0.23 (petroleum ether: diethyl ether, 1:1).
10.24 Cyclisation of methyl N , -dibenzyl-2,3-diaminopropyl ether 182a with 
methyl a-bromo phenylacetate 253
Methyl TV,AP-dibenzyl-2,3-diaminopropyl ether 182a (500 mg, 1.76 mmol), 
diisopropylethylamine (232 mg, 1.8 mmol) and xylene (5 ml) were placed into a 50 ml 
two neck round bottom flask provided with a condensor and under a nitrogen 
atmosphere. The mixture was heated until reflux and methyl a-bromophenylacetate 
( 6 8 8  mg, 2.3 mmol) was added dropwise over 30 minutes. The reaction was refluxed for 
3 hours. The reaction was cooled to room temperature and sodium hydroxide (2 M) was 
added until pH 14, was washed with brine (10 ml) and dried over anhydrous sodium
Ha); 2.9 (1H, t J  7.7, 6 -Hb); 3.02 (1H, m, 5-H); 3.2 (1H, d J  9.3, 2-Ha); 3.25 (3H, s, 8 - 
H3); 3.3 (1H, d J 9.3, 2-Hb); 3.5 (2H, m, 4-H2); 3.62 (1H, d J  13.0, 9-Ha); 3.95 (1H, d J
13.1, 9-Hb); 7.5 (10H, m, ar-H); 5C (DEPT, 6 h 'H - i3C ‘j-COSY) 57.57 (CH2, 3.62,
3.95, 9-C); 58.00 (CH3, 3.25, 8 -C); 58.58 (CH3, 2.5, 2.9, 6 -C); 61.53 (CH, 3.02, 5-C); 
74.78 (CH2, 3.5, 4-C); 75.74 (CH2, 3.2, 3.3, 2-C); 125.98- 128.08 (CH, 7.5, ar-C);
Xylene, A
11 Ph 
262182a 253 261
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sulphate. Xylene was removed and the crude mixture was obtained (730 mg). 
Purification by column chromatography using a slow gradient of petroleum ether, ethyl 
acetate, ethanol gave piperazinones 261 (177 mg, 25%) and 262 (210 mg, 35%) as 
yellow oils. Spectroscopic data for l,4-dibenzyl-6-methoxymethyl-3-phenyl- 
piperazin-2-one 261: Vmax (neatycm ' 1 3000; 1645 (str. sh., C=0); 1494; 1266 (str. sh., 
lactam C-N); 6 H (CDC13) 2.03 ( 1 H, dd J  12.1, 3.1, 5-Ha); 3.0 (1H, d, J  13.4, ll-H a),
3.02 (1H, dd J  11.8, 3.5, 5-Hb); 3.18 (3H, s, 9-H3); 3.3 (1H, m, 6 -H); 3.61 (1H, dd J 8 .8 ,
4.5, 7-Ha); 3.71 (1H, t J 8 .0 , 7-Hb); 3.71 (1H, d .713.4, l l-H b), 3.95 ( 1 H, d 714.8, 10- 
Ha); 4.0 (1H, s, 3-H); 5.0 (1H, d J  14.8, 10-Hb); 7.0-7.5 (15H, m, ar-H); 5C (DEPT, 
5h !H - 13C lJ-COSY) 47.96 (CH2, 2.03, 3.0, 3.95, 5.0, 5-C, 10-C); 53.35 (CH, 3.3, 6 -C);
57.65 (CH2, 3.0, 3.71, 11-C); 57.91 (CH, 4.0, 3-C); 70.73 (CH3, 3.18, 9-C); 72.00 (CH2, 
3.61, 3.71, 7-C); 125.54-137.14 (CH, 7.0-7.5, ar-C); 167.65 (C=0, 2-C); HRMS ES+ 
calcd for [C26H28N 20 2]: 401.2224, found: 401.2224, error +0.00 ppm; Rf= 0.35 
(petroleum ether: ethyl acetate, 2:1). Spectroscopic data for l,4-dibenzyl-6- 
methoxymethyl-3-phenyl-piperazin-2-one 262: vmax (neat)/cm_1 2926; 1645 (str. sh., 
C=0); 1451 (bend, sh., NH); 5H (CDC13) 2.44 (1H, d d ./ 12.2, 7.2, 5-Hb); 2.85 (1H, d d J
12.2, 4.1, 5-Ha); 3.09 (3H, s, 9-H3); 3.18 (lH ,d J  13.5, ll-H a); 3.25 (1H, dd J9 .7 , 3.6, 
7-Ha); 3.4 (2H, m, 7-Hb, l l-H b); 3.5 (1H, m, 6 -H); 4.05 (1H, d J  14.9, 10-Ha); 4.2 (1H, 
s, 3-H); 5.25 (1H, d J  14.9, 10-Hb); 7.0-7.5 (15H, m, ar-H); 5C (DEPT, dHll l - u C lJ- 
COSY) 47.01 (CH2, 4.05, 5.25, 10-C); 47.97 (CH2, 2.44, 2.85, 5-C); 54.81 (CH, 3.5, 6 - 
C); 58.36 (CH2, 3.18, 3.4, 11-C); 59.03 (CH3, 3.09, 9-C); 71.74 (CH, 4.2, 3-C); 73.54 
(CH2, 3.25, 3.4, 7-C); 126.76-137.94 (CH, 7.0-7.5, ar-C); 169.66 (C=0, 2-C); HRMS 
ES+ calcd for [C26H28N20 2]: 401.2224, found: 401.2225, error -2.49 ppm; Rf= 0.24 
(petroleum ether: ethyl acetate, 2 :1 ).
10.25 Cyclisation of methyl TV,TV-dibenzyl-2,3-diaminopropyl ether 182a with 
phenylglyoxal 177
EtOH, H2O H3CO
182a 177 261 262 312
Methyl N ,N '-dibenzyl-2,3-diaminopropyl ether 182a (500 mg, 1.76 mmol) was 
placed in a 25 ml round bottom flask with a mixture o f ethanol, water 9:1 (10ml). 
Phenylglyoxal 177 (1.18 g, 8 . 8  mmol) was added dropwise and the mixture was
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refluxed for 20 hours. The reaction mixture was cooled to room temperature and the 
ethanol was removed. NaOH pellets (0.5 g) were added and the mixture was extracted 
with ethyl acetate (3x15 ml), dried over anhydrous sodium sulphate and concentrated. 
The crude mixture was a dark oil (680 mg). Purification by column chromatography 
using a slow gradient o f petroleum ether, ethyl acetate, ethanol gave 6 -piperazinone 261 
(121 mg, 17%), 6 -piperazinone 262 (167 mg, 24%) and 5-piperazinone 312 (178 mg, 
25%) as yellow oils. Spectroscopic data for l,4-dibenzyl-5-methoxymethyl-3- 
phenyl-piperazin-2-one 312: vmax (neat)/cm_ 1 3052; 1646 (str. sh., C=0); 1246 (str. sh., 
lactam C-N); 6H(CDC13) 3.0 (2H, m, 5-H, 6 -Ha); 3.05 (3H, s, 9-H3); 3.16 ( 1 H, dd, 75.8,
3.2, 7-Ha); 3.21 (1H, dd, J  11.7, 2.7, 6-Hb); 3.26 (1H, dd, 78 .4 , 3.2, 7-Hb); 3.7 (1H, d J
14.0, l l-H a); 3.83 (1H, d J  14.0, ll-H b); 4.35 (1H, s, 3-H); 4.52 (1H, d J  14.6, 10-Ha);
4.58 (1H, d J  14.6, 10-Hb); 7.2-7 5 (15H, m, ar-H); 6C (DEPT, dHlH - l3C lJ-COSY) 
45.97 (CH2, 3.0, 3.21, 6 -C); 48.89 (CH2, 4.52, 4.58, 10-C); 57.66 (CH, 3.0, 5-C); 57.72 
(CH3, 3.05, 9-C); 58.65 (CH2, 3.7, 3.83, 11-C); 66.9 (CH, 4.35, 3-C); 72.43 (CH2, 3.16, 
3.26, 7-C); 125.7-135.0 (CH, 7.2-7.5, ar-C); 191.42 (C=0, 2-C); HRMS ES+ calcd for 
[C26H28N20 2]: 401.2224, found: 401.2223, error +2.49 ppm; Rf= 0.21 (petroleum ether: 
ethyl acetate, 2 :1 ).
10.26 Equilibration of l,4-dibenzyI-6-methoxymethyl-3-phenyl-piperazin-2-one 
261 and l,4-dibenzyl-6-methoxymethyl-3-phenyl-piperazin-2-one 262
f-BuOK
MeOH, rt H3CO'
261,262  262
A 50:50 mixture o f piperazinones 261 and 262 (500 mg, 1.2 mmol) were placed 
in a 25 ml bottom flask in methanol (5 ml). The mixture was cooled to 0°C in an ice 
bath and potassium t-butoxide (24 mg, 0.2 mmol) was added slowly. After 48 h stirring 
at room temperature the mixture was neutralised with hydrochloric acid (1 M, 6 ml), 
extracted with diethyl ether (3x10 ml) and washed with brine (15 ml). The organic 
layer was dried over anhydrous sodium sulphate and concentrated (432 mg). The 1H- 
NMR spectrum showed a mixture o f piperazinones 262, 261 with ratio 84: 16.
10.27 Preparation of (l,3-dibenzyl-4-methoxymethyl-imidazolidin-2-yl)-phenyl- 
methanone 315a
h3c o
Ph
98
EtOH H3CO'
Ph
315a182a 177
Methyl -dibenzyl-2,3-diaminopropyl ether 182a (250 mg, 0.88 mmol) was
placed in a 25 ml round bottom flask with ethanol (5 ml). Phenylglyoxal (295 g, 2.2
mmol) was added dropwise and the mixture was stirred for 5 days. The ethanol was
removed and sodium hydroxide pellets (0.5 g) were added. The mixture was extracted 
with ethyl acetate (3x10 ml), dried over anhydrous sodium sulphate and concentrated. 
The crude mixture was a red oil (250 mg). Purification by column chromatography 
using a slow gradient o f petroleum ether, ethyl acetate, ethanol gave piperazinones 262 
and 312 (36 mg, 10%) and the (l,3-dibenzyl-4-methoxymethyl-imidazolidin-2-yl)- 
phenyl-methanone 315a ( 2 0  mg, 8 %) as yellow oils. Spectroscopic data for (1,3- 
dibenzyl-4-methoxymethyl-imidazolidin-2-yl)-phenyl-methanone 315a: vmax
(neatycm 1 3053 (str., arC-H); 1645 (str. sh., C=0); 1451; 1265; 5H(CDC13) 2.65 (1H, t 
J  8 .8 , 3-Ha); 3.05 (2H, ddd J  14.6, 10.9, 9.2, 3-Hb, 7-Ha); 3.13 (3H, s, 9-H3); 3.15 (1H, 
m, 2-H); 3.28 (2H, m, 7-Hb, l l-H a); 3.7 (1H, d 7  13.3, 10-Ha); 3.75 (1H, d J1 2 .9 , l l -  
Hb); 3.8 (1H, d J  13.3, 10-Hb); 3.97 (1H, s, 5-H); 7.01-8.05 (15H, m, ar-H); 6 C (DEPT, 
5h 1H -13C lJ-COSY) 54.12 (CH2, 2.65, 3.05, 3-C); 55.99 (CH2, 3.28, 3.75, 11-C); 57.37 
(CH2, 3.7, 3.8, 10-C); 57.88 (CH3, 3.13, 9-C); 61.07 (CH, 3.15, 2-C); 90.99 (CH, 3.97,
5-C); 127.01-129.9 (CH, 7.01-8.05, ar-C); 132.63 (CH2, 3.28, 3.05, 7-C); 199.6 (C=0,
6-C); HRMS ES+ calcd for [C26H28N20 2]: 401.2224, found: 401.2224, error +0.00 ppm; 
Rf= 0.35 (petroleum ether: ethyl acetate, 2:1).
10.28 Preparation of (4-methoxymethyl-l,3-diphenyl-imidazolidin-2-yl)-phenyl 
methanone 319, 320
EtOH
164
Methyl A,TV-diphenyl-2,3-diaminopropyl ether 182d (500 mg, 1.95 mmol) was 
placed in a 25 ml round bottom flask with 9:1 ethanol, water mixture (10 ml). 
Phenylglyoxal 177 (274 mg, 2 mmol) was added and the mixture was stirred for 5 
hours. The ethanol was removed and sodium hydroxide pellets (0.5 g) were added. The 
mixture was extracted with dichloromethane (3x10 ml), dried over anhydrous sodium 
sulphate and concentrated to give a 319:320, a: b mixture (560 mg). Purification by 
column chromatography using a slow gradient of petroleum ether, diethyl ether, ethyl 
acetate gave one fraction containing a and b (65:35, 470 mg, 65%) as bright yellow 
gum. Spectroscopic data for (4-methoxymethyl-l,3-diphenyl-imidazoIidin-2-yI)- 
phenyl-methanone 319 and 320 (A is 319, B is 320): vmax (neat)/cm_1 3053 (str., arC- 
H); 1597 (str. sh., C=0); 1501; 1265; 5H(CDC13, 500 MHz) 2.92 (1H, t / 7 .1 ,  7-Ha(A)); 
3.08 (1H, 1 /7 .1 , 7-Ha(B)); 3.2 (3H, s, 9-H3(b)); 3.23 (3H, s, 9-H3(A)); 3.41 (1H, d d /9 .3 ,
4.6, 7-Hb(B)); 3.6 (3H, m, 3 - H ^ ,  3-H^b), 7-Ha(A)); 3.7 (1H, d d /9 .6 ,  1.5, 3-HKA)); 3.76 
(1H, dd J9 .0 , 7.8, 3-Hb(B)); 4.13 (1H, ddd J  12.3, 8.7, 4.3, 2-H<b)); 4.42 (1H, pd J4 .6 ,
1.7, 2-H(A)); 5.72 (1H, s, 5 - ^ ) ) ;  5.9 (1H, s, 5-H(A)); 6.7-7.2 (10H, ar-H(A), ar-H^)); 8c 
(DEPT, 8h ^ - “ C V-COSY) 50.28 (CH2, 3-C(A)); 52.01 (CH2,3-C(B)); 56.31 (CH, 2- 
C(A)); 59.18 (CH3, 9-C(A), 9-C(B>); 59.42 (CH, 2-C(B)); 71.06 (CH2, 7-C(A)); 73.73 (CH2,
7-C(B)); 78.62 (CH, 5-C(A)); 80.55 (CH, 5-C(A)); 113.66-146.31 (CH, ar-C(A), ar-C^));
199.65 (C=0, 6-C(A)); 200.80 (C=0, 6-C(B)); m/z (APCI) 373 (M +l, 100%), 265 (M-Bz, 
18%); HRMS ES+ calcd for [C24H24N20 2]: 373.1911, found: 373.1911, error +0.00 
ppm; ES+ calcd for [Ci7H2iN20]: 265.1333, found: 265.1333, error +0.00 ppm; Rf= 
0.32 (petroleum ether: diethyl ether, 3:1).
10.29 Preparation of 6-methoxy methyl-1,3,4-triphenyIpiperazin-2-one 263, 264
98
Xylene, A  H3CO"
182d 253 263 264
Methyl Af.M-diphenyl-2,3-diaminopropyl ether 182d (500 mg, 1.9 mmol), 
diisopropylethylamine (368 mg, 2.85 mmol) and xylene (5 ml) were placed into a 50 ml 
two neck round bottom flask provided with a condensor and under a nitrogen 
atmosphere. The mixture was heated until reflux and methyl a-bromophenylacetate 253 
(652 mg, 2.85 mmol) was added dropwise over 30 minutes. The reaction was refluxed
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for 48 hours. The reaction was cooled to room temperature and sodium hydroxide (2 M) 
was added until pH 14, was washed with brine (10 ml) and dried over anhydrous 
sodium sulphate. Xylene was removed and the crude mixture was obtained (1.324 g). 
Purification by column chromatography using a slow gradient o f petroleum ether, ethyl 
acetate, ethanol gave piperazinones 263 (231 mg, 34%) and 264 (199 mg, 29%) as 
needle crystals. Spectroscopic data for 6-methoxymethyl-l,3,4-triphenylpiperazin-
2-one 263: vmax (neat)/cm_1 2929 (str., arC-H); 1652 (str. sh., C=0); 1505; 5 h(CDC 13, 
500 MHz) 3.28 (3H, s, 9-H3); 3.4 (1H, dd J 8 .8 , 3.7, 7-Ha); 3.48 (1H, t J9 .3 , 7-Hb); 3.9 
(1H, dd J  13.7, 3.1, 5-Ha); 4.05 (1H, ddd J9 .5 , 6.5, 3.2, 6 -H); 4.32 (1H, dd J  13.7, 1.2,
5-Hb); 5.6 (1H, s, 3-H); 6.7-7.2-7 5 (15H, m, ar-H); 5C (DEPT, 6h ‘H - 13C ‘./-COSY)
46.35 (CH2, 3.9, 4.32, 5-C); 58.79 (CH3, 3.28, 9-C); 58.91 (CH, 4.05, 6 -C); 67.81 (CH,
5.6, 3-C); 69.83 (CH2, 3.4, 3.48, 7-C); 127.48-129.53(CH, 6.7-7.2-7 5, ar-C); 169.56 
(C=0, 2-C); Rf= 0.28 (petroleum ether: diethyl ether, 3:1). X-ray crystallography, 
crystal data for piperazinone 263: C24H24N2O2 , FW= 372.45, monoclinic, space group 
P 2 1 /n, a  =8. 870(3) A, A = 15.9610(6) A, =13.6330(6) A, p =  97.269(2)°, 
1918.24(13) A3, T =  150(2) K, A= 0.71073 A, Z = 4, D(cal) = 1.290 Mg/m3, F(0 0 0 ) = 
792, n=0. 82 mm'1. Crystal character: white needle. Crystal dimensions 0.40 x 0.38 x
0.13 mm3.
Spectroscopic data for 6-methoxymethy 1-1,3,4-triphenylpiperazin-2-one 264: vmax 
(neat)/cm'‘ 2932 (str., arC-H); 1651 (str. sh., C=0); 6H(CDC13, 500 MHz) 3.22 (3H, s,
9-H3); 3.26 (1H, dd J9 .2 , 3.5, 7-H J; 3.54 (1H, dd J9 .2 , 8.2, 7-Hb); 3.65 (1H, d d .713.2, 
4.1, 5-H„); 3.93 (1H, dd .713.2, 5.9, 5-Hb); 4.09 (1H, d d d /9 .5 , 8.1, 4.0, 6 -H); 5.25 (1H, 
s, 3-H); 6.7-7.2-7 5 (15H, m, ar-H); 5C (DEPT, 5H 'H - 13C ‘./-COSY) 47.49 (CH2, 3.65, 
3.93, 5-C); 57.72 (CH, 4.09, 6 -C); 59.08 (CH3, 3.22, 9-C); 66.34 (CH, 5.25, 3-C); 70.85 
(CH2, 3.26, 3.54, 7-C); 127.43-140.25 (CH, 6.7-7.2-7 5, ar-C); 169.45 (C=0, 2-C); 
HRMS ES+ calcd for [C24H 24N 20 2]: 373.1911, found: 373.1911, error 0.00 ppm; Rf= 
0.19 (petroleum ether: diethyl ether, 3:1). X-ray crystallography, crystal data for 
piperazinone 264: C24H24N2O2 , FW= 372.45, monoclinic, space group P21/c, a  = 
10.3570(3) A, b = 9.4610(3) A, c = 20.4340(8) A, p  = 92.3750(10)°, U =  2000.56(12) 
A3, T =  150(2) K, X = 0.71073 A, Z = 4, £>(cal) = 1.237 Mg/m3, F (0 0 0 ) = 792, m = 
0.079 mm'1. Crystal character: white needles. Crystal dimensions 0 . 2 0  x 0.15 x 0 . 1 0  
mm3.
10.30 Equilibration of trans-6-methoxymethyl-1,3,4-triphenylpiperazin-2-one 263
f-BuOK 
MeOH, rt
I I
Ph Ph
263 264
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Pure crystals o f piperazinone 263 (50 mg, 0.14 mmol) were placed in a 10 ml 
bottom flask in methanol (3 ml). The mixture was cooled to 0°C in an ice bath and 
potassium t-butoxide (27 mg, 0.28 mmol) was added slowly. After 48 h stirring at room 
temperature the mixture was neutralised with hydrochloric acid (1 M, 6 ml), extracted 
with diethyl ether (3x10 ml) and washed with brine (15 ml). The organic layer was 
dried over anhydrous sodium sulphate and concentrated (45 mg). The ^ -N M R  
spectrum showed a mixture o f piperazinones 263:264 in the ratio o f 40:60.
10.30.1 Equilibration of cis-6-methoxymethyl-1,3,4-triphenylpiperazin-2-one 264
Pure crystals o f piperazinone 264 (50 mg, 0.14 mmol) were placed in a 10 ml 
bottom flask in methanol (3 ml). The mixture was cooled to 0°C in an ice bath and 
potassium t-butoxide (27 mg, 0.28 mmol) was added slowly. After 48 h stirring at room 
temperature the mixture was neutralised with hydrochloric acid (1 M, 6 ml), extracted 
with diethyl ether (3x10 ml) and washed with brine (15 ml). The organic layer was 
dried over anhydrous sodium sulphate and concentrated (45 mg). The 'H-NMR 
spectrum showed a mixture o f piperazinones 264:263 in the ratio o f 80:20.
10.31 Cyclisation of methyl N ,N  -dibenzyl-2,3-diaminopropyl ether 182a with 
methyl 2-bromopropionate 252
h3c o
BnI
NH
NHI
Bn
Br DIEA, xylene 
OCH3 n 2 atm., A
Y Ph
H3CO
" S h
N 3 '"/12
182a 252 259 260
Methyl N ,N '-dibenzyl-2,3-diaminopropyl ether 182a (500 mg, 1.76 mmol), 
diisopropylethylamine (232 mg, 1.8 mmol) in xylene (5 ml) were placed in a 25 ml two 
neck round bottom flask provided with a condensor and under a nitrogen atmosphere. 
The mixture was heated until reflux and methyl 2-bromopropionate 252 (380 mg, 2.3 
mmol) was added dropwise over 30 minutes. The reaction was refluxed for 24 hours. 
The reaction was cooled to room temperature sodium hydroxide (2 M) was added until 
pH 14, washed with brine and dried over anhydrous sodium sulphate. Xylene was 
removed and the crude mixture was obtained (545 mg). Purification by column
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chromatography using a slow gradient of petroleum ether, ethyl acetate, ethanol gave 
piperazinone 259 (135-2, 163 mg, 30%) and piperazinone 260 (158-3, 140 mg, 25%) as 
red oils. Spectroscopic data for l,4-dibenzyl-6-methoxymethyl-3-methyl-piperazin-
2-one 259: (neat)/cm_i 3053 (str., arC-H); 2984; 2929; 2813; 1652 (str. sh., C=0); 
1265 (str. sh., lactam C-N); 6H(CDC13) 1.5 (3H, d J6 .7 , 12-H3); 2.15 (1H, dd J  11.9,
3.3, 5-Ha); 2.7 (1H dd J  11.9, 2.3, 5-Hb); 3.05 (1H, d J  13.5, l l-H b); 3.055 (1H, d J6 .6 ,
3-H); 3.09 (3H, s, 9-H3); 3.15 (1H, m, 6-H); 3.43 (1H, dd J4 .8 , 9.0, 7-Ha); 3.5 (1H, dd J
7.6, 8.9, 7-Hb); 3.9 (1H, d J  13.6, l l-H b); 4.01 (1H, d J  14.9, 10-Ha); 5.12 (1H, d J14.9 ,
10-Hb); 7.35 (10H, m, ar-H); 8C (DEPT, S ^ H - ^ C  lJ-COSY) 16.06 (CH3, 1.5, 12-C); 
47.86 (CH2, 2.15, 2.7, 5-C); 53.13 (CH, 3.15, 6-C); 57.54 (CH2, 3.43, 3.5, 7-C); 57.78 
(CH, 3.05, 3-C); 60.47 (CH3, 3.05, 9-C); 71.74 (CH2, 3.05, 3.9, 11-C); 125.89-142.51 
(CH, 7.35, ar-C); 173.25 (C=0, 2-C); HRMS ES+ calcd for [C2iH26N20 2]: 339.2067, 
found: 339.2064, error +8.84 ppm; Rf= 0.51 (petroleum ether: ethyl acetate, 3:1). 
Spectroscopic data for l,4-dibenzyl-6-methoxymethyl-3-methyI-piperazin-2-one 
260: vmax (neatycnrtO Sl (str., arC-H); 1651 (str. sh., C=0); 1263 (str. sh., lactam C- 
N); 5h (CDC13) 1.35 (3H, d J6 .9 , 12-H3); 2.55 (1H, d d J  12.2, 2.5, 5-Ha); 2.65 (1H, dd J
12.0, 2.1, 5-Hb); 3.05 (3H, s, 9-H3); 3.15 (1H, m, 6-H); 3.4 (1H, dd J  9.0, 3.8, 7-Ha); 
3.49 (1H, dd J  8.9, 7.9, 7-Hb); 3.55 (3H, m, 11-H2, 3-H); 4.0 (1H, d J  15.0, 10-Ha); 5.2 
(1H, d J  10-Hb); 7.1-7.35 (10H, m, ar-H); 6C (DEPT, 5H !H - I3C V-COSY) 17.04 (CH3, 
1.35, 12-C); 44.49 (CH2, 2.55, 2.65, 5-C); 47.72 (CH2, 4.0, 5.2, 10-C); 54.94 (CH, 3.15,
6-C); 57.19 (CH2, 3.55, 11-C); 58.6 (CH3, 3.05, 9-C); 59.03 (CH, 3.55, 3-C); 71.93 
(CH2, 3.4, 3.49, 7-C); 127.3-138.15 (CH, 7.1-7.35, ar-C); 171.84 (C=0, 2-C); HRMS 
ES+ calcd for [C2iH26N20 2]: 339.2067, found: 339.2065, error +5.89 ppm; Rf= 0.39 
(petroleum ether: ethyl acetate, 3:1).
10.32 Equilibration of l,4-dibenzyl-6-methoxymethyI-3-methyl-piperazin-2-one 
259 and l,4-dibenzyl-6-methoxymethyl-3-methyl-piperazin-2-one 260
t-BuOK
MeOH, rt
259, 260 259
168
A 50:50 mixture o f piperazinones 259 and 260 (500 mg, 1.2 mmol) were placed 
in a 25 ml bottom flask in methanol-di (5 ml). The mixture was cooled to 0°C in an ice 
bath and potassium /-butoxide (24 mg, 0.2 mmol) was added slowly. After 7 days 
stirring at room temperature the mixture was neutralised with hydrochloric acid (1 M, 6 
ml) and extracted with dichloromethane (3x 10 ml). The organic layer was dried over 
anhydrous sodium sulphate and concentrated (472 mg). The !H-NMR spectrum showed 
a mixture o f piperazinones 259, 260 with ratio 69: 31.
10.33 Cyclisation of methyl AyV-dibenzyl-2,3-diaminopropyl ether 182a with 
methylglyoxal 306
H3c o ^ NH ^
Bn
I.. O
Ph
98
EtOH, H20  H3CO'
A, N2 atm.
PhPh
259 307
NH O
Bn
182a 306
Methyl N ,N '-dibenzyl-2,3-diaminopropyl ether 182a (500 mg, 1.76 mmol) was 
placed in a 50 ml round bottom flask with a mixture of ethanol, water 9:1 (10 ml). 
Methylglyoxal 306 (139 mg, 1.93 mmol) was added dropwise with a pressure-equalised 
dropping funnel over 30 minutes. The reaction mixture refluxed for 110 hours. The 
ethanol was removed and NaOH pellets (0.5 g) were added. The mixture was extracted 
with ethyl acetate (3x20 ml), dried over anhydrous sodium sulphate and concentrated. 
The crude material was a black oil (589 mg). Purification by column chromatography 
using a slow gradient of petroleum ether, ethyl acetate and ethanol gave piperazinone 
307 (138 mg, 25%) and piperazinone 259 (20 mg, 3%) as yellow oils. Spectroscopic 
data for l,4-dibenzyl-5-methoxymethyl-3-methyl-piperazin-2-one 307: 5h(CDC13) 
1.3 (3H, d.79.6, 12-H3); 2.95 (1H, m, 5-H); 3.03 (3H, s, 9-H3); 3.05 (1H, m, 7-Ha); 3.18 
(1H, dd J  12.6, 6.8, 6-Ha); 3.25 (1H, dd J9 .3 , 4.2, 7-Hb); 3.3 (1H, dd J  12.6, 4.2, 6-Hb);
3.35 (1H, d J 6.9, 3-H); 3.78 (2H, dd J  17.4, 14.6, 10-H2); 4.55 (1H, d J  14.5, l l-H a);
4.58 (1H, d J  14.5, 11-H„); 7.2 (10H, m, ar-H); Sc (DEPT, SH ‘H - I3C './-COSY) 19.2 
(CH3, 1.3, 12-C); 46.5 (CH2, 3.18, 3.3, 6-C); 50.14 (CH2, 4.55, 4.58, 11-C); 56.7 (CH,
2.95, 5-C); 57.9 (CH2, 3.78, 10-C); 58.7 (CH3, 3.03, 9-C); 59.2 (CH, 3.35, 3-C); 72.7 
(CH2, 3.05, 3.25, 7-C); 125.64-139.24 (CH, 7.2, ar-C); 171.3 (C=0, 2-C); HRMS ES+
169
calcd for [C21H 26N 2O2]: 339.2067, found: 339.2067, error +0.00 ppm; Rr= 0.23 
(petroleum ether:ethyl acetate, 3:1).
10.34 Preparation of 13C-labelled phenylglyoxal 321
o o
H20 , dioxane
S e 0 2 .0
327 321
Selenium dioxide (0.4 g, 3.9 mmol) was placed in a 1:1 mixture o f 
dioxane:water (3 ml). The solution was warmed to 50°C until the selenium dioxide was 
completely dissolved. 13C-Labelled acetophenone 327 (0.5 g, 3.9 mmol) was slowly 
added to the mixture and was refluxed for 4 hours. The hot solution was decanted from 
the precipitate selenium and the solvents removed with high vacuum rotary evaporator 
to give a clear oil of pure phenylglyoxal 321 (522 mg, 94%).
10.35 Preparation of {Benzyl-[2-(ethoxycarbonylmethyl-amino)-l-methoxymethyl- 
ethyI]-amino}-acetic acid ethyl ester 245a
Ethyl bromoacetate 88 (3.25 g; 19.5 mmol) in benzene (7 ml) was placed in 25 
ml bottom flask and kept at 0°C in an ice bath. Methyl N ,N '-dibenzyl-2,3- 
diaminopropyl ether 182a (1 g; 3.9 mmol) and diisopropylethylamine (1.512 g; 11.7 
mmol) were added with a syringe. The mixture was stirred for 2 hours and sodium 
hydroxide (2 M) was added until pH 14. The mixture was extracted with 
dichloromethane (3x20 ml), dried over anhydrous sodium sulphate and concentrated to 
give the crude mixture (1.78 g). Purification by column chromatography using a slow 
gradient of petroleum ether, diethyl ether, ethyl acetate gave the diester 245a as yellow 
oil (1.246 g, 85%). Spectroscopic data for {BenzyI-[2-(ethoxycarbonyImethyl- 
amino)-l-methoxymethyl-ethyl]-amino}-acetic acid ethyl ester 245a: vmax (neat)/cm‘ 
*2925 (str., arC-H); 1744 (str. sh., C=0); 1639; 1453; 1167; 5H(CDC13) 1.2 (3H, t . / 7  1.
N^ o + - i 3
Ph
Ph'
182a 88 245a
13-H3); 1.22 (3H, t J  7.1, 14-H3); 2.67 (1H, dd J  13.3, 7.7, 3-Ha); 2.83 (1H, dd J  13.3,
170
6.0, 3-Hb); 2.97 (1H, ddd J  10.7, 7.4, 4.9, 2-H); 3.19 (3H, s, 4-H3); 3.25 (2H, s, 7-H2); 
3.33 (1H, d . /  17.3, 5-Ha); 3.42 (1H, d J  17.3, 5-Hb); 3.47 (2H, d J 4.7, 1-H2); 3.69 (2H, 
s, 8-H2); 3.75 (1H, d J  13.9, 6-H,); 3.82 (1H, d 13.9, 6-Hb); 4.02 (2H, q J7 .2 , 12-H2);
4.05 (2H, q J7.2, 11-H2); 7.02-7.05 (10H, m, ar-H); 6C (DEPT, SH ‘H -13C V-COSY)
14.25 (CH3, 1.2, 13-C); 14.31 (CH3, 1.22, 14-C); 52.31 (CH2, 3.33, 3.42, 5-C); 53.50 
(CH2, 2.67, 2.83, 3-C); 54.42 (CH2, 3.25, 7-C); 55.59 (CH2, 3.75, 3.82, 6-C); 57.97 
(CH, 2.97, 2-C); 58 77 (CH2, 3.69, 8-C); 60.13 (CH3, 3.19, 4-C); 72.54 (CH2, 3.47, 1- 
C); 126.88-129.03 (CH, 7.02-7.05, ar-C); 139.15 (C, ar-C); 139.91 (C, ar-C); 171.67 
(C=0, 9-C); 172.61 (C=0, 10-C); m/z(APCI) 457 (100%, M +l); HRMS ES+ calcd for 
[C26H36N2O5]: 457.2697, found: 457.2706, error -1.96 ppm; Rf= 0.23 (petroleum ether: 
ethyl acetate, 3:1).
10.36 Preparation of 5-methoxymethyl-(2-oxo-piperazin-l-yl)-acetic acid ethyl 
ester 271a
245a 271a
{Benzyl-[2-(ethoxycarbonylmethyl-amino)-l-methoxymethyl-ethyl]-amino}- 
acetic acid ethyl ester 245a (500 mg, 1.3 mmol) was placed in a round bottom flask 
with THF (20 ml) and 5% Pd/C (50 mg). The mixture was connected to an hydrogen 
line and it was stirred until the consumption o f hydrogen ceased. The palladium was 
filtrated off and the sodium hydroxide (2 M) was added until pH 14. The mixture was 
extracted with dichloromethane (3x 15 ml), dried over anhydrous sodium sulphate and 
concentrated to give a clear oil (308 mg). Purification by column chromatography using 
a slow gradient of petroleum ether, diethyl ether, ethyl acetate gave the piperazinone 
271a as an amber oil (213 mg, 72%). Spectroscopic data for 5-methoxymethyl-(2- 
oxo-piperazin-l-yl)-acetic acid ethyl ester 271a: vmax (neatycm 1 3434 (str., NH); 
2964 (str., arC-H); 1742 (str. sh., C =0 ester); 1638 (str. sh., C =0 lactam); 1204; 1098; 
6h (CDC13) 1.22 (3H, 177.1, 14-H3); 2.26 (1H, bs, 4-H); 3.19 (1H, dd J  10.7, 3.3, 6-Ha);
3.25 (1H, dddd, 9.8, 5.2, 4.4, 3.3, 5-H); 3.29 (1H, m, 6-Hb); 3.3 (3H, s, 9-H3); 3.37 (2H, 
ty 4 .9 , 7-H2); 3.5 (1H, d J17 .5 , 3-Ha); 3.59 (1H, d J  17.5, 3-Hb); 4.05 (2H, d .710.6, 10- 
H2); 4.2 (2H, q /7 .1 ,  13-H2); SC(DEPT, S h 'H -13C V -CO SY ) 14.17 (CH3, 1.22, 14-C);
171
48.15 (CH2, 4.05, 10-C); 49.05 (CH2, 3.5, 3.59, 3-C); 50.82 (CH2, 3.19, 3.29, 6-C); 
52.13 (CH, 3.25, 5-C); 59.30 (CH3, 3.3, 9-C); 61.40 (CH2, 4.2, 13-C); 73.08 (CH2, 3.37,
7-C); m/z (APCI) 457 (M +l); HRMS ES+ calcd for [Ci0Hi8N2O4]: 231.1339, found: 
231.1340, erro r+4.3 ppm; Rf= 0.15 (petroleum ether: ethyl acetate, 3:1).
10.37 Preparation of {Benzyl-[2-(benzyl-ethoxycarbonylmethyl-amino)-l,l- 
dimethyl-ethyl]-amino}-acetic acid ethyl ester 245b
Bn
Y HBrJ l
NH ^ 0E'I
Bn
242b 88 245b
Ethyl bromoacetate 88 (1.87 g; 11.2 mmol) in dichloromethane (10 ml) was 
placed in 25 ml bottom flask and kept at 0°C in an ice bath. A^A^-dibenzyl-2-methyl- 
1,2-diaminopropane 242b (1 g; 3.7 mmol) and diisopropylethylamine (1.488 g; 11.2 
mmol) were added with a syringe. The mixture was stirred for 48 hours and sodium 
hydroxide (2 M) was added until pH 14. The mixture was extracted with 
dichloromethane (3x20 ml), dried over anhydrous sodium sulphate and concentrated to 
give the crude mixture (2.476 g). Purification by column chromatography using a slow 
gradient o f petroleum ether, diethyl ether, ethyl acetate gave the diester 245b as major 
product (1.15 g, 43%). Spectroscopic data for {Benzyl- [2-(benzyl-
ethoxycarbonyImethyl-amino)-l,l-dimethyI-ethyl]-amino}-acetic acid ethyl ester 
245b: vmax (neatycm'1 2249; 1729 (str. sh., C =0 ester); 1453; 1378; 6H.(CDC13, 400 
MHz) 1.1 (12H, m, 9-H3, 14-H3, 17-H3, 18-H3); 2.72 (2H, s, 3-H2); 3.25 (2H, s, 10-H2);
3.43 (2H, s, 5-H2); 3.81 (2H, s, 15-H2); 3.91 (2H, s, 16-H2), 9.93 (2H, q J 7 .1 ,  8-H2);
4.05 (2H, q J  7.1, 13-H2); 7.2 (10H, m, ar-H); 6C (DEPT, 6H *H-13C lJ-COSY) 14.52 
(CH3, 9-C); 14.7 (CH3, 14-C); 24.00 (CH3, 17-C, 18-C); 51.39 (CH2, 10-C); 53.75 
(CH2, 15-C); 55.23 (CH2, 5-C); 60.00 (CH2, 16-C); 60.36 (C, 2-C); 60.40 (CH2, 13-C);
60.60 (CH2, 8-C); 62.17 (CH2, 3-C); 127.04-141.17 (CH, ar-C); 172.58 (C=0, 6-C); 
173.76 (C=0, 11-C); m/z (APCI) 441 (41%, M +l); 355 (26%, M- CH3CH2OCOCH2-); 
248 (100%); 130 (30%); HRMS ES+ calcd for [C26H36N20 4]: 441.2748, found: 
441.2749, error-2.26 ppm; Rf= 0.45 (ethyl acetate: ethanol, 3: 1).
1 5 , ^ Ph
> 6  O
Ph
172
10.38 Preparation of (5,5-dimethyl-2-oxo-piperazin-l-yl)-acetic acid ethyl ester
{Benzyl-[2-(benzyl-ethoxycarbonylmethyl-amino)-1,1 -dimethyl-ethyl]-amino} - 
acetic acid ethyl ester 245b (400 mg; 0.9 mmol) was placed in a round bottom flask 
with THF (20 ml) and 10% Pd/C (50 mg). The mixture was connected to a hydrogen 
line and it was stirred until the consumption o f hydrogen ceased. The palladium was 
filtrated off and the sodium hydroxide (2 M) was added until pH 14. The mixture was 
extracted with dichloromethane (3x 15 ml), dried over anhydrous sodium sulphate and 
concentrated to give a clear oil o f (5,5-dimethyl-2-oxo-piperazin-l-yl)-acetic acid ethyl 
ester 271b as pure product (165 mg, 85 %). Spectroscopic data for (5,5-dimethyl-2- 
oxo-piperazin-l-yl)-acetic acid ethyl ester 271b: vmax (neatycm 1 3435 (str., NH);
2978 (str., arC-H); 1743 (str. sh., C =0 ester); 1644 (str. sh., C O  lactam); 1204; 6 H
H2); 4.08 (2H, s, 9-H2); 4.15 (2H, q J7 .1 , 12-H2); 8 C(DEPT, 8 H ‘H-13C V-COSY) 14.18
C); 168.85 (C=0, 10-C); m/z (APCI) 215 (100%, M +l); 169 (16%, M- CH3CH20-); 
151 (33%); 139 (19%, M-CH3CH2OCO-); HRMS ES+ calcd for [C10H ,8N2O3]: 
215.1390, found: 215.1388, error-9.29 ppm; Rf=0.25 (petroleum ether: diethyl ether, 3: 
1).
10.39 Preparation of {Benzyl-[2-(benzyl-ethoxycarbonylmethyl-amino)-l-phenyl- 
ethyl]-amino}-acetic acid ethyl ester 245d
271b
245b 271b
(CDCl3, 500 MHz) 1.1 (9H, m, 7-H3, 8 -H3 , 13-H3); 3.15 (2H, s, 6 -H2); 3.52 (2H, s, 3-
(CH3, 1.1, 13-C); 25.43 (CH3, 1.1, 7-C, 8 -C); 45.58 (CH2, 3.52, 3-C); 48.31 (CH2, 4.08,
9-C); 48.94 (C, 5-C); 59.59 (CH2, 3.15, 6 -C); 61.36 (CH2, 4.15, 12-C); 167.90 (C O , 2-
c h 2c i2, d ie a
Ph
242d 88 245d
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Ethyl bromoacetate 88 (295 mg; 1.77 mmol) in dichloromethane (2 ml) was 
placed in 10 ml bottom flask and kept at 0°C in an ice bath. N,N'-dibenzyl-l,2- 
diaminoethylenebenzene 242d (140 mg; 0.44 mmol) and diisopropylethylamine (342 
mg; 2.64 mmol) were added with a syringe. The mixture was stirred for 48 hours and 
sodium hydroxide (2 M) was added until pH 14. The mixture was extracted with 
dichloromethane (3x 20 ml), dried over anhydrous sodium sulphate and concentrated to 
give the crude mixture (170 mg). Purification by column chromatography using a slow 
gradient o f petroleum ether, diethyl ether, ethyl acetate gave the diester 245d as a clear 
oil (75 mg, 35 %). Spectroscopic data  for { Benzyl-[2-(benzyl-
ethoxycarbonylm ethyl-amino)-l-phenyl-ethyl]-amino}-acetic acid ethyl ester 245d: 
vmax (neatycm'1 2253; 1731 (str. sh., C =0 ester); 1455; 1387; 5H.(CDC13, 400 MHz)
1.15 (6H, m, 9-H3, 14-H3); 2.6 (1H, dd J  13.3, 6.9, 3-Ha); 3.05 (1H, d J  18.3, 15-Ha); 
3.22 (1H, t J6 .8 , 3-Hb); 3.25 (2H, d J3 .3 , 16-H2); 3.4 (1H, d J  18.2, 15-Hb); 3.52 (1H, d 
J  13.7, 10-Ha); 3.63 (1H, d J  13.3, 5-Ha); 3.72 (1H, d J  13.5, 5-Hb); 3.75 (1H, d J  13.3,
10-Hb); 4.02 (4H, m, 8-H2,13-H2); 4.1 (1H, t J6 .7 , 2-H); 7.1 (15H, m, ar-H); 5C(DEPT, 
8s IH -13C \/-COSY) 14.24 (CH3, 1.15, 14-C); 14.31 (CH3, 1.15, 9-C); 51.08 (CH2, 3.05,
3.4, 15-C); 53.58 (CH2, 3.25, 16-C); 54.95 (CH2, 3.52, 3.75, 10-C); 56.49 (CH2, 2.6, 
3.22, 3-C); 58.59 (CH2, 3.63, 3.72, 5-C); 60.06 (CH2, 4.02, 13-C); 60.15 (CH2, 4.02, 8- 
C); 62.49 (CH, 4.1, 2-C); 126.93-140.45 (CH, 7.1, ar-C); 171.58 (C=0, 6-C); 172.00 
(C=0, 11-C); m/z (APCI) 489 (M +l); HRMS ES+ calcd for [C30H36N2O4]: 489.2748, 
found: 489.2747, error-2.04 ppm; Rf=0.22 (petroleum ether: diethyl ether, 3: 1).
10.40 Preparation of {BenzyI-[2-(benzyl-ethoxycarbonylmethyl-amino)-l-methyl- 
ethyl]-amino}-acetic acid ethyl ester 245c
Bn
NH °
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Ethyl bromoacetate 88 (394 mg; 2.36 mmol) in dichloromethane (2 ml) was 
placed in 10 ml bottom flask and kept at 0°C in an ice bath. A, A-dibenzyl-propane-1,2- 
diamine 242c (150 mg; 0.6 mmol) and diisopropylethylamine (305 mg; 2.36 mmol) 
were added with a syringe. The mixture was stirred for 24 hours and sodium hydroxide
174
(2 M) was added until pH 14. The mixture was extracted with dichloromethane (3x20 
ml), dried over anhydrous sodium sulphate and concentrated to give the crude mixture 
(170 mg) containing the diester at 95%. Purification by column chromatography using a 
slow gradient o f petroleum ether, diethyl ether, ethyl acetate gave the diester 245c as a
clear oil (167 mg, 65%). Spectroscopic data of {Benzyl-[2-(benzyl-
ethoxycarbonylmethyl-amino)-l-methyl-ethyl]-amino}-acetic acid ethyl ester 245c: 
(neatycm'1 3053 (str., arC-H); 1737 (str., C=0); 8H(CDC13, 500 MHz) 0.9 (3H, d 
17-H3); 1.2 (6H, m, 14-H3, 9-H3); 2.4 (1H, dd .1 13 1, 7.2, 3-Ha); 2.8 (1H, d d ./ 13 1, 6.5,
3-Hb); 2.9 (1H, dt J  19.8, 6.6, 2-H); 3.2 (1H, d 16.9, 15-Ha); 3.25 (1H, d 16.9, 15- 
H,); 3.3 (2H, d ./3 .5 , 10-H2); 3.57 (2H, d J3 .5 , 16-Ha); 3.6 (2H, s, 5-H2); 3.75 (1H, d 
13.8, 16-Hb); 4.0 (4H, m, 13-H2, 8-H2); 7.1 (10H  m, ar-H); 5C (DEPT, 8 h ‘H - 13C ' J- 
COSY) 13.8 (CH3, 0.9, 17-C); 14.22 (CH3, 1.2, 14-C); 14.32 (CH3, 1.2, 9-C); 51.49 
(CH2, 3.2, 3.25, 15-C); 53.52 (CH, 2.9, 2-C); 54.30 (CH2, 3.3, 10-C); 54.47 (CH2, 3.57, 
3.75, 16-C); 57.38 (CH2, 2.4, 2.8, 3-C); 58.66 (CH2, 3.64, 5-C); 60.07 (CH2, 4.0, 8-C);
60.31 (CH2, 4.0, 13-C); 128.16-128.98 (CH, 7.1, ar-C); 167.35 (C=0, 6-C); 167.95
(C=0, 11-C); m/z (APCI) 427 (M +l); HRMS ES+ calcd for [C25H34N20 4] : 427.2591, 
found: 427.2591, error 0.00 ppm; Rf= 0.22 (petroleum ether: diethyl ether, 3:1).
10.41 Preparation of (5-methyl-2-oxo-piperazin-l-yl)-acetic acid ethyl ester 271c
r Ph o
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{Benzyl-[2-(benzyl-ethoxycarbonylmethyl-amino)-l-methyl-ethyl]-amino}- 
acetic acid ethyl ester 245c (150 mg; 0.35 mmol) was placed in a round bottom flask 
with THF (20 ml) and 10% Pd/C (50 mg). The mixture was connected to a hydrogen 
line and it was stirred until the consumption o f hydrogen ceased. The palladium was 
filtrated off and the sodium hydroxide (2 M) was added until pH 14. The mixture was 
extracted with dichloromethane (3x 15 ml), dried over anhydrous sodium sulphate and 
concentrated to give a clear oil o f  (5-methyl-2-oxo-piperazin-l-yl)-acetic acid ethyl 
ester 271c (42 mg, 60%). Spectroscopic data for (5,5-dimethyl-2-oxo-piperazin-l- 
yl)-acetic acid ethyl ester 271c: vmax (neatycm '1 3443 (str., NH); 2920 (str., arC-H);
175
1739 (str. sh., C =0 ester); 1642 (str. sh., C =0 lactam); 8h (CDCI3 , 500 MHz) 0.8 (3H, d 
J1 .0 , 7 -H3); 1.02 (3H, td J7 .1 , 2.0, 12-H3); 1.5 (1H, br. s, 4-H); 2.65 (1H, d d J9 .4 , 3.2, 
6-Ha); 2.72 (1H, ddd <79.5, 6.1, 3.4, 5-H); 2.78 (1H, m, 6-Hb); 3.4 (1H, d J  17.1, 3-Ha); 
3.55 (1H, d J  17.1, 3-Hb); 4.0 (2H, m, 8-H2, 11-H2); 6C (DEPT, 5H *H-13C ^-COSY) 
13.90 (CH3, 0.8, 7-C); 18.53 (CH3, 1.02, 12-C); 47.90 (CH2, 4.0, 11-C); 48.14 (CH2, 
2.72, 5-C); 49.93 (CH2, 3.4, 3.55, 3-C); 55.23 (CH2, 2.65, 2.78, 6-C); 60.70 (CH2, 4.0,
8-C); 167.57 (C=0, 2-C); 168.88 (C=0, 9-C); m/z (APCI) 201.1 (85%, M +l); 155.1 
(100%, M-CH3CH20-); 127.1 (M-CH3CH2OCO-); HRMS ES+ calcd for [C9Hi6N20 3]: 
201.1234, found: 201.1235, error -^4.59 ppm; Rf= 0.14 (petroleum ether: diethyl ether, 
3:1).
10.42 Preparation of (f?)-2-benzoylamino-3-hydroxy-propionic acid 364175
_ ^ ° H PhCOCI
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363 364
D-Serine 363 (30 g, 0.28 mol) was dissolved in sodium hydroxide (2M, 140 ml). 
The mixture was cooled to 0° C in an ice bath and benzoyl chloride (43.96 g, 0.31 mol) 
was added dropwise over 20 minutes with simultaneous addition of sodium hydroxide 
drops to keep the solution basic. The reaction was stirred overnight. The white 
precipitate was filtered off and the water was evaporated to give a yellow precipitate of 
pure product (52 g, 89%). Spectroscopic data of (/?)-2-benzoyIamino-3-hydroxy- 
propionic acid 364176: [a]D25= -168° (c=0.025, MeOH).
10.43 Preparation of (/?)-./V-(l-benzyIcarbamoyl-2-hydroxy-ethyl)-benzamide 365
.OH O S
? OH BnNH2, EDC 
BHT, CH2CI2
O
364 365
(^)-2-Benzoylamino-3-hydroxy-propionic acid 364 (30 g, 0.14 mol),
benzylamine (17.97 g, 0.17 mol), triethylamine (16 g, 0.16 mol) and 1-
176
hydroxybenzotriazole (21.2 g, 0.16 mol) were placed in two neck round bottom flask 
with dichloromethane (1 L). The mixture was cooled to 0° C and EDC (30.15 g, 0.16 
mol) was added over 30 minutes. The reaction mixture was stirred for 24 hours and the 
white precipitate was filtered off. The filtrate was washed with sodium hydroxide (3x 
500 ml), water (3x 500 ml), hydrochloric acid (3x 500 ml) and water (3x 500 ml). The 
organic layer was dried over anhydrous sodium sulphate and concentrated. The product 
was obtained pure as yellow solid (32.54 g, 76 %). Spectroscopic data of (R)-N -(l- 
benzylcarbamoyl-2-hydroxy-ethyl)-benzamide 365177’170: m. p. 146° C; [a]D25= -73° 
(c=0.12, MeOH); vmax (neatycm 1 3417 (str., br., OH, NH); 1645 (str., C =0 amide); 
5h (CDCI3 , 500 MHz) 3.68 (1H, dd J  11.5, 5.0, 5-Ha); 4.18 (1H, dd .711.5, 3.0, 5-Hb);
4.36 (2H, dd J  5.5, 4.1, 8-H2); 4.62 (1H, m, 2-H); 7.3 (10H, m, ar-H); 6C (DEPT, 
dHlH - l3C \/-COSY) 43.90 (CH2, 4.36, 8-C); 54.08 (CH, 4.62, 2-C); 62.79 (CH2, 3.68, 
4.18, 5-C); 126.96-138.14 (CH, 7.3, lOar-C); 168.29 (C=0, 7-C); 171.06 (C=0, 3-C); 
m/z (APCI) 299 (M +l); HRMS ES+ calcd for [Ci7Hi8N20 3]: 299.1390, found: 
299.1393, error -1.00 ppm; Rf= 0.28 (diethyl ether).
10.44 Preparation of (iS)-2,3-bis-benzylamino-propan-l-ol 382
7 5^ ° H"
382
Lithium aluminium hydride (5 g, 134 mmol) was placed in THF (120 ml) at 0° 
C. The mixture refluxed and (7?)-2-benzoylamino-3-hydroxy-propionic acid 365 (5 g,
16.7 mmol) in THF (60 ml) was added slowly over 2 hours. The reaction mixture was 
refluxed for 48 hours. Ethanol (60 ml) was added to quence the lithium in excess and 
the solvents evaporated. Sodium hydroxide (2 M, 200 ml) was added and 
dichloromethane (5x 100 ml) was used to extract the product. The organic layer was 
dried over anhydrous sodium sulphate and concentrated to give a yellow oil o f pure 
product 382 (2.02 g, 89 %). Spectroscopic data of (A)-2,3-bis-benzylamino-propan-l- 
ol 382: Vmax (neatycm 1 3301 (str., br., OH, NH); 3027 (str., arC-H); 5H(CDC13, 500 
MHz) 2.68 (1H, m, 2-H); 2.71 (2H, m, 3-H2); 3.52 (1H, dd 10.8, 3.2, 5-H*); 3.62 (1H, 
m, 5-Hb); 3.65 (3H, m, 7-Ha, 8-H2); 3.73 (1H, d 1.6, 7-H„); 7.2 (10H, m, ar-H); 6c
LiAIH4, THF
365
177
(DEPT, SH‘H - 13C ‘7-COSY) 51.47 (CH2, 3.65, 3.73, 7-C); 51.78 (CH2, 2.71, 3-C);
54.02 (CH2, 3.65, 8-C); 56.70 (CH, 2.68, 2-H); 64.16 (CH2, 3.52, 5-C); 126.99-140.38 
(CH, 7.2, lOar-C); m/2(APCI) 271 (M +l); 132; HRMS ES+ calcd for [Ci7H22N20]: 
271.1805, found: 271.1805, error 0.00 ppm; Rf= 0.25 (diethyl ether: ethyl acetate, 2:1).
10.45 Preparation of (f?)-7V-(l-benzylcarbamoyl-2-methoxy-ethyl)-benzaimde 366
o | ^ j |
365 366
(7?)-./V-(l-Benzylcarbamoyl-2-hydroxy-ethyl)-benzamide 365 (1.0 g, 3.35 mmol) 
with acetonitrile (10 ml) and silver (I) oxide (3.88 g, 16.8 mmol) was placed in a round 
bottom flask. Methyl iodide (8.3 g, 66 mmol) was added dropwise over 2 hours. The 
reaction mixture was stirred for 3 days. The silver iodide was filtrated and the mixture 
was concentrated to give the pure product as yellow powder (1.00 g, 99%). 
Spectroscopic data of (/?)-./V-(l-benzylcarbainoyl-2-inethoxy-ethyl)-benzainide 366: 
m. p. 124° C; [a]D25= -116° (c=0.0075, MeOH); vmax (neatycm'1 1654 (str., C=0 
amide); 1508; 1482; 5H(CDC13, 500 MHz) 3.34 (3H, s, 7-H3); 3.48 (1H, dd J9 .1 , 7.5, 5- 
Ha); 3.86 (1H, dd J9 .1 , 4.0, 5-Hb); 4.4 (1H, dd J  15.0, 5.7, 9-Ha); 4.46 (1H, dd J  15.0,
6.0, 9-Hb), 4.71 (1H, m, 2-H); 12-1.9  (10H, m, ar-H); 5C(DEPT, 5h 1H -13C xJ-COSY)
43.61 (CH2, 4.4, 4.46, 9-C); 52.69 (CH, 4.71, 2-C); 59.19 (CH3, 3.34, 7-C); 71.77 (CH2, 
3.48, 3.86, 5-C); 127.16 (CH, 12-1.9, lOar-C); 167.32 (C=0, 8-C); 170.08 (C=0, 3-C); 
HRMS ES+ calcd for [CigH2oN20 3]: 313.1547, found: 313.1544, error -1.26 ppm; Rf= 
0.5 (diethyl ether).
10.46 LAH reduction of (/?)-Ar-(l-benzyIcarbamoyl-2-methoxy-ethyI)-benzamide 
362
366 362
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Lithium aluminium hydride (970 mg, 25 mmol) was placed in THF (50 ml) at 0° 
C. The mixture refluxed and (7?)-Ar-(l-benzylcarbamoyl-2-methoxy-ethyl)-benzamide 
366 (1 g, 3.2 mmol) in THF (10 ml) was added slowly over 2 hours. The reaction 
mixture was refluxed for 48 hours. Ethanol (20 ml) was added to quence the lithium in 
excess and the solvents evaporated. Sodium hydroxide (2 M, 200 ml) was added and 
dichloromethane (5x 100 ml) was used to extract the product. The organic layer was 
dried over anhydrous sodium sulphate and concentrated to give a yellow oil of pure 
product 362 (610 mg, 67 %). Spectroscopic data for ./V/V-dibenzyl-3- 
methoxypropane-1,2-diamine 362: same as the racemic compound130.
10.47 Cyclisation of (iS)-2,3-bis-benzylamino-propan-l-ol 382 with methyl 
bromoacetate
(S)-2,3-Bis-benzylamino-propan-l-ol 382 (500 mg, 1.76 mmol) was placed in 
two round flask with diisopropylethylamine (1.5 eq., 425 mg, 2.7 mmol) and xylene (5 
ml). The reaction mixture was heated in an oil bath and methyl bromoacetate (1.5 eq., 
425 mg, 2.7 mmol) was added dropwise with a syringe. The mixture refluxed under 
nitrogen atmosphere for 24 hours. The crude was allowed to cool to room temperature 
and was washed with sodium hydroxide (2 M, pH 14) and with brine (10 ml). The 
solvent was removed to give crude mixture (530 mg). Purification by column 
chromatography using a slow gradient o f petroleum ether, diethyl ether, ethyl acetate 
gave the piperazinone 375 (56 mg; 10 %). Spectroscopic data of [Benzyl-(4-benzyl-6- 
oxo-morpholin-3ylmethyl)-amino]-acetic acid methyl ester 375: vmax (neatycm 1
1741 (str., C =0 ester); 1365; 1187; 6H(CDC13, 500 MHz) 2.64 (1H, dd J  13.2, 9.2, 8- 
Ha), 2.77 (1H, m, 5-H), 2.85 (1H, dd /  13.2, 4.3, 8-Hb), 3.16 (1H, d J  17.1, 10-Ha), 3.24
14
Bn
382 375
(2H, d J  1.2, 11-H2), 3.35 (1H, d J  17.1, 10-Hb), 3.51 (1H, d J  13.1, 3-Ha), 3.6 (3H, s,
14-H3), 3.66 (2H, d J  3.2, 7-H2), 3.74 (1H, d J  13.1, 3-Hb), 4.3 (1H, dd J  11.4, 5.6, 6- 
Ha), 4.36 (1H, dd J  11.4, 4.2, 6-Hb), 7.2 (10H, m, ar-H); 6C (DEPT, Sh 'H -^C  lJ-
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COSY) 50.98 (CH2, 3.16, 3.35, 10-C), 51.02 (CH3, 3.6, 14-C), 51.43 (CH2, 2.64, 2.85,
8-C), 54.40 (CH2, 2.77, 5-C), 54.43 (CH2, 3.24, 11-C), 58.96 (CH2, 3.66, 7-C), 59.02 
(CH2, 3.51, 3.74, 3-C), 69.38 (CH2, 4.3, 4.36, 6-C), 127.40- 138.37 (CH, 7.2, ar-C), 
169.59 (C=Q, 2-C), 171.56 (C=0, 12-C); Rf= 0.56 (diethyl ether).
10.48 Preparation of (Y)-l,4-dibenzyl-6-methoxymethyl-piperazin-2-one 367
DIEA, xylene H3CO
362 367
Methyl N ,N '-dibenzyl-2,3-diaminopropyl ether 362 (500 mg, 1.76 mmol) was 
placed in two round flask with diisopropylethylamine (1.3 eq., 279 mg, 2.3 mmol) and 
xylene (5 ml). The reaction mixture was heated in an oil bath and methyl bromoacetate 
(1.3 eq., 350 mg, 2.28 mmol) was added dropwise with a syringe. The mixture refluxed 
under nitrogen atmosphere for 24 hours. The crude was allowed to cool to room 
temperature and was washed with sodium hydroxide (2 M, pH 14) and with brine (10 
ml). The solvent was removed to give crude mixture (480 g). Purification by column 
chromatography using a slow gradient o f petroleum ether, diethyl ether, ethyl acetate 
gave the piperazinone 367 (440 mg; 80 %). Spectroscopic data for 6-methoxymethyl-
l,4-bis-(4-methoxy-phenyI)-piperazin-2-one 367: same NMR data as racemic
product130.
10.49 Preparation of (*S)-l-benzyl-6-methoxymethyl-4-methyl-piperazin-2-one 369
Bn Bn
Bn
367 369
6-Methoxymethyl-l,4-bis-(4-methoxy-phenyl)-piperazin-2-one 367 (130 mg; 
0.39 mmol) was placed in a round bottom flask with MeOH (5 ml) and 10% Pd/C (150 
mg). The mixture was connected to a hydrogen line and it was stirred until the 
consumption o f hydrogen ceased. The palladium was filtrated off and the sodium 
hydroxide (2 M) was added until pH 14. The mixture was extracted with
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dichloromethane (3x15 ml), dried over anhydrous sodium sulphate and concentrated to 
give a clear oil o f  (5)-l-benzyl-6-methoxymethyl-4-methyl-piperazin-2-one 369 (70 mg, 
71%). Spectroscopic data for (<S)-l-benzyl-6-methoxymethyl-4-methyI-piperazin-2-
1 on
one 369: same NMR data as racemic product
10.50 Cyclisation of methyl N ,N '-dibenzyl-2,3-diaminopropyl ether 182a with 
benzil 139
DMSQ  ^ H3CO‘
182a 139 312 350
Methyl AfN-dibenzyl-2,3-diaminopropyl ether 182a (150 mg, 0.53 mmol) was 
placed in DMSO (4 ml) and was warmed up to 100°C. Benzil 139 (333 mg, 1.58 mmol) 
was added and the mixture was refluxed at 165°C for 3 days. The crude mixture was 
washed with NaOH (2 M) and extracted with ethyl acetate (3x10 ml). The solvent was 
removed to give a 50:50 mixture o f the two piperazinones 312 and 350 (450 mg). Upon 
flash chromatography using a slow gradient of petroleum ether and diethyl ether, 
analytical pure sample were obtained (25 mg, 11%, 312; 63 mg, 30%, 350). The 
spectroscopic data o f piperazinone 312 are described in section 10.25. Spectroscopic 
data of l,4-dibenzyI-5-methoxymethyl-3-phenyl-piperazin-2-one 350: vmax
(neatycm '1 3048; 1655 (str. sh., C=0); 1245 (str. sh., lactam C-N); 5H(CDC13) 3.05 (3H, 
s, 9-H3); 3.1 (1H, m, 5-H); 3.22 (1H, dd, J7 .9 , 4.9, 6-Ha); 3.23 (1H, m, 7-Ha); 3.41 (1H, 
dd, J 7 .9 , 2.7, 6-Hb); 3.54 (1H, d J  13.6, 11-H,); 3.6 (1H, 13.6, ll-Hb); 4.35 (1H, s,
3-H); 4.41 (1H, d J  14.3, 10-Ha); 4.6 (1H, d 14.6, 10-Hb); 7.2-7.5 (15H, m, ar-H); 5C 
(DEPT, 5h 1H - I3C ’./-COSY) 44.97 (CH2, 3.0, 3.21, 6-C); 45.89 (CH2, 4.52, 4.58, 10- 
C); 55.66 (CH, 3.0, 5-C); 56.95 (CH3, 3.05, 9-C); 59.57 (CH2, 3.7, 3.83, 11-C); 65.95 
(CH, 4.35, 3-C); 71.79 (CH2, 3.16, 3.26, 7-C); 124.8-134.9 (CH, 7.2-7 5, ar-C); 190.92 
(C O , 2-C); HRMS ES+ calcd for [C26H28N20 2]: 401.2224, found: 401.2224, error 
+0.00 ppm; Rf= 0.21 (petroleum ether: ethyl acetate, 2:1).
10.51 Cyclisation of N ,N -dibenzyl ethylenediamine 72d with benzil 139
181
BnI
NH
NHI
Bn
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Ph
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351
N ,N '-dibenzyl ethylenediamine 72d (500 mg, 2.05 mmol) was placed in DMSO 
(8 ml) and was warmed up to 100°C. Benzil (517 mg, 2.5 mmol) was added and the 
mixture was refluxed at 165°C for 3 days. The crude mixture was washed with NaOH 
(2 M) and extracted with ethyl acetate (3x10 ml). The solvent was removed to give the 
crude mixture (750 mg). Upon flash chromatography using a slow gradient o f petroleum 
ether and diethyl ether, analytically pure sample was obtained (510 mg, 70%, 351). 
Spectroscopic data of l,4-dibenzyl-3-phenyl-piperazin-2-one 35170: same data as 
literature.
APPENDIX
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X-R ay Crystallographic data for N-[2- 
(benzoylam ino)phenyl]benzam ide diam ide 225
Table 1. Atomic coordinates ( x ICh ) and equivalent isotropic displacement parameters 
(A2x 1O2) for 225. U(eq) is defined as one third of the trace o f the orthogonalized U!J 
tensor.
X y z U (eq)
C(l) 3 0 9 3 (1 ) 7 2 1 9 (2 ) 7668(2 ) 23(1 )
c(2) 2 6 8 3 (1 ) 60 7 6 (2 ) 7134 (2 ) 27(1)
c(3) 2 8 0 8 (1 ) 55 9 7 (2 ) 5785 (2 ) 29(1 )
c(4) 33 4 5 (1 ) 6 2 7 1 (2 ) 4 971 (2 ) 27(1)
c(5) 3 7 5 1 (1 ) 74 3 0 (2 ) 5497 (2 ) 22(1)
c(6) 36 2 6 (1 ) 79 1 4 (2 ) 6 851 (2 ) 18(1)
c(7) 4 0 2 6 (1 ) 9181 (2 ) 7491 (2 ) 18(1)
c(8) 4 6 9 3 (1 ) 11445(2 ) 7051 (2 ) 19(1)
c(9) 4 4 0 7 (1 ) 12758(2) 6 582 (2 ) 24(1)
c(10) 4 7 1 0 (1 ) 14066(2 ) 7032 (2 ) 30(1)
n ( l) 4 3 5 1 (1 ) 10127(2 ) 6603 (1 ) 19(1)
o ( l ) 4 0 3 1 (1 ) 93 5 2 (1 ) 8764 (1 ) 27(1)
Table 2. Bond lengths [A] and angles [°] for 225.
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c ( l) -c (2 ) 1 .381(3 )
c (l) -c (6 ) 1 .391(3 )
c(2)-c(3 ) 1 .385 (3 )
c(3)-c(4 ) 1 .386(3 )
c(4)-c(5 ) 1 .385(3 )
c(5)-c(6 ) 1 .391 (3 )
c(6)-c(7 ) 1 .499 (2 )
c (7 ) -o ( l) 1 .231(2 )
c (7 )-n (l) 1 .350(2 )
c(8)-c(9 ) 1 .386 (2 )
c (8 )-c (8 )# l 1 .399 (4 )
c (8 )-n (l) 1 .424 (2 )
c(9 )-c(10 ) 1 .389(3 )
c (1 0 )-c (1 0 )# l 1 .373 (4 )
c (2 )-c ( l)-c (6 ) 120 .4 0 (1 7 )
c ( l)-c (2 )-c (3 ) 120 .1 3 (1 8 )
c (2 )-c (3 )-c (4 ) 119 .7 9 (1 8 )
c (5 )-c (4 )-c (3 ) 120 .2 0 (1 7 )
c(4 )-c (5 )-c (6 ) 120 .1 4 (1 7 )
c (5 ) -c (6 )-c ( l) 1 1 9 .32 (16 )
c(5 )-c (6 )-c (7 ) 1 2 3 .65 (16 )
c ( l) -c (6 )-c (7 ) 117 .0 1 (1 5 )
o ( l ) - c ( 7 ) -n ( l ) 122 .69 (16 )
o (l) -c (7 )-c (6 ) 120 .62 (15 )
n ( l)-c (7 )-c (6 ) 116 .66 (15 )
c (9 )-c (8 )-c (8 )# l 119 .44 (11 )
c (9 ) -c (8 )-n (l) 118 .91 (16 )
c (8 )# l-c (8 ) -n ( l ) 121 .65(9 )
Sym m etry transform ations used  to  generate equivalent atoms: 
#1 -x + l,y ,-z + 3 /2
Table 3. Anisotropic displacement parameters (A^x 10^)for 225. The anisotropic 
displacement factor exponent takes the form: -2D^[ h^a*^Ul 1 + ... + 2 h k a* b* ]
u 11 u22 u33 u23 u 13 u 12
185
c ( l ) 2 7 (1 ) 2 5 (1 ) 17(1) -1 (1 ) 2 (1 ) 1(1)
0(2) 26 (1 ) 2 9 (1 ) 2 6 (1 ) 6 (1 ) 0 (1 ) -8(1)
c(3 ) 31 (1 ) 2 6 (1 ) 29 (1 ) -2(1) -7(1) -7(1)
c(4) 33 (1 ) 2 8 (1 ) 2 0 (1 ) -3 (1 ) 0 (1 ) -2(1)
c(5) 24 (1 ) 2 4 (1 ) 19(1) 1(1) 1(1) -2(1)
c(6) 18(1) 17(1) 18(1) 2 (1) -1 (1 ) 3(1)
c(7) 19(1) 2 0 (1 ) 16(1) 0 (1 ) -1 (1 ) 4 (1 )
c(8) 22 (1 ) 2 0 (1 ) 15(1) 0 (1 ) 2 (1 ) -2(1)
c(9) 25 (1 ) 2 4 (1 ) 2 4 (1 ) 3(1) -3 (1 ) 2 (1 )
c(10) 35(1 ) 2 0 (1 ) 36 (1 ) 3 (1) -2 (1 ) 5 (1 )
n ( l ) 2 5 (1 ) 2 0 (1 ) 13(1) -1 (1 ) 0 (1 ) -2(1)
o ( l ) 39(1 ) 2 8 (1 ) 15(1) 0 (1 ) 1(1) -7 (1 )
Table 4. Hydrogen coordinates ( x 10^) and isotropic displacement parameters (A^x 
103) for 225.
X y z U (eq)
h ( l ) 3010 7534 8598 28
h(2) 23 1 4 56 1 7 7693 33
h(3) 2 5 2 7 4 8 0 9 5419 34
h(4) 3435 5937 40 4 9 32
h(5) 4115 7895 4933 27
h(9) 4 0 0 0 12763 5948 29
h(10) 4 5 1 8 14961 6691 36
h ( l a ) 4352 9919 5707 23
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X-Ray C rystallographic data for A^,A^-l,4-diphenyl-6-methoxymethyl-
piperazin-2-one 246d
£ ( 12)
C(15)0 (2)
M16)C(11), 0 (1 4 )
C(17)
(18)
C(9) N(2)
N<1
C(8)0 (2) 0 ( 1)
C(6) 0 (7 )
0(3 )
0 (4 )
Table 1. Atomic coordinates (x 10^) and equivalent isotropic displacement parameters
(A2x 1(P) for 246d. U(eq) is defined as one third o f the trace of the orthogonalized U1] 
tensor.
X y z U (eq)
C ( l) 6 7 2 4 (6 ) -7 2 4 (2 ) 6 523 (2 ) 27(1)
C (2) 6 9 4 9 (7 ) -1 5 3 2 (2 ) 6 3 7 4 (2 ) 34(1)
C (3) 5 2 2 7 (7 ) -1 9 6 9 (2 ) 5 971 (2 ) 34(1)
C(4) 3 2 6 1 (7 ) -1 5 7 7 (2 ) 5714(2 ) 32(1)
C (5) 3 0 2 0 (6 ) -7 6 0 (2 ) 5857(2 ) 28(1)
C (6) 4 7 4 2 (6 ) -3 1 8 (2 ) 6 272 (2 ) 25(1)
C (7) 2 6 0 1 (6 ) 9 0 9 (2 ) 5997(2 ) 27(1)
C (8) 2 4 2 0 (6 ) 1808(2) 6 087 (2 ) 26(1)
C (9) 6 4 5 1 (5 ) 9 9 1 (2 ) 6 650 (2 ) 25(1)
C (10) 5 7 8 7 (6 ) 1763(2) 7078 (2 ) 27(1)
C (11) 4 8 1 8 (6 ) 1626(2) 7 980(2 ) 29(1)
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C (12) 5 8 76 (7 ) 1187(2) 9 406 (2 ) 45(1)
C (13) 4 2 3 4 (6 ) 30 65 (2 ) 650 5 (2 ) 24(1)
C (14) 6 1 3 0 (6 ) 340 7 (2 ) 6 1 5 3 (2 ) 29(1 )
C (15) 6 3 3 9 (6 ) 4 2 3 1 (2 ) 6 1 1 0 (2 ) 34(1)
C (16) 4 6 0 1 (6 ) 470 4 (2 ) 6 4 0 6 (2 ) 31(1)
C (17) 2 7 0 6 (6 ) 4 3 7 0 (2 ) 6 7 5 3 (2 ) 32(1)
C (18) 2 5 3 1 (6 ) 354 4 (2 ) 6 8 1 3 (2 ) 27 (1 )
N ( l ) 4 4 4 9 (5 ) 5 00 (1 ) 6 4 6 6 (2 ) 24(1 )
N (2) 4 0 9 8 (5 ) 2 2 0 2 (1 ) 6 5 3 8 (2 ) 24(1)
0 ( 1 ) 800 (4 ) 214 6 (1 ) 5 7 28 (2 ) 34(1)
0 ( 2 ) 6 5 8 2 (4 ) 1287(1) 8 525 (2 ) 35(1)
Table 2. Bond lengths [A] and angles [°] for 246d
C (l)-C (2 ) 1 .379(4 )
C (l)-C (6 ) 1 .394(4 )
C (2)-C (3) 1 .379(5 )
C (3)-C (4) 1 .377(5)
C (4)-C (5) 1 .393(4)
C (5)-C (6) 1 .391(4)
C (6 )-N (l) 1 .413(3)
C (7 )-N (l) 1 .455(4)
C (7)-C (8) 1 .514(4)
C ( 8 ) - 0 ( l ) 1 .223(4)
C (8)-N (2) 1 .358(4)
C (9 )-N (l) 1 .457(4)
C (9)-C (10) 1 .507(4)
C (10 )-N (2 ) 1 .468(4)
C (1 0 )-C ( l l) 1 .529(4)
C ( l l ) - 0 ( 2 ) 1 .427(4)
C (1 2 )-0 (2 ) 1 .434(4 )
C (13)-C (18) 1 .380(4 )
C (13)-C (14) 1 .381(4)
C (13)-N (2) 1 .447(4 )
C (14)-C (15) 1 .386(4 )
C (15)-C (16) 1 .384(4 )
C (16)-C (17) 1 .372(4)
C (17)-C (18) 1 .390(4)
C (2 )-C (l)-C (6 )
C (l)-C (2 )-C (3 )
C (4)-C (3)-C (2)
C (3)-C (4)-C (5)
C (6)-C (5)-C (4)
C (5 )-C (6 )-C (l)
C (5 )-C (6 )-N (l)
C (l) -C (6 )-N (l)
N (l)-C (7 )-C (8 )
0 (1 )-C (8 )-N (2 )
0 (1 )-C (8 )-C (7 )
N (2)-C (8)-C (7)
N (l)-C (9 )-C (1 0 )
N (2)-C (10)-C (9)
N (2 )-C (1 0 )-C ( ll)
C (9 )-C (1 0 )-C (ll)
O (2 )-C (ll)-C (1 0 )
C ( 18)-C ( 13)-C ( 14)
C (18)-C (13)-N (2)
C ( 14)-C ( 13 )-N (2 )
C ( 13)-C ( 14)-C ( 15)
C( 16)-C ( 15)-C ( 14)
C ( 17)-C ( 16)-C ( 15)
C (16)-C ( 17)-C( 18)
C (13)-C (18)-C (17)
C (6 )-N (l)-C (7 )
C (6 )-N (l)-C (9 )
C (7 )-N (l)-C (9 )
C (8)-N (2)-C (13)
C (8)-N (2)-C (10)
C (13)-N (2)-C (10)
C ( ll ) -0 (2 ) -C (1 2 )
121 .1 (4 )
121 .3(4)
118 .3 (3 )
120 .8 (4 )
121 .1 (3 )
117 .3 (3 )
121 .2 (3 )
121 .4 (3 )
118 .5 (3 )
123 .2 (3 )
118 .4 (3 )
118 .4 (3 )
110 .3 (3 )
111 .5 (3 )
108 .4 (3 )
111 .9 (2 )
107 .4 (3 )
120 .1 (3 )
121 .7 (3 )
118 .3 (3 )
120 .3 (3 )
119 .1 (3 )
121 .0 (3 )
119 .7 (3 )
119 .9 (3 )
116 .6 (3 )
118 .8 (3 )
114 .8 (2 )
120 .5 (3 )
120 .7 (3 )
118 .8 (3 )
111 .4 (3 )
Sym m etry transform ations u sed  to  generate equivalent atoms:
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Table 3. Anisotropic displacement parameters (A^x 103) for 246d. The anisotropic 
displacement factor exponent takes the form: -2p^[ * + ... + 2 h k a* b* ]
U 11 U 22 U 33 u 23 U 13 u 12
C(1) 27 (3 ) 30 (2 ) 24 (2 ) -1(2) 1(2) 3(2)
C (2) 34(3 ) 3 0 (2 ) 36 (3 ) 7 (2) 1(2) 10(2)
C (3) 4 2 (3 ) 2 6 (2 ) 32 (3 ) 0 (2 ) 3 (2 ) 3(2)
C (4) 47 (3 ) 2 6 (2 ) 24 (2 ) -4 (2 ) 3 (2) -9(2)
C (5) 32(3 ) 2 9 (2 ) 23 (2 ) 2 (2 ) -4 (2 ) 2(2)
C (6) 32(3 ) 2 5 (2 ) 18(2) 2 (2 ) 5 (2 ) 4 (2 )
C (7) 25 (2 ) 2 4 (2 ) 31 (2 ) -1 (2 ) -5 (2 ) 1(2)
C (8) 23(2 ) 3 1 (2 ) 25 (2 ) 3 (2 ) 4 (2 ) 2 (2 )
C (9) 25 (2 ) 3 0 (2 ) 21 (2 ) -1 (2 ) -2 (2 ) 2(2)
C (10) 27 (2 ) 2 2 (2 ) 31 (2 ) 3 (2 ) -5 (2 ) 0 (2 )
C (11) 37(3 ) 2 9 (2 ) 2 1 (2 ) 1(2) -2(2) 4 (2 )
C (12) 70(3 ) 4 5 (2 ) 2 1 (3 ) 5 (2 ) -2 (2 ) 5(2)
C (13) 31(2 ) 2 1 (2 ) 20 (2 ) 0 (2 ) -5 (2 ) 0 (2 )
C (14) 32(3 ) 2 9 (2 ) 2 7 (2 ) -1 (2 ) 2 (2 ) 3 (2 )
C (15) 36(3 ) 3 2 (2 ) 33 (3 ) 0 (2 ) 3 (2) -1(2)
C (16) 48 (3 ) 2 6 (2 ) 20 (2 ) 3 (2 ) -3(2) 1(2)
C (17) 4 3 (3 ) 2 8 (2 ) 2 4 (2 ) -1 (2 ) 3 (2 ) 10(2)
C (18) 2 9 (2 ) 2 6 (2 ) 2 6 (2 ) 3 (2 ) -2(2) 1(2)
N ( l ) 2 6 (2 ) 2 4 (2 ) 2 1 (2 ) -1 (1 ) -6 (2 ) 1(1)
N (2) 23 (2 ) 2 3 (2 ) 2 5 (2 ) 2 (1 ) -5 (2 ) 1(1)
0 ( 1 ) 34(2) 2 9 (1 ) 3 8 (2 ) 1(1) -9 (1 ) 5(1)
0 ( 2 ) 4 8 (2 ) 38 (1 ) 2 0 (2 ) 1(1) -1(1) 9(1)
Table 4. Hydrogen coordinates (x 10^) and isotropic displacement parameters (A^x 
103) for 246d
x y z U(eq)
H (l)  7 9 3 9  -4 3 8  68 0 2  32
H (2) 8 3 1 9  -1793  6552  40
H (3) 5392  -2 5 2 6  5873 40
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H (4) 2055 -1868 5435
H (5) 1657 -500 5669
H (7A ) 1159 675 61 9 0
H (7B ) 2 7 1 7 785 5367
H (9A ) 72 1 7 1106 6097
H (9B ) 7528 696 7041
H (10) 71 7 4 21 0 4 7151
H (11A ) 43 0 4 2138 8230
H (11B ) 35 0 6 1257 7935
H (12A ) 5563 1711 9662
H (12B ) 7 0 8 4 921 9754
H (12C ) 4 4 9 8 859 9407
H (14) 72 9 7 3075 5940
H (15) 7 6 5 7 4 4 6 7 5881
H (16) 4 7 2 2 5 2 6 9 63 6 9
H (17) 1521 47 0 2 6 9 5 0
H (18) 1241 3309 70 6 6
38
34
32
32
30
30
32
35
35
68
68
68
35
41
38
38
33
191
X -R ay C rystallographic data for 6-m ethoxy m ethyl-1,3,4- 
triphenylpiperazin-2-one 263
Table 1. Atomic coordinates (x 10^) and equivalent isotropic displacement parameters 
(A2x 1C)3) for 263. U(eq) is defined as one third o f the trace o f the orthogonalized 
tensor.
X y z U (eq)
C (1) 9 3 0 7 (2 ) 28 0 5 (1 ) 4684 (1 ) 30(1)
C(2) 9 1 4 2 (2 ) 4 1 8 6 (1 ) 5494(1) 24(1)
C(3) 10611(2 ) 3 9 8 6 (1 ) 6 187 (1 ) 24(1)
C (4) 11000 (2 ) 2 9 3 5 (1 ) 4 927 (1 ) 31(1)
C (5) 8 6 9 0 (2 ) 2 1 0 5 (1 ) 5281 (2 ) 39(1)
C (6) 8 4 8 2 (3 ) 7 6 1 (2 ) 4 559 (2 ) 62(1)
C (7) 7 1 3 1 (2 ) 3 7 8 7 (1 ) 4229 (1 ) 27(1)
C (8) 7 1 0 3 (2 ) 38 0 1 (1 ) 3209(1) 33(1)
C (9) 5 7 5 5 (3 ) 39 7 9 (1 ) 2611(2) 44(1)
C (10) 4 4 6 2 (2 ) 4 1 5 4 (1 ) 3030(2 ) 50(1)
C ( l l ) 4 4 9 5 (2 ) 4 1 4 7 (1 ) 4049 (2 ) 45(1)
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C (12) 5 8 24 (2 ) 3 9 56 (1 ) 465 1 (2 ) 34(1)
C (13) 10193(2) 3 9 92 (1 ) 7242 (1 ) 24(1)
C (14) 980 9 (2 ) 4 7 4 7 (1 ) 766 2 (1 ) 32(1)
C (15) 9 30 7 (2 ) 4 7 5 8 (1 ) 8586 (1 ) 39(1 )
C (16) 9 21 1 (2 ) 4 0 2 3 (1 ) 9 108 (1 ) 38(1)
C (17) 9 6 2 8 (2 ) 327 5 (1 ) 8715 (1 ) 33(1)
C (18) 10121 (2 ) 3 259 (1 ) 778 6 (1 ) 27 (1 )
C (19) 12885 (2 ) 3 098 (1 ) 6 3 9 0 (1 ) 25 (1 )
C (20) 13708 (2 ) 371 4 (1 ) 694 4 (1 ) 36(1)
C (21) 15196 (2 ) 356 8 (1 ) 736 6 (2 ) 40 (1 )
C (22) 15895 (2 ) 2 8 1 3 (1 ) 724 4 (1 ) 38(1 )
C (23) 15085 (2 ) 2 1 9 3 (1 ) 670 1 (1 ) 37(1 )
C (24) 13600 (2 ) 2 3 2 9 (1 ) 628 6 (1 ) 32(1 )
N ( l) 8 5 2 7 (2 ) 3 5 9 7 (1 ) 484 4 (1 ) 26 (1 )
N (2) 11356 (2 ) 3 2 0 4 (1 ) 5961 (1 ) 26 (1 )
0 ( 1 ) 8 5 7 4 (1 ) 4 8 7 7 (1 ) 5 5 67 (1 ) 28 (1 )
0 (2 ) 9 3 9 1 (2 ) 1333(1 ) 5 086 (2 ) 65 (1 )
Table 2. Bond lengths [A] and angles [°] for 263.
C ( l) -N ( l) 1 .470(2 )
C (l)-C (4 ) 1 .513(2 )
C (l)-C (5 ) 1 .526 (3 )
C ( l) -H ( l) 1.0000
C (2 ) -0 ( l) 1 .2210 (19 )
C (2 )-N (l) 1 .359(2 )
C (2)-C (3) 1 .544 (2 )
C (3)-N (2) 1 .463 (2 )
C (3)-C (13) 1 .531(2 )
C (3)-H (3) 1.0000
C (4)-N (2) 1 .469(2 )
C (4)-H (4A ) 0 .9 9 0 0
C (4)-H (4B ) 0 .9 9 0 0
C (5 )-0 (2 ) 1 .422(2 )
C (5)-H (5A ) 0 .9 9 0 0
C (5)-H (5B ) 0 .9 9 0 0
C (6 )-0 (2 ) 1 .361(3 )
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C (6)-H (6A ) 0 .9 8 0 0
C (6)-H (6B ) 0 .9 8 0 0
C (6)-H (6C ) 0 .9 8 0 0
C (7)-C (12) 1 .386(3)
C (7)-C (8) 1 .388(2 )
C (7 )-N (l) 1 .439(2 )
C (8)-C (9) 1 .390(3 )
C (8)-H (8) 0 .9 5 0 0
C (9)-C (10) 1 .375 (3 )
C (9)-H (9) 0 .9 5 0 0
C (1 0 )-C (ll) 1 .386(3 )
C (10)-H (10) 0 .9 5 0 0
C (ll) -C (1 2 ) 1 .384(3 )
C ( l l ) - H ( l l ) 0 .9 5 0 0
C (12)-H (12) 0 .9 5 0 0
C (13)-C (18) 1 .390(2 )
C (13)-C (14) 1 .395(2 )
C (14)-C (15) 1 .388(3 )
C (14)-H (14) 0 .9 5 0 0
C (15)-C (16) 1 .380(3 )
C (15)-H (15) 0 .9 5 0 0
C (16)-C (17) 1 .379(3 )
C (16)-H (16) 0 .9 5 0 0
C (17)-C (18) 1 .392(3 )
C (17)-H (17) 0 .9 5 0 0
C (18)-H (18) 0 .9 5 0 0
C (19)-C (20) 1 .391 (2 )
C (19)-C (24) 1 .397 (2 )
C (19)-N (2) 1 .419(2 )
C (20)-C (21) 1 .392(3 )
C (20)-H (20) 0 .9 5 0 0
C (21)-C (22) 1 .376(3 )
C (21)-H (21) 0 .9 5 0 0
C (22)-C (23) 1 .383(3 )
C (22)-H (22) 0 .9 5 0 0
C (23)-C (24) 1 .385(3 )
C (23)-H (23) 0 .9 5 0 0
C (24)-H (24) 0 .9 5 0 0
N (l) -C ( l) -C (4 ) 1 0 8 .93 (14 )
N (l) -C ( l) -C (5 ) 1 1 0 .03 (14 )
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C (4)-C (l)-C (5 )
N ( l) -C ( l) - H ( l )
C (4 )-C (l)-H (l)
C (5 )-C (l)-H (l)
0 (1 )-C (2 )-N (1 )
0 (1 )-C (2 )-C (3 )
N (l)-C (2 )-C (3 )
N (2)-C (3)-C (13)
N (2)-C (3)-C (2)
C (13)-C (3)-C (2)
N (2)-C (3)-H (3)
C (13)-C (3)-H (3)
C (2)-C (3)-H (3)
N (2 )-C (4 )-C (l)
N (2)-C (4)-H (4A )
C( 1)-C (4)-H (4 A )
N (2)-C (4)-H (4B )
C (1)-C (4)-H (4B )
H (4A )-C (4)-H (4B )
0 (2 ) -C (5 )-C (l)
0 (2 )-C (5 )-H (5 A )
C (1)-C (5)-H (5A )
0 (2 )-C (5 )-H (5 B )
C (1)-C (5)-H (5B )
H (5A )-C (5)-H (5B )
0 (2 )-C (6 )-H (6 A )
0(2 )-C (6 )-H (6 B )
H (6A )-C (6)-H (6B )
0(2 )-C (6 )-H (6 C )
H (6A )-C (6)-H (6C )
H (6B )-C (6)-H (6C )
C (12)-C (7)-C (8)
C (1 2 )-C (7 )-N (l)
C (8 )-C (7 )-N (l)
C (7)-C (8)-C (9)
C (7)-C (8)-H (8)
C (9)-C (8)-H (8)
C (10)-C (9)-C (8)
C (10)-C (9)-H (9)
C (8)-C (9)-H (9)
113.44(15)
108.1
108.1
108.1
122 .80(15)
1 17 .62 (14 )
1 1 9 .58 (14 )
111 .91 (13 )
1 1 4 .76 (13 )
1 0 6 .61 (13 )
107 .8
107 .8
107 .8  
1 0 9 .74 (14 )
109 .7
109 .7
109 .7
109.7
108.2
109 .87 (17 )
109.7
109 .7
109 .7
109 .7
108 .2
109.5
109.5
109.5
109.5
109.5
109.5  
1 20 .28 (16 ) 
1 2 0 .28 (16 )  
1 1 9 .44 (15 ) 
1 1 9 .64 (19 )
120.2
120.2 
120.1(2)
119.9
119 .9
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C (9 )-C (1 0 )-C (ll)  
C (9)-C ( 10)-H ( 10) 
C (ll)-C (1 0 )-H (1 0 )  
C (1 2 )-C (ll)-C (1 0 )  
C (1 2 ) -C ( l l) - H ( l l)  
C( 10)-C ( 11 )-H ( 11) 
C (ll)-C (1 2 )-C (7 )  
C (ll)-C (1 2 )-H (1 2 )  
C (7)-C (12)-H (12) 
C (18)-C (13)-C (14) 
C (18)-C (13)-C (3) 
C (14)-C (13)-C (3) 
C (15)-C (14)-C (13) 
C( 15)-C ( 14)-H ( 14) 
C( 13 )-C ( 14)-H ( 14) 
C( 16)-C ( 15)-C ( 14) 
C (16)-C (15)-H (15) 
C (14)-C (15)-H (15) 
C( 17)-C ( 16)-C ( 15) 
C ( 17)-C ( 16)-H ( 16) 
C (15)-C (16)-H (16) 
C (16)-C (17)-C (18) 
C( 16)-C ( 17)-H ( 17) 
C( 18)-C ( 17)-H ( 17) 
C (13)-C (18)-C (17) 
C ( 13 )-C ( 18)-H ( 18) 
C( 17)-C ( 18)-H ( 18) 
C (20)-C ( 19)-C (24) 
C (20)-C ( 19)-N (2)  
C (24)-C ( 19)-N (2)  
C( 19)-C (20 )-C (21) 
C (19)-C (20)-H (20) 
C (21)-C (20)-H (20) 
C (22)-C (21 )-C (20) 
C (22)-C (21 )-H (2 1) 
C (20)-C (21 )-H (2 1) 
C (21)-C (22)-C (23)  
C (2 1 )-C (22)-H (22) 
C (23)-C (22)-H (22) 
C (22)-C (23)-C (24)
120.11(18)
119.9
119.9  
120 .3 (2 )
119 .9
119 .9
1 1 9 .55 (19 )
120.2
120.2
1 1 8 .54 (15 )
12 1 .89 (14 )
11 9 .51 (14 )
120 .41 (16 )
119 .8
119 .8
1 2 0 .33 (17 )
119 .8
119 .8
1 1 9 .94 (17 )
120.0
120.0
11 9 .96 (16 )
120.0
120.0
1 2 0 .76 (15 )
119 .6
119 .6
1 1 7 .52 (16 )
1 2 3 .30 (15 )
11 9 .14 (15 )
12 0 .80 (17 )
119 .6
119 .6  
1 2 1 .08 (18 )
119.5
119.5
1 1 8 .69 (17 )
120 .7
120 .7  
12 0 .65 (18 )
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C (22)-C (23)-H (23) 119.7
C (24)-C (23)-H (23) 119.7
C (23)-C (24)-C (19) 121 .24(17)
C (23)-C (24)-H (24) 119.4
C ( 19)-C (24)-H (24) 119.4
C (2 )-N (l)-C (7 ) 118 .65(13)
C (2 )-N (l)-C (l) 1 2 2 .25 (13 )
C (7 )-N (l)-C (l) 118 .86 (13 )
C (19)-N (2)-C (3) 116 .79 (13 )
C (19)-N (2)-C (4) 1 1 5 .99 (13 )
C (3)-N (2)-C (4) 1 1 3 .74 (13 )
C (6 )-0 (2 )-C (5 ) 1 1 5 .74 (17 )
Symm etry transform ations used  to generate equivalent atoms:
Table 3. Anisotropic displacement parameters (A^x l(P )for 263. The anisotropic 
displacement factor exponent takes the form: -2p^[ h ^ a^ U ^   ^ + ... + 2 h k a* b* ]
U 11 u22 U 33 u23 u13 u12
C (l) 28 (1 ) 33 (1 ) 2 8 (1 ) -11 (1 ) -3 (1 ) 7 (1 )
C (2) 24(1 ) 2 8 (1 ) 20 (1 ) 0 (1 ) 4 (1 ) 1(1)
C(3) 22 (1 ) 2 7 (1 ) 2 3 (1 ) -3 (1 ) 2(1 ) KD
C (4) 27 (1 ) 3 7 (1 ) 2 7 (1 ) -9 (1 ) 0(1 ) 5 (1 )
C (5) 31(1) 32 (1 ) 52 (1 ) -5 (1 ) -7 (1 ) 2(1 )
C (6) 60 (2 ) 50 (1 ) 73 (2 ) -2 5 (1 ) -6 (1 ) 0(1 )
C(7) 24(1 ) 25 (1 ) 31 (1 ) -2 (1 ) -3 (1 ) 0 (1 )
C (8) 37(1) 30 (1 ) 32 (1 ) -2 (1 ) -2 (1 ) -4(1)
C (9) 56(1) 31 (1 ) 4 0 (1 ) 1(1) -20 (1 ) -5 (1 )
C (10) 39(1 ) 2 9 (1 ) 72 (2 ) -2 (1 ) -26(1 ) 3(1)
C ( l l ) 26(1 ) 32 (1 ) 7 7 (2 ) -9 (1 ) -3 (1 ) 2(1)
C (12) 28(1 ) 32 (1 ) 4 3 (1 ) -5 (1 ) 4(1 ) 0 (1)
C (13) 22(1 ) 27 (1 ) 2 2 (1 ) -2 (1 ) -2 (1 ) -1(1)
C (14) 45 (1 ) 2 5 (1 ) 2 6 (1 ) -1 (1 ) 4 (1 ) KD
C (15) 59(1) 34 (1 ) 2 6 (1 ) -7 (1 ) 6 (1 ) 7 (1 )
C (16) 48 (1 ) 4 4 (1 ) 22 (1 ) 1(1) 6 (1 ) 1(1)
C (17) 36(1 ) 34 (1 ) 2 8 (1 ) 6(1 ) -1 (1 ) -4(1)
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C (18) 28 (1 ) 25 (1 ) 29 (1 ) -2 (1 ) -2 (1 ) 1(1)
C (19) 21 (1 ) 30 (1 ) 24 (1 ) 2 (1 ) 4 (1 ) 1(1)
C (20) 32 (1 ) 31 (1 ) 41 (1 ) -3 (1 ) -4 (1 ) 2 (1 )
C (21) 30 (1 ) 4 3 (1 ) 45 (1 ) 0 (1 ) -8 (1 ) -5 (1 )
C (22) 22 (1 ) 53 (1 ) 37 (1 ) 9 (1 ) 0 (1 ) 3 (1)
C (23) 31(1 ) 4 1 (1 ) 40 (1 ) 3 (1 ) 6 (1 ) 12(1)
C (24) 30 (1 ) 33 (1 ) 32 (1 ) -2 (1 ) 4 (1 ) 2 (1 )
N ( l ) 24 (1 ) 2 9 (1 ) 25 (1 ) -4 (1 ) -2 (1 ) 4 (1 )
N (2) 23 (1 ) 2 8 (1 ) 26 (1 ) -7 (1 ) 0 (1 ) 4 (1 )
0 ( 1 ) 28 (1 ) 2 8 (1 ) 26 (1 ) -2 (1 ) 2 (1 ) 5 (1)
0 ( 2 ) 49 (1 ) 33 (1 ) 102(1) -20(1 ) -27 (1 ) 10(1)
Table 4. Hydrogen coordinates ( x 10^) and isotropic displacement parameters (A^x 
103) for 263.
x  y  z  U (eq)
H ( l) 9088 2 6 5 8 3967 36
H (3) 11343 4 4 5 4 6 1 3 0 29
H (4A ) 11538 2406 48 2 4 37
H (4B ) 11345 3 3 6 6 4483 37
H (5A ) 88 9 4 22 3 5 5996 47
H (5B ) 7 5 7 8 2 0 5 9 5101 47
H (6A ) 7 7 5 6 534 4974 93
H (6B ) 9 105 306 43 4 7 93
H (6C ) 79 3 0 1034 3976 93
H (8) 8001 3 688 2921 40
H (9) 5 728 3981 1912 53
H (10) 3544 4 2 8 0 2620 59
H ( l l ) 3602 4 2 7 4 4 3 3 6 55
H (12) 5841 39 4 0 5349 41
H (14) 9891 52 5 7 7314 38
H (15) 9029 5274 8 860 47
H (16) 8859 4033 9737 45
H (17) 95 7 8 2 7 7 0 9078 40
H (18) 10411 2 7 4 2 7520 33
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H (20) 13250  4241  7 0 3 7  43
H (21) 15737 3997  7744  48
H (22) 16913 2 7 1 9  7 5 2 8  46
H (23) 15552 1668 66 1 0  44
H (24) 13057  1892 5924  38
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X-R ay C rystallographic data for 6-m ethoxym ethyl-l,3,4- 
triphenyIpiperazin-2-one 264
£(24)
C(9) 023)
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C(1)C(8| C(2)
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C(3)C(4)
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Table 1. Atomic coordinates ( x 1()4) and equivalent isotropic displacement parameters 
(A2x 10^) for 264. U(eq) is defined as one third o f the trace o f the orthogonalized U9 
tensor.
X y z U (eq)
C (1) 10993(2) 2 064 (1 ) 4 927 (2 ) 33(1)
C (2) 9 308 (2 ) 2 194 (1 ) 4 686 (2 ) 32(1)
C (3) 9145 (2 ) 8 1 5 (1 ) 5 496 (2 ) 25(1)
C (4) 10602(2) 1013(1) 6 186 (2 ) 26(1)
C (5) 12887(2) 1902(1) 6 390 (2 ) 27(1)
C (6) 13710(2) 1285(1) 6 947 (2 ) 37(1)
C (7) 15193(3) 1433(2) 7364 (2 ) 41(1)
C (8) 15891(3) 2 1 8 5 (2 ) 7243 (2 ) 39(1)
C (9) 15085(3) 2 8 0 3 (2 ) 6 703 (2 ) 39(1)
C (10) 13604(2) 2 6 6 9 (1 ) 6 288 (2 ) 34(1)
C ( l l ) 7 1 2 7 (2 ) 1213(1) 4228 (2 ) 28(1)
C (12) 7 1 0 2 (3 ) 1200(1) 3212(2) 35(1)
C (13) 5757 (3 ) 1018(1) 2613(2) 45(1)
C (14) 4 4 6 2 (3 ) 8 47 (2 ) 3 0 32 (2 ) 51(1)
C (15) 4 4 9 4 (3 ) 8 53 (1 ) 40 4 9 (2 ) 48(1 )
C (16) 582 0 (2 ) 1045(1) 4 6 4 9 (2 ) 36(1 )
C (17) 10192(2 ) 1008(1) 7 2 45 (2 ) 25(1 )
C (18) 980 3 (3 ) 254 (1 ) 7 6 62 (2 ) 34(1)
C (19) 93 1 2 (3 ) 2 47 (2 ) 8 5 83 (2 ) 4 2 (1 )
C (20) 92 0 6 (3 ) 9 77 (1 ) 9 1 07 (2 ) 39(1 )
C (21) 962 1 (2 ) 1723(1) 8 7 12 (2 ) 34 (1 )
C (22) 10117(2 ) 1737(1) 778 9 (2 ) 30(1 )
C (23) 8 6 8 6 (3 ) 289 4 (1 ) 5 277 (2 ) 41 (1 )
C (24) 8 4 8 1 (3 ) 4 2 4 5 (2 ) 4 5 6 4 (2 ) 67 (1 )
N ( l ) 1 1 3 56 (2 ) 1795(1 ) 5 9 60 (1 ) 28 (1 )
N (2) 8 5 2 8 (2 ) 1402(1) 48 4 5 (1 ) 29(1 )
0 ( 1 ) 8 5 7 5 (2 ) 123(1) 5 5 68 (1 ) 31(1 )
0 ( 2 ) 9 3 8 4 (2 ) 36 6 8 (1 ) 5 0 87 (2 ) 67 (1 )
Table 2. Bond lengths [A] and angles [°] for 264.
C ( l) - N ( l) 1 .468(3)
C (l) -C (2 ) 1 .506(3)
C (1)-H (1A ) 0 .9 9 0 0
C (1)-H (1B ) 0 .9 9 0 0
C (2 )-N (2 ) 1 .472(3)
C (2)-C (23) 1 .522(3)
C (2)-H (2) 1.0000
C ( 3 ) - 0 ( l ) 1 .224(2)
C (3 )-N (2 ) 1 .356(3)
C (3)-C (4) 1 .535(3)
C (4 )-N (l) 1 .468(2)
C (4)-C (17) 1 .532(3)
C (4)-H (4) 1.0000
C (5)-C (6) 1 .393(3 )
C (5)-C (10) 1 .395(3 )
C (5 )-N (l) 1 .423(3 )
C (6)-C (7) 1 .388(3 )
C (6)-H (6) 0 .9 5 0 0
C (7)-C (8) 1 .369(3)
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C (7)-H (7)
C (8)-C (9)
C (8)-H (8)
C (9)-C (10)
C (9)-H (9)
C (10)-H (10)
C ( ll) -C (1 2 )
C (ll) -C (1 6 )
C ( l l ) -N (2 )
C (12)-C (13)
C (12)-H (12)
C (13)-C (14)
C (13)-H (13)
C (14)-C (15)
C (14)-H (14)
C (15)-C (16)
C (15)-H (15)
C (16)-H (16)
C (17)-C (22)
C (17)-C (18)
C (18)-C (19)
C (18)-H (18)
C (19)-C (20)
C (19)-H (19)
C (20)-C (21)
C (20)-H (20)
C (21)-C (22)
C (21)-H (21)
C (22)-H (22)
C (2 3 )-0 (2 )
C (23)-H (23A )
C (23)-H (23B )
C (2 4 )-0 (2 )
C (24)-H (24A )
C (24)-H (24B )
C (24)-H (24C )
N (l) -C ( l) -C (2 )
N (1)-C (1)-H (1A )
C (2)-C (1)-H (1A )
N (1)-C (1)-H (1B )
0 .9 5 0 0
1.376(3)
0 .9 5 0 0
1.383(3 )
0 .9 5 0 0
0 .9 5 0 0
1.383(3 )
1 .385(3 )
1 .443(3 )
1 .390(3 )
0 .9 5 0 0
1 .375(4)
0 .9 5 0 0
1 .383(4)
0 .9 5 0 0
1 .381(3)
0 .9 5 0 0
0 .9 5 0 0
1 .386(3)
1 .393(3 )
1 .381(3)
0 .9 5 0 0
1 .377(3)
0 .9 5 0 0
1.375(3)
0 .9 5 0 0
1 .386(3)
0 .9 5 0 0
0 .9 5 0 0
1 .420(3)
0 .9 9 0 0
0 .9 9 0 0
1 .362(3 )
0 .9 8 0 0
0 .9 8 0 0
0 .9 8 0 0
109 .93(17)
109.7
109 .7
109.7
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C (2)-C (1)-H (1B )
H( 1 A )-C ( 1 )-H ( IB )
N (2 )-C (2 )-C (l)
N (2)-C (2)-C (23)
C (l)-C (2 )-C (2 3 )
N (2)-C (2)-H (2)
C (l)-C (2 )-H (2 )
C (23)-C (2)-H (2)
0 (1 )-C (3 )-N (2 )
0 ( 1 ) - C ( 3 ) - C X 4 )
N (2)-C (3)-C (4)
N (l)-C (4 )-C (1 7 )
N (l)-C (4 )-C (3 )
C (17)-C (4)-C (3)
N (l)-C (4 )-H (4 )
C (17)-C (4)-H (4)
C (3)-C (4)-H (4)
C (6)-C (5)-C (10)
C (6 )-C (5 )-N (l)
C (1 0 )-C (5 )-N (l)
C (7)-C (6)-C (5)
C (7)-C (6)-H (6)
C (5)-C (6)-H (6)
C (8)-C (7)-C (6)
C (8)-C (7)-H (7)
C (6)-C (7)-H (7)
C (7)-C (8)-C (9)
C (7)-C (8)-H (8)
C (9)-C (8)-H (8)
C (8)-C (9)-C (10)
C (8)-C (9)-H (9)
C (10)-C (9)-H (9)
C (9)-C (10)-C (5)
C (9)-C ( 10)-H ( 10)
C (5)-C ( 10)-H ( 10)
C (12)-C ( 11)-C ( 16)
C ( 12)-C ( 11)-N (2)
C (1 6 )-C (ll)-N (2 )
C (ll)-C (1 2 )-C (1 3 )
C (11)-C (12)-H (12)
109.7
108.2
108 .88(17)
110 .03(17)
113 .78(19)
108 .0
108 .0
108 .0
122 .5 (2 )
117 .54(19)
119 .92 (18 )
111 .87 (17 )
114 .71 (17 )
107 .07 (16 )
107 .6
107 .6
107.6  
117 .4(2)  
123 .31(19)  
119 .25(19)  
120.6(2)
119.7
119.7  
121.4(2)
119.3
119.3  
118 .6(2)
120.7
120.7  
120.8(2)
119.6
119.6  
121.2(2)
119.4
119.4  
120.2(2) 
119 .39(19) 
120 .4(2) 
119.7(2)
120.2
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C( 13)-C ( 12)-H ( 12) 120.2
C (14)-C (13)-C (12) 120.0(3)
C (14)-C (13)-H (13) 120.0
C (12)-C (13)-H (13) 120.0
C( 13)-C ( 14)-C ( 15) 120 .1(2)
C (13)-C (14)-H (14) 119.9
C (15)-C (14)-H (14) 119.9
C( 16)-C ( 15)-C ( 14) 120 .2 (2 )
C (16)-C (15)-H (15) 119.9
C (14)-C (15)-H (15) 119 .9
C ( 15)-C ( 16)-C (11) 119 .7(2)
C( 15)-C ( 16)-H ( 16) 120.2
C (ll)-C (1 6 )-H (1 6 ) 120.2
C (22)-C ( 17)-C ( 18) 118 .4(2)
C (22)-C (17)-C (4) 122 .14(18)
C (18)-C (17)-C (4) 119 .37(18)
C( 19)-C ( 18)-C ( 17) 120 .1(2)
C( 19)-C ( 18)-H ( 18) 120.0
C( 17)-C ( 18)-H ( 18) 120.0
C (20)-C ( 19)-C ( 18) 121 .0 (2 )
C (20)-C ( 19)-H ( 19) 119.5
C (18)-C (19)-H (19) 119.5
C (2 1 )-C (20 )-C ( 19) 119 .3(2)
C (2 1 )-C (20 )-H (20 ) 120.3
C( 19 )-C (20 )-H (20 ) 120.3
C (2 0 )-C (2 1 )-C (22) 120.1(2)
C (2 0 )-C (2 1 )-H (2 1) 119.9
C (2 2 )-C (2 1 )-H (2 1) 119.9
C (21)-C (22)-C (17) 120 .95(19)
C (21)-C (22)-H (22) 119.5
C (17)-C (22)-H (22) 119.5
0 (2 )-C (2 3 )-C (2 ) 110 .19(19)
0 (2 )-C (2 3 )-H (2 3 A ) 109.6
C (2)-C (23)-H (23A ) 109.6
0 (2 )-C (2 3 )-H (2 3 B ) 109.6
C (2)-C (23)-H (23B ) 109.6
H (23A )-C (23)-H (23B ) 108.1
0 (2 )-C (2 4 )-H (2 4 A ) 109.5
0 (2 )-C (2 4 )-H (2 4 B ) 109.5
H (24A )-C (24)-H (24B ) 109.5
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0 (2 )-C (2 4 )-H (2 4 C ) 109.5
H (24A )-C (24)-H (24C ) 109.5
H (24B )-C (24)-H (24C ) 109.5
C (5 )-N (l)-C (4 ) 1 16 .94(17)
C (5 )-N (l) -C (l) 116 .26(16)
C (4 )-N (l) -C (l) 1 13 .58(17)
C (3 )-N (2 ) -C ( ll) 118 .97 (17 )
C (3)-N (2)-C (2) 122 .04 (18 )
C (ll) -N (2 )-C (2 ) 118 .76(17)
C (2 4 )-0 (2 )-C (2 3 ) 116 .2 (2 )
Sym m etry transform ations used  to  generate equivalent atoms:
Table 3. Anisotropic displacement parameters (A^x l(P )for 264. The anisotropic 
displacement factor exponent takes the form: -2p2[ h ^ a ^ l j l  1 + ... + 2 h k a* b* ]
U11 U22 u33 U 23 u 13 U12
C (l) 2 7 (1 ) 4 0 (1 ) 31(1 ) 12(1) 1(1) -7(1)
C (2) 2 6 (1 ) 38 (1 ) 31(1 ) 10(1) -4 (1 ) -6(1)
C (3) 2 4 (1 ) 3 1 (1 ) 22(1 ) -1 (1 ) 4 (1 ) -2(1)
C (4) 2 2 (1 ) 2 7 (1 ) 30(1 ) 4 (1 ) 1(1) -2(1)
C (5) 22 (1 ) 3 1 (1 ) 27 (1 ) -1 (1 ) 4 (1 ) -1(1)
C (6) 30 (1 ) 35 (1 ) 46 (2 ) 2 (1 ) -4 (1 ) -1(1)
C (7) 31 (1 ) 42 (2 ) 48 (2 ) 2 (1 ) -6 (1 ) 4 (1 )
C (8) 25 (1 ) 52(2 ) 39(2 ) -8 (1 ) 2 (1 ) -2(1)
C (9) 33(1 ) 4 2 (1 ) 44 (2 ) -2 (1 ) 7 (1 ) -12(1 )
C (10) 32 (1 ) 3 4 (1 ) 35(1 ) 0 (1 ) 3 (1 ) -2(1)
C ( l l ) 2 4 (1 ) 26 (1 ) 32(1 ) 1(1) -4 (1 ) 0 (1 )
C (12) 3 6 (1 ) 34(1 ) 3 5 (2 ) 1(D -2 (1 ) 3(1)
C (13) 57 (2 ) 33(1 ) 40 (2 ) -2 (1 ) -19(1 ) 4 (1 )
C (14) 39(2 ) 33 (1 ) 72 (2 ) 2 (1 ) -26(2 ) -3(1)
C (15) 26 (1 ) 34 (1 ) 81 (2 ) 8 (1 ) 0 (1 ) -1(1)
C (16) 3 0 (1 ) 33(1 ) 4 6 (2 ) 5 (1 ) 5 (1 ) -3(1)
C (17) 21 (1 ) 3 0 (1 ) 2 4 (1 ) 2 (1 ) -1 (1 ) 0 (1)
C (18) 44 (1 ) 27 (1 ) 30 (1 ) -1 (1 ) 4 (1 ) -2(1)
C (19) 6 0 (2 ) 37 (1 ) 29 (2 ) 5 (1 ) 8 (1 ) -8(1)
C (20) 49 (2 ) 45 (2 ) 24 (1 ) -2 (1 ) 6 (1 ) 0 (1)
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C (21) 3 6 (1 ) 3 3 (1 ) 31(1 ) -6 (1 ) 0 (1 ) 4 (1 )
C (22) 2 5 (1 ) 29 (1 ) 34 (1 ) 3 (1 ) -3 (1 ) -1(1)
C (23) 33 (1 ) 30 (1 ) 58(2 ) 5(1) -3 (1 ) -3 (1 )
C (24) 6 2 (2 ) 52 (2 ) 82(2 ) 25 (2 ) -10 (2 ) -1 (2 )
N ( l) 22 (1 ) 3 3 (1 ) 30(1 ) 6 (1 ) -1 (1 ) -5 (1 )
N (2) 23 (1 ) 31 (1 ) 31(1 ) 4 (1 ) -2 (1 ) -5 (1 )
0 ( 1 ) 30 (1 ) 30 (1 ) 32 (1 ) 2 (1 ) 2 (1 ) -6 (1 )
0 ( 2 ) 49 (1 ) 35 (1 ) 106(2) 20 (1 ) -28(1 ) -10(1 )
Table 4. Hydrogen coordinates ( x 10^) and isotropic displacement parameters (A^x 
103)fo r  264.
x  y  z  U (eq)
H (1A ) 11337 1633 4482 39
H (1B ) 11532 2593 4822 39
H (2) 9091 2340 3968 39
H (4) 11332 544 6 1 2 9 32
H (6) 13253 758 7042 45
H (7) 15736 1004 7740 49
H (8) 16909 22 7 8 75 2 7 46
H (9) 15554 3328 6 6 1 4 47
H (10) 13064 3107 5926 40
H (12) 8000 1314 2925 42
H (13) 5732 1012 1915 54
H (14) 3543 724 2622 61
H (15) 3602 725 4335 57
H (16) 5835 1063 5346 44
H (18) 9876 -257 7312 40
H (19) 9044 -270 8860 51
H (20) 8849 966 9735 47
H (21) 9567 2 2 2 8 9073 40
H (22) 10410 2 2 5 4 7524 36
H (23A ) 7575 2 9 3 8 5093 50
H (23B ) 8883 2763 5992 50
H (24A ) 7973 3986 3959 101
206
H (24B ) 9102  4 7 1 6  4391  101
H (24C ) 77 1 7  4 4 4 7  49 6 7  101
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